
<html lang="en"     class="pb-page"  data-request-id="9736072e-eb45-4a3c-97e6-0ae5a8a37bdf"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-6;article:article:10.1021/acs.jmedchem.7b01781;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma with a G-Quadruplex-Binding Small Molecule" /></meta><meta name="dc.Creator" content="Chiara  Marchetti" /></meta><meta name="dc.Creator" content="Katherine G.  Zyner" /></meta><meta name="dc.Creator" content="Stephan A.  Ohnmacht" /></meta><meta name="dc.Creator" content="Mathew  Robson" /></meta><meta name="dc.Creator" content="Shozeb M.  Haider" /></meta><meta name="dc.Creator" content="Jennifer P.  Morton" /></meta><meta name="dc.Creator" content="Giovanni  Marsico" /></meta><meta name="dc.Creator" content="Tam  Vo" /></meta><meta name="dc.Creator" content="Sarah  Laughlin-Toth" /></meta><meta name="dc.Creator" content="Ahmed A.  Ahmed" /></meta><meta name="dc.Creator" content="Gloria  Di Vita" /></meta><meta name="dc.Creator" content="Ingrida  Pazitna" /></meta><meta name="dc.Creator" content="Mekala  Gunaratnam" /></meta><meta name="dc.Creator" content="Rachael J.  Besser" /></meta><meta name="dc.Creator" content="Ana C. G.  Andrade" /></meta><meta name="dc.Creator" content="Seckou  Diocou" /></meta><meta name="dc.Creator" content="Jeremy A.  Pike" /></meta><meta name="dc.Creator" content="David  Tannahill" /></meta><meta name="dc.Creator" content="R. Barbara  Pedley" /></meta><meta name="dc.Creator" content="T. R. Jeffry  Evans" /></meta><meta name="dc.Creator" content="W. David  Wilson" /></meta><meta name="dc.Creator" content="Shankar  Balasubramanian" /></meta><meta name="dc.Creator" content="Stephen  Neidle" /></meta><meta name="dc.Description" content="Human pancreatic ductal adenocarcinoma (PDAC) involves the dysregulation of multiple signaling pathways. A novel approach to the treatment of PDAC is described, involving the targeting of cancer ge..." /></meta><meta name="Description" content="Human pancreatic ductal adenocarcinoma (PDAC) involves the dysregulation of multiple signaling pathways. A novel approach to the treatment of PDAC is described, involving the targeting of cancer ge..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 22, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01781" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01781" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01781" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01781" /></link>
        
    
    

<title>Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma with a G-Quadruplex-Binding Small Molecule | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01781" /></meta><meta property="og:title" content="Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma with a G-Quadruplex-Binding Small Molecule" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0007.jpeg" /></meta><meta property="og:description" content="Human pancreatic ductal adenocarcinoma (PDAC) involves the dysregulation of multiple signaling pathways. A novel approach to the treatment of PDAC is described, involving the targeting of cancer genes in PDAC pathways having over-representation of G-quadruplexes, using the trisubstituted naphthalene diimide quadruplex-binding compound 2,7-bis(3-morpholinopropyl)-4-((2-(pyrrolidin-1-yl)ethyl)amino)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone (CM03). This compound has been designed by computer modeling, is a potent inhibitor of cell growth in PDAC cell lines, and has anticancer activity in PDAC models, with a superior profile compared to gemcitabine, a commonly used therapy. Whole-transcriptome RNA-seq methodology has been used to analyze the effects of this quadruplex-binding small molecule on global gene expression. This has revealed the down-regulation of a large number of genes, rich in putative quadruplex elements and involved in essential pathways of PDAC survival, metastasis, and drug resistance. The changes produced by CM03 represent a global response to the complexity of human PDAC and may be applicable to other currently hard-to-treat cancers." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01781"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01781">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01781&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01781&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01781&amp;href=/doi/10.1021/acs.jmedchem.7b01781" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2500-2517</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01752" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01854" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma with a G-Quadruplex-Binding Small Molecule</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Chiara Marchetti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chiara Marchetti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chiara++Marchetti">Chiara Marchetti</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katherine G. Zyner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katherine G. Zyner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katherine+G.++Zyner">Katherine G. Zyner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephan A. Ohnmacht</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephan A. Ohnmacht</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephan+A.++Ohnmacht">Stephan A. Ohnmacht</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mathew Robson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mathew Robson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Centre, UCL Cancer Institute, University College London, London WC1E 6BT, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mathew++Robson">Mathew Robson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shozeb M. Haider</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shozeb M. Haider</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shozeb+M.++Haider">Shozeb M. Haider</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jennifer P. Morton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jennifer P. Morton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK, Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD U.K.</div><div class="loa-info-affiliations-info">Institute of Cancer Sciences. University of Glasgow, Glasgow G12 8QQ, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+P.++Morton">Jennifer P. Morton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Giovanni Marsico</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giovanni Marsico</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giovanni++Marsico">Giovanni Marsico</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tam Vo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tam Vo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Center for Biotechnology and Drug Design, Georgia State University, Atlanta, Georgia 30303-3083, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tam++Vo">Tam Vo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sarah Laughlin-Toth</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sarah Laughlin-Toth</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Center for Biotechnology and Drug Design, Georgia State University, Atlanta, Georgia 30303-3083, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sarah++Laughlin-Toth">Sarah Laughlin-Toth</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ahmed A. Ahmed</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ahmed A. Ahmed</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ahmed+A.++Ahmed">Ahmed A. Ahmed</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gloria Di Vita</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gloria Di Vita</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gloria++Di+Vita">Gloria Di Vita</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ingrida Pazitna</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ingrida Pazitna</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ingrida++Pazitna">Ingrida Pazitna</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mekala Gunaratnam</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mekala Gunaratnam</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mekala++Gunaratnam">Mekala Gunaratnam</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rachael J. Besser</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rachael J. Besser</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rachael+J.++Besser">Rachael J. Besser</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ana C. G. Andrade</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ana C. G. Andrade</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ana+C.+G.++Andrade">Ana C. G. Andrade</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Seckou Diocou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Seckou Diocou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCL Cancer Institute, University College London, London WC1E 6BT, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Seckou++Diocou">Seckou Diocou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeremy A. Pike</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeremy A. Pike</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeremy+A.++Pike">Jeremy A. Pike</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Tannahill</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Tannahill</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Tannahill">David Tannahill</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">R. Barbara Pedley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">R. Barbara Pedley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCL Cancer Institute, University College London, London WC1E 6BT, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=R.+Barbara++Pedley">R. Barbara Pedley</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">T. R. Jeffry Evans</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">T. R. Jeffry Evans</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK, Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD U.K.</div><div class="loa-info-affiliations-info">Institute of Cancer Sciences. University of Glasgow, Glasgow G12 8QQ, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=T.+R.+Jeffry++Evans">T. R. Jeffry Evans</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">W. David Wilson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">W. David Wilson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Center for Biotechnology and Drug Design, Georgia State University, Atlanta, Georgia 30303-3083, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=W.+David++Wilson">W. David Wilson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shankar Balasubramanian</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shankar Balasubramanian</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, U.K.</div><div class="loa-info-affiliations-info">The School of Clinical Medicine, University of Cambridge, Cambridge CB2 0SP, U.K.</div><div class="loa-info-affiliations-info">Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shankar++Balasubramanian">Shankar Balasubramanian</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0281-5815" title="Orcid link">http://orcid.org/0000-0002-0281-5815</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Stephen Neidle</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen Neidle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: 0044-207-753-5969. E-mail: <a href="/cdn-cgi/l/email-protection#4f3c61212a262b232a0f3a2c23612e2c613a24"><span class="__cf_email__" data-cfemail="4c3f622229252820290c392f20622d2f623927">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Neidle">Stephen Neidle</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0622-6548" title="Orcid link">http://orcid.org/0000-0003-0622-6548</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01781&amp;href=/doi/10.1021%2Facs.jmedchem.7b01781" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2500–2517</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 22, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 December 2017</li><li><span class="item_label"><b>Published</b> online</span>22 January 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 March 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01781" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01781</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01781"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5670</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">59</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01781" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma with a G-Quadruplex-Binding Small Molecule&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Chiara&quot;,&quot;last_name&quot;:&quot;Marchetti&quot;},{&quot;first_name&quot;:&quot;Katherine&quot;,&quot;last_name&quot;:&quot;G. Zyner&quot;},{&quot;first_name&quot;:&quot;Stephan&quot;,&quot;last_name&quot;:&quot;A. Ohnmacht&quot;},{&quot;first_name&quot;:&quot;Mathew&quot;,&quot;last_name&quot;:&quot;Robson&quot;},{&quot;first_name&quot;:&quot;Shozeb&quot;,&quot;last_name&quot;:&quot;M. Haider&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;P. Morton&quot;},{&quot;first_name&quot;:&quot;Giovanni&quot;,&quot;last_name&quot;:&quot;Marsico&quot;},{&quot;first_name&quot;:&quot;Tam&quot;,&quot;last_name&quot;:&quot;Vo&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;Laughlin-Toth&quot;},{&quot;first_name&quot;:&quot;Ahmed&quot;,&quot;last_name&quot;:&quot;A. Ahmed&quot;},{&quot;first_name&quot;:&quot;Gloria&quot;,&quot;last_name&quot;:&quot;Di Vita&quot;},{&quot;first_name&quot;:&quot;Ingrida&quot;,&quot;last_name&quot;:&quot;Pazitna&quot;},{&quot;first_name&quot;:&quot;Mekala&quot;,&quot;last_name&quot;:&quot;Gunaratnam&quot;},{&quot;first_name&quot;:&quot;Rachael&quot;,&quot;last_name&quot;:&quot;J. Besser&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;C. G. Andrade&quot;},{&quot;first_name&quot;:&quot;Seckou&quot;,&quot;last_name&quot;:&quot;Diocou&quot;},{&quot;first_name&quot;:&quot;Jeremy&quot;,&quot;last_name&quot;:&quot;A. Pike&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Tannahill&quot;},{&quot;first_name&quot;:&quot;R.&quot;,&quot;last_name&quot;:&quot;Barbara Pedley&quot;},{&quot;first_name&quot;:&quot;T.&quot;,&quot;last_name&quot;:&quot;R. Jeffry Evans&quot;},{&quot;first_name&quot;:&quot;W.&quot;,&quot;last_name&quot;:&quot;David Wilson&quot;},{&quot;first_name&quot;:&quot;Shankar&quot;,&quot;last_name&quot;:&quot;Balasubramanian&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Neidle&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;2500-2517&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01781&quot;},&quot;abstract&quot;:&quot;Human pancreatic ductal adenocarcinoma (PDAC) involves the dysregulation of multiple signaling pathways. A novel approach to the treatment of PDAC is described, involving the targeting of cancer genes in PDAC pathways having over-representation of G-quadruplexes, using the trisubstituted naphthalene diimide quadruplex-binding compound 2,7-bis(3-morpholinopropyl)-4-((2-(pyrrolidin-1-yl)ethyl)amino)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone (CM03). This compound has been designed by computer modeling, is a potent inhibitor of cell growth in PDAC cell lines, and has anticancer activity in PDAC models, with a superior profile compared to gemcitabine, a commonly used therapy. Whole-transcriptome RNA-seq methodology has been used to analyze the effects of this quadruplex-binding small molecule on global gene expression. This has revealed the down-regulation of a large number of genes, rich in putative quadruplex elements and involved in essential pathways of PDAC survival, metastasis, and drug resistance&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01781&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01781" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01781&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01781" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01781&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01781" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01781&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01781&amp;href=/doi/10.1021/acs.jmedchem.7b01781" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01781" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01781" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01781%26sid%3Dliteratum%253Aachs%26pmid%3D29356532%26genre%3Darticle%26aulast%3DMarchetti%26date%3D2018%26atitle%3DTargeting%2BMultiple%2BEffector%2BPathways%2Bin%2BPancreatic%2BDuctal%2BAdenocarcinoma%2Bwith%2Ba%2BG-Quadruplex-Binding%2BSmall%2BMolecule%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D6%26spage%3D2500%26epage%3D2517%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (11)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291297" title="Cell signaling">Cell signaling</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/jmcmar.2018.61.issue-6/20180322/jmcmar.2018.61.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01781&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Human pancreatic ductal adenocarcinoma (PDAC) involves the dysregulation of multiple signaling pathways. A novel approach to the treatment of PDAC is described, involving the targeting of cancer genes in PDAC pathways having over-representation of G-quadruplexes, using the trisubstituted naphthalene diimide quadruplex-binding compound 2,7-bis(3-morpholinopropyl)-4-((2-(pyrrolidin-1-yl)ethyl)amino)benzo[<i>lmn</i>][3,8]phenanthroline-1,3,6,8(2<i>H</i>,7<i>H</i>)-tetraone (CM03). This compound has been designed by computer modeling, is a potent inhibitor of cell growth in PDAC cell lines, and has anticancer activity in PDAC models, with a superior profile compared to gemcitabine, a commonly used therapy. Whole-transcriptome RNA-seq methodology has been used to analyze the effects of this quadruplex-binding small molecule on global gene expression. This has revealed the down-regulation of a large number of genes, rich in putative quadruplex elements and involved in essential pathways of PDAC survival, metastasis, and drug resistance. The changes produced by CM03 represent a global response to the complexity of human PDAC and may be applicable to other currently hard-to-treat cancers.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12310" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12310" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pancreatic cancer remains one of the most difficult to treat human cancers.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Pancreatic ductal adenocarcinomas (PDACs) comprise some 85% of diagnosed cases and are classified into several subtypes on the basis of expression analysis of major mutated genes.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> PDACs typically have extensive patterns of germline mutations, especially in DNA repair and signaling pathways.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> The most common mutations in PDACs are in the <i>KRAS</i>, <i>TP53</i>, <i>SMAD4</i>, and <i>CDKN2A</i> genes, with a lower frequency of mutations in many other genes.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6">(3−6)</a> A feature of PDACs is the distinctive pattern of changes in several gene pathways such as those involved in axon guidance and dysregulation of signal transduction via inhibition of Rho-GTPases.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a></div><div class="NLM_p">Only <4% of those diagnosed with stage III of PDAC survive for more than five years,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> a situation that has not significantly changed for more than 40 years. Surgery is an option for <15–20% of cases, and chemotherapy for locally advanced inoperable or metastatic disease is still largely palliative. The nucleoside analogue gemcitabine remains a widely used monotherapy regimen used to treat PDAC.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Various formulations of gemcitabine and combinations with, in particular, paclitaxel, have been developed; some have been in clinical trial,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and a small number have received regulatory approval<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> but their benefit is limited. The use of combination regimens of cytotoxic agents, as in the FOLFIRINOX (folinic acid + irinotecan + 5-fluorouracil + oxaliplatin) combination,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> is restricted in use due to their toxicity. By contrast to other cancers, immunotherapy has not shown promising clinical results with PDAC,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> possibly due to its inherent immunosuppression. Therapies based on the common mutations in pancreatic cancer that target hard-to-drug proteins such as KRAS have not yet reached the clinic, although recent results suggest promise for the future.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p">Here, we report an alternative approach, of selectively targeting G-quadruplex (G4) elements in the genomes of pancreatic cancer cells. The human genome contains a large number of putative G4 sequences comprising several (typically four) short guanine tracts separated by more general sequence loops (reviewed in ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a>). G4 sequences are over-represented in promoters<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and untranslated regions, particularly in genes associated with cell proliferation and cancer.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> In principle, this over-representation in cancer-associated genes gives G4 targeting a therapeutic advantage, which can be emphasized by stabilizing individual G4 structures with an appropriate G4-selective small molecule. Visualization of G4s in cancer cells<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> and tissues<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> has further demonstrated their potential for selectivity. Many studies have examined the effects of such compounds on G4s within individual target genes,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> arising from the concept that stabilization of a promoter G4 can result in inhibition of the expression of the gene involved.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> A wide range of chemotypes as G4 stabilizers have been examined although they tend to share common structural features of an extended aromatic or heteroaromatic core with one or more cationic side chains.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Down-regulation of “targeted” genes such as <i>MYC</i>, <i>KIT</i>, <i>BCL2</i>, <i>VEGF</i>, and <i>KRAS</i> has often been reported (reviewed in ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a>), although unequivocal demonstrations of direct cause and effect at the cellular level have rarely been made.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The synthetic fluoroquinolone compound Quarfloxin (CX-3543)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> has been evaluated in human cancer clinical trials, and its G4-binding was reported as inhibiting RNA biogenesis. More recently, another fluoroquinolone, CX-5461,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> has been shown to be a G4-binding compound with selective effects in BRCA1/2-deficient cells; CX-5461 has recently entered clinical trials for patients with BRCA-deficient tumors.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">We have adopted a distinct approach in comparison to the single G4 promoter targeting strategy, in which we have not a priore assumed any particular promoter G4 targets. Instead, we have used global genome transcriptome profiling to determine which genes are affected by a rationally designed G4-binding small molecule. This has enabled us to determine potential targets at the whole genome level in two pancreatic cancer cell lines. We find that pancreatic cancer cell growth is especially sensitive to CM03 and that it strikingly inhibits tumor growth in PDAC animal models.</div><div class="NLM_p">Naphthalene diimides are a favored chemotype for G4 binding because of their high target affinity, synthetic accessibility, and potential for chemical variability.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> We have previously disclosed several focused libraries of naphthalene diimides, in particular, tetra-substituted analogues<a onclick="showRef(event, 'ref30 ref31 cit32a ref33'); return false;" href="javascript:void(0);" class="ref ref30 ref31 cit32a ref33">(30,31,32a,33)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a) with molecular design based on crystallographic data for a series of G4–ligand complexes.<a onclick="showRef(event, 'cit32a'); return false;" href="javascript:void(0);" class="ref cit32a">(32a)</a> We report here on a new lead compound, 2,7-bis(3-morpholinopropyl)-4-((2-(pyrrolidin-1-yl)ethyl)amino)benzo[<i>lmn</i>][3,8]phenanthroline-1,3,6,8(2<i>H</i>,7<i>H</i>)-tetraone (CM03, 633.34 Da; compound <b>4</b> in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> and <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c), which contains two side chains terminating in morpholino groups, a third side chain terminating in a protonated pyrrolidino group, and a lower molecular weight compared to the parent tetra-substituted compound MM41<a onclick="showRef(event, 'cit32a'); return false;" href="javascript:void(0);" class="ref cit32a">(32a)</a> (831.08 Da; <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a). We report here that CM03 (i) has potent growth inhibitory activity in vitro for pancreatic cancer cells, (ii) has antitumor activity in vivo in PDAC animal models, (iii) down-regulates the expression of key genes involved in maintaining the progression of PDAC and in drug resistance, and (iv) targets genes which have high G4 propensity.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. G4 modeling, FRET, and cell line growth inhibition studies of the trisubstituted naphthalene diimide derivatives MM41 and CM03. (a) MM41 structure and (b) molecular model of MM41 bound to a human telomeric G4, following docking and minimization and using the co-crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UYH">3UYH</a>)<a onclick="showRef(event, 'cit32a'); return false;" href="javascript:void(0);" class="ref cit32a">(32a)</a> as a starting point. The red dotted circle highlights the fourth pyrrolidino side chain substituent of MM41, which is not buried in a G4 groove, by contrast with the other three side chains. (c) CM03 structure and (d) molecular model of CM03 bound to the native parallel human telomeric G4 structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KF1">1KF1</a>)<a onclick="showRef(event, 'cit32b'); return false;" href="javascript:void(0);" class="ref cit32b">(32b)</a> following docking and minimization. MM41 and CM03 are shown in ball-and-stick representation and the G4 in surface representation, with electrostatic interaction regions colored yellow. (e) Table showing melting temperature changes (Δ<i>T</i><sub>m</sub>) in °C, for CM03 and MM41 with a panel of G4s, determined using a FRET procedure performed in solution containing 50 mM K<sup>+</sup> ion. Ligands were used at 1 μM concentration. Standard deviations are from triplicate measurements. (f) Growth inhibition assays. Short-term 96 h IC<sub>50</sub> values (in nM) for the two compounds in cancer and normal fibroblast cell line panel. Average growth inhibition is shown with standard deviations from >3 individual determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01781&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Altogether these results demonstrate that G4 targeting is a realistic and attainable concept for potent G4-binding compounds, and has promise to lead to significant therapeutic advantage in the treatment of PDAC.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64203" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64203" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design and Synthesis of the Trisubstituted Naphthalene Diimide Compound</h3><div class="NLM_p">The starting-point for CM03 design was the co-crystal structure of MM41 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a,b), with an intramolecular human telomeric parallel G4. We reasoned that although the nature and structures of most potential target G4s are unknown, several features are common to all G4s, in particular a core of stacked G-quartets with small-molecule binding at one end of the core, as observed in all such NMR and crystal structures to date. These crystal and docked structures revealed that the chromophore of MM41 is bound slightly asymmetrically onto the terminal G-quartet. Consequently, although three out of four of the substituent chains are each well positioned at the mouth of a G4 groove, the fourth is not. This is due to the limited surface area of the naphthalene diimide chromophore, so that the fourth side chain cannot make effective contacts with a G4 groove and is oriented away from the G4 surface (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b), consequently, its contribution to overall binding is minimal. We hypothesized that a naphthalene diimide with three substituents would bind with similar affinity and has the advantage of lower molecular weight and reduced overall cationic charge. CM03 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c) was therefore conceived and is the subject of the studies reported here. Docking with MM41 and CM03 reveals that the poses for the resulting G4 complexes are similar, even though the CM03 side chains can access only three grooves, while the MM41 targets all four. CM03 is predicted to have each side chain positioned at the mouth of a quadruplex groove (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>d). The aromatic chromophore is positioned slightly off-center because the side chains are not long enough to interact symmetrically in each groove. The two morpholino side chains serve to maximize the binding onto the G-quartet platform.</div><div class="NLM_p">The synthetic approach to the trisubstituted series adapts previously published procedures to simplify purification and increase yields of both intermediates and final compounds (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). 5,5-Dimethyl-1,3-dibromohydantoin was used for the regioselective bromination of the starting material, enabling more efficient and convenient purification. The separation of final products was achieved using column chromatography, giving a 26% overall yield for CM03. It has been formulated as a highly stable mixed chloride/formate salt (pH 6.9), freely soluble in water and saline (>10 mg/mL).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound CM03 (<b>4</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01781&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(i) 5,5-Dimethyl-1,3-dibromohydantoin, H<sub>2</sub>SO<sub>4</sub>, 80° C, 72 h; (ii) 3-morpholinopropylamine, acetic acid, microwave, 130 °C, 25 min (The intermediate <b>3b</b> was not isolated); (iii) amine, NMP, microwave, 125 °C, 30 min. For CM03, n = 2, R = pyrrolidino. The overall yield of the synthesis for steps i to iii (compound <b>4</b>: CM03) was 26%. The yield for steps i and ii (from compound <b>1</b> to compound <b>3a</b>) was 35%; the yield for final step (iii) (compound <b>3a</b> to compound <b>4</b> (CM03)) was 75%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> CM03 Shows in Vitro G4 Binding Together with Selective and Potent Antiproliferative Activity</h3><div class="NLM_p">CM03 and MM41 were evaluated for their ability to stabilize G4 binding by means of a fluorescence resonance energy transfer (FRET) protocol using a FAM/TAMRA donor/acceptor combination to measure the temperature (<i>T</i><sub>m</sub>) of the helix–coil transition on gradual heating. A human telomeric G4 sequence (F21T), together with promoter G4 sequences (from the <i>HSP90</i>, <i>BCL-2</i>, and <i>KRAS</i> genes), and a duplex control (T loop) were screened against the two compounds (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>e). CM03 shows a consistent pattern of ∼2-fold (range 1.98–2.25) lower melting stabilization temperature (Δ<i>T</i><sub>m</sub>) compared to MM41 for all tested G4s. The pattern of differences in Δ<i>T</i><sub>m</sub> values between individual G4s is closely similar between the two compounds. Duplex DNA stabilization is significantly reduced for CM03 compared to MM41.</div><div class="NLM_p">Quantitative binding estimates as <i>K</i><sub>D</sub> values were obtained from fluorescence anisotropy titrations (MM41) and direct fluorescence titrations (CM03). The DNA human telomeric G4 sequence 5′-d(GGGTTAGGGTTAGGGTTAGGG)-3′ was used to enable direct comparisons to be made with the modeling studies. Both compounds bind with nanomolar affinity to this DNA G4, with a ∼3-fold difference between MM41 (20 ± 2 nM) and CM03 (67 ± 4 nM).</div><div class="NLM_p last">Compounds were screened with a 96 h SRB (sulforhodamine B) assay for their antiproliferative activity in a panel of human cancer cell lines comprising lung adenocarcinoma (A549), breast adenocarcinoma (MCF7), and PDAC (MIA PaCa-2 and PANC-1) cell lines, as well as a fetal lung fibroblast-like nononcogenic control cell line (WI-38) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>f). Both compounds show highly potent growth inhibition activity, particularly for the lung and pancreatic cancer cell lines, which are responsive at low nM concentrations. The responses are highly cell-line-dependent; CM03 shows >20-fold selectivity for MIA PaCa-2 compared to MCF-7 cells. CM03 also shows greater selectivity than MM41 relative to the nononcogenic control fibroblasts (e.g., ∼170-fold vs ∼21-fold for MIA PaCa-2 cells compared to WI-38 cells for CM03 vs MM41, respectively). CM03 was further examined in additional pancreatic adenocarcinoma cell lines (CAPAN-1 and BX-PC3) and again showed low nM activity (IC<sub>50</sub> 16 ± 4 and 19 ± 4 nM, respectively). Gemcitabine is also active in these lines at low nanomolar levels, although less so in MIA PaCa-2 (IC<sub>50</sub> 19 ± 5 nM) and more so in BX-PC3 cells (6 ± 2 nM). Taken together, these results show that CM03 has very potent growth inhibitory activity in cancer versus “normal” cells, particularly for PDAC cells.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> CM03 Has in Vivo Antitumor Activity</h3><div class="NLM_p">To determine if the in vitro activity of CM03 was paralleled in vivo, we explored the activity of CM03 in a mouse xenograft model of PDAC. We have previously reported that the maximum tolerated dosage (MTD) for intravenous (IV) administration of MM41 is 25 mg/kg.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> CM03 was well tolerated, up to a dosage of 45–50 mg/kg, as judged by a dose-escalation MTD study. A therapeutic schedule of two CM03 intravenous (IV) doses was explored using a subcutaneous MIA PaCa-2 pancreatic tumor xenograft model derived from the human cell line used in the cell growth inhibition studies. A group size of eight CD-1 nude mice was used, and dosing was conducted at 10 and 15 mg/kg, each twice weekly, over a period of 4 weeks (28 days: 8 doses). Two further groups were given either MM41 or gemcitabine at 15 mg/kg and received the same dose regimen. Over the course of the experiment, CM03 showed a dose-dependent antitumor response. At the conclusion of dosing on day 28, all four therapy groups showed significant tumor growth inhibition compared to the vehicle control group (<i>p</i> < 0.001) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a,c), but notably 15 mg/kg CM03 resulted in the highest mean decrease in tumor volume (MTV) (−73%). From day 28 onward, while all treatment groups also showed significant reduction in MTV compared to the control (<i>p</i> < 0.05), the 15 mg/kg CM03 cohort consistently showed the greatest therapeutic effect and no tumor regrowth was observed. Five out of the eight animals had tumor volumes that shrank to <0.05 cm<sup>3</sup> by day 62. No body weight reduction (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b) or adverse effects such as tumor ulceration were observed in this group at any time during the study. Histopathological analysis of vital organs from control and CM03-treated animals sacrificed at the end of the experiments also showed no sign of organ damage (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>d). IVIS imaging of treated mice was performed by taking account of the intrinsic fluorescence of CM03. This showed significant accumulation of CM03 in the tumor xenograft on the flank of the animal (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>e). Thus, in contrast to MM41 and gemcitabine, the higher-dose CM03 treatment results in a statistically significant (<i>p</i> < 0.001) antitumor effect, which persisted long after dosing had ceased, up to the termination of the xenograft experiment (62 days).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CM03 treatment reduces tumor volume in a MIA PaCa-2 xenograft model of PDAC. (a) Plot showing the tumor volume of MIA PaCa-2 xenografts treated with CM03, MM41, gemcitabine, or saline (control) over 62 days. There are eight CD-1 mice per condition and dosing for all cohorts was stopped on day 28, shown by the red arrow. Standard error of the mean (SEM) is indicated for all growth curves for each tumor volume. * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 (Student <i>t</i> test). (b) A plot of weight for the eight mice in the 15 mg/kg CM03 cohort of this xenograft experiment, for the first 40 days of the experiment. (c) Table showing changes in tumor volume (TV), in cm<sup>3</sup>, relative to the control cohort at the selected three time points (MTV represents mean tumor volume). Statistical analysis between the average tumor volume of treated versus control mice cohorts at the given time points was performed using the Student <i>t</i> test * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001. (d) Sections of hematoxylin and eosin-stained organ tissue, taken from animals at the termination of the xenograft experiment. In each case, images from a single animal are shown. No differences between animals in a cohort were observed. Sections through (i) kidneys and (ii) livers taken from a control (untreated) and a CM03-treated mouse. (e) (i) IVIS images of a saline (control) untreated mouse and a 10 mg/kg CM03 treated mouse with tumors on their flank, 4 h after administration; (ii) IVIS images of the excised tumor from each animal (untreated control and 10 mg/kg CM03 treated) 4 h after administration. (f) Kaplan–Meier plot showing survival of PDAC-bearing KPC mice post onset of treatment (CM03, <i>n</i> = 7, control, <i>n</i> = 5, Mann–Whitney, <i>p</i> = 0.217).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01781&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We also tested the higher dose of CM03 in a genetically engineered mouse model of PDAC. The KPC (<i>Pdx1-Cre</i>; <i>LSL-Kras</i><sup><i>G12D/+</i></sup>; <i>LSL-Trp53</i><sup><i>R172H/+</i></sup>) mouse model is commonly used for preclinical PDAC cancer studies as it develops tumors that exhibit many of the genetic and pathological features of the human disease, including resistance to chemotherapy.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Mice with late-stage disease, characterized by swollen abdomen, loss of body conditioning, and palpable tumor, were treated with CM03 intraperitoneally (ip) using the 15 mg/kg twice weekly dosing regimen employed for the xenografts. While the median survival between treated and untreated animals is similar, we note that 3/7 mice survived much longer than all of the untreated animals with two surviving more than twice as long (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>f).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> CM03 Induces Down-Regulation of Genes Enriched in G4s</h3><div class="NLM_p">CM03 is a potent G4 ligand, as shown by the FRET and quantitative binding experiments reported here. We therefore reasoned that the potent CM03 antiproliferative activity on PDAC cells could be mediated through a G4-targeting mechanism. To test this hypothesis, we determined whether transcriptome changes upon early CM03 treatment were correlated with G4 presence in promoters and/or gene bodies. Two PDAC cell lines, PANC-1 and MIA PaCa-2 (both with activating KRAS mutations), were treated for 6 or 24 h with 400 nM CM03 (1/10 of the calculated GI<sub>50</sub> at 24 h, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Figure 1a</a>), RNA was harvested and gene expression levels analyzed by RNA-Seq. The time and dose of CM03 treatment were selected to reveal initial but robust mRNA changes while minimizing chronic effects due to cell toxicity. In both cell lines, the number of genes with altered expression (as defined by >0.5 increase in Log 2 of fold change [Log<sub>2</sub> FC], or < −0.5 decrease; false discovery rate [FDR] < 0.1) increased with duration of CM03 treatment. In PANC-1 cells 2165 genes at 6 h and 3977 genes at 24 h were seen to change, while in MIA PaCa-2 cells, 5306 genes changed at 6 h and 5477 genes at 24 h compared to untreated controls (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Table 1</a>). Suggestive of a common mechanism of action of CM03, the differentially expressed genes were well correlated between the two cell lines at both treatment times (6 h, <i>r</i> = 0.511; 24 h, <i>r</i> = 0.518) (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Figure 1b–h</a>) with 13044 expressed genes in common (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Table 2</a>) and a high number of genes changed in both cell lines (1185 genes at 6 h, 1917 genes at 24 h). Remarkably, the differentially down-regulated gene set (considering each cell line individually or combined) was significantly enriched (<i>p</i> < 1 × 10<sup>–10</sup>) for putative G-quadruplexes (PQs), as defined by the G<sub>≥3</sub>N<sub>1–7</sub>G<sub>≥3+</sub>N<sub>1–7</sub>G<sub>3≥</sub>N<sub>1–7</sub>G<sub>≥3</sub> consensus sequence,<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> in promoters and gene bodies at both 6 and 24 h treatments compared to up-regulated or unaltered genes (cell lines combined, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a,b; cell lines considered individually, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Figures 2a,b and 3a,b</a>). This association was more marked for genes that were down-regulated to the greatest extent by CM03 (Log<sub>2</sub> FC ≤ 1.0, FDR < 0.05) after 6 h treatment (down strong > down, ratio of means) (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Table 3</a>). To validate that the targeting of G4-containing genes is not a general feature of antiproliferative agents, we also examined the effects of the first-line therapeutic agent for PDAC, gemcitabine,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> a potent antiproliferative DNA synthesis inhibitor whose mechanism of action is G4-independent and which remains a standard therapy option in advanced PDAC. Both cell lines were treated with a range of gemcitabine concentrations (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Figure 4, Table 4</a>) for 6 or 24 h. Crucially, no significant PQ enrichment was observed for the down-regulated genes in any gemcitabine condition (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Figures 2c,d and 3c,d</a>; 300 nM gemcitabine is shown as an example)). These results strongly support the hypothesis that CM03 specifically targets G4-bearing genes and represses their expression.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Differentially down-regulated genes common to both PANC-1 and MIA PaCa-2 are enriched in PQs after treatment with 400 nM CM03. (a,b) MIA PaCa-2 and PANC-1 cells were treated with 400 nM CM03 for 6 and 24 h and mRNA extracted for analysis by RNA-Seq. Genes were split into four subgroups according to their fold change upon CM03 treatment versus untreated: Down (Log<sub>2</sub> FC < 0.5, FDR < 0.1), Up (Log<sub>2</sub> FC > 0.5, FDR < 0.1), Down strong (Log<sub>2</sub> FC ≤ 1.0, FDR < 0.05) and Up strong (Log<sub>2</sub> FC ≥ 1.0, FDR < 0.05) and analyzed for PQs occurrence in both (a) promoter (100 bp downstream and 2 kb upstream of the TSS) and (b) gene bodies (exons and introns). See Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Table 3</a> for median and IQR for box and whisker plots. Significance between differentially deregulated gene sets was calculated using the Wilcox statistical test via R software. *<i>p</i> < 0.05, ** <i>p</i> < 1 × 10<sup>–10</sup>, *** <i>p</i> < 1 × 10<sup>–25</sup>. PQs mean number is significantly lower (red asterisks) or higher (black asterisks) than the no differential expression group (NO). (c,d) enriched KEGG pathways (<i>p</i> < 0.05 with Bonferroni correction) and associated down-regulated genes (Log<sub>2</sub> FC < 0.5, FDR < 0.1) common to both PANC-1 and MIA PaCa-2 cell lines after (c) 6 h and (d) 24 h CM03 treatment using the ClueGO Cytoscape App. (e) Scatter plot of significant down-regulated KEGG pathways (p-EASE ≤ 0.05) upon 6 and 24 h CM03 treatment. (f,g) Common (f) down-regulated KEGG pathways after 6 h CM03 treatment are also enriched in promoter and gene body PQs compared to (g) common-up regulated KEGG pathways at 6 h. The significance threshold of 0.05 is represented by the dotted line on the graph.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01781&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To gain insights into possible gene types and pathways targeted by CM03, we performed a KEGG gene enrichment pathway analysis of the common down-regulated genes. This revealed a total of 11 and 46 significant pathways (p-EASE ≤ 0.05) after 6 and 24 h CM03 treatment, respectively. Many of these pathways, or genes within them, have been previously associated with PDAC (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>c,d, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Figures 5, 6; Tables 5, 6</a>) such as axon guidance (14 genes, <i>p</i> = 5.75 × 10<sup>–5</sup>),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> the hippo signaling pathway (13 genes, <i>p</i> = 1.15 × 10<sup>–3</sup>)<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> at 6 h, mTOR (12 genes, <i>p</i> = 1.07 × 10<sup>–4</sup>)<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and VEGF signaling pathways (11 genes, p = 7.45 × 10<sup>–4</sup>)<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> after 24 h and insulin resistance,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and Rap1 and MAPK signaling pathways across both time points<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>e). This contrasts with the pattern of the common up-regulated genes at 6 and 24 h (9 and 10 significant pathways, respectively) after CM03 treatment, with particular enrichment in cellular matrix adhesion and major histocompatibility complex proteins pathways (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Figure 7a</a>). As anticipated, 300 nM gemcitabine treatment affected strikingly different KEGG pathways compared to CM03 (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Table 7</a>). The most significant down-regulated gemcitabine pathways (for both cell lines) were cell cycle after 6 h and ribosome-associated pathways after 24 h, which is consistent with its known mechanism of action in inhibiting DNA synthesis, cell cycle progression, and global translation.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> This contrasts with known pathways seen to be up-regulated after gemcitabine treatment which includes the NF-Kappa B signaling pathway (<i>p</i> = 1.61 × 10<sup>–6</sup>) for PANC-1<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and the Fanconi anemia pathway (<i>p</i> = 6.46 × 10<sup>–6</sup>) for MIA PaCa-2.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> It is notable that PQs in promoters and gene bodies are highly enriched within down-regulated KEGG gene pathways after CM03 treatment (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>f, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Figure 7b</a>) compared to random sampling across the expressed genes or to up-regulated genes (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>g and Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Figure 7c</a>). Overall, these results robustly support our contention that CM03 specifically targets critical pathways that lead to pancreatic cell death via the inhibition of expression gene sets harboring a G4 structure.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> CM03 Treatment Results in an Increase in BG4 Foci and DNA Damage</h3><div class="NLM_p">Because many established G4-stabilizing ligands induce transcription and replication-coupled DNA damage in the vicinity of G4-forming sequences,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> we investigated whether CM03 treatment affects cellular G4 occurrence and/or induces a DNA damage response. To do this, we treated asynchronous PANC-1 cells with CM03 and performed immunofluorescence staining using the G4-specific antibody BG4<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and an antibody against the DNA damage and double-strand break (DSB) marker 53BP1<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> followed by 3D image construction and analysis. As predicted, 400 nM CM03 treatment resulted in a time-dependent significant (<i>p</i> < 0.05) increase in the number of nuclear BG4 foci (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a,b) (393 ± 13 at 6 h and 444 ± 39 BG4 foci at 24 h) compared to controls (297 ± 3 BG4 foci). This further confirms that CM03 has a direct action at G4 sites to increase G4 stabilization. Consistent with the capability of unresolved endogenous genomic G4 sites<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and small molecule-stabilized G4s to obstruct DNA replication,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> a 2-fold increase in the number of 53BP1 foci was only apparent after 24 h treatment with CM03 (11 ± 2 compared to 21 ± 3 53BP1 foci) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a,c). To determine if CM03 induced DNA damage directly at G4 sites, we calculated the extent of co-localization between BG4 and 53BP1 foci using object-based image co-localization analysis. While the percentage of co-localization between BG4 and 53BP1 reproducibly increased by 50% after 24 h 400 nM CM03 treatment (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>d), only 1.4% of total BG4 foci per nucleus were associated with DNA damage foci (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>e). Nonetheless, our data strongly suggests CM03 stabilizes G4 structures leading to an accumulation of nuclear G4 foci accompanied by the induction of DNA damage and replicative stress.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. CM03 treatment induces DNA damage and increases the presence of nuclear G4. (a) Following 6 and 24 h treatment with 400 nM CM03, PANC-1 cells were fixed with paraformaldehyde and stained with antibodies against G4s (BG4, green) and the DNA damage marker 53BP1 (red). <i>Z</i>-Stack images (11 μm × 0.3 μm spacing) were captured using a Nikon wide-field microscope and deconvolved using Hugyens Professional software. The central slice of the <i>Z</i>-stack is shown in the representative images. White scale bar is 10 μm. Zoom panel represents increased magnification of the highlighted section of the nucleus (dotted square) in the Merge panel. Yellow scale bar is 2.5 μm. Detection and co-localization between BG4 and 53BP1 foci (white arrows) were performed using a custom protocol in the ICY software, which utilizes the spot detector and co-localization studio plugins with the wavelet and Ripley’s K functions (see <a class="ref internalNav" href="#sec4" aria-label="Methods">Methods</a>). (b–e) The graphs show the mean number of (b) BG4 foci, (c) 53BP1 foci, (d) BG4-53BP1 co-localizations, or (e) percentage of total BG4 co-localizing with 53BP1 per nucleus with the standard deviation from three biological replicates. A two-tailed Student’s <i>t</i> test was used to determine statistical significance across each condition (<i>p</i> < 0.05 = *, <i>p</i> < 0.01 = **; n.s. = not significant). Each biological replicate represents 50–100 nuclei.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01781&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14185" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14185" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While PDAC is predominantly (>95%) driven by oncogenic KRAS,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> the development of more targeted therapies against KRAS and other core PDAC associated pro-survival pathways including: Ras-Raf-MEK-ERK and PI3K-AKt-mTOR have proved futile owing to the highly mutagenic nature of the disease<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a> and the ability of PDAC cells to rapidly switch between phenotypic states, resulting in the evasion of therapy.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> As novel alternative strategies for intervention in PDAC are urgently required, the targeting of G4s with small molecules has been proposed as an innovative method for selective cancer therapy.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This is supported by recent G4-ChIP-seq and G4-IF studies identifying an increased abundance of G4s in cancer versus normal cells, as well as G4 structure enrichment at oncogenes.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> We have recently reported that the G4 ligand MM41<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> reduces tumor volume by ∼80% in a PDAC xenograft model. MM41 binds strongly to the G4s in the down-regulated genes <i>KRAS</i> and <i>BCL-2</i>, resulting in cell apoptosis, and suggested that G4 ligand treatment is potentially a highly effective method for targeting PDAC. MM41 is a suboptimal drug candidate due to its higher molecular weight and four positive charges.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> We present here CM03 as an improved rationally designed derivative of MM41 and as a novel lead candidate compound for potential PDAC therapy in humans. CM03 has comparable affinity for a human telomeric G4 to the tetra-substituent compound MM41, indicating that the fourth side chain and increased cationic charge on MM41 does not make a major contribution to affinity. Although affinities for CM03 or MM41 binding to (a single) G4 in vitro may be difficult to directly relate to cell growth inhibitory properties, CM03 is as potent in cells as MM41. Both compounds show good selectivity for cancer cell lines (especially pancreatic) over “normal” nononcogenic fibroblasts, but CM03 shows >4-fold less activity toward the WI-38 cell line. This enhanced selectivity is also apparent in vivo, where CM03 has a higher level of tolerability (higher MTD) compared to MM41. This suggests that the fourth side chain of MM41 may add to off-target toxicity burden; however, neither MM41 nor CM03 show significant hERG liabilities (unpublished data), a common indicator of cardiotoxic effects. The antitumor activity of CM03 results in sustained tumor growth arrest, which continues long after dosing is ceased and compares favorably with the growth delay typically seen with experimental antitumor agents.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The increased animal survival in a subset of the autochthonous KPC mice to CM03 suggests that CM03 may be able to effectively penetrate the tumor stroma microenvironment characteristic of human PDAC.</div><div class="NLM_p">The RNA-seq data revealed that treatment with CM03 resulted in a striking global differential down-regulation of genes containing putative G4s (PQs), which occurred as early as 6 h after treatment. We have performed RT-qPCR on a small set of the genes down-regulated by CM03 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a, b). The results confirm the RNA-seq analyses: that these PDAC-pathway genes are transcriptionally down-regulated in both cell lines and that they are not significantly affected by gemcitabine (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>c,d). The RNA-seq results are consistent with the hypothesis that G4 ligands can alter gene expression when PQs are targets in individual genes.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Previously, global G4-motif specific changes in the transcriptome with bisquinolinium compounds in HeLa cells have been reported using microarray analysis.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> However, our work represents the first comprehensive analysis using state-of-the-art RNA-seq methodology. This is the first demonstration that a G4-binding small molecule produces global down-regulation of G4-containing genes in human cancer cell lines, in striking comparison with a non-G4 targeting drug, the modified nucleoside gemcitabine. Moreover, as we identify G4 effects at much earlier times and smaller doses than earlier studies, this further demonstrates that CM03 is a bona fide G4 ligand in cells and, by implication, in vivo as well. The observed transcriptional effects of CM03 also align with the hypothesis that down-regulation of gene expression is mediated through ligand-stabilized G4s, causing for example steric hindrance and inhibition of RNA pol II in the transcription bubble (reviewed in ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a>). The observations that transcriptional effects are closely aligned in two PDAC cell lines, independently sequenced, gives added confidence to these conclusions.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Validation of mRNA down regulation by qRT-PCR for a subset of down-regulated genes, selected from RNA-Seq experiments. (a–d) MIA PaCa-2 and PANC-1 cells were treated (a and b) with 400 nM CM03 and (c and d) with 400 nM gemcitabine, all for 6 and 24 h. Total mRNA was extracted, reverse transcribed into cDNA, and then qRT-PCR was performed. The <i>C</i><sub>t</sub> values were normalized to the genomic mean of three housekeeping genes (<i>ACTB</i>, <i>GAPDH</i>, and <i>TUBB</i>), and the relative gene expression was determined using the Livak method, 2<sup>–ΔΔ<i>C</i>t</sup>. The log-fold expression changes (Log<sub>2</sub> FC) for each gene are shown relative to vehicle-treated controls (PBS for CM03 and DMSO for gemcitabine). Student’s <i>t</i> test along with 2<sup>–Δ<i>C</i>t</sup> values were used to determine the statistical significance of the observed changes, which are the mean of in each case at least three determinations. Those genes with changes in expression with <i>p</i> < 0.05 have been marked *.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01781&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">KEGG pathway analysis shows that CM03 targets 42 pathways, many of which are key to PDAC development and maintenance. The most significant down-regulated pathways after 6 h were the hippo signaling, axon guidance, and endocytosis pathways, which are all deregulated in PDAC.</div><div class="NLM_p">Hippo signaling acts through the core transcription factors, YAP and TAZ. In PDAC, both YAP and TAZ are overexpressed and are essential for neoplastic progression.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> YAP/TAZ also contributes to PDAC resistance to therapeutic approaches directly targeting mutant KRAS.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> Notably, CM03 down-regulates three prime effectors of YAP function, TEAD2 and -4 (MIA PaCa-2 only) and TEAD3 (both cell lines) at 6 h. As TEAD 2/4 are oncogenic in many cancers,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> CM03 may be suitable as a global cancer therapeutic agent. CM03 also down-regulates the oncogenic Gli transcription factors Gli2/4, downstream of TEAD and highly up regulated in PDAC.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> As Gli2 is essential for KRAS-driven oncogenesis in vivo<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and plays a role in PDAC resistance to both gemcitabine<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and BET inhibitors,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> this suggests CM03 may have a novel therapeutic potential.</div><div class="NLM_p">For the axon guidance pathway, key PQs-containing genes down-regulated by CM03 are <i>PAK1</i>,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a><i>ROBO3</i>,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and <i>PLXNA1</i>,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> all of which are highly overexpressed in PDAC. While axon guidance is a neurodevelopmental process, many axon guidance genes are deregulated in many cancers, including PDAC, and contribute to metastasis and tumor growth.<a onclick="showRef(event, 'ref7 ref59'); return false;" href="javascript:void(0);" class="ref ref7 ref59">(7,59)</a><i>PAK1</i> mediates pancreatic cancer cell migration, growth, promotes epithelial to mesenchymal transition (EMT), and is crucial in conferring gemcitabine resistance.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Expression of the SLIT3 receptor, ROBO3, increases with PDAC clinical grade and is anticorrelated with patient survival.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> As ROBO3 promotes liver metastasis and tumor growth via Wnt signaling pathway,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> this again suggests a more general CM03 therapeutic applicability. Likewise, the SEMA3A receptor, PLXNA1, is up-regulated in PDAC and linked with poor patient prognosis due to altered PLXNA1–SEMA3A signaling.<a onclick="showRef(event, 'ref7 ref58'); return false;" href="javascript:void(0);" class="ref ref7 ref58">(7,58)</a></div><div class="NLM_p">PDAC tumors experience hypoxia and nutrient deprivation due to the dense surrounding tissue stroma, thus PDAC heavily relies on endocytosis for scavenging of essential metabolites and receptors/transporters recycling.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> A key endocytotic gene <i>ARF6</i>, a member of the RAS superfamily of small GTPases involved in plasma membrane trafficking, cell motility, cytokinesis, and cholesterol homeostasis,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> is strikingly down-regulated by CM03 (by 6 h). Mutant KRAS induces ARF6, which acts as an oncogene in PDAC to drive the constitutive activation of the ERK1/2 signaling and downstream effector MYC, to regulate the Warburg effect.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> ARF6 has many other roles including GLUT1 and CD95 receptor recycling,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> noncanonical EGRF and Hedgehog (Hh) signaling, and Hh-mediated chemo-resistance.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Furthermore, CM03 also targets <i>IQSEC1</i>, a guanine nucleotide-exchange factor that is responsible for activating ARF6 and whose down-regulation inhibits PDAC invasion by preventing internalization of E-cadherin from the plasma membrane.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Other significant pathways with CM03 down-regulated genes (at 24 h) involved in altered PDAC metabolism include: fatty acid synthesis (oncogene fatty acid synthase (<i>FASN</i>)),<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> glycolysis (<i>PCK2</i>, <i>PFKL</i>, and <i>PFKFB4</i>),<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> autophagy (<i>ULK1</i>), and macropinocytosis (<i>PAK1</i> and <i>CTBP1</i>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div><div class="NLM_p">Other key genes down-regulated by CM03 (by 6 h) which also impinge on the above pathways include the binding partners Par6 (<i>PARD6A</i>) and PRKCZ that are important for tumor cell motility and metastatic potential in PDAC through activation of JAK/STAT signaling pathway.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Par6 also binds PRKCi, another atypical protein kinase, which promotes PDAC transformation partly through activation of the Rac1-MEK/ERK signaling pathway.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Of note, <i>PARD6A</i> knockdown significantly reduces anchorage dependent growth and cell invasion of both PRKCZ and PRKCi nonredundant pathways.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> The PKCi–Par6 complex also plays an oncogenic role in lung, ovarian, and colon cancer.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Together, this suggests that CM03 could be effective in multiple cancer types. Other CM03 down-regulated genes whose DNA methylation status correlates with pancreatic cancer patient survival<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> include <i>PRDM16</i> (rank 2), <i>SHANK2</i> (rank 31), <i>CBFA2T3</i> (rank 4), and <i>TP73</i> (rank 20) (at 6 h, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Table 2</a>).</div><div class="NLM_p">For PDACs driven by mutant KRAS, drug resistance depends on a balance between PI3K/AKT/mTOR and MAPK/ERK pathways and YAP1 and MYC up-regulation.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> It is striking that CM03 treatment down regulates many elements of this mechanism (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). For example AKT (<i>AKT1</i>), key effectors of mTOR (<i>RPTOR</i>, <i>mLST8</i>, <i>AKT1S1</i>), PI3K pathway (<i>PIK3R3</i> and <i>PIK3R2</i>) and MAPK proteins (<i>MAPK9</i>, <i>MAPK11</i>, and <i>MAPK12</i>) are down-regulated in both PDAC cell lines by CM03 (by 24 h). In the noncanonical Hh-mediated gemcitabine resistance pathway the transcript levels of <i>SMO</i> and <i>GLI1</i> are also down-regulated by CM03.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Tumor associated macrophages and cancer-associated myofibroblasts in tissue stroma are also key drivers for chemoresistance in PDAC, and it is notable that IGF2 and SHC2 are down-regulated by CM03 as these proteins have been implicated in insulin receptor-mediated chemoresistance.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Collectively, these findings clearly demonstrate the ability of CM03 to simultaneously target several fundamental PDAC tumorigenesis mechanisms.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. RNA-Seq Expression Data for a Select Set of Down-Regulated Genes after CM03 Treatment<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">Log<sub>2</sub> FC (6 h)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">Log<sub>2</sub> FC (24 h)</th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">no. of PQs</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">gene symbol</th><th class="colsep0 rowsep0" align="center" char=".">PANC-1</th><th class="colsep0 rowsep0" align="center" char=".">MIA PaCa-2</th><th class="colsep0 rowsep0" align="center" char=".">PANC-1</th><th class="colsep0 rowsep0" align="center" char=".">MIA PaCa-2</th><th class="colsep0 rowsep0" align="center">gene function</th><th class="colsep0 rowsep0" align="center" char=".">exons and introns</th><th class="colsep0 rowsep0" align="center" char=".">promoter</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>AKT1</i></td><td class="colsep0 rowsep0" align="char" char=".">–0.18</td><td class="colsep0 rowsep0" align="char" char=".">–0.20</td><td class="colsep0 rowsep0" align="char" char=".">–1.04</td><td class="colsep0 rowsep0" align="char" char=".">–0.98</td><td class="colsep0 rowsep0" align="center">key protein kinase for (the AKT-mTOR signaling pathway: involved in metabolism, proliferation, cell survival, growth, and angiogenesis</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>AKT1S1</i></td><td class="colsep0 rowsep0" align="char" char=".">–0.11</td><td class="colsep0 rowsep0" align="char" char=".">–0.54</td><td class="colsep0 rowsep0" align="char" char=".">–0.83</td><td class="colsep0 rowsep0" align="char" char=".">–1.09</td><td class="colsep0 rowsep0" align="center">subunit of mTORC1: regulates cell growth and survival in response to nutrient and hormone signals</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>ARF6</i><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–0.74</td><td class="colsep0 rowsep0" align="char" char=".">–0.89</td><td class="colsep0 rowsep0" align="char" char=".">–0.69</td><td class="colsep0 rowsep0" align="char" char=".">–0.54</td><td class="colsep0 rowsep0" align="center">RAS GTPase, protein trafficking, regulates endocytic recycling and cytoskeleton remodelling, noncanonical EGRF, and hedgehog signaling pathways</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>CBFA2T3</i><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–2.18</td><td class="colsep0 rowsep0" align="char" char=".">–2.74</td><td class="colsep0 rowsep0" align="char" char=".">–2.25</td><td class="colsep0 rowsep0" align="char" char=".">–2.86</td><td class="colsep0 rowsep0" align="center">transcription regulator, HDAC pathways</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>CTBP1</i><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–0.66</td><td class="colsep0 rowsep0" align="char" char=".">–0.52</td><td class="colsep0 rowsep0" align="char" char=".">–0.98</td><td class="colsep0 rowsep0" align="char" char=".">–1.17</td><td class="colsep0 rowsep0" align="center">transcriptional corepressor: oncogenic, required for PAK1-dependent macropinocytosis</td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>FASN</i></td><td class="colsep0 rowsep0" align="char" char=".">–0.73</td><td class="colsep0 rowsep0" align="char" char=".">–0.06</td><td class="colsep0 rowsep0" align="char" char=".">–0.70</td><td class="colsep0 rowsep0" align="char" char=".">–0.54</td><td class="colsep0 rowsep0" align="center">fatty acid synthase</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>GLI1</i></td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">–0.61</td><td class="colsep0 rowsep0" align="char" char=".">–0.57</td><td class="colsep0 rowsep0" align="char" char=".">–0.64</td><td class="colsep0 rowsep0" align="center">transcriptional activator, mediates hedgehog signaling</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>GLI2</i></td><td class="colsep0 rowsep0" align="char" char=".">–0.67</td><td class="colsep0 rowsep0" align="char" char=".">–1.17</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">–1.24</td><td class="colsep0 rowsep0" align="center">KRAS-driven oncogenesis, gemcitabine and BET inhibitor resistance, effector of TEAD proteins, transcription regulator in hedgehog pathway</td><td class="colsep0 rowsep0" align="char" char=".">71</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>GLI4</i><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–1.26</td><td class="colsep0 rowsep0" align="char" char=".">–1.71</td><td class="colsep0 rowsep0" align="char" char=".">–1.71</td><td class="colsep0 rowsep0" align="char" char=".">–1.85</td><td class="colsep0 rowsep0" align="center">up-regulated in PDAC, effector of TEAD proteins</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>IGF2</i></td><td class="colsep0 rowsep0" align="char" char=".">–1.15</td><td class="colsep0 rowsep0" align="char" char=".">–2.72</td><td class="colsep0 rowsep0" align="char" char=".">–1.53</td><td class="colsep0 rowsep0" align="char" char=".">0.72</td><td class="colsep0 rowsep0" align="center">insulin-like growth factor</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>IQSEC1</i><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–0.86</td><td class="colsep0 rowsep0" align="char" char=".">–1.11</td><td class="colsep0 rowsep0" align="char" char=".">–0.50</td><td class="colsep0 rowsep0" align="char" char=".">–0.53</td><td class="colsep0 rowsep0" align="center">guanine nucleotide exchange factor for ARF1 and ARF6</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>MAPK11</i></td><td class="colsep0 rowsep0" align="char" char=".">–0.38</td><td class="colsep0 rowsep0" align="char" char=".">–0.53</td><td class="colsep0 rowsep0" align="char" char=".">–1.60</td><td class="colsep0 rowsep0" align="char" char=".">–2.56</td><td class="colsep0 rowsep0" align="center">essential effector kinase of p38 MAPK pathway</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>MAPK12</i></td><td class="colsep0 rowsep0" align="char" char=".">–0.75</td><td class="colsep0 rowsep0" align="char" char=".">–0.47</td><td class="colsep0 rowsep0" align="char" char=".">–1.44</td><td class="colsep0 rowsep0" align="char" char=".">–1.23</td><td class="colsep0 rowsep0" align="center">essential effector kinase of p38 MAPK pathway</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>MAPK9</i></td><td class="colsep0 rowsep0" align="char" char=".">–0.28</td><td class="colsep0 rowsep0" align="char" char=".">–0.09</td><td class="colsep0 rowsep0" align="char" char=".">–0.75</td><td class="colsep0 rowsep0" align="char" char=".">–0.60</td><td class="colsep0 rowsep0" align="center">essential effector kinase of JNK signaling pathway</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>mLST8</i><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–0.54</td><td class="colsep0 rowsep0" align="char" char=".">–0.76</td><td class="colsep0 rowsep0" align="char" char=".">–1.72</td><td class="colsep0 rowsep0" align="char" char=".">–1.28</td><td class="colsep0 rowsep0" align="center">subunit of both mTORC1 and mTORC2</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>PAK1</i><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–0.54</td><td class="colsep0 rowsep0" align="char" char=".">–0.59</td><td class="colsep0 rowsep0" align="char" char=".">–1.11</td><td class="colsep0 rowsep0" align="char" char=".">–1.13</td><td class="colsep0 rowsep0" align="center">protein kinase: involved in cancer cell migration and growth, macropinocytosis, gemcitabine resistance</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>PARD6A</i><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–0.63</td><td class="colsep0 rowsep0" align="char" char=".">–0.83</td><td class="colsep0 rowsep0" align="char" char=".">–1.41</td><td class="colsep0 rowsep0" align="char" char=".">–1.40</td><td class="colsep0 rowsep0" align="center">tumour cell motility and metastatic potential</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>PCK2</i></td><td class="colsep0 rowsep0" align="char" char=".">–0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">–0.56</td><td class="colsep0 rowsep0" align="char" char=".">–0.82</td><td class="colsep0 rowsep0" align="center">catalytic enzyme required for rate limiting step in gluconeogenesis</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>PFKFB4</i><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–0.57</td><td class="colsep0 rowsep0" align="char" char=".">–1.02</td><td class="colsep0 rowsep0" align="char" char=".">–0.74</td><td class="colsep0 rowsep0" align="char" char=".">–0.93</td><td class="colsep0 rowsep0" align="center">glycolysis: synthesis and degradation of fructose 2,6-bisphosphate</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>PFKL</i></td><td class="colsep0 rowsep0" align="char" char=".">–0 21</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">–0.98</td><td class="colsep0 rowsep0" align="char" char=".">–1.18</td><td class="colsep0 rowsep0" align="center">catalytic enzyme for first step of glycolysis</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>PIK3R2</i></td><td class="colsep0 rowsep0" align="char" char=".">–0.45</td><td class="colsep0 rowsep0" align="char" char=".">–0.55</td><td class="colsep0 rowsep0" align="char" char=".">–0.88</td><td class="colsep0 rowsep0" align="char" char=".">–1.14</td><td class="colsep0 rowsep0" align="center">regulatory subunit of PI3K</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>PIK3R3</i></td><td class="colsep0 rowsep0" align="char" char=".">–0.16</td><td class="colsep0 rowsep0" align="char" char=".">–0.28</td><td class="colsep0 rowsep0" align="char" char=".">–0.54</td><td class="colsep0 rowsep0" align="char" char=".">–1.47</td><td class="colsep0 rowsep0" align="center">binds to activated PI3K and regulates kinase activity</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>PLXNA1</i><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–0.84</td><td class="colsep0 rowsep0" align="char" char=".">–0.98</td><td class="colsep0 rowsep0" align="char" char=".">–1.50</td><td class="colsep0 rowsep0" align="char" char=".">–1.56</td><td class="colsep0 rowsep0" align="center">receptor for class 3 semaphorins: involved in cancer invasion, migration, and growth</td><td class="colsep0 rowsep0" align="char" char=".">54</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>PRDM16</i><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–2.40</td><td class="colsep0 rowsep0" align="char" char=".">–2.73</td><td class="colsep0 rowsep0" align="char" char=".">–314</td><td class="colsep0 rowsep0" align="char" char=".">–3.39</td><td class="colsep0 rowsep0" align="center">transcription regulator: TGF8, SMAD pathways</td><td class="colsep0 rowsep0" align="char" char=".">260</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>PRKCZ</i><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–1.44</td><td class="colsep0 rowsep0" align="char" char=".">–1.87</td><td class="colsep0 rowsep0" align="char" char=".">–1.23</td><td class="colsep0 rowsep0" align="char" char=".">–2.01</td><td class="colsep0 rowsep0" align="center">cell polarity: PI3K, MAPK signaling pathway, NF-kappa-beta activation</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>ROBO3</i><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–0.75</td><td class="colsep0 rowsep0" align="char" char=".">–0.86</td><td class="colsep0 rowsep0" align="char" char=".">–0.85</td><td class="colsep0 rowsep0" align="char" char=".">–0.53</td><td class="colsep0 rowsep0" align="center">axon guidance receptor, promoters liver metastasis through Wnt signaling, expression increases with clinical grade of PDAC</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>RPTOR</i><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–0.80</td><td class="colsep0 rowsep0" align="char" char=".">–1.41</td><td class="colsep0 rowsep0" align="char" char=".">–0.50</td><td class="colsep0 rowsep0" align="char" char=".">–0 68</td><td class="colsep0 rowsep0" align="center">scaffold lor recruiting mTORC1 substrates</td><td class="colsep0 rowsep0" align="char" char=".">104</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>SHANK2</i><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">–1.65</td><td class="colsep0 rowsep0" align="char" char=".">–1.87</td><td class="colsep0 rowsep0" align="char" char=".">–0.44</td><td class="colsep0 rowsep0" align="char" char=".">–1.96</td><td class="colsep0 rowsep0" align="center">axon guidance, SRC pathways</td><td class="colsep0 rowsep0" align="char" char=".">203</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>SHC2</i><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–0.52</td><td class="colsep0 rowsep0" align="char" char=".">–0.83</td><td class="colsep0 rowsep0" align="char" char=".">–1.47</td><td class="colsep0 rowsep0" align="char" char=".">–1.96</td><td class="colsep0 rowsep0" align="center">signaling adapter for insulin and VEGF signaling</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>SMO</i></td><td class="colsep0 rowsep0" align="char" char=".">–0.92</td><td class="colsep0 rowsep0" align="char" char=".">–0.34</td><td class="colsep0 rowsep0" align="char" char=".">–0.82</td><td class="colsep0 rowsep0" align="char" char=".">–1.21</td><td class="colsep0 rowsep0" align="center">G protein-coupled receptor: transduces hedgehog signaling</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>TEAD2</i></td><td class="colsep0 rowsep0" align="char" char=".">–0.22</td><td class="colsep0 rowsep0" align="char" char=".">–0.65</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">–0.91</td><td class="colsep0 rowsep0" align="center">transcription factor, facilitates YAP interaction with DNA (Hippo pathway)</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>TEAD3</i></td><td class="colsep0 rowsep0" align="char" char=".">–0.59</td><td class="colsep0 rowsep0" align="char" char=".">–1.06</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">–0.66</td><td class="colsep0 rowsep0" align="center">transcription factor, facilitates YAP interaction with DNA (Hippo pathway)</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>TEAD4</i></td><td class="colsep0 rowsep0" align="char" char=".">–0.23</td><td class="colsep0 rowsep0" align="char" char=".">–0.79</td><td class="colsep0 rowsep0" align="char" char=".">–0.47</td><td class="colsep0 rowsep0" align="char" char=".">–0.31</td><td class="colsep0 rowsep0" align="center">transcription factor, facilitates YAP interaction with DNA (Hippo pathway)</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>TP73</i><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–1.44</td><td class="colsep0 rowsep0" align="char" char=".">–2.36</td><td class="colsep0 rowsep0" align="char" char=".">–0.99</td><td class="colsep0 rowsep0" align="char" char=".">–1.19</td><td class="colsep0 rowsep0" align="center">cell cycle, DNA repair regulation</td><td class="colsep0 rowsep0" align="char" char=".">91</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>ULK1</i></td><td class="colsep0 rowsep0" align="char" char=".">0.19</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">–0.81</td><td class="colsep0 rowsep0" align="char" char=".">–0.60</td><td class="colsep0 rowsep0" align="center">protein kinase  autophagy: regulates formation of autophagosomes</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup><sup>a</sup></sup><p class="last">Log<sub>2</sub> FC gene expression changes after 6 and 24 h CM03 treatment, the number of PQs and gene function are shown. Common down-regulated genes are defined as having Log<sub>2</sub> FC < 0.05 and FDR < 0.1 in both cell lines and genes are ranked by the lowest average Log<sub>2</sub> FC.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">The methylation status of genes has been associated with patient survival (see <a class="ref internalNav" href="#sec3" aria-label="Discussion">Discussion</a>).</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Genes down-regulated (Log<sub>2</sub> FC < 0.05, FDR < 0.1) in both cell lines at 6 and 24 h CM03 treatment.</p></div></div></div><div class="NLM_p">Curiously, while CM03 shows binding affinity to <i>KRAS</i> G4s in vitro (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>e), our RNA-SEQ studies show that <i>KRAS</i> mRNA expression is unaffected by CM03 treatment in either pancreatic cell line at the times and doses tested (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Table 1</a>). It may be that in a cellular context the <i>KRAS</i> G4 is rapidly resolved by unwinding helicases or that G4 binding proteins hinder drug accessibility. Thus, while the <i>KRAS</i> G4s may not be the main/initial target of CM03, we cannot assume the accessibility of <i>KRAS</i> G4 for CM03 within the native epigenetic environment. Nonetheless, our results suggests that simultaneous targeting of multiple fundamental PDAC pathways (including important KRAS effector and feedback loop signaling pathways and those involved in drug resistance) by G4 stabilization will be an advantageous approach.</div><div class="NLM_p">CM03 also resulted in the induction of DNA damage in a replication-dependent manner. While the number of BG4 foci increased upon CM03 treatment suggesting increased G4 stabilization, only a small increase in BG4 and 53BP1 co-localization was observed. It is tempting to suggest that CM03 does not cause an increase in damage at G4 sites, however, the dynamics of whether a G4 structure can co-exist with DNA damage response proteins is not well understood or whether G4s persist after DNA damage response and repair have been elicited. In support, many DNA repair pathway proteins are capable of unwinding and destabilizing G4,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> and a recent study has elucidated the role of PARP3 negatively regulating G4 in order to initiate DNA repair at DSB sites.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Hence, by 24 h, the small number of co-localizations could represent an intermediate repair state of DNA at a G4 site.</div><div class="NLM_p">In summary, we have demonstrated that CM03 is a highly potent G4-binding small molecule, with in vitro cell assays and in vivo models for human PDAC. Treatment with CM03 successfully reduced tumor growth for an extended period in PDAC xenografts and also prolonged survival in the KPC mouse model for this disease at dosage levels that do not cause observable damage to major organs yet enable selective tumor targeting. It is notable that the antitumor effects of CM03 in the xenograft model persisted until the termination of the experiment at day 62 (34 days beyond the end of dosing). This is in striking contrast to the antitumor response to gemcitabine, with tumor regrowth being apparent as soon as dosing was stopped.</div><div class="NLM_p last">Studies with PDAC cell lines suggest that the mechanism of action of CM03 is via the G4-dependent down-regulation of genes in a number of essential pathways associated with PDAC survival, metastasis, and drug resistance, together with the activation of G4 replication-dependent DNA damage. Furthermore, given the good bioavailability of CM03 and its ability to target many oncogenic pathways essential to tumorigenesis in general, we suggest that CM03 has the potential to be used as an effective anticancer therapeutic in a number of other cancers in addition to PDAC. It is tempting to speculate that the selective tumor targeting is associated with G4 binding, and future studies will address this question.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemistry</h3><div class="NLM_p">The synthesis and characterization of MM41 (4,9-bis((3-(4-methylpiperazin-1-yl)propyl)amino)-2,7-bis(3-morpholinopropyl)benzo[<i>lmn</i>][3,8]phenanthroline-1,3,6,8(2<i>H</i>,7<i>H</i>)-tetraone: molecular weight 831.08) has been previously reported.<a onclick="showRef(event, 'cit32a'); return false;" href="javascript:void(0);" class="ref cit32a">(32a)</a> MM41 was analytically pure as shown by LC-MS and NMR methods and was formulated for biological studies as the freely water-soluble formate salt.</div><div class="NLM_p">The traditional synthetic route to highly substituted naphthalene diimides starts from 1,4,5,8-naphthalene tetracarboxylic dianhydride, which is then reacted with dibromoisocyanuric acid, leading to the mono- and dibromonaphthalene diimide as key intermediates, followed by introduction of the amine chains at the imide and bay positions, in that order. This synthesis results in a complex mixture requiring purification by preparative HPLC at least twice to obtain the desired products in very low yield (less than 10%). The critical aspect of the present synthetic scheme was preparation of the monobrominated naphthalene diimide precursor; this is insoluble, so purification at this stage was not attempted, nor was there any evaluation of the amount of monobromo derivative obtained. Purification can be performed only after the N–N′ imidation reaction due to the aqueous solubility that is imparted by the introduction of the basic morpholino side chains. Instead, the procedure was modified as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><div class="NLM_p">All chemicals, reagents, and solvents were purchased from Sigma-Aldrich, Alfa Aesar, Lancaster Synthesis, and Fluorochem (UK) and used without further purification. Solvents were supplied by VWR and Fisher Scientific. Column chromatography was performed using BDH silica gel (BDH 153325P). Chromatography was conducted under medium pressure in glass columns or using a Biotage SP4 instrument in prepacked columns (FLASH Silica columns (40–63 μm, 60 Å)). HPLC analysis was carried out with a Gilson apparatus combining a 322 pump and an Agilent 1100 series detector, using a C18 5 μ (100 mm × 4.6 mm) column (41622271 (W), YMC, Japan) at a flow of 1 mL/min. Preparative HPLC was carried out with a Gilson apparatus combining a 322 pump and a UV/vis-155 detector with detection at 280 nm, using a C18 5 μ (100 mm × 20 mm) column (201022272) (W), YMC, Japan, at a flow of 20 mL/min. Water and methanol with 0.1% formic acid were used as solvents for HPLC. For the purification of compound CM03, the following method was used: 100% aqueous solution for 5 min after injection, then gradually decreased to 60% aqueous solution over 25 min.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 2-Bromo-1,4,5,8-naphthalenetetracarboxylic Acid Dianhydride (<b>2a</b>) and 2,6-Dibromo-1,4,5,8-naphthalenetetracarboxylic Acid Dianhydride (<b>2b</b>)</h4><div class="NLM_p last">Naphthalene dianhydride (<b>1</b>, from Sigma-Aldrich) (150 mg, 0.56 mmol) was slurried in sulfuric acid (1.5 mL), and the suspension obtained was stirred for 5 min at room temperature to allow the complete dissolution. 5,5-Dimethyl-1,3-dibromohydantoin (88 mg, 0.308 mmol) was added slowly over a period of 1 h, and the round-bottom flask was tightly stopped to avoid the escape of bromine from the reaction mixture. The solution was stirred at 80 °C for 72 h and then poured onto ice (30 mL). The yellow solid formed was filtered, washed with water (2 × 10 mL), and dried under vacuum, yielding a mixture <b>2a</b> and <b>2b</b>. No NMR data were obtained due to solubility issues. The resulting mixture was used without further purification in the next step.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> <i>N</i>,<i>N</i>′-Bis(3-(morpholino)propylamino)-2-bromo-1,4,5,8-naphthalenetetracarboxylic Acid Diimide (<b>3a</b>)</h4><div class="NLM_p last">Compounds <b>2a</b> and <b>2b</b> (194 mg, 0.56 mmol) were suspended with sonication in glacial acetic acid (1.5 mL) in a microwave reaction vessel. 3-Morpholinopropyalamine (242 mg, 245 μL, 1.68 mmol) was added dropwise to the stirring mixture. The reaction tube was sealed and treated for 30 min at 125 °C in the microwave. The solution was then basified with potassium carbonate and extracted with chloroform (3 × 5 mL). The organic phases were collected, dried over sodium sulfate, and evaporated. The residue obtained was purified through column chromatography using as eluent a CH<sub>2</sub>Cl<sub>2</sub>/MeOH 96/40 mixture. Yield <b>3a</b> (107 mg, 0.18 mmol, 35%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.95–1.97 (m, 4H), 2.40–2.43 (m, 8H), 2.52–2.53 (m, 4H), 3.51–3.54 (m, 8H), 4.28–4.33 (q, 4H, <i>J</i> = 8 Hz), 8.77 (d, 1H, <i>J</i> = 8 Hz), 8.82 (d, 1H, <i>J</i> = 7.6 Hz), 8.935 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, TMS) δ 23.31, 23.44, 38.81, 39.11, 52.50, 55.51, 55.45, 65.37, 65.41, 123.97, 125.75, 125.95 (2C), 126.01, 126.84, 128.68, 128.76, 130.73, 131.71, 138.44, 161.17, 161.87, 161.98, 162.56. HRMS (ES<sup>+</sup>) calculated C<sub>28</sub>H<sub>33</sub>BrN<sub>4</sub>O<sub>6</sub> [M + 2H]<sup>+</sup> 600.1543, found 600.1536.</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 2,7-Bis(3-morpholinopropyl)-4-((2-(pyrrolidin-1-yl)ethyl)amino)benzo[<i>lmn</i>][3,8]phenanthroline-1,3,6,8(2<i>H</i>,7<i>H</i>)-tetraone (Compound <b>4</b>: CM03)</h4><div class="NLM_p">Compound <b>3a</b> (0.15 g, 0.25 mmol), 1-(2-aminoethyl)pyrrolidine (0.06 mL, 0.51 mmol), and NMP (1 mL) were suspended in a microwave reaction vessel. The reaction tube was sealed and treated for 25 min at 130 °C in the microwave. After having been cooled to room temperature, the solvent was concentrated and the crude mixture was purified by column chromatography, using as eluent a mixture of CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>3</sub> 95/5/0.4. Compound <b>4</b> was obtained as a red oil (118 mg, 0.186 mmol, 75% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, TMS) δ 2.019–2.040 (m, 8H), 2.683–2.782 (m, 12H), 3.195 (t, 4H, <i>J</i> = 6.4 Hz), 3.32 (t, 2H, <i>J</i> = 6.6 Hz), 3.708 (t, 4H, <i>J</i> = 4.8 Hz), 3.764 (t, 4H, <i>J</i> = 4.6 Hz), 4.009–4.024 (m, 2H), 4.22 (t, 4H, <i>J</i> = 7 Hz), 8.237 (s, 1H), 8.28 (d, 1H, <i>J</i> = 7.6 Hz), 8.56 (d, 1H, <i>J</i> = 8 Hz), 10.174 (t, 1H, exch D<sub>2</sub>O, <i>J</i> = 4.2 Hz). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 23.3, 23.6, 23.7, 38.2, 38.9, 40.1, 52.6, 52.8, 53.9, 53.9, 55.8 (2C), 65.6, 65.8, 100.7, 119.1, 119.5, 123.5, 124.9, 126.1, 128.0, 129.2, 131.4, 151.8, 162.8, 163.2, 165.9, 166.5. HRMS (ES<sup>+</sup>) calculated for (M + H)<sup>+</sup> C<sub>34</sub>H<sub>45</sub>N<sub>6</sub>O<sub>6</sub> 633.3389, found 633.3401. For the HPLC purity analysis of this compound, the method used was: 100% aqueous solution for 5 min after injection, to 60% w/v aqueous solution over 18 min as well as 100% aqueous for 5 min after injection, to 60% w/v aqueous over 43 min. The purity for the final compound was greater than 95% (HPLC, 280 nm) and was further checked by LC-MS.</div><div class="NLM_p last">CM03 was then converted to a mixed hydrochloride/formate salt in order to enhance its aqueous solubility. At a concentration of 5 mg/mL, the pH of the CM03 salt solution was 6.95.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Molecular Modeling</h3><div class="NLM_p">The crystal structure of the naphthalene diimide intramolecular telomeric G4 complexes<a onclick="showRef(event, 'ref32 ref74'); return false;" href="javascript:void(0);" class="ref ref32 ref74">(32,74)</a> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2T5E">2T5E</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DA3">4DA3</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UYH">3UYH</a>) were used as starting points to study G4–ligand interactions, in particular that with the compound MM41.<a onclick="showRef(event, 'cit32a'); return false;" href="javascript:void(0);" class="ref cit32a">(32a)</a> The structure of the native human intramolecular DNA quadruplex with parallel-stranded propeller-type topology was extracted from the Protein Data Bank (<a href="http://www.rscb.org" class="extLink">www.rscb.org</a>) and used for docking with CM03. The final structures were subjected to 1000 steps of conjugate gradient energy minimization to relieve any structural distortions.</div><div class="NLM_p last">The docking protocol was consistent for all systems. The chemical structures of the ligands MM41 and CM03 were sketched, built, and docked using ICM-Pro software (<a href="http://www.molsoft.com" class="extLink">www.molsoft.com</a>). Atom-centered charges were assigned using the ICFF force field.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Grid maps were made that encompassed the terminal quartets, central K<sup>+</sup> ions, and the loops. Docking was done using the automated docking module in the ICM-Pro package, employing the default parameters. The final docked conformations were chosen based on the strongest binding energy between the docked ligands and the G4. The grids were large enough to allow translation and rotation of the ligands. The top 20 plausible conformations of the ligands were then analyzed. The final docked models were chosen based on the largest interaction energy between G4 and ligand. The positively charged ions were retained within the central axis of the G4 channel and were treated as an integral part of the G4 structure.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> FRET Studies</h3><div class="NLM_p">FRET DNA melting assays on MM41 and CM03 were performed using a fluorescence resonance energy transfer (FRET) assay.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The labeled oligonucleotides had the fluorophores 6-carboxyfluorescein (FAM) as donor and fluorophore 6-carboxytetramethyl-rhodamine (TAMRA) attached as acceptor. The sequences used are</div><div class="NLM_p">Human telomeric G4 (F21T): 5′-FAM-d(GGG[TTAGGG]<sub>3</sub>)-TAMRA-3′.</div><div class="NLM_p">Duplex sequence 5′-FAM-d(TATAGCTATA-HEG-TATAGCTATA)-TAMRA-3′ (HEG linker, [(−CH<sub>2</sub>-CH<sub>2</sub>-O−)<sub>6</sub>])).</div><div class="NLM_p">HSP90a: 5′-FAM-d(GGGCCAAAGGGAAGGGGTGGG)-TAMRA-3′.</div><div class="NLM_p">HSP90b: 5′-FAM-d(GGGCGGGCCAAAGGGAAGGGG)-TAMRA-3′.</div><div class="NLM_p">Kras21: 5′-FAM-d(AGGGCGGTGTGGGAAGAGGGA)-TAMRA-3′.</div><div class="NLM_p">Kras32: 5′-FAM-d(AGGGCGGTGTGGGAAGAGGGAAGAGGGGGAGG)-TAMRA-3′.</div><div class="NLM_p">Bcl-2: 5′-FAM-d(GGGCGCGGGAGGAAGGGGGCGGG)-TAMRA-3′.</div><div class="NLM_p last">The FRET probe sequences were diluted from stock to the correct concentration (400 nM) in a 60 mM potassium cacodylate buffer (pH 7.4) and then annealed by heating to 95 °C for 10 min, followed by cooling to RT in a heating block (3–3.5 h). Drug stock solutions (at 2× concentration) were prepared using 60 mM potassium cacodylate buffer (pH 7.4). Then 96-well plates (MJ Research, Waltham, MA) were prepared by aliquoting 50 μL of annealed DNA into each well, followed by 50 μL of the compound solutions. Measurements were made on a DNA Opticon Engine (MJ Research) with excitation at 450–495 nm and detection at 515–545 nm. Fluorescence readings were taken at intervals of 0.5 °C in the range 30–100 °C, with a constant temperature being maintained for 30 s prior to each reading to ensure a stable value. Final analysis of the data was carried out using a script written in the Origin 7.0 (OriginLab Corp., Northampton, MA) package and its advanced curve-fitting function for derivation of Δ<i>T</i><sub>m</sub> values.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Quantitative G4 Binding Studies</h3><div class="NLM_p">Human telomeric DNA G4 was prepared using oligonucleotides purchased from Integrated DNA Technologies (Coralville, IA, USA). The DNA purity and sequence was verified by mass spectrometry. Desalted oligonucleotide sequences were initially suspended in 150 mM NH<sub>4</sub>OAc (pH 6.8) in nuclease-free water to yield a final concentration of 1 mM and determined spectroscopically at 260 nm using the nearest-neighbor method. The stock solution was aliquoted into 20 μL samples in 200 μL PCR tubes. Using a thermocycler, samples were heated to 98 °C for 10 min, slowly cooled for 15 min while remaining within the thermocycler, followed by an additional cooling session at RT for 30 min, and stored at 4 °C before use.</div><div class="NLM_p">Fluorescence anisotropy measurements were obtained on a Variant Cary Eclipse fluorescence spectrophotometer (Agilent Technologies, Santa Clara, CA, USA) equipped with a polarization attachment. The excitation and emission polarizers were fixed between the light source and detector, respectively. Measurements were converted into anisotropy values by using <a class="ref internalNav" href="#eq1" aria-label="eqs 1">eqs 1</a> and <a class="ref internalNav" href="#eq2" aria-label="2">2</a>:<span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_m001.gif" alt="" id="_i20" /></img><span class="labelSpan">(1)</span></span><span class="NLM_disp-formula" id="eq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_m002.gif" alt="" id="_i21" /></img><span class="labelSpan">(2)</span></span></div><div class="NLM_p"><i>r</i> is the anisotropy value, <i>I</i><sub>vv</sub> is the fluorescence intensity of the samples when excitation and emission polarizers are aligned in vertical positions, <i>I</i><sub>vh</sub> is the fluorescence intensity of the samples when the excitation and emission polarizers are in vertical and horizontal positions, respectively, <i>I</i><sub>hv</sub> is the fluorescence intensity of compound when excitation and emission polarizers are aligned in horizontal and vertical positions, <i>I</i><sub>vv</sub> is the fluorescence intensity of compound when excitation and emission polarizers are aligned in vertical positions, and GF is the grating factor of the polarizers. The GF value was introduced to the equation to correct for unequal sensitivity of the excitation and emission polarizers.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><div class="NLM_p">To determine dissociation constants, MM41 was added to a 3 mL volume of the experimental buffer (50 mM KCl, 10 mM Tris-HCl, 1 mM EDTA in nuclease-free water at 25 °C, pH 7.3) in a quartz fluorescence cuvette at a fixed concentration of 50 nM, and G4 was titrated into the cuvette. Oligonucleotide concentrations were calculated before each titration experiment and fluorophore concentrations corrected after each addition by taking dilution into account. Measurements were taken at a maximum emission wavelength of MM41 (λ<sub>em</sub> = 670 nm) with excitation at λ<sub>ex</sub> = 630 nm. Both excitation and emission slits were at 20 nm. Each set of measurements were taken from a 50 s average reading measurement (PMT = 630 V). The dissociation constant (<i>K</i><sub>D</sub>) of MM41 to G4 was obtained by fitting the change in anisotropy value of the compound titration using the following equation:<span class="NLM_disp-formula" id="eq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_m003.gif" alt="" id="_i22" /></img><span class="labelSpan">(3)</span></span></div><div class="NLM_p"><i>r</i><sub>min</sub> is the anisotropy value of free MM41, <i>r</i><sub>max</sub> is the anisotropy value of bound MM41, <i>L</i> is the total concentration of MM41, and <i>D</i> is the total concentration of G4.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><div class="NLM_p">Direct fluorescence measurements were performed using the same instrument and experimental buffer. Both emission and excitation slits were set to 20 nm. Fluorescence was measured in a quartz fluorescence cuvette with a starting CM03 concentration of 25 nM. The amount of oligonucleotide needed for the experiment was calculated and titrated into the cuvette. Changes in maximum emission intensity of CM03 (λ<sub>em</sub> = 570 nm) were observed and recorded upon binding to telomeric DNA. The curve fit equation is similar to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>, taking into account that fluorescence intensity values decrease upon titration (initial intensity > final intensity). The results were fitted to obtain a dissociation constant (<i>K</i><sub>D</sub>) using the fluorescence quenching equation below:<span class="NLM_disp-formula" id="eq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_m004.gif" alt="" id="_i23" /></img><span class="labelSpan">(4)</span></span></div><div class="NLM_p last"><i>A</i><sub>initial</sub> is the intensity measured for free CM03, <i>A</i><sub>final</sub> is the intensity measured of bound CM03, <i>K</i><sub>D</sub> is the dissociation constant of the complex, <i>L</i> is the total concentration of CM03, and <i>D</i> is total concentration of G4.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Cell Culture Studies</h3><div class="NLM_p last">All cell lines were purchased from ATCC and maintained in appropriate medium supplemented with 10% fetal bovine serum (Invitrogen, UK), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Invitrogen, Netherlands), and other components as specified by the suppliers. Cell lines were maintained at 37 °C, 5% CO<sub>2</sub>, and routinely passaged. Drugs were dissolved in H<sub>2</sub>O and filtered through 0.22 μm pore-size filter units (stock 10 mM) before addition to appropriate cell line media. Cellular growth inhibition was measured using the sulforhodamine B (SRB) assay in 96-well plates as described previously.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The 50% inhibitory concentrations (IC<sub>50</sub>) were determined by taking the mean absorbance at 540 nm for each drug concentration expressed as a percentage of the absorbance of untreated control wells.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Xenograft Studies</h3><div class="NLM_p">All animal experiments were performed in accordance with the UK Home Office Animals Scientific Procedures Act 1986 and the United Kingdom Coordinating Committee on Cancer Research Guidelines for the Welfare and Use of Animals in Cancer Research<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> and with the approval of the University College London Animal Ethics Committee. Mice had access to food and water ad libitum.</div><div class="NLM_p">The maximum tolerated dose (MTD) studies of MM41 and CM03 were performed in CD-1 nude mice. The MTD of a single dose administered intravenously (IV) was examined, and repeat dosing was performed per week at different concentrations of MM41 (20, 25, and 30 mg/kg) and CM03 (10, 20, 30, 35, 40, 45, 50, and 60 mg/kg), with two mice per group. Compounds were administered in saline. Mice were monitored visually for signs of adverse effects over periods of up to 72 h. The maximum tolerated dose was judged to have been reached when all mice in a particular dose cohort survived in the absence of any observed ill effects for the period of the experiment.</div><div class="NLM_p">For therapy studies, female CD-1 nude mice (2–3 months old, weighing 20–25 g) were injected subcutaneously with 5 × 10<sup>6</sup> MIA PaCa-2 cells in the right flank (unsupplemented RPMI + Matrigel). When the tumors were established (approximately 13 days, mean size 0.05 cm<sup>3</sup>), the mice were divided into five treatment groups with eight mice/group. The MM41 and CM03 samples were dissolved directly in saline to the required concentrations and administered IV. Tumor size was measured weekly by calliper using the π-based ellipsoid volume formula (length × width × height × π/6) every 3–4 days, and the mice were also weighed and examined at the same time to determine any signs of toxicity from the drug.</div><ul class="NLM_list-list_type-label"><li><p class="inline">Group 1:15 mg/kg of gemcitabine (Sigma), twice weekly dose.</p></li><li><p class="inline">Group 2:15 mg/kg of MM41, twice weekly dose.</p></li><li><p class="inline">Group 3:10 mg/kg of CM03, twice weekly dose.</p></li><li><p class="inline">Group 4:15 mg/kg of CM03, twice weekly dose.</p></li><li><p class="inline">Group 5: saline only, twice weekly dose.</p></li></ul><div class="NLM_p last">The xenograft data was analyzed using Student’s <i>t</i> test (GraphPad Inc.). Responses were considered to be significant for those with probabilities (<i>p</i>) less than 5% (<i>p</i> < 0.05). Mice were culled if there was any sign of tumor ulceration, if tumor volume exceeded 1.5 cm<sup>3</sup>, or if a weight loss over 20% of initial body weight was observed. Samples of liver, kidney, and spleen from each animal in the CM03 (15 mg/kg) and untreated control groups were excised at the end of the therapy experiment, then fixed in 10% neutral buffered formalin for at least 48 h prior to processing and paraffin embedding. Tissue slices were stained with hematoxylin and eosin and assessed visually for any obvious differences compared with controls, indicative of toxicity and tissue damage. For the imaging study mice were anesthetized using isoflurane and imaged using the IVIS preclinical imaging system from PerkinElmer. Images were captured after 4 h following intravenous administration of CM03 using Cy5.5 excitation for 5 s.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> KPC Mouse Model</h3><div class="NLM_p last">KPC (<i>Pdx1-Cre</i>; <i>LSL-Kras</i><sup><i>G12D/+</i></sup>; <i>LSL-Trp53</i><sup><i>R172H/+</i></sup>) mice were described previously.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Mice on a mixed background were bred in-house and maintained in conventional caging with environmental enrichment, access to standard chow, and water ad libitum. Genotyping was performed by Transnetyx (Cordoba, TN, USA). Mice were monitored three times weekly and randomized to receive either 15 mg/kg of CM03, or saline control IP, twice weekly when exhibiting symptoms of PDAC (swollen abdomen, loss of body conditioning resembling cachexia, reduced mobility). Pancreatic malignancy was confirmed by abdominal palpation. Mice were culled by schedule 1 method when symptoms progressed. All animal experiments were performed under a UK Home Office license and approved by the University of Glasgow Animal Welfare and Ethical Review Board.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> RNA-seq Studies</h3><div class="NLM_p">RNA-seq analyses of exposure to CM03 were undertaken at Cambridge with PANC-1 cells and at UCL with MIA PaCa-2 cells. Data merging and subsequent analyses were undertaken in Cambridge.</div><div id="sec4_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Cell Culture</h4><div class="NLM_p last">The PDAC cell lines PANC-1 (ATCC, catalogue no. CRL-1469) and MIA PaCa-2 (ATCC, catalogue no. CRL-142) were maintained in DMEM (ThermoFisher, catalogue no. 11965092) supplemented with 10% (v/v) heat inactivated FBS (ThermoFisher) in a humidified atmosphere containing 5% CO<sub>2</sub> at 37 °C. Cell lines were confirmed mycoplasma free by RNA-capture ELISA, and their genotypes were certified by STR profiling.</div></div><div id="sec4_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Determination of CM03 and Gemcitabine Dosage for RNA-Seq</h4><div class="NLM_p last">PANC-1 and MIA PaCa-2 cell lines were seeded overnight at 3 × 10<sup>3</sup> cells/well and 2 × 10<sup>3</sup> cells/well in 96-well plates, respectively. Next morning, cells were treated with 0–10 μM CM03 (stock 10 mM in dH<sub>2</sub>0) for 24 h. For treatment with gemcitabine-HCl (Tocris, catalogue no. 3259) (stock 50 mM in DMSO), cells were treated with 0–5 mM for 24, 48, 72, and 96 h. Cells were then incubated with 100 μL/well of CellTiter-Glo One Solution Assay reagent (Promega, catalogue no. G8461) for 30 min at RT, and luminescence was measured using a PHERAstar FS microplate reader (BMG LabTech). Cell survival curves were then plotted and GI<sub>50</sub> values were calculated using GraphPad Prism version 6.00 (GraphPad Software Inc.). Error bars represent standard deviation of the mean of four technical replicates.</div></div><div id="sec4_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> RNA-seq</h4><div class="NLM_p last">PANC-1 (0.35 × 10<sup>6</sup> cells/well) and MIA PaCa-2 (1.5 × 10<sup>6</sup> cells/well) cell lines were seeded overnight in 60 mm plates. Next day, cells were treated with 400 nM CM03 for 6 and 24 h. For gemcitabine treatment, cells were treated for 6 and 24 h with DMSO or 30 nM, 100 nM, 300 nM, 1 μM, 3 μM, and 10 μM gemcitabine-HCL for PANC-1 cells and 30 nM, 300 nM, and 3 μM gemcitabine-HCl for MIA PaCa-2 cells. Total RNA was extracted using the Qiagen RNeasy Plus Mini Kit (ThermoFisher, catalogue no. 74134) as per the manufacturer’s instructions. RNA quality (RIN > 9.0) was checked with an Aligent 2100 bioanalyzer RNA 6000 Nano Chip, and RNA concentration was quantified using a Qubit fluorometer (ThermoFisher) and Qubit RNA HS Assay Kit (Qiagen, catalogue no. Q32852). RNA-seq libraries were then generated using the Illumina Truseq RNA HT (stranded mRNA) kit (Illumina, catalogue no. RS-122–2103) as per the manufacturer’s instructions and sequenced using an Illumina HiSeq4000.</div></div><div id="sec4_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> RNA-Seq Analysis</h4><div class="NLM_p last">Fastq raw sequencing files were preprocessed using cutadapt<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> to remove sequencing adapters and low quality sequencing tails (options −q 10) and then aligned to the human genome (GRCh37/hg19) using tophat2<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> and using the UCSC gtf file provided by Illumina iGenomes as an annotation file (<a href="http://support.illumina.com/sequencing/sequencing_software/igenome.html" class="extLink">http://support.illumina.com/sequencing/sequencing_software/igenome.html</a>). Gene counts were calculated using htseq-count<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> and the same gtf file. Differential expression analysis was done using the R package edgeR.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Differentially expressed genes were estimated independently for both cell lines (MIA PaCa-2 and PANC-1) and for the different time points (6 and 24 h) and were then intersected to inspect the common genes. The sequencing data is available at the GEO public functional genomics data repository (<a href="https://www.ncbi.nlm.nih.gov/geo/" class="extLink">https://www.ncbi.nlm.nih.gov/geo/</a>) as GSE105083. Details of the putative G4 sequence (PQs) analysis are given in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>.</div></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Immunofluorescence Microscopy</h3><div class="NLM_p last">BG4 and 53BP1 immunofluorescence experiments were performed essentially as described,<a onclick="showRef(event, 'ref16 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref18">(16,18)</a> with slight modifications. In brief, 8 × 10<sup>4</sup> PANC-1 cells were seeded overnight on circular no. 1.5 coverslips per well in 12-well plates. Next day, cells were incubated with 400 nM CM03 (or left untreated) in 1 mL of media at 37 °C for 6 and 24 h and then fixed with 4 (v/v) % freshly prepared paraformaldehyde in 1× PBS for 10 min at RT. Coverslips were washed 1× PBS, permeabilized with 0.1% (v/v) Triton-X100 in PBS for 10 min, washed with 1× PBS, and blocked with 2% (w/v) Marvel milk (Premier Foods plc) in PBS for 1 h at 37 °C. After blocking, coverslips were incubated with BG4 (20 nM) at 37 °C for 1 h, washed three times for 5 min with PBST (0.1% (v/v) Tween 20), and then incubated with 37 °C for 1 h with rabbit α-FLAG 1:800 (CST, catalogue no. 2368) and mouse α-53BP1 1:500 (Millipore, catalogue no. MAB2803). Subsequently, all coverslips were washed as described and incubated for 30 min at 37 °C with goat α-rabbit Alexa-488 (Thermofisher, catalogue no. A-11034) and goat α-mouse Alexa-647 (ThermoFisher, catalogue no. A-21236) at 1:800 dilution. DAPI nuclear counterstain was included in the final antibody incubation. Coverslips were then rinsed three times with reverse osmosis grade water, air-dried, and mounted onto Superfrost Plus slides (ThermoFisher, catalogue no. 4951PLUS) with ProLong Diamond Antifade Mountant (Invitrogen, catalogue no. P36961). Three biological replicates were performed. <i>Z</i>-Stack images (11 steps, 0.3 μm apart) were acquired on a Nikon Eclipse TE2000E inverted microscope with a Nikon Plan Apo λ 100× NA 1.45 oil DIC H immersion objective using an Andor Neo SCC-00488 camera at 0.06 μm per pixel. Fluorescence illumination was with a xenon source and FITC, Cy5, and DAPI fluorescent filter cubes used to image BG4, 53BP1, and the nuclei, respectively. Then 10–12 <i>Z</i>-stacks were taken per replica representing approximately 50–100 nuclei. Images were deconvolved using Huygens Professional Software (Scientific Volume Imaging BV). See extended methods, immunofluorescence, for the custom protocol designed for the BG4-53BP1 foci quantification and co-localization method.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> RT-qPCR Studies</h3><div class="NLM_p last">MIA PaCa-2 (6 h = 2.5 × 10<sup>6</sup> and 24 h = 1.0 × 10<sup>6</sup> cells/well) and PANC-1 (6 h = 1.0 × 10<sup>6</sup> and 24 h = 0.5 × 10<sup>6</sup> cells/well) cell lines were seeded in 100 mm plates and incubated overnight. In the following day, cells were treated with 400 nM CM03, 400 nM gemcitabine, PBS, or DMSO for 6 and 24 h. Total RNA was extracted from 2–4 × 10<sup>6</sup> cells using the RNeasy mini kit (Qiagen, catalogue no. 74104), and on-column DNaseI digestion (Qiagen, catalogue no. 79254) was performed to remove residual genomic DNA. The concentration of harvested RNA was measured with a NanoDrop 2000/2000c spectrophotometer (ThermoFisher). The required amount of RNA was reverse transcribed into cDNA using a SuperScript III First-Strand Synthesis System (ThermoFisher, catalogue no. 18080051) following the manufacturer’s instructions. RT-qPCR was performed using Power SYBR Green Master Mix (ThermoFisher, catalogue no. 4368706) with a 50 ng template and 150 nM primers in an AriaMx Realtime PCR System (Agilent). Primers were purchased from Eurofins Genomics or from Sigma (KiCqStart SYBR Green Primers). Data was derived from three or four independent experiments, each performed in triplicate. The <i>C</i><sub>t</sub> values were normalized to the genomic mean of three housekeeping genes <i>ACTB</i>, <i>GAPDH</i>, and <i>TUBB</i>, and the fold change was determined using 2<sup>–ΔΔ<i>C</i>t</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Ancillary Data</h3><div class="NLM_p last">The sequencing data is available at the GEO public functional genomics data repository (<a href="https://www.ncbi.nlm.nih.gov/geo/" class="extLink">https://www.ncbi.nlm.nih.gov/geo/</a>), as GSE105083. The PDB files for the “best” molecular models of MM41 and CM03 with the human DNA telomeric quadruplex are available as <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01781" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26326" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26326" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01781" class="ext-link">10.1021/acs.jmedchem.7b01781</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Supplementary figures and extended descriptions of the methodology and results of the RNA-seq experiments (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">MIAPACA2 PANC1 degene PQs summary CM03 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_002.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">Common degene PQs summary CM03 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_003.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">PQs Box Whisker Plots statistics (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_004.xls" class="ext-link">XLS</a>)</p></li><li><p class="inline">Degenes 300 nM gemcitabine (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_005.xls" class="ext-link">XLS</a>)</p></li><li><p class="inline">KEGG pathway common degenes PQs summary CM03 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_006.xls" class="ext-link">XLS</a>)</p></li><li><p class="inline">MIAPACA2 PANC1 KEGG pathway degenes summary CM03 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_007.xls" class="ext-link">XLS</a>)</p></li><li><p class="inline">KEGG pathway degenes 300 nM gemcitabine (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_008.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">SMILES molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_009.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">CM03 with human telomeric G4 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_010.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">MM41 with human telomeric G4 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_011.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf">jm7b01781_si_001.pdf (2.97 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_002.xlsx">jm7b01781_si_002.xlsx (4.25 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_003.xlsx">jm7b01781_si_003.xlsx (3.62 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_004.xls">jm7b01781_si_004.xls (61.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_005.xls">jm7b01781_si_005.xls (15.75 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_006.xls">jm7b01781_si_006.xls (107.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_007.xls">jm7b01781_si_007.xls (161.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_008.xlsx">jm7b01781_si_008.xlsx (84.42 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_009.csv">jm7b01781_si_009.csv (0.34 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_010.pdb">jm7b01781_si_010.pdb (61.09 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_011.pdb">jm7b01781_si_011.pdb (42.18 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01781" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33816" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33816" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Neidle</span> - <span class="hlFld-Affiliation affiliation">UCL
School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0622-6548" title="Orcid link">http://orcid.org/0000-0003-0622-6548</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#55267b3b303c313930152036397b34367b203e"><span class="__cf_email__" data-cfemail="02712c6c676b666e674277616e2c63612c7769">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiara Marchetti</span> - <span class="hlFld-Affiliation affiliation">UCL
School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katherine G. Zyner</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephan A. Ohnmacht</span> - <span class="hlFld-Affiliation affiliation">UCL
School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mathew Robson</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Centre, UCL Cancer Institute, University College London, London WC1E 6BT, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shozeb M. Haider</span> - <span class="hlFld-Affiliation affiliation">UCL
School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer P. Morton</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK, Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Cancer Sciences. University of Glasgow, Glasgow G12 8QQ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanni Marsico</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tam Vo</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Center for Biotechnology and Drug Design, Georgia State University, Atlanta, Georgia 30303-3083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah Laughlin-Toth</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Center for Biotechnology and Drug Design, Georgia State University, Atlanta, Georgia 30303-3083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ahmed A. Ahmed</span> - <span class="hlFld-Affiliation affiliation">UCL
School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gloria Di Vita</span> - <span class="hlFld-Affiliation affiliation">UCL
School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ingrida Pazitna</span> - <span class="hlFld-Affiliation affiliation">UCL
School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mekala Gunaratnam</span> - <span class="hlFld-Affiliation affiliation">UCL
School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachael J. Besser</span> - <span class="hlFld-Affiliation affiliation">UCL
School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana C. G. Andrade</span> - <span class="hlFld-Affiliation affiliation">UCL
School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seckou Diocou</span> - <span class="hlFld-Affiliation affiliation">UCL
Cancer Institute, University College London, London WC1E 6BT, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeremy A. Pike</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, U.K.</span>; 
    <span>Present Address:
                        For J.A.P.: Centre of Membrane Proteins and Receptors, University of Birmingham, Birmingham B15 2TT, U.K</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Tannahill</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">R. Barbara Pedley</span> - <span class="hlFld-Affiliation affiliation">UCL
Cancer Institute, University College London, London WC1E 6BT, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">T. R. Jeffry Evans</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK, Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Cancer Sciences. University of Glasgow, Glasgow G12 8QQ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">W. David Wilson</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Center for Biotechnology and Drug Design, Georgia State University, Atlanta, Georgia 30303-3083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shankar Balasubramanian</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">The
School of Clinical Medicine, University
of Cambridge, Cambridge CB2 0SP, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Cambridge, Cambridge CB2 1EW, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0281-5815" title="Orcid link">http://orcid.org/0000-0002-0281-5815</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>C.M. and K.G.Z. contributed equally to this work. In London, S.N. conceived the overall project, coordinated the various activities, analyzed the modeling data and the RNA-seq analysis performed at UCL, and oversaw writing the manuscript. C.M. and S.A.O. designed CM03, developed the synthetic route, and undertook the FRET studies, with the help of I.P. and G.Di.V. S.M.H. undertook the molecular modeling and simulation studies. M.G., R.J.B., and A.C.G.A. undertook the cell biology and RNA extraction for the RNA-seq studies at UCL. M.R., R.B.P., and S.D. undertook the xenograft studies, and J.M. and T.R.J.E. were responsible for the KPC study. A.A.A. undertook the qRT-PCR studies. T.V., S.L.T., and W.D.W. performed the quantitative binding studies in Atlanta, Georgia, USA. At Cambridge UK, K.G.Z. carried out all experiments, RNA-seq library preparation and sequencing, which was carried out by the Genomic Core service at the CRUK Cambridge Institute. G.M. designed, implemented, and performed the genomic bioinformatics analyses. D.T. and K.G.Z. designed immunofluorescence microscopy experiments, and D.T., G.M. and K.G.Z. designed the RNA-seq experiments. K.G.Z. and J.A.P. designed and quantitated the colocalization immunofluorescence microscopy experiments. All Cambridge authors interpreted the data and wrote the sequencing and immunofluorescence sections of manuscript as well as a major part of the discussion.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d59e3596-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64630" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64630" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Work in the S.N. laboratory has been supported by the Pancreatic Cancer Research Fund, the Medical Research Council, the Wellcome Trust, and Johnson & Johnson, with current support from the UCL Technology Fund. K.G. Z, D.T., and G.M. thank the staff of the Genomic, Light Microscopy and Biorepository core facilities at Cancer Researcher UK Cambridge Institute. S.N. thanks Tony Brooks and the staff of the UCL Genomics Facility for expert assistance with RNA-seq studies at UCL. S.B. acknowledges the support of the University of Cambridge and a Cancer Research UK programme grant. K.G.Z, D.T., and G.M. are supported by core funding from Cancer Research UK (C14303/A17197). S.B. is a Wellcome Trust Senior Investigator. We are grateful to Drs. Richard Angell and Sally Oxenford (UCL Drug Discovery Group) and Professor Daniel Hochhauser (UCL Cancer Institute) for helpful discussions. J.P.M. and T.R.J.E. acknowledge the support of the Cancer Research UK Glasgow Centre and the BSU facilities at the Cancer Research UK Beatson Institute (C596/A18076, C596/A17196).</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65841" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65841" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 84 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamisawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaori, K.</span></span> <span> </span><span class="NLM_article-title">Pancreatic cancer</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(16)00141-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2FS0140-6736%2816%2900141-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26830752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2mtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2016&pages=73-85&author=T.+Kamisawaauthor=L.+D.+Woodauthor=T.+Itoiauthor=K.+Takaori&title=Pancreatic+cancer&doi=10.1016%2FS0140-6736%2816%2900141-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer</span></div><div class="casAuthors">Kamisawa, Terumi; Wood, Laura D.; Itoi, Takao; Takaori, Kyoichi</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">10039</span>),
    <span class="NLM_cas:pages">73-85</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pancreatic cancer is a highly lethal disease, for which mortality closely parallels incidence.  Most patients with pancreatic cancer remain asymptomatic until the disease reaches an advanced stage.  There is no std. program for screening patients at high risk of pancreatic cancer (eg, those with a family history of pancreatic cancer and chronic pancreatitis).  Most pancreatic cancers arise from microscopic non-invasive epithelial proliferations within the pancreatic ducts, referred to as pancreatic intraepithelial neoplasias.  There are four major driver genes for pancreatic cancer: KRAS, CDKN2A, TP53, and SMAD4.  KRAS mutation and alterations in CDKN2A are early events in pancreatic tumorigenesis.  Endoscopic ultrasonog. and endoscopic ultrasonog.-guided fine-needle aspiration offer high diagnostic ability for pancreatic cancer.  Surgical resection is regarded as the only potentially curative treatment, and adjuvant chemotherapy with gemcitabine or S-1, an oral fluoropyrimidine deriv., is given after surgery.  FOLFIRINOX (fluorouracil, folinic acid [leucovorin], irinotecan, and oxaliplatin) and gemcitabine plus nanoparticle albumin-bound paclitaxel (nab-paclitaxel) are the treatments of choice for patients who are not surgical candidates but have good performance status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowv4Kc18l117Vg90H21EOLACvtfcHk0lg6q688WWDCdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2mtb8%253D&md5=008fad5f1be8c3c6f3534c5bc3c3ea3a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2816%2900141-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252816%252900141-0%26sid%3Dliteratum%253Aachs%26aulast%3DKamisawa%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DL.%2BD.%26aulast%3DItoi%26aufirst%3DT.%26aulast%3DTakaori%26aufirst%3DK.%26atitle%3DPancreatic%2520cancer%26jtitle%3DLancet%26date%3D2016%26volume%3D388%26spage%3D73%26epage%3D85%26doi%3D10.1016%2FS0140-6736%2816%2900141-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nones, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patch, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingras, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruxner, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nourse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murtaugh, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harliwong, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idrisoglu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nourbakhsh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakoff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloonan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassahn, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mincarelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colvin, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagrial, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantrill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarlett, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinho, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giry-Laterriere, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samra, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kench, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrett, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toon, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeps, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran-Jones, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duthie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oien, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hair, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grutzmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfgang, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawlor, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rusev, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munzy, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karim, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilarsky, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musgrove, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biankin, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimmond, S. M.</span></span> <span> </span><span class="NLM_article-title">Genomic analyses identify molecular subtypes of pancreatic cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>531</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1038/nature16965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnature16965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26909576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFOisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=531&publication_year=2016&pages=47-52&author=P.+Baileyauthor=D.+K.+Changauthor=K.+Nonesauthor=A.+L.+Johnsauthor=A.+M.+Patchauthor=M.+C.+Gingrasauthor=D.+K.+Millerauthor=A.+N.+Christauthor=T.+J.+Bruxnerauthor=M.+C.+Quinnauthor=C.+Nourseauthor=L.+C.+Murtaughauthor=I.+Harliwongauthor=S.+Idrisogluauthor=S.+Manningauthor=E.+Nourbakhshauthor=S.+Waniauthor=L.+Finkauthor=O.+Holmesauthor=V.+Chinauthor=M.+J.+Andersonauthor=S.+Kazakoffauthor=C.+Leonardauthor=F.+Newellauthor=N.+Waddellauthor=S.+Woodauthor=Q.+Xuauthor=P.+J.+Wilsonauthor=N.+Cloonanauthor=K.+S.+Kassahnauthor=D.+Taylorauthor=K.+Quekauthor=A.+Robertsonauthor=L.+Pantanoauthor=L.+Mincarelliauthor=L.+N.+Sanchezauthor=L.+Eversauthor=J.+Wuauthor=M.+Pineseauthor=M.+J.+Cowleyauthor=M.+D.+Jonesauthor=E.+K.+Colvinauthor=A.+M.+Nagrialauthor=E.+S.+Humphreyauthor=L.+A.+Chantrillauthor=A.+Mawsonauthor=J.+Humphrisauthor=A.+Chouauthor=M.+Pajicauthor=C.+J.+Scarlettauthor=A.+V.+Pinhoauthor=M.+Giry-Laterriereauthor=I.+Roomanauthor=J.+S.+Samraauthor=J.+G.+Kenchauthor=J.+A.+Lovellauthor=N.+D.+Merrettauthor=C.+W.+Toonauthor=K.+Epariauthor=N.+Q.+Nguyenauthor=A.+Barbourauthor=N.+Zepsauthor=K.+Moran-Jonesauthor=N.+B.+Jamiesonauthor=J.+S.+Grahamauthor=F.+Duthieauthor=K.+Oienauthor=J.+Hairauthor=R.+Grutzmannauthor=A.+Maitraauthor=C.+A.+Iacobuzio-Donahueauthor=C.+L.+Wolfgangauthor=R.+A.+Morganauthor=R.+T.+Lawlorauthor=V.+Corboauthor=C.+Bassiauthor=B.+Rusevauthor=P.+Capelliauthor=R.+Salviaauthor=G.+Tortoraauthor=D.+Mukhopadhyayauthor=G.+M.+Petersenauthor=D.+M.+Munzyauthor=W.+E.+Fisherauthor=S.+A.+Karimauthor=J.+R.+Eshlemanauthor=R.+H.+Hrubanauthor=C.+Pilarskyauthor=J.+P.+Mortonauthor=O.+J.+Sansomauthor=A.+Scarpaauthor=E.+A.+Musgroveauthor=U.+M.+Baileyauthor=O.+Hofmannauthor=R.+L.+Sutherlandauthor=D.+A.+Wheelerauthor=A.+J.+Gillauthor=R.+A.+Gibbsauthor=J.+V.+Pearsonauthor=N.+Waddellauthor=A.+V.+Biankinauthor=S.+M.+Grimmond&title=Genomic+analyses+identify+molecular+subtypes+of+pancreatic+cancer&doi=10.1038%2Fnature16965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Genomic analyses identify molecular subtypes of pancreatic cancer</span></div><div class="casAuthors">Bailey, Peter; Chang, David K.; Nones, Katia; Johns, Amber L.; Patch, Ann-Marie; Gingras, Marie-Claude; Miller, David K.; Christ, Angelika N.; Bruxner, Tim J. C.; Quinn, Michael C.; Nourse, Craig; Murtaugh, L. Charles; Harliwong, Ivon; Idrisoglu, Senel; Manning, Suzanne; Nourbakhsh, Ehsan; Wani, Shivangi; Fink, Lynn; Holmes, Oliver; Chin, Venessa; Anderson, Matthew J.; Kazakoff, Stephen; Leonard, Conrad; Newell, Felicity; Waddell, Nick; Wood, Scott; Xu, Qinying; Wilson, Peter J.; Cloonan, Nicole; Kassahn, Karin S.; Taylor, Darrin; Quek, Kelly; Robertson, Alan; Pantano, Lorena; Mincarelli, Laura; Sanchez, Luis N.; Evers, Lisa; Wu, Jianmin; Pinese, Mark; Cowley, Mark J.; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chantrill, Lorraine A.; Mawson, Amanda; Humphris, Jeremy; Chou, Angela; Pajic, Marina; Scarlett, Christopher J.; Pinho, Andreia V.; Giry-Laterriere, Marc; Rooman, Ilse; Samra, Jaswinder S.; Kench, James G.; Lovell, Jessica A.; Merrett, Neil D.; Toon, Christopher W.; Epari, Krishna; Nguyen, Nam Q.; Barbour, Andrew; Zeps, Nikolajs; Moran-Jones, Kim; Jamieson, Nigel B.; Graham, Janet S.; Duthie, Fraser; Oien, Karin; Hair, Jane; Grutzmann, Robert; Maitra, Anirban; Iacobuzio-Donahue, Christine A.; Wolfgang, Christopher L.; Morgan, Richard A.; Lawlor, Rita T.; Corbo, Vincenzo; Bassi, Claudio; Rusev, Borislav; Capelli, Paola; Salvia, Roberto; Tortora, Giampaolo; Mukhopadhyay, Debabrata; Petersen, Gloria M.; Munzy, Donna M.; Fisher, William E.; Karim, Saadia A.; Eshleman, James R.; Hruban, Ralph H.; Pilarsky, Christian; Morton, Jennifer P.; Sansom, Owen J.; Scarpa, Aldo; Musgrove, Elizabeth A.; Bailey, Ulla-Maja Hagbo; Hofmann, Oliver; Sutherland, Robert L.; Wheeler, David A.; Gill, Anthony J.; Gibbs, Richard A.; Pearson, John V.; Waddell, Nicola; Biankin, Andrew V.; Grimmond, Sean M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">531</span>
        (<span class="NLM_cas:issue">7592</span>),
    <span class="NLM_cas:pages">47-52</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Integrated genomic anal. of 456 pancreatic ductal adenocarcinomas identified 32 recurrently mutated genes that aggregate into 10 pathways: KRAS, TGF-β, WNT, NOTCH, ROBO/SLIT signaling, G1/S transition, SWI-SNF, chromatin modification, DNA repair and RNA processing.  Expression anal. defined 4 subtypes: (1) squamous; (2) pancreatic progenitor; (3) immunogenic; and (4) aberrantly differentiated endocrine exocrine (ADEX) that correlate with histopathol. characteristics.  Squamous tumors are enriched for TP53 and KDM6A mutations, upregulation of the TP63ΔN transcriptional network, hypermethylation of pancreatic endodermal cell-fate detg. genes and have a poor prognosis.  Pancreatic progenitor tumors preferentially express genes involved in early pancreatic development (FOXA2/3, PDX1 and MNX1).  ADEX tumors displayed upregulation of genes that regulate networks involved in KRAS activation, exocrine (NR5A2 and RBPJL), and endocrine differentiation (NEUROD1 and NKX2-2).  Immunogenic tumors contained upregulated immune networks including pathways involved in acquired immune suppression.  These data infer differences in the mol. evolution of pancreatic cancer subtypes and identify opportunities for therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDwApQBihoOLVg90H21EOLACvtfcHk0lhAqYgXKShl7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFOisr0%253D&md5=6bc3da87878717d45460a164f970638a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature16965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature16965%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DD.%2BK.%26aulast%3DNones%26aufirst%3DK.%26aulast%3DJohns%26aufirst%3DA.%2BL.%26aulast%3DPatch%26aufirst%3DA.%2BM.%26aulast%3DGingras%26aufirst%3DM.%2BC.%26aulast%3DMiller%26aufirst%3DD.%2BK.%26aulast%3DChrist%26aufirst%3DA.%2BN.%26aulast%3DBruxner%26aufirst%3DT.%2BJ.%26aulast%3DQuinn%26aufirst%3DM.%2BC.%26aulast%3DNourse%26aufirst%3DC.%26aulast%3DMurtaugh%26aufirst%3DL.%2BC.%26aulast%3DHarliwong%26aufirst%3DI.%26aulast%3DIdrisoglu%26aufirst%3DS.%26aulast%3DManning%26aufirst%3DS.%26aulast%3DNourbakhsh%26aufirst%3DE.%26aulast%3DWani%26aufirst%3DS.%26aulast%3DFink%26aufirst%3DL.%26aulast%3DHolmes%26aufirst%3DO.%26aulast%3DChin%26aufirst%3DV.%26aulast%3DAnderson%26aufirst%3DM.%2BJ.%26aulast%3DKazakoff%26aufirst%3DS.%26aulast%3DLeonard%26aufirst%3DC.%26aulast%3DNewell%26aufirst%3DF.%26aulast%3DWaddell%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DWilson%26aufirst%3DP.%2BJ.%26aulast%3DCloonan%26aufirst%3DN.%26aulast%3DKassahn%26aufirst%3DK.%2BS.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DQuek%26aufirst%3DK.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DPantano%26aufirst%3DL.%26aulast%3DMincarelli%26aufirst%3DL.%26aulast%3DSanchez%26aufirst%3DL.%2BN.%26aulast%3DEvers%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DPinese%26aufirst%3DM.%26aulast%3DCowley%26aufirst%3DM.%2BJ.%26aulast%3DJones%26aufirst%3DM.%2BD.%26aulast%3DColvin%26aufirst%3DE.%2BK.%26aulast%3DNagrial%26aufirst%3DA.%2BM.%26aulast%3DHumphrey%26aufirst%3DE.%2BS.%26aulast%3DChantrill%26aufirst%3DL.%2BA.%26aulast%3DMawson%26aufirst%3DA.%26aulast%3DHumphris%26aufirst%3DJ.%26aulast%3DChou%26aufirst%3DA.%26aulast%3DPajic%26aufirst%3DM.%26aulast%3DScarlett%26aufirst%3DC.%2BJ.%26aulast%3DPinho%26aufirst%3DA.%2BV.%26aulast%3DGiry-Laterriere%26aufirst%3DM.%26aulast%3DRooman%26aufirst%3DI.%26aulast%3DSamra%26aufirst%3DJ.%2BS.%26aulast%3DKench%26aufirst%3DJ.%2BG.%26aulast%3DLovell%26aufirst%3DJ.%2BA.%26aulast%3DMerrett%26aufirst%3DN.%2BD.%26aulast%3DToon%26aufirst%3DC.%2BW.%26aulast%3DEpari%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DN.%2BQ.%26aulast%3DBarbour%26aufirst%3DA.%26aulast%3DZeps%26aufirst%3DN.%26aulast%3DMoran-Jones%26aufirst%3DK.%26aulast%3DJamieson%26aufirst%3DN.%2BB.%26aulast%3DGraham%26aufirst%3DJ.%2BS.%26aulast%3DDuthie%26aufirst%3DF.%26aulast%3DOien%26aufirst%3DK.%26aulast%3DHair%26aufirst%3DJ.%26aulast%3DGrutzmann%26aufirst%3DR.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%2BA.%26aulast%3DWolfgang%26aufirst%3DC.%2BL.%26aulast%3DMorgan%26aufirst%3DR.%2BA.%26aulast%3DLawlor%26aufirst%3DR.%2BT.%26aulast%3DCorbo%26aufirst%3DV.%26aulast%3DBassi%26aufirst%3DC.%26aulast%3DRusev%26aufirst%3DB.%26aulast%3DCapelli%26aufirst%3DP.%26aulast%3DSalvia%26aufirst%3DR.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3DMukhopadhyay%26aufirst%3DD.%26aulast%3DPetersen%26aufirst%3DG.%2BM.%26aulast%3DMunzy%26aufirst%3DD.%2BM.%26aulast%3DFisher%26aufirst%3DW.%2BE.%26aulast%3DKarim%26aufirst%3DS.%2BA.%26aulast%3DEshleman%26aufirst%3DJ.%2BR.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DPilarsky%26aufirst%3DC.%26aulast%3DMorton%26aufirst%3DJ.%2BP.%26aulast%3DSansom%26aufirst%3DO.%2BJ.%26aulast%3DScarpa%26aufirst%3DA.%26aulast%3DMusgrove%26aufirst%3DE.%2BA.%26aulast%3DBailey%26aufirst%3DU.%2BM.%26aulast%3DHofmann%26aufirst%3DO.%26aulast%3DSutherland%26aufirst%3DR.%2BL.%26aulast%3DWheeler%26aufirst%3DD.%2BA.%26aulast%3DGill%26aufirst%3DA.%2BJ.%26aulast%3DGibbs%26aufirst%3DR.%2BA.%26aulast%3DPearson%26aufirst%3DJ.%2BV.%26aulast%3DWaddell%26aufirst%3DN.%26aulast%3DBiankin%26aufirst%3DA.%2BV.%26aulast%3DGrimmond%26aufirst%3DS.%2BM.%26atitle%3DGenomic%2520analyses%2520identify%2520molecular%2520subtypes%2520of%2520pancreatic%2520cancer%26jtitle%3DNature%26date%3D2016%26volume%3D531%26spage%3D47%26epage%3D52%26doi%3D10.1038%2Fnature16965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, P.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yachida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mudie, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleasance, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stebbings, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morsberger, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latimer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaren, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nik-Zainal, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzies, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swerdlow, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futreal, P. A.</span></span> <span> </span><span class="NLM_article-title">The patterns and dynamics of genomic instability in metastatic pancreatic cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>467</i></span>,  <span class="NLM_fpage">1109</span>– <span class="NLM_lpage">1113</span>, <span class="refDoi"> DOI: 10.1038/nature09460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnature09460" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=467&publication_year=2010&pages=1109-1113&author=P.%0AJ.+Campbellauthor=S.+Yachidaauthor=L.+J.+Mudieauthor=P.+J.+Stephensauthor=E.+D.+Pleasanceauthor=L.+A.+Stebbingsauthor=L.+A.+Morsbergerauthor=C.+Latimerauthor=S.+McLarenauthor=M.+L.+Linauthor=D.+J.+McBrideauthor=I.+Varelaauthor=S.+A.+Nik-Zainalauthor=C.+Leroyauthor=M.+Jiaauthor=A.+Menziesauthor=A.+P.+Butlerauthor=J.+W.+Teagueauthor=C.+A.+Griffinauthor=J.+Burtonauthor=H.+Swerdlowauthor=M.+A.+Quailauthor=M.+R.+Strattonauthor=C.+Iacobuzio-Donahueauthor=P.+A.+Futreal&title=The+patterns+and+dynamics+of+genomic+instability+in+metastatic+pancreatic+cancer&doi=10.1038%2Fnature09460"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature09460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09460%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DP.%2BJ.%26aulast%3DYachida%26aufirst%3DS.%26aulast%3DMudie%26aufirst%3DL.%2BJ.%26aulast%3DStephens%26aufirst%3DP.%2BJ.%26aulast%3DPleasance%26aufirst%3DE.%2BD.%26aulast%3DStebbings%26aufirst%3DL.%2BA.%26aulast%3DMorsberger%26aufirst%3DL.%2BA.%26aulast%3DLatimer%26aufirst%3DC.%26aulast%3DMcLaren%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DM.%2BL.%26aulast%3DMcBride%26aufirst%3DD.%2BJ.%26aulast%3DVarela%26aufirst%3DI.%26aulast%3DNik-Zainal%26aufirst%3DS.%2BA.%26aulast%3DLeroy%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DM.%26aulast%3DMenzies%26aufirst%3DA.%26aulast%3DButler%26aufirst%3DA.%2BP.%26aulast%3DTeague%26aufirst%3DJ.%2BW.%26aulast%3DGriffin%26aufirst%3DC.%2BA.%26aulast%3DBurton%26aufirst%3DJ.%26aulast%3DSwerdlow%26aufirst%3DH.%26aulast%3DQuail%26aufirst%3DM.%2BA.%26aulast%3DStratton%26aufirst%3DM.%2BR.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%26aulast%3DFutreal%26aufirst%3DP.%2BA.%26atitle%3DThe%2520patterns%2520and%2520dynamics%2520of%2520genomic%2520instability%2520in%2520metastatic%2520pancreatic%2520cancer%26jtitle%3DNature%26date%3D2010%26volume%3D467%26spage%3D1109%26epage%3D1113%26doi%3D10.1038%2Fnature09460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patch, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassahn, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nones, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, M. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadlullah, M. Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruxner, T. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harliwong, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idrisoglu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nourse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nourbakhsh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloonan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakoff, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poudel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagrial, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantrill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmann, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colvin, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarlett, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinho, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giry-Laterriere, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samra, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kench, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettitt, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrett, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeps, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niclou, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjerkvig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grutzmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aust, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfgang, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawlor, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falconi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempero, M. A.</span></span>; <span class="NLM_contrib-group">Australian Pancreatic Cancer</span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genome, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilarsky, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musgrove, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biankin, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimmond, S. M.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Whole genomes redefine the mutational landscape of pancreatic cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>518</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1038/nature14169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnature14169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25719666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsVagurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=518&publication_year=2015&pages=495-501&author=N.+Waddellauthor=M.+Pajicauthor=A.-M.+Patchauthor=D.+K.+Changauthor=K.+S.+Kassahnauthor=P.+Baileyauthor=A.+L.+Johnsauthor=D.+Millerauthor=K.+Nonesauthor=K.+Quekauthor=M.+C.+J.+Quinnauthor=A.+J.+Robertsonauthor=M.+Z.+H.+Fadlullahauthor=T.+J.+C.+Bruxnerauthor=A.+N.+Christauthor=I.+Harliwongauthor=S.+Idrisogluauthor=S.+Manningauthor=C.+Nourseauthor=E.+Nourbakhshauthor=S.+Waniauthor=P.+J.+Wilsonauthor=E.+Markhamauthor=N.+Cloonanauthor=M.+J.+Andersonauthor=J.+L.+Finkauthor=O.+Holmesauthor=S.+H.+Kazakoffauthor=C.+Leonardauthor=F.+Newellauthor=B.+Poudelauthor=S.+Songauthor=D.+Taylorauthor=N.+Waddellauthor=S.+Woodauthor=Q.+Xuauthor=J.+Wuauthor=M.+Pineseauthor=M.+J.+Cowleyauthor=H.+C.+Leeauthor=M.+D.+Jonesauthor=A.+M.+Nagrialauthor=J.+Humphrisauthor=L.+A.+Chantrillauthor=V.+Chinauthor=A.+M.+Steinmannauthor=A.+Mawsonauthor=E.+S.+Humphreyauthor=E.+K.+Colvinauthor=A.+Chouauthor=C.+J.+Scarlettauthor=A.+V.+Pinhoauthor=M.+Giry-Laterriereauthor=I.+Roomanauthor=J.+S.+Samraauthor=J.+G.+Kenchauthor=J.+A.+Pettittauthor=N.+D.+Merrettauthor=C.+Toonauthor=K.+Epariauthor=N.+Q.+Nguyenauthor=A.+Barbourauthor=N.+Zepsauthor=N.+B.+Jamiesonauthor=J.+S.+Grahamauthor=S.+P.+Niclouauthor=R.+Bjerkvigauthor=R.+Grutzmannauthor=D.+Austauthor=R.+H.+Hrubanauthor=A.+Maitraauthor=C.+A.+Iacobuzio-Donahueauthor=C.+L.+Wolfgangauthor=R.+A.+Morganauthor=R.+T.+Lawlorauthor=V.+Corboauthor=C.+Bassiauthor=M.+Falconiauthor=G.+Zamboniauthor=G.+Tortoraauthor=M.+A.+Temperoauthor=Australian+Pancreatic+Cancerauthor=I.+Genomeauthor=A.+J.+Gillauthor=J.+R.+Eshlemanauthor=C.+Pilarskyauthor=A.+Scarpaauthor=E.+A.+Musgroveauthor=J.+V.+Pearsonauthor=A.+V.+Biankinauthor=S.+M.+Grimmond&title=Whole+genomes+redefine+the+mutational+landscape+of+pancreatic+cancer&doi=10.1038%2Fnature14169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Whole genomes redefine the mutational landscape of pancreatic cancer</span></div><div class="casAuthors">Waddell, Nicola; Pajic, Marina; Patch, Ann-Marie; Chang, David K.; Kassahn, Karin S.; Bailey, Peter; Johns, Amber L.; Miller, David K.; Nones, Katia; Quek, Kelly; Quinn, Michael C. J.; Robertson, Alan J.; Fadlullah, Muhammad Z. H.; Bruxner, Tim J. C.; Christ, Angelika N.; Harliwong, Ivon; Idrisoglu, Senel; Manning, Suzanne; Nourse, Craig; Nourbakhsh, Ehsan; Wani, Shivangi; Wilson, Peter J.; Markham, Emma; Cloonan, Nicole; Anderson, Matthew J.; Fink, J. Lynn; Holmes, Oliver; Kazakoff, Stephen H.; Leonard, Conrad; Newell, Felicity; Poudel, Barsha; Song, Sarah; Taylor, Darrin; Waddell, Nick; Wood, Scott; Xu, Qinying; Wu, Jianmin; Pinese, Mark; Cowley, Mark J.; Lee, Hong C.; Jones, Marc D.; Nagrial, Adnan M.; Humphris, Jeremy; Chantrill, Lorraine A.; Chin, Venessa T.; Steinmann, Angela M.; Mawson, Amanda; Humphrey, Emily S.; Colvin, Emily K.; Chou, Angela; Scarlett, Christopher J.; Pinho, Andreia V.; Giry-Laterriere, Marc; Rooman, Ilse; Samra, Jaswinder S.; Kench, James G.; Pettitt, Jessica A.; Merrett, Neil D.; Toon, Christopher; Epari, Krishna P.; Nguyen, Nam Q.; Barbour, Andrew P.; Zeps, Nikolajs; Jamieson, Nigel B.; Graham, Janet S.; Niclou, Simone P.; Bjerkvig, Rolf; Grutzmann, Robert; Aust, Daniela; Hruban, Ralph H.; Maitra, Anirban; Iacobuzio-Donahue, Christine A.; Wolfgang, Christopher L.; Morgan, Richard A.; Lawlor, Rita T.; Corbo, Vincenzo; Bassi, Claudio; Falconi, Massimo; Zamboni, Giuseppe; Tortora, Giampaolo; Tempero, Margaret A.; Biankin, Andrew V.; Brancato, Mary-Anne L.; Rowe, Sarah J.; Simpson, Skye H.; Martyn-Smith, Mona; Thomas, Michelle T.; Chou, Angela; Mead, R. Scott; Pettit, Jessica; Tao, Jiang; Di Pietro, Renee; Watson, Clare; Lee, Hong Ching; Wong, Rachel; Giry-Laterriere, Marc; Daly, Roger J.; Musgrove, Elizabeth A.; Sutherland, Robert L.; Patch, Ann-Marie; Gongora, Milena; Xu, Christina; Lynn Fink, J.; Bruxner, Tim; Pearson, John V.; Nagaraj, Shivashankar; Krisnan, Keerthana; Wood, David; Gill, Anthony J.; Pavlakis, Nick; Guminski, Alex; Asghari, Ray; Pavey, Darren; Das, Amitabha; Cosman, Peter H.; Ismail, Kasim; O'Connnor, Chelsie; Lam Duncan McLeod, Vincent W.; Pleass, Henry C.; Richardson, Arthur; James, Virginia; Cooper, Caroline L.; Joseph, David; Sandroussi, Charbel; Crawford, Michael; Gallagher, James; Texler, Michael; Forest, Cindy; Laycock, Andrew; Ballal, Mo; Fletcher, David R.; Mukhedkar, Sanjay; Spry, Nigel A.; De Boer, Bastiaan; Chai, Ming; Beilin, Maria; Feeney, Kynan; Nguyen, Nan Q.; Ruszkiewicz, Andrew R.; Worthley, Chris; Tan, Chuan P.; Debrencini, Tamara; Chen, John; Brooke-Smith, Mark E.; Papangelis, Virginia; Tang, Henry; Clouston, Andrew D.; Martin, Patrick; O'Rourke, Thomas J.; Chiang, Amy; Fawcett, Jonathan W.; Slater, Kellee; Yeung, Shinn; Hatzifotis, Michael; Hodgkinson, Peter; Christophi, Christopher; Nikfarjam, Mehrdad; Mountain, Angela; Eshleman, James R.; Schulick, Richard D.; Hodgin, Mary; Scarpa, Aldo; Beghelli, Stefania; Scardoni, Maria; Grimmond, Sean M.; Oien, Karen; Hair, Jane; Pilarsky, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">518</span>
        (<span class="NLM_cas:issue">7540</span>),
    <span class="NLM_cas:pages">495-501</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pancreatic cancer remains one of the most lethal of malignancies and a major health burden.  We performed whole-genome sequencing and copy no. variation (CNV) anal. of 100 pancreatic ductal adenocarcinomas (PDACs).  Chromosomal rearrangements leading to gene disruption were prevalent, affecting genes known to be important in pancreatic cancer (TP53, SMAD4, CDKN2A, ARID1A and ROBO2) and new candidate drivers of pancreatic carcinogenesis (KDM6A and PREX2).  Patterns of structural variation (variation in chromosomal structure) classified PDACs into 4 subtypes with potential clin. utility: the subtypes were termed stable, locally rearranged, scattered and unstable.  A significant proportion harbored focal amplifications, many of which contained druggable oncogenes (ERBB2, MET, FGFR1, CDK6, PIK3R3 and PIK3CA), but at low individual patient prevalence.  Genomic instability co-segregated with inactivation of DNA maintenance genes (BRCA1, BRCA2 or PALB2) and a mutational signature of DNA damage repair deficiency.  Of 8 patients who received platinum therapy, 4 of 5 individuals with these measures of defective DNA maintenance responded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVXQXYMEyD4bVg90H21EOLACvtfcHk0ljgedwgHuLJJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsVagurc%253D&md5=8e517355c91236f9f1717c21e4cfafe6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature14169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14169%26sid%3Dliteratum%253Aachs%26aulast%3DWaddell%26aufirst%3DN.%26aulast%3DPajic%26aufirst%3DM.%26aulast%3DPatch%26aufirst%3DA.-M.%26aulast%3DChang%26aufirst%3DD.%2BK.%26aulast%3DKassahn%26aufirst%3DK.%2BS.%26aulast%3DBailey%26aufirst%3DP.%26aulast%3DJohns%26aufirst%3DA.%2BL.%26aulast%3DMiller%26aufirst%3DD.%26aulast%3DNones%26aufirst%3DK.%26aulast%3DQuek%26aufirst%3DK.%26aulast%3DQuinn%26aufirst%3DM.%2BC.%2BJ.%26aulast%3DRobertson%26aufirst%3DA.%2BJ.%26aulast%3DFadlullah%26aufirst%3DM.%2BZ.%2BH.%26aulast%3DBruxner%26aufirst%3DT.%2BJ.%2BC.%26aulast%3DChrist%26aufirst%3DA.%2BN.%26aulast%3DHarliwong%26aufirst%3DI.%26aulast%3DIdrisoglu%26aufirst%3DS.%26aulast%3DManning%26aufirst%3DS.%26aulast%3DNourse%26aufirst%3DC.%26aulast%3DNourbakhsh%26aufirst%3DE.%26aulast%3DWani%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DP.%2BJ.%26aulast%3DMarkham%26aufirst%3DE.%26aulast%3DCloonan%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DM.%2BJ.%26aulast%3DFink%26aufirst%3DJ.%2BL.%26aulast%3DHolmes%26aufirst%3DO.%26aulast%3DKazakoff%26aufirst%3DS.%2BH.%26aulast%3DLeonard%26aufirst%3DC.%26aulast%3DNewell%26aufirst%3DF.%26aulast%3DPoudel%26aufirst%3DB.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DWaddell%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DPinese%26aufirst%3DM.%26aulast%3DCowley%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BC.%26aulast%3DJones%26aufirst%3DM.%2BD.%26aulast%3DNagrial%26aufirst%3DA.%2BM.%26aulast%3DHumphris%26aufirst%3DJ.%26aulast%3DChantrill%26aufirst%3DL.%2BA.%26aulast%3DChin%26aufirst%3DV.%26aulast%3DSteinmann%26aufirst%3DA.%2BM.%26aulast%3DMawson%26aufirst%3DA.%26aulast%3DHumphrey%26aufirst%3DE.%2BS.%26aulast%3DColvin%26aufirst%3DE.%2BK.%26aulast%3DChou%26aufirst%3DA.%26aulast%3DScarlett%26aufirst%3DC.%2BJ.%26aulast%3DPinho%26aufirst%3DA.%2BV.%26aulast%3DGiry-Laterriere%26aufirst%3DM.%26aulast%3DRooman%26aufirst%3DI.%26aulast%3DSamra%26aufirst%3DJ.%2BS.%26aulast%3DKench%26aufirst%3DJ.%2BG.%26aulast%3DPettitt%26aufirst%3DJ.%2BA.%26aulast%3DMerrett%26aufirst%3DN.%2BD.%26aulast%3DToon%26aufirst%3DC.%26aulast%3DEpari%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DN.%2BQ.%26aulast%3DBarbour%26aufirst%3DA.%26aulast%3DZeps%26aufirst%3DN.%26aulast%3DJamieson%26aufirst%3DN.%2BB.%26aulast%3DGraham%26aufirst%3DJ.%2BS.%26aulast%3DNiclou%26aufirst%3DS.%2BP.%26aulast%3DBjerkvig%26aufirst%3DR.%26aulast%3DGrutzmann%26aufirst%3DR.%26aulast%3DAust%26aufirst%3DD.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%2BA.%26aulast%3DWolfgang%26aufirst%3DC.%2BL.%26aulast%3DMorgan%26aufirst%3DR.%2BA.%26aulast%3DLawlor%26aufirst%3DR.%2BT.%26aulast%3DCorbo%26aufirst%3DV.%26aulast%3DBassi%26aufirst%3DC.%26aulast%3DFalconi%26aufirst%3DM.%26aulast%3DZamboni%26aufirst%3DG.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3DTempero%26aufirst%3DM.%2BA.%26aulast%3D%26aulast%3DGenome%26aufirst%3DI.%26aulast%3DGill%26aufirst%3DA.%2BJ.%26aulast%3DEshleman%26aufirst%3DJ.%2BR.%26aulast%3DPilarsky%26aufirst%3DC.%26aulast%3DScarpa%26aufirst%3DA.%26aulast%3DMusgrove%26aufirst%3DE.%2BA.%26aulast%3DPearson%26aufirst%3DJ.%2BV.%26aulast%3DBiankin%26aufirst%3DA.%2BV.%26aulast%3DGrimmond%26aufirst%3DS.%2BM.%26atitle%3DWhole%2520genomes%2520redefine%2520the%2520mutational%2520landscape%2520of%2520pancreatic%2520cancer%26jtitle%3DNature%26date%3D2015%26volume%3D518%26spage%3D495%26epage%3D501%26doi%3D10.1038%2Fnature14169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makohon-Moore, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohutek, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attiyeh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C. A.</span></span> <span> </span><span class="NLM_article-title">Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.1038/ng.3764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fng.3764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28092682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2017&pages=358-366&author=A.+P.+Makohon-Mooreauthor=M.+Zhangauthor=J.+G.+Reiterauthor=I.+Bozicauthor=B.+Allenauthor=D.+Kunduauthor=K.+Chatterjeeauthor=F.+Wongauthor=Y.+Jiaoauthor=Z.+A.+Kohutekauthor=J.+Hongauthor=M.+Attiyehauthor=B.+Javierauthor=L.+D.+Woodauthor=R.+H.+Hrubanauthor=M.+A.+Nowakauthor=N.+Papadopoulosauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=C.+A.+Iacobuzio-Donahue&title=Limited+heterogeneity+of+known+driver+gene+mutations+among+the+metastases+of+individual+patients+with+pancreatic+cancer&doi=10.1038%2Fng.3764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer</span></div><div class="casAuthors">Makohon-Moore, Alvin P.; Zhang, Ming; Reiter, Johannes G.; Bozic, Ivana; Allen, Benjamin; Kundu, Deepanjan; Chatterjee, Krishnendu; Wong, Fay; Jiao, Yuchen; Kohutek, Zachary A.; Hong, Jungeui; Attiyeh, Marc; Javier, Breanna; Wood, Laura D.; Hruban, Ralph H.; Nowak, Martin A.; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Iacobuzio-Donahue, Christine A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">358-366</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The extent of heterogeneity among driver gene mutations present in naturally occurring metastases-i.e., treatment-naive metastatic disease-is largely unknown.  To address this issue, we carried out 60× whole-genome sequencing of 26 metastases from four patients with pancreatic cancer.  We found that identical mutations in known driver genes were present in every metastatic lesion for each patient studied.  Passenger gene mutations, which do not have known or predicted functional consequences, accounted for all intratumoral heterogeneity.  Even with respect to these passenger mutations, our anal. suggests that the genetic similarity among the founding cells of metastases was higher than that expected for any two cells randomly taken from a normal tissue.  The uniformity of known driver gene mutations among metastases in the same patient has crit. and encouraging implications for the success of future targeted therapies in advanced-stage disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriVIIRrBsoCbVg90H21EOLACvtfcHk0ljgedwgHuLJJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCls7Y%253D&md5=82eb3061ea531307627bed2a6f1be543</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fng.3764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.3764%26sid%3Dliteratum%253Aachs%26aulast%3DMakohon-Moore%26aufirst%3DA.%2BP.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DReiter%26aufirst%3DJ.%2BG.%26aulast%3DBozic%26aufirst%3DI.%26aulast%3DAllen%26aufirst%3DB.%26aulast%3DKundu%26aufirst%3DD.%26aulast%3DChatterjee%26aufirst%3DK.%26aulast%3DWong%26aufirst%3DF.%26aulast%3DJiao%26aufirst%3DY.%26aulast%3DKohutek%26aufirst%3DZ.%2BA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DAttiyeh%26aufirst%3DM.%26aulast%3DJavier%26aufirst%3DB.%26aulast%3DWood%26aufirst%3DL.%2BD.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DNowak%26aufirst%3DM.%2BA.%26aulast%3DPapadopoulos%26aufirst%3DN.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%2BA.%26atitle%3DLimited%2520heterogeneity%2520of%2520known%2520driver%2520gene%2520mutations%2520among%2520the%2520metastases%2520of%2520individual%2520patients%2520with%2520pancreatic%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D2017%26volume%3D49%26spage%3D358%26epage%3D366%26doi%3D10.1038%2Fng.3764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leary, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angenendt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankoo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimeno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calhoun, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolskaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolsky, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartigan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffee, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karchin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmigiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velculescu, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span> <span> </span><span class="NLM_article-title">Core signaling pathways in human pancreatic cancers revealed by global genomic analyses</span>. <i>Science (Washington, DC, U. S.)</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>321</i></span>,  <span class="NLM_fpage">1801</span>– <span class="NLM_lpage">1806</span>, <span class="refDoi"> DOI: 10.1126/science.1164368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1126%2Fscience.1164368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=18772397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2008&pages=1801-1806&author=S.+Jonesauthor=X.+Zhangauthor=D.+W.+Parsonsauthor=J.+C.-H.+Linauthor=R.+J.+Learyauthor=P.+Angenendtauthor=P.+Mankooauthor=H.+Carterauthor=H.+Kamiyamaauthor=A.+Jimenoauthor=S.-M.+Hongauthor=B.+Fuauthor=M.-T.+Linauthor=E.+S.+Calhounauthor=M.+Kamiyamaauthor=K.+Walterauthor=T.+Nikolskayaauthor=Y.+Nikolskyauthor=J.+Hartiganauthor=D.+R.+Smithauthor=M.+Hidalgoauthor=S.+D.+Leachauthor=A.+P.+Kleinauthor=E.+M.+Jaffeeauthor=M.+Gogginsauthor=A.+Maitraauthor=C.+Iacobuzio-Donahueauthor=J.+R.+Eshlemanauthor=S.+E.+Kernauthor=R.+H.+Hrubanauthor=R.+Karchinauthor=N.+Papadopoulosauthor=G.+Parmigianiauthor=B.+Vogelsteinauthor=V.+E.+Velculescuauthor=K.+W.+Kinzler&title=Core+signaling+pathways+in+human+pancreatic+cancers+revealed+by+global+genomic+analyses&doi=10.1126%2Fscience.1164368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses</span></div><div class="casAuthors">Jones, Sian; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Leary, Rebecca J.; Angenendt, Philipp; Mankoo, Parminder; Carter, Hannah; Kamiyama, Hirohiko; Jimeno, Antonio; Hong, Seung-Mo; Fu, Baojin; Lin, Ming-Tseh; Calhoun, Eric S.; Kamiyama, Mihoko; Walter, Kimberly; Nikolskaya, Tatiana; Nikolsky, Yuri; Hartigan, James; Smith, Douglas R.; Hidalgo, Manuel; Leach, Steven D.; Klein, Alison P.; Jaffee, Elizabeth M.; Goggins, Michael; Maitra, Anirban; Iacobuzio-Donahue, Christine; Eshleman, James R.; Kern, Scott E.; Hruban, Ralph H.; Karchin, Rachel; Papadopoulos, Nickolas; Parmigiani, Giovanni; Vogelstein, Bert; Velculescu, Victor E.; Kinzler, Kenneth W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">5897</span>),
    <span class="NLM_cas:pages">1801-1806</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">There are currently few therapeutic options for patients with pancreatic cancer, and new insights into the pathogenesis of this lethal disease are urgently needed.  Toward this end, the authors performed a comprehensive genetic anal. of 24 pancreatic cancers.  The authors first detd. the sequences of 23,219 transcripts, representing 20,661 protein-coding genes, in these samples.  Then, the authors searched for homozygous deletions and amplifications in the tumor DNA by using microarrays contg. probes for ~106 single-nucleotide polymorphisms.  It was found that pancreatic cancers contain an av. of 63 genetic alterations, the majority of which are point mutations.  These alterations defined a core set of 12 cellular signaling pathways and processes that were each genetically altered in 67 to 100% of the tumors.  Anal. of these tumors' transcriptomes with next-generation sequencing-by-synthesis technologies provided independent evidence for the importance of these pathways and processes.  These data indicate that genetically altered core pathways and regulatory processes only become evident once the coding regions of the genome are analyzed in depth.  Dysregulation of these core pathways and processes through mutation can explain the major features of pancreatic tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopWEan4wZjSLVg90H21EOLACvtfcHk0lhOJnpzSn-g0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtLrL&md5=62aa344f0bd3ba335cf6a8263ebbf29a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1164368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1164368%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DLin%26aufirst%3DJ.%2BC.-H.%26aulast%3DLeary%26aufirst%3DR.%2BJ.%26aulast%3DAngenendt%26aufirst%3DP.%26aulast%3DMankoo%26aufirst%3DP.%26aulast%3DCarter%26aufirst%3DH.%26aulast%3DKamiyama%26aufirst%3DH.%26aulast%3DJimeno%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DS.-M.%26aulast%3DFu%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DM.-T.%26aulast%3DCalhoun%26aufirst%3DE.%2BS.%26aulast%3DKamiyama%26aufirst%3DM.%26aulast%3DWalter%26aufirst%3DK.%26aulast%3DNikolskaya%26aufirst%3DT.%26aulast%3DNikolsky%26aufirst%3DY.%26aulast%3DHartigan%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%2BR.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DLeach%26aufirst%3DS.%2BD.%26aulast%3DKlein%26aufirst%3DA.%2BP.%26aulast%3DJaffee%26aufirst%3DE.%2BM.%26aulast%3DGoggins%26aufirst%3DM.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%26aulast%3DEshleman%26aufirst%3DJ.%2BR.%26aulast%3DKern%26aufirst%3DS.%2BE.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DKarchin%26aufirst%3DR.%26aulast%3DPapadopoulos%26aufirst%3DN.%26aulast%3DParmigiani%26aufirst%3DG.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26atitle%3DCore%2520signaling%2520pathways%2520in%2520human%2520pancreatic%2520cancers%2520revealed%2520by%2520global%2520genomic%2520analyses%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D2008%26volume%3D321%26spage%3D1801%26epage%3D1806%26doi%3D10.1126%2Fscience.1164368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biankin, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingras, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthuswamy, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patch, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harliwong, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idrisoglu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nourse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nourbakhsh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gongora, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarlett, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinho, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nones, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruxner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloonan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mead, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphris, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colvin, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagrial, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantrill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samra, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kench, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrett, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeps, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakkar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzny, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunicardi, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodges, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhay, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timms, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Borja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denroche, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yung, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onetto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulick, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfgang, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawlor, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scardoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempero, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Mancera, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Largaespada, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wessels, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rust, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musgrove, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimmond, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassahn, K. S.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>491</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1038/nature11547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnature11547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=23103869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOmt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=491&publication_year=2012&pages=399-405&author=A.+V.+Biankinauthor=N.+Waddellauthor=M.+C.+Gingrasauthor=L.+B.+Muthuswamyauthor=A.+L.+Johnsauthor=D.+K.+Millerauthor=P.+J.+Wilsonauthor=A.+M.+Patchauthor=J.+Wuauthor=D.+K.+Changauthor=M.+J.+Cowleyauthor=B.+B.+Gardinerauthor=S.+Songauthor=I.+Harliwongauthor=S.+Idrisogluauthor=C.+Nourseauthor=E.+Nourbakhshauthor=S.+Manningauthor=S.+Waniauthor=M.+Gongoraauthor=M.+Pajicauthor=C.+J.+Scarlettauthor=A.+J.+Gillauthor=A.+V.+Pinhoauthor=I.+Roomanauthor=M.+Andersonauthor=O.+Holmesauthor=C.+Leonardauthor=D.+Taylorauthor=S.+Woodauthor=Q.+Xuauthor=K.+Nonesauthor=J.+L.+Finkauthor=A.+Christauthor=T.+Bruxnerauthor=N.+Cloonanauthor=G.+Kolleauthor=F.+Newellauthor=M.+Pineseauthor=R.+S.+Meadauthor=J.+L.+Humphrisauthor=W.+Kaplanauthor=M.+D.+Jonesauthor=E.+K.+Colvinauthor=A.+M.+Nagrialauthor=E.+S.+Humphreyauthor=A.+Chouauthor=V.+T.+Chinauthor=L.+A.+Chantrillauthor=A.+Mawsonauthor=J.+S.+Samraauthor=J.+G.+Kenchauthor=J.+A.+Lovellauthor=R.+J.+Dalyauthor=N.+D.+Merrettauthor=C.+Toonauthor=K.+Epariauthor=N.+Q.+Nguyenauthor=A.+Barbourauthor=N.+Zepsauthor=N.+Kakkarauthor=F.+Zhaoauthor=Y.+Q.+Wuauthor=M.+Wangauthor=D.+M.+Muznyauthor=W.+E.+Fisherauthor=F.+C.+Brunicardiauthor=S.+E.+Hodgesauthor=J.+G.+Reidauthor=J.+Drummondauthor=K.+Changauthor=Y.+Hanauthor=L.+R.+Lewisauthor=H.+Dinhauthor=C.+J.+Buhayauthor=T.+Beckauthor=L.+Timmsauthor=M.+Samauthor=K.+Begleyauthor=A.+Brownauthor=D.+Paiauthor=A.+Panchalauthor=N.+Buchnerauthor=R.+De+Borjaauthor=R.+E.+Denrocheauthor=C.+K.+Yungauthor=S.+Serraauthor=N.+Onettoauthor=D.+Mukhopadhyayauthor=M.+S.+Tsaoauthor=P.+A.+Shawauthor=G.+M.+Petersenauthor=S.+Gallingerauthor=R.+H.+Hrubanauthor=A.+Maitraauthor=C.+A.+Iacobuzio-Donahueauthor=R.+D.+Schulickauthor=C.+L.+Wolfgangauthor=R.+A.+Morganauthor=R.+T.+Lawlorauthor=P.+Capelliauthor=V.+Corboauthor=M.+Scardoniauthor=G.+Tortoraauthor=M.+A.+Temperoauthor=K.+M.+Mannauthor=N.+A.+Jenkinsauthor=P.+A.+Perez-Manceraauthor=D.+J.+Adamsauthor=D.+A.+Largaespadaauthor=L.+F.+Wesselsauthor=A.+G.+Rustauthor=L.+D.+Steinauthor=D.+A.+Tuvesonauthor=N.+G.+Copelandauthor=E.+A.+Musgroveauthor=A.+Scarpaauthor=J.+R.+Eshlemanauthor=T.+J.+Hudsonauthor=R.+L.+Sutherlandauthor=D.+A.+Wheelerauthor=J.+V.+Pearsonauthor=J.+D.+McPhersonauthor=R.+A.+Gibbsauthor=S.+M.+Grimmondauthor=K.+S.+Kassahn&title=Pancreatic+cancer+genomes+reveal+aberrations+in+axon+guidance+pathway+genes&doi=10.1038%2Fnature11547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes</span></div><div class="casAuthors">Biankin, Andrew V.; Waddell, Nicola; Kassahn, Karin S.; Gingras, Marie-Claude; Muthuswamy, Lakshmi B.; Johns, Amber L.; Miller, David K.; Wilson, Peter J.; Patch, Ann-Marie; Wu, Jianmin; Chang, David K.; Cowley, Mark J.; Gardiner, Brooke B.; Song, Sarah; Harliwong, Ivon; Idrisoglu, Senel; Nourse, Craig; Nourbakhsh, Ehsan; Manning, Suzanne; Wani, Shivangi; Gongora, Milena; Pajic, Marina; Scarlett, Christopher J.; Gill, Anthony J.; Pinho, Andreia V.; Rooman, Ilse; Anderson, Matthew; Holmes, Oliver; Leonard, Conrad; Taylor, Darrin; Wood, Scott; Xu, Christina; Nones, Katia; Lynn Fink, J.; Christ, Angelika; Bruxner, Tim; Cloonan, Nicole; Kolle, Gabriel; Newell, Felicity; Pinese, Mark; Scott Mead, R.; Humphris, Jeremy L.; Kaplan, Warren; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chou, Angela; Chin, Venessa T.; Chantrill, Lorraine A.; Mawson, Amanda; Samra, Jaswinder S.; Kench, James G.; Lovell, Jessica A.; Daly, Roger J.; Merrett, Neil D.; Toon, Christopher; Epari, Krishna P.; Nguyen, Nam Q.; Barbour, Andrew P.; Zeps, Nikolajs; Brancato, Mary-Anne L.; Rowe, Sarah J.; Simpson, Skye L.; Martyn-Smith, Mona; Thomas, Michelle T.; Pettit, Jessica; Tao, Jiang; DiPietro, Renee; Watson, Clare; Wong, Rachel; Giry-Laterriere, Marc; Musgrove, Elizabeth A.; Sutherland, Robert L.; Grimmond, Sean M.; Patch, Ann-Marie; Nourse, Craig; Anderson, Matthew; Pavlakis, Nick; Guminski, Alex; Asghari, Ray; Pavey, Darren A.; Das, Amitabha; Cosman, Peter H.; Ismail, Kasim; O'Connor, Chelsie; Lam, Vincent W.; McLeod, Duncan; Pleass, Henry C.; Richardson, Arthur; James, Virginia; Cooper, Caroline L.; Joseph, David; Sandroussi, Charbel; Crawford, Michael; Gallagher, James; Texler, Michael; Forrest, Cindy; Laycock, Andrew; Ballal, Mo; Fletcher, David R.; Mukhedkar, Sanjay; Spry, Nigel A.; DeBoer, Bastiaan; Chai, Ming; Beilin, Maria; Feeney, Kynan; Ruszkiewicz, Andrew R.; Worthley, Chris; Tan, Chuan P.; Debrencini, Tamara; Chen, John; Brooke-Smith, Mark E.; Papangelis, Virginia; Tang, Henry; Clouston, Andrew D.; Martin, Patrick; O'Rourke, Thomas J.; Chiang, Amy; Fawcett, Jonathan W.; Slater, Kellee; Yeung, Shinn; Hatzifotis, Michael; Hodgkinson, Peter; Christophi, Christopher; Nikfarjam, Mehrdad; Eshleman, James R.; Hruban, Ralph H.; Maitra, Anirban; Iacobuzio-Donahue, Christine A.; Schulick, Richard D.; Wolfgang, Christopher L.; Morgan, Richard A.; Hodgin, Mary B.; Scarpa, Aldo; Lawlor, Rita T.; Capelli, Paola; Beghelli, Stefania; Corbo, Vincenzo; Scardoni, Maria; Pederzoli, Paolo; Tortora, Giampaolo; Bassi, Claudio; Tempero, Margaret A.; Kakkar, Nipun; Zhao, Fengmei; Wu, Yuan Qing; Wang, Min; Muzny, Donna M.; Fisher, William E.; Charles Brunicardi, F.; Hodges, Sally E.; Reid, Jeffrey G.; Drummond, Jennifer; Chang, Kyle; Han, Yi; Lewis, Lora R.; Dinh, Huyen; Buhay, Christian J.; Beck, Timothy; Timms, Lee; Sam, Michelle; Begley, Kimberly; Brown, Andrew; Pai, Deepa; Panchal, Ami; Buchner, Nicholas; De Borja, Richard; Denroche, Robert E.; Yung, Christina K.; Serra, Stefano; Onetto, Nicole; Mukhopadhyay, Debabrata; Tsao, Ming-Sound; Shaw, Patricia A.; Petersen, Gloria M.; Gallinger, Steven; Iacobuzio-Donahue, Christine A.; Mann, Karen M.; Jenkins, Nancy A.; Perez-Mancera, Pedro A.; Adams, David J.; Largaespada, David A.; Wessels, Lodewyk F. A.; Rust, Alistair G.; Stein, Lincoln D.; Tuveson, David A.; Copeland, Neal G.; Hudson, Thomas J.; Wheeler, David A.; McPherson, John D.; Gibbs, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">491</span>
        (<span class="NLM_cas:issue">7424</span>),
    <span class="NLM_cas:pages">399-405</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pancreatic cancer is a highly lethal malignancy with few effective therapies.  We performed exome sequencing and copy no. anal. to define genomic aberrations in a prospectively accrued clin. cohort (n = 142) of early (stage I and II) sporadic pancreatic ductal adenocarcinoma.  Detailed anal. of 99 informative tumors identified substantial heterogeneity with 2,016 non-silent mutations and 1,628 copy-no. variations.  We define 16 significantly mutated genes, reaffirming known mutations (KRAS, TP53, CDKN2A, SMAD4, MLL3, TGFBR2, ARID1A and SF3B1), and uncover novel mutated genes including addnl. genes involved in chromatin modification (EPC1 and ARID2), DNA damage repair (ATM) and other mechanisms (ZIM2, MAP2K4, NALCN, SLC16A4 and MAGEA6).  Integrative anal. with in vitro functional data and animal models provided supportive evidence for potential roles for these genetic aberrations in carcinogenesis.  Pathway-based anal. of recurrently mutated genes recapitulated clustering in core signalling pathways in pancreatic ductal adenocarcinoma, and identified new mutated genes in each pathway.  We also identified frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, which was also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement of axon guidance genes in pancreatic carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6I8TIAplbi7Vg90H21EOLACvtfcHk0ljXg6LVuOKUnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOmt7jN&md5=482b61e2d2caec25b5b68aa955f2fb74</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature11547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11547%26sid%3Dliteratum%253Aachs%26aulast%3DBiankin%26aufirst%3DA.%2BV.%26aulast%3DWaddell%26aufirst%3DN.%26aulast%3DGingras%26aufirst%3DM.%2BC.%26aulast%3DMuthuswamy%26aufirst%3DL.%2BB.%26aulast%3DJohns%26aufirst%3DA.%2BL.%26aulast%3DMiller%26aufirst%3DD.%2BK.%26aulast%3DWilson%26aufirst%3DP.%2BJ.%26aulast%3DPatch%26aufirst%3DA.%2BM.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DD.%2BK.%26aulast%3DCowley%26aufirst%3DM.%2BJ.%26aulast%3DGardiner%26aufirst%3DB.%2BB.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DHarliwong%26aufirst%3DI.%26aulast%3DIdrisoglu%26aufirst%3DS.%26aulast%3DNourse%26aufirst%3DC.%26aulast%3DNourbakhsh%26aufirst%3DE.%26aulast%3DManning%26aufirst%3DS.%26aulast%3DWani%26aufirst%3DS.%26aulast%3DGongora%26aufirst%3DM.%26aulast%3DPajic%26aufirst%3DM.%26aulast%3DScarlett%26aufirst%3DC.%2BJ.%26aulast%3DGill%26aufirst%3DA.%2BJ.%26aulast%3DPinho%26aufirst%3DA.%2BV.%26aulast%3DRooman%26aufirst%3DI.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DHolmes%26aufirst%3DO.%26aulast%3DLeonard%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DNones%26aufirst%3DK.%26aulast%3DFink%26aufirst%3DJ.%2BL.%26aulast%3DChrist%26aufirst%3DA.%26aulast%3DBruxner%26aufirst%3DT.%26aulast%3DCloonan%26aufirst%3DN.%26aulast%3DKolle%26aufirst%3DG.%26aulast%3DNewell%26aufirst%3DF.%26aulast%3DPinese%26aufirst%3DM.%26aulast%3DMead%26aufirst%3DR.%2BS.%26aulast%3DHumphris%26aufirst%3DJ.%2BL.%26aulast%3DKaplan%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DM.%2BD.%26aulast%3DColvin%26aufirst%3DE.%2BK.%26aulast%3DNagrial%26aufirst%3DA.%2BM.%26aulast%3DHumphrey%26aufirst%3DE.%2BS.%26aulast%3DChou%26aufirst%3DA.%26aulast%3DChin%26aufirst%3DV.%2BT.%26aulast%3DChantrill%26aufirst%3DL.%2BA.%26aulast%3DMawson%26aufirst%3DA.%26aulast%3DSamra%26aufirst%3DJ.%2BS.%26aulast%3DKench%26aufirst%3DJ.%2BG.%26aulast%3DLovell%26aufirst%3DJ.%2BA.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26aulast%3DMerrett%26aufirst%3DN.%2BD.%26aulast%3DToon%26aufirst%3DC.%26aulast%3DEpari%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DN.%2BQ.%26aulast%3DBarbour%26aufirst%3DA.%26aulast%3DZeps%26aufirst%3DN.%26aulast%3DKakkar%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DY.%2BQ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DMuzny%26aufirst%3DD.%2BM.%26aulast%3DFisher%26aufirst%3DW.%2BE.%26aulast%3DBrunicardi%26aufirst%3DF.%2BC.%26aulast%3DHodges%26aufirst%3DS.%2BE.%26aulast%3DReid%26aufirst%3DJ.%2BG.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DK.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DLewis%26aufirst%3DL.%2BR.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DBuhay%26aufirst%3DC.%2BJ.%26aulast%3DBeck%26aufirst%3DT.%26aulast%3DTimms%26aufirst%3DL.%26aulast%3DSam%26aufirst%3DM.%26aulast%3DBegley%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DPai%26aufirst%3DD.%26aulast%3DPanchal%26aufirst%3DA.%26aulast%3DBuchner%26aufirst%3DN.%26aulast%3DDe%2BBorja%26aufirst%3DR.%26aulast%3DDenroche%26aufirst%3DR.%2BE.%26aulast%3DYung%26aufirst%3DC.%2BK.%26aulast%3DSerra%26aufirst%3DS.%26aulast%3DOnetto%26aufirst%3DN.%26aulast%3DMukhopadhyay%26aufirst%3DD.%26aulast%3DTsao%26aufirst%3DM.%2BS.%26aulast%3DShaw%26aufirst%3DP.%2BA.%26aulast%3DPetersen%26aufirst%3DG.%2BM.%26aulast%3DGallinger%26aufirst%3DS.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%2BA.%26aulast%3DSchulick%26aufirst%3DR.%2BD.%26aulast%3DWolfgang%26aufirst%3DC.%2BL.%26aulast%3DMorgan%26aufirst%3DR.%2BA.%26aulast%3DLawlor%26aufirst%3DR.%2BT.%26aulast%3DCapelli%26aufirst%3DP.%26aulast%3DCorbo%26aufirst%3DV.%26aulast%3DScardoni%26aufirst%3DM.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3DTempero%26aufirst%3DM.%2BA.%26aulast%3DMann%26aufirst%3DK.%2BM.%26aulast%3DJenkins%26aufirst%3DN.%2BA.%26aulast%3DPerez-Mancera%26aufirst%3DP.%2BA.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DLargaespada%26aufirst%3DD.%2BA.%26aulast%3DWessels%26aufirst%3DL.%2BF.%26aulast%3DRust%26aufirst%3DA.%2BG.%26aulast%3DStein%26aufirst%3DL.%2BD.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DCopeland%26aufirst%3DN.%2BG.%26aulast%3DMusgrove%26aufirst%3DE.%2BA.%26aulast%3DScarpa%26aufirst%3DA.%26aulast%3DEshleman%26aufirst%3DJ.%2BR.%26aulast%3DHudson%26aufirst%3DT.%2BJ.%26aulast%3DSutherland%26aufirst%3DR.%2BL.%26aulast%3DWheeler%26aufirst%3DD.%2BA.%26aulast%3DPearson%26aufirst%3DJ.%2BV.%26aulast%3DMcPherson%26aufirst%3DJ.%2BD.%26aulast%3DGibbs%26aufirst%3DR.%2BA.%26aulast%3DGrimmond%26aufirst%3DS.%2BM.%26aulast%3DKassahn%26aufirst%3DK.%2BS.%26atitle%3DPancreatic%2520cancer%2520genomes%2520reveal%2520aberrations%2520in%2520axon%2520guidance%2520pathway%2520genes%26jtitle%3DNature%26date%3D2012%26volume%3D491%26spage%3D399%26epage%3D405%26doi%3D10.1038%2Fnature11547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2016</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.3322/caac.21332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.3322%2Fcaac.21332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26742998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC28rot1Kjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2016&pages=7-30&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2016&doi=10.3322%2Fcaac.21332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2016</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries.  Mortality data were collected by the National Center for Health Statistics.  In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States.  Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009-2012), much of which is because of recent rapid declines in prostate cancer diagnoses.  The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012.  Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease.  Among children and adolescents (aged birth-19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia.  Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKAn5ROFAaRS86Js-BCLiifW6udTcc2eZ_BhWpPrYgpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rot1Kjug%253D%253D&md5=2d4030a531945c5ebaaab181bfd80457</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21332%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202016%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2016%26volume%3D66%26spage%3D7%26epage%3D30%26doi%3D10.3322%2Fcaac.21332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span> <i>Statistics
by Cancer Type</i>; <span class="NLM_publisher-name">Cancer Research</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2017</span>; <a href="http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer_-_heading-Two" class="extLink">http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer_-_heading-Two</a> (accessed January 6, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Statistics%0Aby+Cancer+Type%3B+Cancer+Research%3A+London%2C+2017%3B+http%3A%2F%2Fwww.cancerresearchuk.org%2Fhealth-professional%2Fcancer-statistics%2Fstatistics-by-cancer-type%2Fpancreatic-cancer_-_heading-Two+%28accessed+January+6%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DStatistics%250Aby%2520Cancer%2520Type%26pub%3DCancer%2520Research%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carmichael, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spittle, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiessi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatter, J.</span></span> <span> </span><span class="NLM_article-title">Phase II study of gemcitabine in patients with advanced pancreatic cancer</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1038/bjc.1996.18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fbjc.1996.18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=8554969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADyaK28Xht12iurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1996&pages=101-105&author=J.+Carmichaelauthor=U.+Finkauthor=R.+C.+Russellauthor=M.+F.+Spittleauthor=A.+L.+Harrisauthor=G.+Spiessiauthor=J.+Blatter&title=Phase+II+study+of+gemcitabine+in+patients+with+advanced+pancreatic+cancer&doi=10.1038%2Fbjc.1996.18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II study of gemcitabine in patients with advanced pancreatic cancer</span></div><div class="casAuthors">Carmichael, J; Fink, U; Russell, RCG; Spittle, MF; Harris, AL; Spiessi, G; Blatter, J</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-5</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The efficacy and safety of gemcitabine at a starting dose of 800 mg/m2 administered once a week for 3 wk with 1 wk's rest was investigated in chemonaive patients with advanced and/or metastatic pancreatic cancer.  Of 34 patients, 32 were evaluable for efficacy, 20 patients had metastatic stage IV disease, 25 had a performance status of 1 and 26 (76%) patients has significant pain on presentation.  All responses were independently validated by an external oncol. review board: two patients achieved a partial response that lasted 5.8 and 5.2 mo (6.3%) and six patients were stable for at least 4 wk.  The median duration of survival for evaluable patients was 6.3 mo (range 1.6-19.2 mo).  The tumor markers, CEA, CA 19-9 and CA 195 were serially measured in 16 patients.  There was a good correlation with tumor response when all three markers were significantly decreased.  In 4 of 16 patients, tumor marker levels decreased by ≈60%, including the two responders, one patient who survived for 12 mo and one patient who showed objective tumor shrinkage but was deemed ineligible for response evaluation because the disease was considered not to be bidimensionally measurable.  Symptomatic benefits included improvement in performance status (17.2%), analgesic requirement (7.4%), pain score (28.6%) and nausea (27.3%).  The mean no. of cycles administered was 2.5 and the mean dosage received was 890 mg/m2 per injection.  Seventy-four per cent of dose administrations were given on schedule.  Toxicity, particularly hematol. toxicity, reported as the max. WHO grade experienced by patients was mild.  Infective episodes were rare and limited to WHO grade 2 (6.7%).  Nausea and vomiting was generally modest (WHO grade 3, 26.7%).  Other side-effects included mild transient flu-like symptoms (seven patients) and peripheral edema (three patients), which was not assocd. with abnormal cardiac hepatic or renal function.  Gemcitabine has modest activity in pancreatic cancer, a limited pos. improvement on a range of patient benefit parameters and has a mild toxicity profile.  For these reasons and because of its novel mode of action, gemcitabine warrants further investigation in combination studies in pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJnn1RADnTt7Vg90H21EOLACvtfcHk0liG5midkV3FxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xht12iurc%253D&md5=32651c020bdac10da4e6d082222b0e24</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1996.18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1996.18%26sid%3Dliteratum%253Aachs%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DFink%26aufirst%3DU.%26aulast%3DRussell%26aufirst%3DR.%2BC.%26aulast%3DSpittle%26aufirst%3DM.%2BF.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26aulast%3DSpiessi%26aufirst%3DG.%26aulast%3DBlatter%26aufirst%3DJ.%26atitle%3DPhase%2520II%2520study%2520of%2520gemcitabine%2520in%2520patients%2520with%2520advanced%2520pancreatic%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1996%26volume%3D73%26spage%3D101%26epage%3D105%26doi%3D10.1038%2Fbjc.1996.18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Von
Hoff, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ervin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiorean, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjulandin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleh, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laheru, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahary, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabernero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Cutsem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iglesias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renschler, M. F.</span></span> <span> </span><span class="NLM_article-title">Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1703</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1304369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1056%2FNEJMoa1304369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=24131140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCjsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=1691-1703&author=D.+D.+Von%0AHoffauthor=T.+Ervinauthor=F.+P.+Arenaauthor=E.+G.+Chioreanauthor=J.+Infanteauthor=M.+Mooreauthor=T.+Seayauthor=S.+A.+Tjulandinauthor=W.+W.+Maauthor=M.+N.+Salehauthor=M.+Harrisauthor=M.+Reniauthor=S.+Dowdenauthor=D.+Laheruauthor=N.+Baharyauthor=R.+K.+Ramanathanauthor=J.+Taberneroauthor=M.+Hidalgoauthor=D.+Goldsteinauthor=E.+Van+Cutsemauthor=X.+Weiauthor=J.+Iglesiasauthor=M.+F.+Renschler&title=Increased+survival+in+pancreatic+cancer+with+nab-paclitaxel+plus+gemcitabine&doi=10.1056%2FNEJMoa1304369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine</span></div><div class="casAuthors">Von Hoff, Daniel D.; Ervin, Thomas; Arena, Francis P.; Chiorean, E. Gabriela; Infante, Jeffrey; Moore, Malcolm; Seay, Thomas; Tjulandin, Sergei A.; Ma, Wen Wee; Saleh, Mansoor N.; Harris, Marion; Reni, Michele; Dowden, Scot; Laheru, Daniel; Bahary, Nathan; Ramanathan, Ramesh K.; Tabernero, Josep; Hidalgo, Manuel; Goldstein, David; Van Cutsem, Eric; Wei, Xinyu; Iglesias, Jose; Renschler, Markus F.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1691-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: In a phase 1-2 trial of albumin-bound paclitaxel (nab-paclitaxel) plus gemcitabine, substantial clin. activity was noted in patients with advanced pancreatic cancer.  We conducted a phase 3 study of the efficacy and safety of the combination vs. gemcitabine monotherapy in patients with metastatic pancreatic cancer.  METHODS: We randomly assigned patients with a Karnofsky performance-status score of 70 or more (on a scale from 0 to 100, with higher scores indicating better performance status) to nab-paclitaxel (125 mg per square meter of body-surface area) followed by gemcitabine (1000 mg per square meter) on days 1, 8, and 15 every 4 wk or gemcitabine monotherapy (1000 mg per square meter) weekly for 7 of 8 wk (cycle 1) and then on days 1, 8, and 15 every 4 wk (cycle 2 and subsequent cycles).  Patients received the study treatment until disease progression.  The primary end point was overall survival; secondary end points were progression-free survival and overall response rate.  RESULTS: A total of 861 patients were randomly assigned to nab-paclitaxel plus gemcitabine (431 patients) or gemcitabine (430).  The median overall survival was 8.5 mo in the nab-paclitaxel-gemcitabine group as compared with 6.7 mo in the gemcitabine group (hazard ratio for death, 0.72; 95% confidence interval [CI], 0.62 to 0.83; P<0.001).  The survival rate was 35% in the nab-paclitaxel-gemcitabine group vs. 22% in the gemcitabine group at 1 yr, and 9% vs. 4% at 2 years.  The median progression-free survival was 5.5 mo in the nab-paclitaxel-gemcitabine group, as compared with 3.7 mo in the gemcitabine group (hazard ratio for disease progression or death, 0.69; 95% CI, 0.58 to 0.82; P<0.001); the response rate according to independent review was 23% vs. 7% in the two groups (P<0.001).  The most common adverse events of grade 3 or higher were neutropenia (38% in the nab-paclitaxel-gemcitabine group vs. 27% in the gemcitabine group), fatigue (17% vs. 7%), and neuropathy (17% vs. 1%).  Febrile neutropenia occurred in 3% vs. 1% of the patients in the two groups.  In the nab-paclitaxel-gemcitabine group, neuropathy of grade 3 or higher improved to grade 1 or lower in a median of 29 days.  CONCLUSIONS: In patients with metastatic pancreatic adenocarcinoma, nab-paclitaxel plus gemcitabine significantly improved overall survival, progression-free survival, and response rate, but rates of peripheral neuropathy and myelosuppression were increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCXpODbQZ6dLVg90H21EOLACvtfcHk0liG5midkV3FxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCjsb7I&md5=b1169c7e9879c08061dd9e9389dc36fe</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1304369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1304369%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DErvin%26aufirst%3DT.%26aulast%3DArena%26aufirst%3DF.%2BP.%26aulast%3DChiorean%26aufirst%3DE.%2BG.%26aulast%3DInfante%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DSeay%26aufirst%3DT.%26aulast%3DTjulandin%26aufirst%3DS.%2BA.%26aulast%3DMa%26aufirst%3DW.%2BW.%26aulast%3DSaleh%26aufirst%3DM.%2BN.%26aulast%3DHarris%26aufirst%3DM.%26aulast%3DReni%26aufirst%3DM.%26aulast%3DDowden%26aufirst%3DS.%26aulast%3DLaheru%26aufirst%3DD.%26aulast%3DBahary%26aufirst%3DN.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DVan%2BCutsem%26aufirst%3DE.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DIglesias%26aufirst%3DJ.%26aulast%3DRenschler%26aufirst%3DM.%2BF.%26atitle%3DIncreased%2520survival%2520in%2520pancreatic%2520cancer%2520with%2520nab-paclitaxel%2520plus%2520gemcitabine%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D1691%26epage%3D1703%26doi%3D10.1056%2FNEJMoa1304369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desseigne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ychou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouche, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimbaud, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becouarn, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adenis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raoul, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourgou-Bourgade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Fouchardiere, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennouna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachet, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khemissa-Akouz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pere-Verge, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assenat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauffert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoto-Grillot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducreux, M.</span></span> <span> </span><span class="NLM_article-title">FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>364</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1825</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1011923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1056%2FNEJMoa1011923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=21561347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvF2jsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=1817-1825&author=T.+Conroyauthor=F.+Desseigneauthor=M.+Ychouauthor=O.+Boucheauthor=R.+Guimbaudauthor=Y.+Becouarnauthor=A.+Adenisauthor=J.+L.+Raoulauthor=S.+Gourgou-Bourgadeauthor=C.+de+la+Fouchardiereauthor=J.+Bennounaauthor=J.+B.+Bachetauthor=F.+Khemissa-Akouzauthor=D.+Pere-Vergeauthor=C.+Delbaldoauthor=E.+Assenatauthor=B.+Chauffertauthor=P.+Michelauthor=C.+Montoto-Grillotauthor=M.+Ducreux&title=FOLFIRINOX+versus+gemcitabine+for+metastatic+pancreatic+cancer&doi=10.1056%2FNEJMoa1011923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">FOLFIRINOX versus gemcitabine or metastatic pancreatic cancer</span></div><div class="casAuthors">Conroy, Thierry; Desseigne, Francoise; Ychou, Marc; Bouche, Olivier; Guimbaud, Rosine; Becouarn, Yves; Adenis, Antoine; Raoul, Jean-Luc; Gourgou-Bourgade, Sophie; de la Fouchardiere, Christelle; Bennouna, Jaafar; Bachet, Jean-Baptiste; Khemissa-Akouz, Faiza; Pere-Verge, Denis; Delbaldo, Catherine; Assenat, Eric; Chauffert, Bruno; Michel, Pierre; Montoto-Grillot, Christine; Ducreux, Michel</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1817-1825</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Data are lacking on the efficacy and safety of a combination chemotherapy regimen consisting of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) as compared with gemcitabine as first-line therapy in patients with metastatic pancreatic cancer.  METHODS We randomly assigned 342 patients with an Eastern Cooperative Oncol. Group performance status score of 0 or 1 (on a scale of 0 to 5, with higher scores indicating a greater severity of illness) to receive FOLFIRINOX (oxaliplatin, 85 mg per square meter of body-surface area; irinotecan, 180 mg per square meter; leucovorin, 400 mg per square meter; and fluorouracil, 400 mg per square meter given as a bolus followed by 2400 mg per square meter given as a 46-h continuous infusion, every 2 wk) or gemcitabine at a dose of 1000 mg per square meter weekly for 7 of 8 wk and then weekly for 3 of 4 wk.  Six months of chemotherapy were recommended in both groups in patients who had a response.  The primary end point was overall survival.  RESULTS The median overall survival was 11.1 mo in the FOLFIRINOX group as compared with 6.8 mo in the gemcitabine group (hazard ratio for death, 0.57; 95% confidence interval [CI], 0.45 to 0.73; P < 0.001).  Median progression-free survival was 6.4 mo in the FOLFIRINOX group and 3.3 mo in the gemcitabine group (hazard ratio for disease progression, 0.47; 95% CI, 0.37 to 0.59; P < 0.001).  The objective response rate was 31.60% in the FOLFIRINOX group vs. 9.4% in the gemcitabine group (P < 0.001).  More adverse events were noted in the FOLFIRINOX group; 5.4% of patients in this group had febrile neutropenia.  At 6 mo, 31% of the patients in the FOLFIRINOX group had a definitive degrdn. of the quality of life vs. 66% in the gemcitabine group (hazard ratio, 0.47; 95% CI, 0.30 to 0.70; P < 0.001).  CONCLUSIONS As compared with gemcitabine, FOLFIRINOX was assocd. with a survival advantage and had increased toxicity.  FOLFIRINOX is an option for the treatment of patients with metastatic pancreatic cancer and good performance status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGyDR85GUgOrVg90H21EOLACvtfcHk0liyv0sf10a4AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvF2jsrw%253D&md5=a1a7135a6c97c4dc47233465ce0defd5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1011923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1011923%26sid%3Dliteratum%253Aachs%26aulast%3DConroy%26aufirst%3DT.%26aulast%3DDesseigne%26aufirst%3DF.%26aulast%3DYchou%26aufirst%3DM.%26aulast%3DBouche%26aufirst%3DO.%26aulast%3DGuimbaud%26aufirst%3DR.%26aulast%3DBecouarn%26aufirst%3DY.%26aulast%3DAdenis%26aufirst%3DA.%26aulast%3DRaoul%26aufirst%3DJ.%2BL.%26aulast%3DGourgou-Bourgade%26aufirst%3DS.%26aulast%3Dde%2Bla%2BFouchardiere%26aufirst%3DC.%26aulast%3DBennouna%26aufirst%3DJ.%26aulast%3DBachet%26aufirst%3DJ.%2BB.%26aulast%3DKhemissa-Akouz%26aufirst%3DF.%26aulast%3DPere-Verge%26aufirst%3DD.%26aulast%3DDelbaldo%26aufirst%3DC.%26aulast%3DAssenat%26aufirst%3DE.%26aulast%3DChauffert%26aufirst%3DB.%26aulast%3DMichel%26aufirst%3DP.%26aulast%3DMontoto-Grillot%26aufirst%3DC.%26aulast%3DDucreux%26aufirst%3DM.%26atitle%3DFOLFIRINOX%2520versus%2520gemcitabine%2520for%2520metastatic%2520pancreatic%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D1817%26epage%3D1825%26doi%3D10.1056%2FNEJMoa1011923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismail, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vartak, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittinghofer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastiaens, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibition of the KRAS-PDEdelta interaction impairs oncogenic KRAS signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>497</i></span>,  <span class="NLM_fpage">638</span>– <span class="NLM_lpage">642</span>, <span class="refDoi"> DOI: 10.1038/nature12205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnature12205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=23698361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFSgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=497&publication_year=2013&pages=638-642&author=G.+Zimmermannauthor=B.+Papkeauthor=S.+Ismailauthor=N.+Vartakauthor=A.+Chandraauthor=M.+Hoffmannauthor=S.+A.+Hahnauthor=G.+Triolaauthor=A.+Wittinghoferauthor=P.+I.+Bastiaensauthor=H.+Waldmann&title=Small+molecule+inhibition+of+the+KRAS-PDEdelta+interaction+impairs+oncogenic+KRAS+signalling&doi=10.1038%2Fnature12205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling</span></div><div class="casAuthors">Zimmermann, Gunther; Papke, Bjoern; Ismail, Shehab; Vartak, Nachiket; Chandra, Anchal; Hoffmann, Maike; Hahn, Stephan A.; Triola, Gemma; Wittinghofer, Alfred; Bastiaens, Philippe I. H.; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">497</span>
        (<span class="NLM_cas:issue">7451</span>),
    <span class="NLM_cas:pages">638-642</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The KRAS oncogene product is considered a major target in anticancer drug discovery.  However, direct interference with KRAS signalling has not yet led to clin. useful drugs.  Correct localization and signalling by farnesylated KRAS is regulated by the prenyl-binding protein PDEδ, which sustains the spatial organization of KRAS by facilitating its diffusion in the cytoplasm.  Here we report that interfering with binding of mammalian PDEδ to KRAS by means of small mols. provides a novel opportunity to suppress oncogenic RAS signalling by altering its localization to endomembranes.  Biochem. screening and subsequent structure-based hit optimization yielded inhibitors of the KRAS-PDEδ interaction that selectively bind to the prenyl-binding pocket of PDEδ with nanomolar affinity, inhibit oncogenic RAS signalling and suppress in vitro and in vivo proliferation of human pancreatic ductal adenocarcinoma cells that are dependent on oncogenic KRAS.  Our findings may inspire novel drug discovery efforts aimed at the development of drugs targeting oncogenic RAS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj4LMNyMIV4LVg90H21EOLACvtfcHk0liyv0sf10a4AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFSgtbs%253D&md5=e8dfd498bfd4dafbebf07fee9128e6b0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature12205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12205%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DG.%26aulast%3DPapke%26aufirst%3DB.%26aulast%3DIsmail%26aufirst%3DS.%26aulast%3DVartak%26aufirst%3DN.%26aulast%3DChandra%26aufirst%3DA.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DHahn%26aufirst%3DS.%2BA.%26aulast%3DTriola%26aufirst%3DG.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DBastiaens%26aufirst%3DP.%2BI.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DSmall%2520molecule%2520inhibition%2520of%2520the%2520KRAS-PDEdelta%2520interaction%2520impairs%2520oncogenic%2520KRAS%2520signalling%26jtitle%3DNature%26date%3D2013%26volume%3D497%26spage%3D638%26epage%3D642%26doi%3D10.1038%2Fnature12205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Quadruplex nucleic acids as novel therapeutic targets</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5987</span>– <span class="NLM_lpage">6011</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01835</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01835" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5987-6011&author=S.+Neidle&title=Quadruplex+nucleic+acids+as+novel+therapeutic+targets&doi=10.1021%2Facs.jmedchem.5b01835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Quadruplex Nucleic Acids as Novel Therapeutic Targets</span></div><div class="casAuthors">Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5987-6011</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quadruplex-forming sequences are widely prevalent in human and other genomes, including bacterial ones.  These sequences are over-represented in eukaryotic telomeres, promoters, and 5' untranslated regions.  They can form quadruplex structures, which may be transient in many situations in normal cells since they can be effectively resolved by helicase action.  Mutated helicases in cancer cells are unable to unwind quadruplexes, which are impediments to transcription, translation, or replication, depending on their location within a particular gene.  Small mols. that can stabilize quadruplex structures augment these effects and produce cell and proliferation growth inhibition.  This article surveys the chem. biol. of quadruplexes.  It critically examines the major classes of quadruplex-binding small mols. that have been developed to date and the various approaches to discovering selective agents.  The challenges of requiring (and achieving) small-mol. targeted selectivity for a particular quadruplex are discussed in relation to the potential of these small mols. as clin. useful therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZLAJfhJHYjrVg90H21EOLACvtfcHk0liwotWNEzDfhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOlsr0%253D&md5=73a5a4b3ba0b33128500a3f9420700ed</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01835%26sid%3Dliteratum%253Aachs%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DQuadruplex%2520nucleic%2520acids%2520as%2520novel%2520therapeutic%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5987%26epage%3D6011%26doi%3D10.1021%2Facs.jmedchem.5b01835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huppert, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span> <span> </span><span class="NLM_article-title">G-quadruplexes in promoters throughout the human genome</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">406</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1093/nar/gkl1057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fnar%2Fgkl1057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=17169996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=406-413&author=J.+L.+Huppertauthor=S.+Balasubramanian&title=G-quadruplexes+in+promoters+throughout+the+human+genome&doi=10.1093%2Fnar%2Fgkl1057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">G-quadruplexes in promoters throughout the human genome</span></div><div class="casAuthors">Huppert, Julian L.; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">406-413</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Certain G-rich DNA sequences readily form four-stranded structures called G-quadruplexes.  These sequence motifs are located in telomeres as a repeated unit, and elsewhere in the genome, where their function is currently unknown.  It has been proposed that G-quadruplexes may be directly involved in gene regulation at the level of transcription.  In support of this hypothesis, we show that the promoter regions (1 kb upstream of the transcription start site TSS) of genes are significantly enriched in quadruplex motifs relative to the rest of the genome, with >40% of human gene promoters contg. one or more quadruplex motif.  Furthermore, these promoter quadruplexes strongly assoc. with nuclease hypersensitive sites identified throughout the genome via biochem. measurement.  Regions of the human genome that are both nuclease hypersensitive and within promoters show a remarkable (230-fold) enrichment of quadruplex elements, compared to the rest of the genome.  These quadruplex motifs identified in promoter regions also show an interesting structural bias towards more stable forms.  These observations support the proposal that promoter G-quadruplexes are directly involved in the regulation of gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofaKOSq_qjKrVg90H21EOLACvtfcHk0liwotWNEzDfhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOls74%253D&md5=626903207653e1c97d568b9b50c093bd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkl1057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkl1057%26sid%3Dliteratum%253Aachs%26aulast%3DHuppert%26aufirst%3DJ.%2BL.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DG-quadruplexes%2520in%2520promoters%2520throughout%2520the%2520human%2520genome%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3D406%26epage%3D413%26doi%3D10.1093%2Fnar%2Fgkl1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansel-Hertsch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beraldi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lensing, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsico, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zyner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Antonio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannahill, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span> <span> </span><span class="NLM_article-title">G-quadruplex structures mark human regulatory chromatin</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1267</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1038/ng.3662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fng.3662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=27618450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFSgurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=1267-1272&author=R.+Hansel-Hertschauthor=D.+Beraldiauthor=S.+V.+Lensingauthor=G.+Marsicoauthor=K.+Zynerauthor=A.+Parryauthor=M.+Di+Antonioauthor=J.+Pikeauthor=H.+Kimuraauthor=M.+Naritaauthor=D.+Tannahillauthor=S.+Balasubramanian&title=G-quadruplex+structures+mark+human+regulatory+chromatin&doi=10.1038%2Fng.3662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">G-quadruplex structures mark human regulatory chromatin</span></div><div class="casAuthors">Hansel-Hertsch, Robert; Beraldi, Dario; Lensing, Stefanie V.; Marsico, Giovanni; Zyner, Katherine; Parry, Aled; Di Antonio, Marco; Pike, Jeremy; Kimura, Hiroshi; Narita, Masashi; Tannahill, David; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1267-1272</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G-quadruplex (G4) structural motifs have been linked to transcription, replication and genome instability and are implicated in cancer and other diseases.  However, it is crucial to demonstrate the bona fide formation of G4 structures within an endogenous chromatin context.  Herein we address this through the development of G4 ChIP-seq, an antibody-based G4 chromatin immunopptn. and high-throughput sequencing approach.  We find ∼10,000 G4 structures in human chromatin, predominantly in regulatory, nucleosome-depleted regions.  G4 structures are enriched in the promoters and 5' UTRs of highly transcribed genes, particularly in genes related to cancer and in somatic copy no. amplifications, such as MYC.  Strikingly, de novo and enhanced G4 formation are assocd. with increased transcriptional activity, as shown by HDAC inhibitor-induced chromatin relaxation and obsd. in immortalized as compared to normal cellular states.  Our findings show that regulatory, nucleosome-depleted chromatin and elevated transcription shape the endogenous human G4 DNA landscape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYo8vsZd_UZLVg90H21EOLACvtfcHk0liwotWNEzDfhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFSgurvP&md5=898d19559a9ccbc0ff468558a653fc43</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fng.3662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.3662%26sid%3Dliteratum%253Aachs%26aulast%3DHansel-Hertsch%26aufirst%3DR.%26aulast%3DBeraldi%26aufirst%3DD.%26aulast%3DLensing%26aufirst%3DS.%2BV.%26aulast%3DMarsico%26aufirst%3DG.%26aulast%3DZyner%26aufirst%3DK.%26aulast%3DParry%26aufirst%3DA.%26aulast%3DDi%2BAntonio%26aufirst%3DM.%26aulast%3DPike%26aufirst%3DJ.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DTannahill%26aufirst%3DD.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DG-quadruplex%2520structures%2520mark%2520human%2520regulatory%2520chromatin%26jtitle%3DNat.%2520Genet.%26date%3D2016%26volume%3D48%26spage%3D1267%26epage%3D1272%26doi%3D10.1038%2Fng.3662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, V.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsico, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Antonio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span> <span> </span><span class="NLM_article-title">High-throughput sequencing of DNA G-quadruplex structures in the human genome</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">881</span>, <span class="refDoi"> DOI: 10.1038/nbt.3295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnbt.3295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26192317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FksFOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=877-881&author=V.%0AS.+Chambersauthor=G.+Marsicoauthor=J.+M.+Boutellauthor=M.+Di+Antonioauthor=G.+P.+Smithauthor=S.+Balasubramanian&title=High-throughput+sequencing+of+DNA+G-quadruplex+structures+in+the+human+genome&doi=10.1038%2Fnbt.3295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput sequencing of DNA G-quadruplex structures in the human genome</span></div><div class="casAuthors">Chambers Vicki S; Marsico Giovanni; Boutell Jonathan M; Smith Geoffrey P; Di Antonio Marco; Balasubramanian Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nature biotechnology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">877-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">G-quadruplexes (G4s) are nucleic acid secondary structures that form within guanine-rich DNA or RNA sequences.  G4 formation can affect chromatin architecture and gene regulation and has been associated with genomic instability, genetic diseases and cancer progression.  Here we present a high-resolution sequencing-based method to detect G4s in the human genome.  We identified 716,310 distinct G4 structures, 451,646 of which were not predicted by computational methods.  These included previously uncharacterized noncanonical long loop and bulged structures.  We observed a high G4 density in functional regions, such as 5' untranslated regions and splicing sites, as well as in genes previously not predicted to contain these structures (such as BRCA2).  G4 formation was significantly associated with oncogenes, tumor suppressors and somatic copy number alterations related to cancer development.  The G4s identified in this study may therefore represent promising targets for cancer intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTr_GulKgy_aSjiVMCqkKxVfW6udTcc2eZzeP_7lvFI9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FksFOltA%253D%253D&md5=e8b1e1dcb44cc030cd843817f507f92e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnbt.3295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.3295%26sid%3Dliteratum%253Aachs%26aulast%3DChambers%26aufirst%3DV.%2BS.%26aulast%3DMarsico%26aufirst%3DG.%26aulast%3DBoutell%26aufirst%3DJ.%2BM.%26aulast%3DDi%2BAntonio%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DG.%2BP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DHigh-throughput%2520sequencing%2520of%2520DNA%2520G-quadruplex%2520structures%2520in%2520the%2520human%2520genome%26jtitle%3DNat.%2520Biotechnol.%26date%3D2015%26volume%3D33%26spage%3D877%26epage%3D881%26doi%3D10.1038%2Fnbt.3295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biffi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannahill, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCafferty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span> <span> </span><span class="NLM_article-title">Quantitative visualization of DNA G-quadruplex structures in human cells</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1038/nchem.1548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnchem.1548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=23422559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=182-186&author=G.+Biffiauthor=D.+Tannahillauthor=J.+McCaffertyauthor=S.+Balasubramanian&title=Quantitative+visualization+of+DNA+G-quadruplex+structures+in+human+cells&doi=10.1038%2Fnchem.1548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative visualization of DNA G-quadruplex structures in human cells</span></div><div class="casAuthors">Biffi, Giulia; Tannahill, David; McCafferty, John; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">182-186</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Four-stranded G-quadruplex nucleic acid structures are of great interest as their high thermodn. stability under near-physiol. conditions suggests that they could form in cells.  Here we report the generation and application of an engineered, structure-specific antibody employed to quant. visualize DNA G-quadruplex structures in human cells.  We show explicitly that G-quadruplex formation in DNA is modulated during cell-cycle progression and that endogenous G-quadruplex DNA structures can be stabilized by a small-mol. ligand.  Together these findings provide substantive evidence for the formation of G-quadruplex structures in the genome of mammalian cells and corroborate the application of stabilizing ligands in a cellular context to target G-quadruplexes and intervene with their function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhn6OP0CwcSLVg90H21EOLACvtfcHk0ljchecOnESa0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSms7o%253D&md5=1721b2fba0fd65bfedd758b273c80f21</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1548%26sid%3Dliteratum%253Aachs%26aulast%3DBiffi%26aufirst%3DG.%26aulast%3DTannahill%26aufirst%3DD.%26aulast%3DMcCafferty%26aufirst%3DJ.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DQuantitative%2520visualization%2520of%2520DNA%2520G-quadruplex%2520structures%2520in%2520human%2520cells%26jtitle%3DNat.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D182%26epage%3D186%26doi%3D10.1038%2Fnchem.1548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosh, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansdorp, P. M.</span></span> <span> </span><span class="NLM_article-title">Detection of G-quadruplex DNA in mammalian cells</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">860</span>– <span class="NLM_lpage">869</span>, <span class="refDoi"> DOI: 10.1093/nar/gkt957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fnar%2Fgkt957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=24163102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlShsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=860-869&author=A.+Hendersonauthor=Y.+Wuauthor=Y.+C.+Huangauthor=E.+A.+Chavezauthor=J.+Plattauthor=F.+B.+Johnsonauthor=R.+M.+Broshauthor=D.+Senauthor=P.+M.+Lansdorp&title=Detection+of+G-quadruplex+DNA+in+mammalian+cells&doi=10.1093%2Fnar%2Fgkt957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of G-quadruplex DNA in mammalian cells</span></div><div class="casAuthors">Henderson, Alexander; Wu, Yuliang; Huang, Yu Chuan; Chavez, Elizabeth A.; Platt, Jesse; Johnson, F. Brad; Brosh, Robert M., Jr.; Sen, Dipankar; Lansdorp, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">860-869</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">It has been proposed that guanine-rich DNA forms four-stranded structures in vivo called G-quadruplexes or G4 DNA.  G4 DNA has been implicated in several biol. processes, but tools to study G4 DNA structures in cells are limited.  Here we report the development of novel murine monoclonal antibodies specific for different G4 DNA structures.  We show that one of these antibodies designated 1H6 exhibits strong nuclear staining in most human and murine cells.  Staining intensity increased on treatment of cells with agents that stabilize G4 DNA and, strikingly, cells deficient in FANCJ, a G4 DNA-specific helicase, showed stronger nuclear staining than controls.  Our data strongly support the existence of G4 DNA structures in mammalian cells and indicate that the abundance of such structures is increased in the absence of FANCJ.  We conclude that monoclonal antibody 1H6 is a valuable tool for further studies on the role of G4 DNA in cell and mol. biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrli0PqZbZA3bVg90H21EOLACvtfcHk0ljchecOnESa0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlShsrw%253D&md5=a16e8096cfaa3f7d8d7d045294a6fa3f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt957%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.%2BC.%26aulast%3DChavez%26aufirst%3DE.%2BA.%26aulast%3DPlatt%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DF.%2BB.%26aulast%3DBrosh%26aufirst%3DR.%2BM.%26aulast%3DSen%26aufirst%3DD.%26aulast%3DLansdorp%26aufirst%3DP.%2BM.%26atitle%3DDetection%2520of%2520G-quadruplex%2520DNA%2520in%2520mammalian%2520cells%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26spage%3D860%26epage%3D869%26doi%3D10.1093%2Fnar%2Fgkt957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biffi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannahill, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howat, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span> <span> </span><span class="NLM_article-title">Elevated levels of G-quadruplex formation in human stomach and liver cancer tissues</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e102711</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0102711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1371%2Fjournal.pone.0102711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25033211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ehur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e102711&author=G.+Biffiauthor=D.+Tannahillauthor=J.+Millerauthor=W.+J.+Howatauthor=S.+Balasubramanian&title=Elevated+levels+of+G-quadruplex+formation+in+human+stomach+and+liver+cancer+tissues&doi=10.1371%2Fjournal.pone.0102711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated levels of G-quadruplex formation in human stomach and liver cancer tissues</span></div><div class="casAuthors">Biffi, Giulia; Tannahill, David; Miller, Jodi; Howat, William J.; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e102711/1-e102711/9, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Four-stranded G-quadruplex DNA secondary structures have recently been visualized in the nuclei of human cultured cells.  Here, we show that BG4, a G-quadruplex-specific antibody, can be used to stain DNA G-quadruplex structures in patient-derived tissues using immunohistochem.  We observe a significantly elevated no. of G-quadruplex-pos. nuclei in human cancers of the liver and stomach as compared to background non-neoplastic tissue.  Our results suggest that G-quadruplex formation can be detected and measured in patient-derived material and that elevated G-quadruplex formation may be a characteristic of some cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNw8M-YLkC47Vg90H21EOLACvtfcHk0ljchecOnESa0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ehur7P&md5=25c316d253cfb80c0f5195ee524a0fe6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0102711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0102711%26sid%3Dliteratum%253Aachs%26aulast%3DBiffi%26aufirst%3DG.%26aulast%3DTannahill%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DJ.%26aulast%3DHowat%26aufirst%3DW.%2BJ.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DElevated%2520levels%2520of%2520G-quadruplex%2520formation%2520in%2520human%2520stomach%2520and%2520liver%2520cancer%2520tissues%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De102711%26doi%3D10.1371%2Fjournal.pone.0102711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Monchaud, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teulade-Fichou, M. P.</span></span> <span> </span><span class="NLM_article-title">A hitchhiker’s guide to G-quadruplex ligands</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">636</span>, <span class="refDoi"> DOI: 10.1039/B714772B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1039%2FB714772B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=18264563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1yksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=627-636&author=D.+Monchaudauthor=M.+P.+Teulade-Fichou&title=A+hitchhiker%E2%80%99s+guide+to+G-quadruplex+ligands&doi=10.1039%2FB714772B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">A hitchhiker's guide to G-quadruplex ligands</span></div><div class="casAuthors">Monchaud, David; Teulade-Fichou, Marie-Paule</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">627-636</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Over the past decade, nucleic acid chemists have seen the spectacular emergence of mols. designed to interact efficiently and selectively with a peculiar DNA structure named G-quadruplex.  Initially derived from classical DNA intercalators, these G-quadruplex ligands progressively became the focal point of new excitement since they appear to inhibit selectively the growth of cancer cells thereby opening interesting perspectives towards the development of novel anti-cancer drugs.  The present review article aims to help researchers enter this exciting research field, and to highlight recent advances in the design of G-quadruplex ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocJwqI1pO4abVg90H21EOLACvtfcHk0lgOCja1GEi0lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1yksLs%253D&md5=6fb7438f6a893ab816818d5799e3ef62</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1039%2FB714772B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB714772B%26sid%3Dliteratum%253Aachs%26aulast%3DMonchaud%26aufirst%3DD.%26aulast%3DTeulade-Fichou%26aufirst%3DM.%2BP.%26atitle%3DA%2520hitchhiker%25E2%2580%2599s%2520guide%2520to%2520G-quadruplex%2520ligands%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D627%26epage%3D636%26doi%3D10.1039%2FB714772B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="note"><p class="first last">29</p></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, R.</span></span> <span> </span><span class="NLM_article-title">G-quadruplex interacting small molecules and drugs: from bench towards bedside</span>. <i>Expert Rev. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">679</span>, <span class="refDoi"> DOI: 10.1586/17512433.2014.945909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1586%2F17512433.2014.945909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25089820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlequ7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=663-679&author=S.+M%C3%BCllerauthor=R.+Rodriguez&title=G-quadruplex+interacting+small+molecules+and+drugs%3A+from+bench+towards+bedside&doi=10.1586%2F17512433.2014.945909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">G-quadruplex interacting small molecules and drugs: from bench toward bedside</span></div><div class="casAuthors">Mueller, Sebastian; Rodriguez, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">663-679</span>CODEN:
                <span class="NLM_cas:coden">ERCPAG</span>;
        ISSN:<span class="NLM_cas:issn">1751-2433</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  G-quadruplexes are non-Watson-Crick four-stranded nucleic acid structures.  Recent evidence points toward their existence in vivo and their implication in various biol. processes.  Over the past two decades, small mols. have been developed to specifically and selectively target these structures in order to dissect mechanisms they have been linked to.  This has led to the development of potential therapeutic agents, particularly for anti-carcinogenic activity.  Here, we first present how major biol. roles of G-quadruplexes have been uncovered by the use of specifically designed small mol. probes.  We use this to highlight how fundamental research has contributed to identifying biol. functions of G-quadruplexes and their potential as therapeutic targets.  We then discuss the development of G-quadruplex interacting small mols. as potential drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe7SVTmBTFjLVg90H21EOLACvtfcHk0lgOCja1GEi0lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlequ7vM&md5=1fd176d2c918892fbb45e8b5e4e2f064</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1586%2F17512433.2014.945909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F17512433.2014.945909%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DRodriguez%26aufirst%3DR.%26atitle%3DG-quadruplex%2520interacting%2520small%2520molecules%2520and%2520drugs%253A%2520from%2520bench%2520towards%2520bedside%26jtitle%3DExpert%2520Rev.%2520Clin.%2520Pharmacol.%26date%3D2014%26volume%3D7%26spage%3D663%26epage%3D679%26doi%3D10.1586%2F17512433.2014.945909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurston, D. E.</span></span> <span> </span><span class="NLM_article-title">Recent advances in targeting the telomeric G-quadruplex DNA sequence with small molecules as a strategy for anticancer therapies</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1259</span>– <span class="NLM_lpage">1290</span>, <span class="refDoi"> DOI: 10.4155/fmc-2015-0017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.4155%2Ffmc-2015-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=27442231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1GitbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1259-1290&author=M.+K.+Islamauthor=P.+J.+Jacksonauthor=K.+M.+Rahmanauthor=D.+E.+Thurston&title=Recent+advances+in+targeting+the+telomeric+G-quadruplex+DNA+sequence+with+small+molecules+as+a+strategy+for+anticancer+therapies&doi=10.4155%2Ffmc-2015-0017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in targeting the telomeric G-quadruplex DNA sequence with small molecules as a strategy for anticancer therapies</span></div><div class="casAuthors">Islam, Mohammad K.; Jackson, Paul JM; Rahman, Khondaker M.; Thurston, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1259-1290</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Human telomeric DNA (hTelo), present at the ends of chromosomes to protect their integrity during cell division, comprises tandem repeats of the sequence d(TTAGGG) which is known to form a G-quadruplex secondary structure.  This unique structural formation of DNA is distinct from the well-known helical structure that most genomic DNA is thought to adopt, and has recently gained prominence as a mol. target for new types of anticancer agents.  In particular, compds. that can stabilize the intramol. G-quadruplex formed within the human telomeric DNA sequence can inhibit the activity of the enzyme telomerase which is known to be upregulated in tumor cells and is a major contributor to their immortality.  This provides the basis for the discovery and development of small mols. with the potential for selective toxicity toward tumor cells.  This review summarizes the various families of small mols. reported in the literature that have telomeric quadruplex stabilizing properties, and assesses the potential for compds. of this type to be developed as novel anticancer therapies.  A future perspective is also presented, emphasizing the need for researchers to adopt approaches that will allow the discovery of mols. with more drug-like properties in order to improve the chances of lead mols. reaching the clinic in the next decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdBY7z5P_hnrVg90H21EOLACvtfcHk0lgOCja1GEi0lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1GitbvN&md5=e4958c74af6d2859a6d997d7d1c0d22b</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2015-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2015-0017%26sid%3Dliteratum%253Aachs%26aulast%3DIslam%26aufirst%3DM.%2BK.%26aulast%3DJackson%26aufirst%3DP.%2BJ.%26aulast%3DRahman%26aufirst%3DK.%2BM.%26aulast%3DThurston%26aufirst%3DD.%2BE.%26atitle%3DRecent%2520advances%2520in%2520targeting%2520the%2520telomeric%2520G-quadruplex%2520DNA%2520sequence%2520with%2520small%2520molecules%2520as%2520a%2520strategy%2520for%2520anticancer%2520therapies%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D1259%26epage%3D1290%26doi%3D10.4155%2Ffmc-2015-0017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grand, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bearss, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, L. H.</span></span> <span> </span><span class="NLM_article-title">Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">11593</span>– <span class="NLM_lpage">11598</span>, <span class="refDoi"> DOI: 10.1073/pnas.182256799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1073%2Fpnas.182256799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=12195017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFWqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11593-11598&author=A.+Siddiqui-Jainauthor=C.+L.+Grandauthor=D.+J.+Bearssauthor=L.+H.+Hurley&title=Direct+evidence+for+a+G-quadruplex+in+a+promoter+region+and+its+targeting+with+a+small+molecule+to+repress+c-MYC+transcription&doi=10.1073%2Fpnas.182256799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription</span></div><div class="casAuthors">Siddiqui-Jain, Adam; Grand, Cory L.; Bearss, David J.; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">11593-11598</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The nuclease hypersensitivity element III1 upstream of the P1 promoter of c-MYC controls 85-90% of the transcriptional activation of this gene.  We have demonstrated that the purine-rich strand of the DNA in this region can form two different intramol. G-quadruplex structures, only one of which seems to be biol. relevant.  This biol. relevant structure is the kinetically favored chairform G-quadruplex, which is destabilized when mutated with a single G → A transition, resulting in a 3-fold increase in basal transcriptional activity of the c-MYC promoter.  The cationic porphyrin TMPyP4, which has been shown to stabilize this G-quadruplex structure, is able to suppress further c-MYC transcriptional activation.  These results provide compelling evidence that a specific G-quadruplex structure formed in the c-MYC promoter region functions as a transcriptional repressor element.  Furthermore, we establish the principle that c-MYC transcription can be controlled by ligand-mediated G-quadruplex stabilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzMKd0v3rpM7Vg90H21EOLACvtfcHk0lispY7FRG16nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFWqsL4%253D&md5=5f2767891816e2364405e1a4b37eba48</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.182256799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.182256799%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DGrand%26aufirst%3DC.%2BL.%26aulast%3DBearss%26aufirst%3DD.%2BJ.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DDirect%2520evidence%2520for%2520a%2520G-quadruplex%2520in%2520a%2520promoter%2520region%2520and%2520its%2520targeting%2520with%2520a%2520small%2520molecule%2520to%2520repress%2520c-MYC%2520transcription%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D11593%26epage%3D11598%26doi%3D10.1073%2Fpnas.182256799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rigo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sissi, C.</span></span> <span> </span><span class="NLM_article-title">G-quadruplexes in human promoters: A challenge for therapeutic applications</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1861</i></span>,  <span class="NLM_fpage">1399</span>– <span class="NLM_lpage">1413</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2016.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.bbagen.2016.12.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28025083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltlShug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1861&publication_year=2017&pages=1399-1413&author=R.+Rigoauthor=M.+Palumboauthor=C.+Sissi&title=G-quadruplexes+in+human+promoters%3A+A+challenge+for+therapeutic+applications&doi=10.1016%2Fj.bbagen.2016.12.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">G-quadruplexes in human promoters: A challenge for therapeutic applications</span></div><div class="casAuthors">Rigo, Riccardo; Palumbo, Manlio; Sissi, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1861</span>
        (<span class="NLM_cas:issue">5_Part_B</span>),
    <span class="NLM_cas:pages">1399-1413</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  G-rich sequences undergo unique structural equil. to form G-quadruplexes (G4) both in vitro and in cell systems.  Several pathologies emerged to be directly related to G4 occurrence at defined genomic portions.  Addnl., G-rich sequences are significantly represented around transcription start sites (TSS) thus leading to the hypothesis of a gene regulatory function for G4.  Thus, the tuning of G4 formation has been proposed as a new powerful tool to regulate gene expression to treat related pathologies.  However, up-to date this approach did not provide any new really efficient treatment.  Here, we summarize the most recent advances on the correlation between the structural features of G4 in human promoters and the role these systems physiol. exert.  In particular we focus on the effect of G4 localization among cell compartments and along the promoters in correlation with protein interaction networks and epigenetic state.  Finally the intrinsic structural features of G4 at promoters are discussed to unveil the contribution of different G4 structural modules in this complex architecture.  It emerges that G4s play several roles in the intriguing and complex mechanism of gene expression, being able to produce opposite effects on the same target.  This reflects the occurrence of a highly variegate network of several components working simultaneously.  The resulting picture is still fuzzy but some points of strength are definitely emerging, which prompts all of us to strengthen our efforts in view of a selective control of gene expression through G4 modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx7Z5yaojLhbVg90H21EOLACvtfcHk0lispY7FRG16nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltlShug%253D%253D&md5=82140fbd55b29ecddf9586d6d9d6701e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2016.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2016.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DRigo%26aufirst%3DR.%26aulast%3DPalumbo%26aufirst%3DM.%26aulast%3DSissi%26aufirst%3DC.%26atitle%3DG-quadruplexes%2520in%2520human%2520promoters%253A%2520A%2520challenge%2520for%2520therapeutic%2520applications%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2017%26volume%3D1861%26spage%3D1399%26epage%3D1413%26doi%3D10.1016%2Fj.bbagen.2016.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Boddupally, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhale, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, L. H.</span></span> <span> </span><span class="NLM_article-title">Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6076</span>– <span class="NLM_lpage">6086</span>, <span class="refDoi"> DOI: 10.1021/jm300282c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300282c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC38Xotlemu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6076-6086&author=P.+V.+Boddupallyauthor=S.+Hahnauthor=C.+Bemanauthor=B.+Deauthor=T.+A.+Brooksauthor=V.+Gokhaleauthor=L.+H.+Hurley&title=Anticancer+activity+and+cellular+repression+of+c-MYC+by+the+G-quadruplex-stabilizing+11-piperazinylquindoline+is+not+dependent+on+direct+targeting+of+the+G-quadruplex+in+the+c-MYC+promoter&doi=10.1021%2Fjm300282c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Activity and Cellular Repression of c-MYC by the G-Quadruplex-Stabilizing 11-Piperazinylquindoline Is Not Dependent on Direct Targeting of the G-Quadruplex in the c-MYC Promoter</span></div><div class="casAuthors">Boddupally, Peda V. L.; Hahn, Seongmin; Beman, Cristina; De, Biswanath; Brooks, Tracy A.; Gokhale, Vijay; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6076-6086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This G-rich region of the c-MYC promoter has been shown to form a G-quadruplex structure that acts as a silencer element for c-MYC transcriptional control.  In the present work, we have synthesized a series of 11-substituted quindoline analogs as c-MYC G-quadruplex-stabilizing compds., and the cell-free and in vitro activity of these compds. were evaluated.  Two lead compds. (4 and 12) demonstrated good cell-free profiles, and compd. 4 (2-(4-(10H-indolo[3,2-b]quinolin-11-yl)piperazin-1-yl)-N,N-dimethylethanamine) significantly down-regulated c-MYC expression.  However, despite the good cell-free activity and the effect of these compds. on c-MYC gene expression, we have demonstrated, using a cellular assay in a Burkitt's lymphoma cell line (CA46-specific), that these effects were not mediated through targeting of the c-MYC G-quadruplex.  Thus, caution should be used in assigning the effects of G-quadruplex-interactive compds. that lower c-MYC to direct targeting of these promoter elements unless this assay, or similar ones, demonstrates direct targeting of the G-quadruplex in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaQnhUeWAjMLVg90H21EOLACvtfcHk0lispY7FRG16nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xotlemu7Y%253D&md5=fb167ae59f4bffbac5bd48672ae4a319</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm300282c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300282c%26sid%3Dliteratum%253Aachs%26aulast%3DBoddupally%26aufirst%3DP.%2BV.%26aulast%3DHahn%26aufirst%3DS.%26aulast%3DBeman%26aufirst%3DC.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DBrooks%26aufirst%3DT.%2BA.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DAnticancer%2520activity%2520and%2520cellular%2520repression%2520of%2520c-MYC%2520by%2520the%2520G-quadruplex-stabilizing%252011-piperazinylquindoline%2520is%2520not%2520dependent%2520on%2520direct%2520targeting%2520of%2520the%2520G-quadruplex%2520in%2520the%2520c-MYC%2520promoter%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6076%26epage%3D6086%26doi%3D10.1021%2Fjm300282c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danford, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhale, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, T. A.</span></span> <span> </span><span class="NLM_article-title">Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">41018</span>– <span class="NLM_lpage">41027</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.274720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1074%2Fjbc.M111.274720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=21956115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOqu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=41018-41027&author=R.+V.+Brownauthor=F.+L.+Danfordauthor=V.+Gokhaleauthor=L.+H.+Hurleyauthor=T.+A.+Brooks&title=Demonstration+that+drug-targeted+down-regulation+of+MYC+in+non-Hodgkins+lymphoma+is+directly+mediated+through+the+promoter+G-quadruplex&doi=10.1074%2Fjbc.M111.274720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Demonstration that drug-targeted down-regulation of MYC in Non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex</span></div><div class="casAuthors">Brown, Robert V.; Danford, Forest L.; Gokhale, Vijay; Hurley, Laurence H.; Brooks, Tracy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">41018-41027</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Most transcription of the MYC proto-oncogene initiates in the near upstream promoter, within which lies the nuclease hypersensitive element (NHE) III1 region contg. the CT-element.  This dynamic stretch of DNA can form at least three different topologies: single-stranded DNA, double-stranded DNA, or higher order secondary structures that silence transcription.  In the current report, we identify the ellipticine analog GQC-05 (NSC338258) as a high affinity, potent, and selective stabilizer of the MYC G-quadruplex (G4).  In cells, GQC-05 induced cytotoxicity with corresponding decreased MYC mRNA and altered protein binding to the NHE III1 region, in agreement with a G4 stabilizing compd.  We further describe a unique feature of the Burkitt's lymphoma cell line CA46 that allowed us to clearly demonstrate the mechanism and location of action of GQC-05 within this region of DNA and through the G4.  Most importantly, these data present, as far as we are aware, the most direct evidence of intracellular G4-mediated control of a particular promoter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg8phSNhEgRrVg90H21EOLACvtfcHk0lhJdsR8eT6xGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOqu7fO&md5=62ecbb643265e2b4e0e7bc051043b46f</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.274720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.274720%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BV.%26aulast%3DDanford%26aufirst%3DF.%2BL.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26aulast%3DBrooks%26aufirst%3DT.%2BA.%26atitle%3DDemonstration%2520that%2520drug-targeted%2520down-regulation%2520of%2520MYC%2520in%2520non-Hodgkins%2520lymphoma%2520is%2520directly%2520mediated%2520through%2520the%2520promoter%2520G-quadruplex%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D41018%26epage%3D41027%26doi%3D10.1074%2Fjbc.M111.274720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit24c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Felsenstein, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gareiss, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneekloth, J. S.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Small molecule microarrays enable the identification of a selective, quadruplex-binding inhibitor of MYC expression</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00577</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00577" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Cqtr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=139-148&author=K.+M.+Felsensteinauthor=L.+B.+Saundersauthor=J.+K.+Simmonsauthor=E.+Leonauthor=D.+R.+Calabreseauthor=S.+Zhangauthor=A.+Michalowskiauthor=P.+Gareissauthor=B.+A.+Mockauthor=J.+S.+Schneekloth&title=Small+molecule+microarrays+enable+the+identification+of+a+selective%2C+quadruplex-binding+inhibitor+of+MYC+expression&doi=10.1021%2Facschembio.5b00577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24cR"><div class="casContent"><span class="casTitleNuber">24c</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression</span></div><div class="casAuthors">Felsenstein, Kenneth M.; Saunders, Lindsey B.; Simmons, John K.; Leon, Elena; Calabrese, David R.; Zhang, Shuling; Michalowski, Aleksandra; Gareiss, Peter; Mock, Beverly A.; Schneekloth, John S., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-148</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transcription factor MYC plays a pivotal role in cancer initiation, progression, and maintenance.  However, it has proven difficult to develop small mol. inhibitors of MYC.  One attractive route to pharmacol. inhibition of MYC has been the prevention of its expression through small mol.-mediated stabilization of the G-quadruplex (G4) present in its promoter.  Although mols. that bind globally to quadruplex DNA and influence gene expression are well-known, the identification of new chem. scaffolds that selectively modulate G4-driven genes remains a challenge.  Here, we report an approach for the identification of G4-binding small mols. using small mol. microarrays (SMMs).  We use the SMM screening platform to identify a novel G4-binding small mol. that inhibits MYC expression in cell models, with minimal impact on the expression of other G4-assocd. genes.  Surface plasmon resonance (SPR) and thermal melt assays demonstrated that this mol. binds reversibly to the MYC G4 with single digit micromolar affinity, and with weaker or no measurable binding to other G4s.  Biochem. and cell-based assays demonstrated that the compd. effectively silenced MYC transcription and translation via a G4-dependent mechanism of action.  The compd. induced G1 arrest and was selectively toxic to MYC-driven cancer cell lines contg. the G4 in the promoter but had minimal effects in peripheral blood mononucleocytes or a cell line lacking the G4 in its MYC promoter.  As a measure of selectivity, gene expression anal. and qPCR expts. demonstrated that MYC and several MYC target genes were downregulated upon treatment with this compd., while the expression of several other G4-driven genes was not affected.  In addn. to providing a novel chem. scaffold that modulates MYC expression through G4 binding, this work suggests that the SMM screening approach may be broadly useful as an approach for the identification of new G4-binding small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc_vBHrAhtdrVg90H21EOLACvtfcHk0lhJdsR8eT6xGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Cqtr7J&md5=2987c07be00c2d7c20e2e991c332a71f</span></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00577%26sid%3Dliteratum%253Aachs%26aulast%3DFelsenstein%26aufirst%3DK.%2BM.%26aulast%3DSaunders%26aufirst%3DL.%2BB.%26aulast%3DSimmons%26aufirst%3DJ.%2BK.%26aulast%3DLeon%26aufirst%3DE.%26aulast%3DCalabrese%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DMichalowski%26aufirst%3DA.%26aulast%3DGareiss%26aufirst%3DP.%26aulast%3DMock%26aufirst%3DB.%2BA.%26aulast%3DSchneekloth%26aufirst%3DJ.%2BS.%26atitle%3DSmall%2520molecule%2520microarrays%2520enable%2520the%2520identification%2520of%2520a%2520selective%252C%2520quadruplex-binding%2520inhibitor%2520of%2520MYC%2520expression%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D139%26epage%3D148%26doi%3D10.1021%2Facschembio.5b00577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drygin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaebe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bliesath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proffitt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trent, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitten, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, W. G.</span></span> <span> </span><span class="NLM_article-title">Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">7653</span>– <span class="NLM_lpage">7661</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-1304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1158%2F0008-5472.CAN-09-1304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=19738048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Skt7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=7653-7661&author=D.+Dryginauthor=A.+Siddiqui-Jainauthor=S.+O%E2%80%99Brienauthor=M.+Schwaebeauthor=A.+Linauthor=J.+Bliesathauthor=C.+B.+Hoauthor=C.+Proffittauthor=K.+Trentauthor=J.+P.+Whittenauthor=J.+K.+Limauthor=D.+Von+Hoffauthor=K.+Anderesauthor=W.+G.+Rice&title=Anticancer+activity+of+CX-3543%3A+a+direct+inhibitor+of+rRNA+biogenesis&doi=10.1158%2F0008-5472.CAN-09-1304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis</span></div><div class="casAuthors">Drygin, Denis; Siddiqui-Jain, Adam; O'Brien, Sean; Schwaebe, Michael; Lin, Amy; Bliesath, Josh; Ho, Caroline B.; Proffitt, Chris; Trent, Katy; Whitten, Jeffrey P.; Lim, John K. C.; Von Hoff, Daniel; Anderes, Kenna; Rice, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7653-7661</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hallmark deregulated signaling in cancer cells drives excessive ribosome biogenesis within the nucleolus, which elicits unbridled cell growth and proliferation.  The rate-limiting step of ribosome biogenesis is synthesis of rRNA (building blocks of ribosomes) by RNA Polymerase I (Pol I).  Numerous kinase pathways and products of proto-oncogenes can up-regulate Pol I, whereas tumor suppressor proteins can inhibit rRNA synthesis.  In tumorigenesis, activating mutations in certain cancer-assocd. kinases and loss-of-function mutations in tumor suppressors lead to deregulated signaling that stimulates Pol I transcription with resultant increases in ribosome biogenesis, protein synthesis, cell growth, and proliferation.  Certain anticancer therapeutics, such as cisplatin and 5-fluorouracil, reportedly exert, at least partially, their activity through disruption of ribosome biogenesis, yet many prime targets for anticancer drugs within the ribosome synthetic machinery of the nucleolus remain largely unexploited.  Herein, we describe CX-3543, a small mol. nucleolus-targeting agent that selectively disrupts nucleolin/rDNA G-quadruplex complexes in the nucleolus, thereby inhibiting Pol I transcription and inducing apoptosis in cancer cells.  CX-3543 is the first G-quadruplex interactive agent to enter human clin. trials, and it is currently under evaluation against carcinoid/neuroendocrine tumors in a phase II clin. trial. [Cancer Res 2009;69(19):7653-61].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkebihaes9wbVg90H21EOLACvtfcHk0lhJdsR8eT6xGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Skt7vF&md5=5608400f3cd64d937a5e3773f9a2caed</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-1304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-1304%26sid%3Dliteratum%253Aachs%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%26aulast%3DSchwaebe%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DBliesath%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DC.%2BB.%26aulast%3DProffitt%26aufirst%3DC.%26aulast%3DTrent%26aufirst%3DK.%26aulast%3DWhitten%26aufirst%3DJ.%2BP.%26aulast%3DLim%26aufirst%3DJ.%2BK.%26aulast%3DVon%2BHoff%26aufirst%3DD.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRice%26aufirst%3DW.%2BG.%26atitle%3DAnticancer%2520activity%2520of%2520CX-3543%253A%2520a%2520direct%2520inhibitor%2520of%2520rRNA%2520biogenesis%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D7653%26epage%3D7661%26doi%3D10.1158%2F0008-5472.CAN-09-1304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Antonio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvester, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabeer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yap, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osako, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Algara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bally, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenton, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cescon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stirling, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hieter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aparicio, S.</span></span> <span> </span><span class="NLM_article-title">CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumors</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">14432</span>, <span class="refDoi"> DOI: 10.1038/ncomms14432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fncomms14432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28211448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVKms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=14432&author=H.+Xuauthor=M.+Di+Antonioauthor=S.+McKinneyauthor=V.+Mathewauthor=B.+Hoauthor=N.+J.+O%E2%80%99Neilauthor=N.+D.+Santosauthor=J.+Silvesterauthor=V.+Weiauthor=J.+Garciaauthor=F.+Kabeerauthor=D.+Laiauthor=P.+Sorianoauthor=J.+Banathauthor=D.+S.+Chiuauthor=D.+Yapauthor=D.+D.+Leauthor=F.+B.+Yeauthor=A.+Zhangauthor=K.+Thuauthor=J.+Soongauthor=S.+C.+Linauthor=A.+H.+Tsaiauthor=T.+Osakoauthor=T.+Algaraauthor=D.+N.+Saundersauthor=J.+Wongauthor=J.+Xianauthor=M.+B.+Ballyauthor=J.+D.+Brentonauthor=G.+W.+Brownauthor=S.+P.+Shahauthor=D.+Cesconauthor=T.+W.+Makauthor=C.+Caldasauthor=P.+C.+Stirlingauthor=P.+Hieterauthor=S.+Balasubramanianauthor=S.+Aparicio&title=CX-5461+is+a+DNA+G-quadruplex+stabilizer+with+selective+lethality+in+BRCA1%2F2+deficient+tumors&doi=10.1038%2Fncomms14432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours</span></div><div class="casAuthors">Xu, Hong; Di Antonio, Marco; McKinney, Steven; Mathew, Veena; Ho, Brandon; O'Neil, Nigel J.; Dos Santos, Nancy; Silvester, Jennifer; Wei, Vivien; Garcia, Jessica; Kabeer, Farhia; Lai, Daniel; Soriano, Priscilla; Banath, Judit; Chiu, Derek S.; Yap, Damian; Le, Daniel D.; Ye, Frank B.; Zhang, Anni; Thu, Kelsie; Soong, John; Lin, Shu-chuan; Tsai, Angela Hsin Chin; Osako, Tomo; Algara, Teresa; Saunders, Darren N.; Wong, Jason; Xian, Jian; Bally, Marcel B.; Brenton, James D.; Brown, Grant W.; Shah, Sohrab P.; Cescon, David; Mak, Tak W.; Caldas, Carlos; Stirling, Peter C.; Hieter, Phil; Balasubramanian, Shankar; Aparicio, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14432</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G-quadruplex DNAs form four-stranded helical structures and are proposed to play key roles in different cellular processes.  Targeting G-quadruplex DNAs for cancer treatment is a very promising prospect.  Here, we show that CX-5461 is a G-quadruplex stabilizer, with specific toxicity against BRCA deficiencies in cancer cells and polyclonal patient-derived xenograft models, including tumors resistant to PARP inhibition.  Exposure to CX-5461, and its related drug CX-3543, blocks replication forks and induces ssDNA gaps or breaks.  The BRCA and NHEJ pathways are required for the repair of CX-5461 and CX-3543-induced DNA damage and failure to do so leads to lethality.  These data strengthen the concept of G4 targeting as a therapeutic approach, specifically for targeting HR and NHEJ deficient cancers and other tumors deficient for DNA damage repair.  CX-5461 is now in advanced phase I clin. trial for patients with BRCA1/2 deficient tumors (Canadian trial, NCT02719977, opened May 2016).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppKJRejuN5X7Vg90H21EOLACvtfcHk0lh44O3mvcsZUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVKms7s%253D&md5=8e496952f88642ff05eaf136fe6856d6</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fncomms14432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms14432%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DDi%2BAntonio%26aufirst%3DM.%26aulast%3DMcKinney%26aufirst%3DS.%26aulast%3DMathew%26aufirst%3DV.%26aulast%3DHo%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DN.%2BJ.%26aulast%3DSantos%26aufirst%3DN.%2BD.%26aulast%3DSilvester%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DV.%26aulast%3DGarcia%26aufirst%3DJ.%26aulast%3DKabeer%26aufirst%3DF.%26aulast%3DLai%26aufirst%3DD.%26aulast%3DSoriano%26aufirst%3DP.%26aulast%3DBanath%26aufirst%3DJ.%26aulast%3DChiu%26aufirst%3DD.%2BS.%26aulast%3DYap%26aufirst%3DD.%26aulast%3DLe%26aufirst%3DD.%2BD.%26aulast%3DYe%26aufirst%3DF.%2BB.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DThu%26aufirst%3DK.%26aulast%3DSoong%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DS.%2BC.%26aulast%3DTsai%26aufirst%3DA.%2BH.%26aulast%3DOsako%26aufirst%3DT.%26aulast%3DAlgara%26aufirst%3DT.%26aulast%3DSaunders%26aufirst%3DD.%2BN.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DXian%26aufirst%3DJ.%26aulast%3DBally%26aufirst%3DM.%2BB.%26aulast%3DBrenton%26aufirst%3DJ.%2BD.%26aulast%3DBrown%26aufirst%3DG.%2BW.%26aulast%3DShah%26aufirst%3DS.%2BP.%26aulast%3DCescon%26aufirst%3DD.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DCaldas%26aufirst%3DC.%26aulast%3DStirling%26aufirst%3DP.%2BC.%26aulast%3DHieter%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DAparicio%26aufirst%3DS.%26atitle%3DCX-5461%2520is%2520a%2520DNA%2520G-quadruplex%2520stabilizer%2520with%2520selective%2520lethality%2520in%2520BRCA1%252F2%2520deficient%2520tumors%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D14432%26doi%3D10.1038%2Fncomms14432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span> </span><span class="NLM_article-title">A Phase I/II Study of CX5461</span>.  <i>ClinicalTrials.gov</i>; <span class="NLM_publisher-name">U.S. National
Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2016</span>; <a href="https://clinicaltrials.gov/ct2/show/NCT02719977" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02719977</a> (accessed Jan 7, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Phase+I%2FII+Study+of+CX5461.+ClinicalTrials.gov%3B+U.S.+National%0AInstitutes+of+Health%3A+Bethesda%2C+MD%2C+2016%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02719977+%28accessed+Jan+7%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Phase%2520I%252FII%2520Study%2520of%2520CX5461%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%250AInstitutes%2520of%2520Health%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Doria, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasotti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freccero, M.</span></span> <span> </span><span class="NLM_article-title">Water soluble extended naphthalene diimides as pH fluorescent sensors and G-quadruplex ligands</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3830</span>– <span class="NLM_lpage">3840</span>, <span class="refDoi"> DOI: 10.1039/c2ob07006e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1039%2Fc2ob07006e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=22469919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFGhtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=3830-3840&author=F.+Doriaauthor=M.+Nadaiauthor=G.+Sattinauthor=L.+Pasottiauthor=S.+N.+Richterauthor=M.+Freccero&title=Water+soluble+extended+naphthalene+diimides+as+pH+fluorescent+sensors+and+G-quadruplex+ligands&doi=10.1039%2Fc2ob07006e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">Water soluble extended naphthalene diimides as pH fluorescent sensors and G-quadruplex ligands</span></div><div class="casAuthors">Doria, Filippo; Nadai, Matteo; Sattin, Giovanna; Pasotti, Luca; Richter, Sara N.; Freccero, Mauro</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3830-3840</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Extended naphthalene diimides (NDIs) fused to 1,4-dihydropyrazine-2,3-dione, contg. two solubilizing moieties, have been synthesized.  Fluorescence spectra of the new NDIs were remarkably affected by pH, as the second deprotonation of the dihydropyrazinedione moiety (pKa 6.9) switched off the emission.  Binding to a G-quadruplex folded oligonucleotide and stoichiometry were evaluated by FRET melting assay and CD anal.  G-quadruplex binding was strongly enhanced shifting from pH 7.4 to pH 6.0 as a consequence of the dihydropyrazinedione moiety protonation.  Cytotoxicity studies using two human telomerase-pos. cell lines (HT29 and A549) revealed that the best G-quadruplex ligand was very active against the colon cell line, with an EC50 of 300 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCoDZL-SHlDbVg90H21EOLACvtfcHk0lh44O3mvcsZUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFGhtr0%253D&md5=9fa4f30354167482c7a7011491166940</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1039%2Fc2ob07006e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob07006e%26sid%3Dliteratum%253Aachs%26aulast%3DDoria%26aufirst%3DF.%26aulast%3DNadai%26aufirst%3DM.%26aulast%3DSattin%26aufirst%3DG.%26aulast%3DPasotti%26aufirst%3DL.%26aulast%3DRichter%26aufirst%3DS.%2BN.%26aulast%3DFreccero%26aufirst%3DM.%26atitle%3DWater%2520soluble%2520extended%2520naphthalene%2520diimides%2520as%2520pH%2520fluorescent%2520sensors%2520and%2520G-quadruplex%2520ligands%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26spage%3D3830%26epage%3D3840%26doi%3D10.1039%2Fc2ob07006e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Spinello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunenberg, J.</span></span> <span> </span><span class="NLM_article-title">Molecular recognition of naphthalene diimide ligands by telomeric quadruplex-DNA: the importance of the protonation state and mediated hydrogen bonds</span>. <i>Phys. Chem. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2871</span>– <span class="NLM_lpage">2877</span>, <span class="refDoi"> DOI: 10.1039/C5CP05576H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1039%2FC5CP05576H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26733046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVajt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=2871-2877&author=A.+Spinelloauthor=G.+Baroneauthor=J.+Grunenberg&title=Molecular+recognition+of+naphthalene+diimide+ligands+by+telomeric+quadruplex-DNA%3A+the+importance+of+the+protonation+state+and+mediated+hydrogen+bonds&doi=10.1039%2FC5CP05576H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of naphthalene diimide ligands by telomeric quadruplex-DNA: the importance of the protonation state and mediated hydrogen bonds</span></div><div class="casAuthors">Spinello, A.; Barone, G.; Grunenberg, J.</div><div class="citationInfo"><span class="NLM_cas:title">Physical Chemistry Chemical Physics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2871-2877</span>CODEN:
                <span class="NLM_cas:coden">PPCPFQ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9076</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In depth Monte Carlo conformational scans in combination with mol. dynamics (MD) simulations and electronic structure calcns. were applied in order to study the mol. recognition process between tetrasubstituted naphthalene diimide (ND) guests and G-quadruplex (G4) DNA receptors.  ND guests are a promising class of telomere stabilizers due to which they are used in novel anticancer therapeutics.  Though several ND guests have been studied exptl. in the past, the protonation state under physiol. conditions is still unclear.  Based on chem. intuition, in the case of N-methyl-piperazine substitution, different protonation states are possible and might play a crucial role in the mol. recognition process by G4-DNA.  Depending on the proton concn., different nitrogen atoms of the N-methyl-piperazine might (or might not) be protonated.  This fact was considered in our simulation in terms of a case by case anal., since the process of mol. recognition is detd. by possible donor or acceptor positions.  The results of our simulations show that the electrostatic interactions between the ND ligands and the G4 receptor are maximized in the case of the protonation of the terminal nitrogen atoms, forming compact ND G4 complexes inside the grooves.  The influence of different protonation states in terms of the ability to form hydrogen bonds with the sugar-phosphate backbone, as well as the importance of mediated vs. direct hydrogen bonding, was analyzed in detail by MD and relaxed force const. (compliance const.) simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Et1eGmdZXrVg90H21EOLACvtfcHk0ljn0UdeCust9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVajt7nJ&md5=ccb7e76763d3ffa74fbab6e4ce13eed7</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1039%2FC5CP05576H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CP05576H%26sid%3Dliteratum%253Aachs%26aulast%3DSpinello%26aufirst%3DA.%26aulast%3DBarone%26aufirst%3DG.%26aulast%3DGrunenberg%26aufirst%3DJ.%26atitle%3DMolecular%2520recognition%2520of%2520naphthalene%2520diimide%2520ligands%2520by%2520telomeric%2520quadruplex-DNA%253A%2520the%2520importance%2520of%2520the%2520protonation%2520state%2520and%2520mediated%2520hydrogen%2520bonds%26jtitle%3DPhys.%2520Chem.%2520Chem.%2520Phys.%26date%3D2016%26volume%3D18%26spage%3D2871%26epage%3D2877%26doi%3D10.1039%2FC5CP05576H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit28c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Răsădean, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantoş, G. D.</span></span> <span> </span><span class="NLM_article-title">Amino-acid-derived naphthalenediimides as versatile G-quadruplex binders</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">8491</span>– <span class="NLM_lpage">8499</span>, <span class="refDoi"> DOI: 10.1002/chem.201700957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1002%2Fchem.201700957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28409867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2sXot12itrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=8491-8499&author=D.+M.+R%C4%83s%C4%83deanauthor=B.+Shengauthor=J.+Dashauthor=G.+D.+Panto%C5%9F&title=Amino-acid-derived+naphthalenediimides+as+versatile+G-quadruplex+binders&doi=10.1002%2Fchem.201700957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28cR"><div class="casContent"><span class="casTitleNuber">28c</span><div class="casTitle"><span class="NLM_cas:atitle">Amino-Acid-Derived Naphthalenediimides as Versatile G-Quadruplex Binders</span></div><div class="casAuthors">Rasadean, Dora M.; Sheng, Bin; Dash, Jyotirmayee; Pantos, G. Dan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">8491-8499</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The design and synthesis of water sol., amino-acid-functionalized naphthalenediimides (NDIs) as potential ligands of native G-quadruplexes is reported.  The NDIs were tested on a panel of oncogene promoters, on the human telomeric sequence h-telo, and on double-stranded DNA.  Out of the ligands tested, NDI 3 (Nε-Boc-L-lysine NDI) exhibited a highly discriminating nature by only stabilizing the oncogene promoter c-kit2, which is up-regulated up to 80% in ovarian, gastrointestinal, and breast malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobOnRf0TMJK7Vg90H21EOLACvtfcHk0ljn0UdeCust9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXot12itrY%253D&md5=a6d12d6fa83e767147d3770bc3fc3993</span></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=10.1002%2Fchem.201700957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201700957%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C4%2583s%25C4%2583dean%26aufirst%3DD.%2BM.%26aulast%3DSheng%26aufirst%3DB.%26aulast%3DDash%26aufirst%3DJ.%26aulast%3DPanto%25C5%259F%26aufirst%3DG.%2BD.%26atitle%3DAmino-acid-derived%2520naphthalenediimides%2520as%2520versatile%2520G-quadruplex%2520binders%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D8491%26epage%3D8499%26doi%3D10.1002%2Fchem.201700957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit28d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Street, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingworth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, M. C.</span></span> <span> </span><span class="NLM_article-title">Divalent naphthalene diimide ligands display high selectivity for the human telomeric G-quadruplex in K<sup>+</sup> buffer</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6953</span>– <span class="NLM_lpage">6958</span>, <span class="refDoi"> DOI: 10.1002/chem.201700140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1002%2Fchem.201700140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28257554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVahtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=6953-6958&author=S.+Streetauthor=D.+Chinauthor=G.+Hollingworthauthor=M.+Berryauthor=J.+C.+Moralesauthor=M.+C.+Galan&title=Divalent+naphthalene+diimide+ligands+display+high+selectivity+for+the+human+telomeric+G-quadruplex+in+K%2B+buffer&doi=10.1002%2Fchem.201700140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28dR"><div class="casContent"><span class="casTitleNuber">28d</span><div class="casTitle"><span class="NLM_cas:atitle">Divalent Naphthalene Diimide Ligands Display High Selectivity for the Human Telomeric G-quadruplex in K+ Buffer</span></div><div class="casAuthors">Street, Steven T. G.; Chin, Donovan N.; Hollingworth, Gregory J.; Berry, Monica; Morales, Juan C.; Galan, M. Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">6953-6958</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Selective G-quadruplex ligands offer great promise for the development of anti-cancer therapies.  A novel series of divalent cationic naphthalene diimide ligands that selectively bind to the hybrid form of the human telomeric G-quadruplex in K+ buffer are described herein.  We demonstrate that an imidazolium-bearing mannoside-conjugate is the most selective ligand to date for this quadruplex against several other quadruplex and duplex structures.  We also show that a similarly selective methylpiperazine-bearing ligand was more toxic to HeLa cancer cells than doxorubicin, while exhibiting three times less toxicity towards fetal lung fibroblasts WI-38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY8kTU_XkfH7Vg90H21EOLACvtfcHk0ljn0UdeCust9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVahtLw%253D&md5=c0a249d79e3c76292c7fb54affd1b9fb</span></div><a href="/servlet/linkout?suffix=cit28d&amp;dbid=16384&amp;doi=10.1002%2Fchem.201700140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201700140%26sid%3Dliteratum%253Aachs%26aulast%3DStreet%26aufirst%3DS.%26aulast%3DChin%26aufirst%3DD.%26aulast%3DHollingworth%26aufirst%3DG.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DMorales%26aufirst%3DJ.%2BC.%26aulast%3DGalan%26aufirst%3DM.%2BC.%26atitle%3DDivalent%2520naphthalene%2520diimide%2520ligands%2520display%2520high%2520selectivity%2520for%2520the%2520human%2520telomeric%2520G-quadruplex%2520in%2520K%252B%2520buffer%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D6953%26epage%3D6958%26doi%3D10.1002%2Fchem.201700140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nadai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimino-Reale, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doria, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butovskaya, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freccero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folini, M.</span></span> <span> </span><span class="NLM_article-title">Assessment of gene promoter Gquadruplex binding and modulation by a naphthalene diimide derivative in tumor cells</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">380</span>, <span class="refDoi"> DOI: 10.3892/ijo.2014.2723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.3892%2Fijo.2014.2723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25370864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovVylsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2015&pages=369-380&author=M.+Nadaiauthor=G.+Cimino-Realeauthor=G.+Sattinauthor=F.+Doriaauthor=E.+Butovskayaauthor=N.+Zaffaroniauthor=M.+Frecceroauthor=M.+Palumboauthor=S.+N.+Richterauthor=M.+Folini&title=Assessment+of+gene+promoter+Gquadruplex+binding+and+modulation+by+a+naphthalene+diimide+derivative+in+tumor+cells&doi=10.3892%2Fijo.2014.2723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of gene promoter G-quadruplex binding and modulation by a naphthalene diimide derivative in tumor cells</span></div><div class="casAuthors">Nadai, Matteo; Cimino-Reale, Graziella; Sattin, Giovanna; Doria, Filippo; Butovskaya, Elena; Zaffaroni, Nadia; Freccero, Mauro; Palumbo, Manlio; Richter, Sara N.; Folini, Marco</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">369-380</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Naphthalene diimide (NDI) derivs. have shown high affinity for telomeric guanine (G)-quadruplexes and good antiproliferative activity in different human tumor exptl. models.  A trisubstituted compd. (H-NDI-NMe2) has been reported to stabilize the telomeric G-quadruplex and to cause telomere dysfunction and downregulation of telomerase expression.  We further investigated its mechanism of action by analyzing the capability of the mol. to interfere with the expression levels of oncogenes, such as MYC, telomerase reverse transcriptase (TERT), KIT and BCL2, known to bear G-quadruplex-forming sequences within their promoters, in human tumor cell lines of different histol. origin.  Exposure to H-NDI-NMe2 resulted in a cell type-dependent perturbation of the expression levels of the four selected genes.  Biophys. and mol. analyses revealed that H-NDI-NMe2 bound with high affinity and effectively stabilized mainly MYC and BCL2, which share long sequences and the possibility of multiple G-quadruplex folding.  The mRNA levels of both genes, but not protein amts. were affected by NDI treatment.  Global gene expression anal. showed modulation of genes implicated in telomere function and mechanisms of cancer; however, G-quadruplex-mediated regulation of gene expression by H-NDI-NMe2 was largely dependent on the cell context.  These data indicate that a deeper knowledge on the mol. mechanisms and biol. effects of G-quadruplex structures is still needed to help developing new effective anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolgiCQ2scOAbVg90H21EOLACvtfcHk0lh-OEAZJo-OUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovVylsrk%253D&md5=1824a62814f486e47a3173e65a5095d6</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.3892%2Fijo.2014.2723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2014.2723%26sid%3Dliteratum%253Aachs%26aulast%3DNadai%26aufirst%3DM.%26aulast%3DCimino-Reale%26aufirst%3DG.%26aulast%3DSattin%26aufirst%3DG.%26aulast%3DDoria%26aufirst%3DF.%26aulast%3DButovskaya%26aufirst%3DE.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DFreccero%26aufirst%3DM.%26aulast%3DPalumbo%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DS.%2BN.%26aulast%3DFolini%26aufirst%3DM.%26atitle%3DAssessment%2520of%2520gene%2520promoter%2520Gquadruplex%2520binding%2520and%2520modulation%2520by%2520a%2520naphthalene%2520diimide%2520derivative%2520in%2520tumor%2520cells%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2015%26volume%3D46%26spage%3D369%26epage%3D380%26doi%3D10.3892%2Fijo.2014.2723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lopergolo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortoreto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doria, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beretta, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuco, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freccero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrello, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folini, M.</span></span> <span> </span><span class="NLM_article-title">Targeting of RET oncogene by naphthalene diimide-mediated gene promoter G-quadruplex stabilization exerts anti-tumor activity in oncogene-addicted human medullary thyroid cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">49649</span>– <span class="NLM_lpage">49663</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.10105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.18632%2Foncotarget.10105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=27351133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC2s7ksFWntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=49649-49663&author=A.+Lopergoloauthor=R.+Perroneauthor=M.+Tortoretoauthor=F.+Doriaauthor=G.+L.+Berettaauthor=V.+Zucoauthor=M.+Frecceroauthor=M.+G.+Borrelloauthor=C.+Lanziauthor=S.+N.+Richterauthor=N.+Zaffaroniauthor=M.+Folini&title=Targeting+of+RET+oncogene+by+naphthalene+diimide-mediated+gene+promoter+G-quadruplex+stabilization+exerts+anti-tumor+activity+in+oncogene-addicted+human+medullary+thyroid+cancer&doi=10.18632%2Foncotarget.10105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting of RET oncogene by naphthalene diimide-mediated gene promoter G-quadruplex stabilization exerts anti-tumor activity in oncogene-addicted human medullary thyroid cancer</span></div><div class="casAuthors">Lopergolo Alessia; Tortoreto Monica; Beretta Giovanni L; Zuco Valentina; Borrello Maria Grazia; Lanzi Cinzia; Zaffaroni Nadia; Folini Marco; Perrone Rosalba; Richter Sara N; Doria Filippo; Freccero Mauro</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">49649-49663</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Medullary thyroid cancer (MTC) relies on the aberrant activation of RET proto-oncogene.  Though targeted approaches (i.e., tyrosine kinase inhibitors) are available, the absence of complete responses and the onset of resistance mechanisms indicate the need for novel therapeutic interventions.  Due to their role in regulation of gene expression, G-quadruplexes (G4) represent attractive targets amenable to be recognized or stabilized by small molecules.  Here, we report that exposure of MTC cells to a tri-substituted naphthalene diimide (NDI) resulted in a significant antiproliferative activity paralleled by inhibition of RET expression.  Biophysical analysis and gene reporter assays showed that impairment of RET expression was consequent to the NDI-mediated stabilization of the G4 forming within the gene promoter.  We also showed for the first time that systemic administration of the NDI in mice xenotransplanted with MTC cells resulted in a remarkable inhibition of tumor growth in vivo.  Overall, our findings indicate that NDI-dependent RET G4 stabilization represents a suitable approach to control RET transcription and delineate the rationale for the development of G4 stabilizing-based treatments for MTC as well as for other tumors in which RET may have functional and therapeutic implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnc_DupHv-_ApJitSxOdIlfW6udTcc2eYRg1Ljsv0qbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7ksFWntw%253D%253D&md5=10918d79c3869f35b2c695b5d81176ae</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.10105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.10105%26sid%3Dliteratum%253Aachs%26aulast%3DLopergolo%26aufirst%3DA.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DDoria%26aufirst%3DF.%26aulast%3DBeretta%26aufirst%3DG.%2BL.%26aulast%3DZuco%26aufirst%3DV.%26aulast%3DFreccero%26aufirst%3DM.%26aulast%3DBorrello%26aufirst%3DM.%2BG.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DRichter%26aufirst%3DS.%2BN.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DFolini%26aufirst%3DM.%26atitle%3DTargeting%2520of%2520RET%2520oncogene%2520by%2520naphthalene%2520diimide-mediated%2520gene%2520promoter%2520G-quadruplex%2520stabilization%2520exerts%2520anti-tumor%2520activity%2520in%2520oncogene-addicted%2520human%2520medullary%2520thyroid%2520cancer%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D49649%26epage%3D49663%26doi%3D10.18632%2Foncotarget.10105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cuenca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greciano, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munnur, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanjunda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Tri- and tetra-substituted naphthalene diimides as potent G-quadruplex ligands</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1668</span>– <span class="NLM_lpage">1673</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.01.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.bmcl.2008.01.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=18243701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1Cktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1668-1673&author=F.+Cuencaauthor=O.+Grecianoauthor=M.+Gunaratnamauthor=S.+Haiderauthor=D.+Munnurauthor=R.+Nanjundaauthor=W.+D.+Wilsonauthor=S.+Neidle&title=Tri-+and+tetra-substituted+naphthalene+diimides+as+potent+G-quadruplex+ligands&doi=10.1016%2Fj.bmcl.2008.01.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Tri- and tetra-substituted naphthalene diimides as potent G-quadruplex ligands</span></div><div class="casAuthors">Cuenca, Francisco; Greciano, Olga; Gunaratnam, Mekala; Haider, Shozeb; Munnur, Deeksha; Nanjunda, Rupesh; Wilson, W. David; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1668-1673</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of tri- and tetra-substituted naphthalene diimides, e.g. I, have been designed and synthesized.  Several compds. show exceptional affinity for telomeric G-quadruplex DNA in classical and competition FRET assays and SPR studies.  They inhibit telomerase in the TRAP assay, and show potent senescence-based short-term anti-proliferative effects on MCF7 and A549 cancer cell lines, and localize in the nucleus and particularly the nucleolus of MCF7 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkbDMZFc0FpbVg90H21EOLACvtfcHk0lh-OEAZJo-OUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1Cktbs%253D&md5=e52c4feda254b7221da45882bea1cc7c</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.01.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.01.050%26sid%3Dliteratum%253Aachs%26aulast%3DCuenca%26aufirst%3DF.%26aulast%3DGreciano%26aufirst%3DO.%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DHaider%26aufirst%3DS.%26aulast%3DMunnur%26aufirst%3DD.%26aulast%3DNanjunda%26aufirst%3DR.%26aulast%3DWilson%26aufirst%3DW.%2BD.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DTri-%2520and%2520tetra-substituted%2520naphthalene%2520diimides%2520as%2520potent%2520G-quadruplex%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1668%26epage%3D1673%26doi%3D10.1016%2Fj.bmcl.2008.01.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swank, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galesa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reszka, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuenca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Targeting human gastrointestinal stromal tumor cells with a quadruplex-binding small molecule</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3774</span>– <span class="NLM_lpage">3783</span>, <span class="refDoi"> DOI: 10.1021/jm900424a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900424a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVegsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3774-3783&author=M.+Gunaratnamauthor=S.+Swankauthor=S.+M.+Haiderauthor=K.+Galesaauthor=A.+P.+Reszkaauthor=M.+Beltranauthor=F.+Cuencaauthor=J.+A.+Fletcherauthor=S.+Neidle&title=Targeting+human+gastrointestinal+stromal+tumor+cells+with+a+quadruplex-binding+small+molecule&doi=10.1021%2Fjm900424a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Human Gastrointestinal Stromal Tumor Cells with a Quadruplex-Binding Small Molecule</span></div><div class="casAuthors">Gunaratnam, Mekala; Swank, Stephen; Haider, Shozeb M.; Galesa, Katja; Reszka, Anthony P.; Beltran, Monica; Cuenca, Francisco; Fletcher, Jonathan A.; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3774-3783</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Most of human gastrointestinal stromal tumors (GIST) are driven by activating mutations in the proto-oncogene KIT, a tyrosine kinase receptor.  Clin. treatment with imatinib targets the kinase domain of KIT, but tumor regrowth occurs as a result of the development of resistant mutations in the kinase active site.  An alternative small-mol. approach to GIST therapy is described, in which the KIT gene is directly targeted, and thus, kinase resistance may be circumvented.  A naphthalene diimide deriv. has been used to demonstrate the concept of dual quadruplex targeting.  This compd. strongly stabilizes both telomeric quadruplex DNA and quadruplex sites in the KIT promoter in vitro.  It is shown here that the compd. is a potent inducer of growth arrest in a patient-derived GIST cell line at a concn. (∼1 μM) that also results in effective inhibition of telomerase activity and almost complete suppression of KIT mRNA and KIT protein expression.  Mol. modeling studies with a telomeric quadruplex have been used to rationalize aspects of the exptl. quadruplex melting data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqPRQUnx-G7bVg90H21EOLACvtfcHk0lhyw06NYJwksA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVegsbc%253D&md5=4784d55409f53593bd924165555524b4</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1021%2Fjm900424a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900424a%26sid%3Dliteratum%253Aachs%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DSwank%26aufirst%3DS.%26aulast%3DHaider%26aufirst%3DS.%2BM.%26aulast%3DGalesa%26aufirst%3DK.%26aulast%3DReszka%26aufirst%3DA.%2BP.%26aulast%3DBeltran%26aufirst%3DM.%26aulast%3DCuenca%26aufirst%3DF.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DTargeting%2520human%2520gastrointestinal%2520stromal%2520tumor%2520cells%2520with%2520a%2520quadruplex-binding%2520small%2520molecule%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3774%26epage%3D3783%26doi%3D10.1021%2Fjm900424a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit30c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hampel, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidibe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riou, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Tetrasubstituted naphthalene diimide ligands with selectivity for telomeric G-quadruplexes and cancer cells</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6459</span>– <span class="NLM_lpage">6463</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.09.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.bmcl.2010.09.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=20932753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSms7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6459-6463&author=S.+M.+Hampelauthor=A.+Sidibeauthor=M.+Gunaratnamauthor=J.-F.+Riouauthor=S.+Neidle&title=Tetrasubstituted+naphthalene+diimide+ligands+with+selectivity+for+telomeric+G-quadruplexes+and+cancer+cells&doi=10.1016%2Fj.bmcl.2010.09.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30cR"><div class="casContent"><span class="casTitleNuber">30c</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrasubstituted naphthalene diimide ligands with selectivity for telomeric G-quadruplexes and cancer cells</span></div><div class="casAuthors">Hampel, Sonja M.; Sidibe, Assitan; Gunaratnam, Mekala; Riou, Jean-Francois; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6459-6463</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of tetrasubstituted naphthalene diimide compds. I (n = 2-4) with N-methylpiperazine end groups has been synthesized and evaluated as G-quadruplex ligands.  They have high affinity and selectivity for telomeric G-quadruplex DNA over duplex DNA.  CD studies show that they induce formation of a parallel G-quadruplex topol.  They inhibit the binding of hPOT1 and topoisomerase IIIα to telomeric DNA and inhibit telomerase activity in MCF7 cells.  I has potent activity in a panel of cancer cell lines, with typical IC50 values of ∼0.1 μM, and up to 100-fold lower toxicity in a normal human fibroblast cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9XMkHrRF7p7Vg90H21EOLACvtfcHk0lhyw06NYJwksA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSms7nJ&md5=9f6b2316116b7d42492641e80a95fc6a</span></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.066%26sid%3Dliteratum%253Aachs%26aulast%3DHampel%26aufirst%3DS.%2BM.%26aulast%3DSidibe%26aufirst%3DA.%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DRiou%26aufirst%3DJ.-F.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DTetrasubstituted%2520naphthalene%2520diimide%2520ligands%2520with%2520selectivity%2520for%2520telomeric%2520G-quadruplexes%2520and%2520cancer%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6459%26epage%3D6463%26doi%3D10.1016%2Fj.bmcl.2010.09.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit30d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Fuente, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampel, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reszka, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schatzlein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Targeting pancreatic cancer with a G-quadruplex ligand</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">7151</span>– <span class="NLM_lpage">7157</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.09.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.bmc.2011.09.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=22041170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVehsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=7151-7157&author=M.+Gunaratnamauthor=M.+de+la+Fuenteauthor=S.+M.+Hampelauthor=A.+K.+Toddauthor=A.+P.+Reszkaauthor=A.+Schatzleinauthor=S.+Neidle&title=Targeting+pancreatic+cancer+with+a+G-quadruplex+ligand&doi=10.1016%2Fj.bmc.2011.09.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30dR"><div class="casContent"><span class="casTitleNuber">30d</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting pancreatic cancer with a G-quadruplex ligand</span></div><div class="casAuthors">Gunaratnam, Mekala; de la Fuente, Maria; Hampel, Sonja M.; Todd, Alan K.; Reszka, Anthony P.; Schaetzlein, Andreas; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7151-7157</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The integrity of telomeres in most cancer cells is maintained by the action of the telomerase enzyme complex, which catalyzes the synthesis of telomeric DNA repeats in order to replace those lost during replication.  Telomerase is esp. up-regulated in metastatic cancer and is thus emerging as a major therapeutic target.  One approach to telomerase inhibition involves the sequestration of the single-stranded 3' ends of telomeric DNA into higher-order quadruplex structures.  We have recently shown that tetra-substituted naphthalene diimide compds. are potent quadruplex-stabilizing mols. with telomerase inhibitory activity in cells.  We show here that one such compd., BMSG-SH-3, which has been optimized by computer modeling, has significant in vivo antitumor activity against a model for pancreatic cancer, a cancer that is esp. resistant to current therapies.  A large redn. in telomerase activity in treated tumors was obsd. and the naphthalene diimide compd. was found to be selectively localized in the treated tumors.  We find that the expression of the therapeutically important chaperone protein HSP90, a regulator of telomerase is also reduced in vivo by BMSG-SH-3 treatment.  The compd. is a potent stabilizer of two G-quadruplex sequences found in the promoter region of the HSP90 gene, as well as a G-quadruplex from human telomeric DNA.  It is proposed that the simultaneous targeting of these quadruplexes may be an effective anti-tumor strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzs1OhYf4VxLVg90H21EOLACvtfcHk0lhyw06NYJwksA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVehsr%252FJ&md5=d40adb1e679a5939c181d7989fb60107</span></div><a href="/servlet/linkout?suffix=cit30d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.09.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.09.055%26sid%3Dliteratum%253Aachs%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3Dde%2Bla%2BFuente%26aufirst%3DM.%26aulast%3DHampel%26aufirst%3DS.%2BM.%26aulast%3DTodd%26aufirst%3DA.%2BK.%26aulast%3DReszka%26aufirst%3DA.%2BP.%26aulast%3DSchatzlein%26aufirst%3DA.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DTargeting%2520pancreatic%2520cancer%2520with%2520a%2520G-quadruplex%2520ligand%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D7151%26epage%3D7157%26doi%3D10.1016%2Fj.bmc.2011.09.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span>; <span class="NLM_string-name">Cuenca, F.</span>; <span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Naphthalene diimide compounds interacting with G-quadruplex regions in DNA</span>. U.S. Patent <span class="NLM_patent">8,796,456</span>, August 14, <span class="NLM_year">2014</span>; Eur. Patent <span class="NLM_patent">2227470</span>, March 5, <span class="NLM_year">2014</span>; Jap. Patent <span class="NLM_patent">5366968</span>, August 29, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+Gunaratnam&author=F.+Cuenca&author=S.+Neidle&title=Naphthalene+diimide+compounds+interacting+with+G-quadruplex+regions+in+DNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGunaratnam%26aufirst%3DM.%26atitle%3DNaphthalene%2520diimide%2520compounds%2520interacting%2520with%2520G-quadruplex%2520regions%2520in%2520DNA%26date%3D2014%26date%3D2014%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Micco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collie, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnmacht, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazitna, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reszka, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design and evaluation of naphthalene diimide G-quadruplex ligands as telomere targeting agents in pancreatic cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2959</span>– <span class="NLM_lpage">2974</span>, <span class="refDoi"> DOI: 10.1021/jm301899y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301899y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlelu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2959-2974&author=M.+Miccoauthor=G.+W.+Collieauthor=A.+G.+Daleauthor=S.+A.+Ohnmachtauthor=I.+Pazitnaauthor=M.+Gunaratnamauthor=A.+P.+Reszkaauthor=S.+Neidle&title=Structure-based+design+and+evaluation+of+naphthalene+diimide+G-quadruplex+ligands+as+telomere+targeting+agents+in+pancreatic+cancer+cells&doi=10.1021%2Fjm301899y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Evaluation of Naphthalene Diimide G-Quadruplex Ligands As Telomere Targeting Agents in Pancreatic Cancer Cells</span></div><div class="casAuthors">Micco, Marialuisa; Collie, Gavin W.; Dale, Aaron G.; Ohnmacht, Stephan A.; Pazitna, Ingrida; Gunaratnam, Mekala; Reszka, Anthony P.; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2959-2974</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tetra-substituted naphthalene diimide (ND) derivs. with pos. charged termini are potent stabilizers of human telomeric and gene promoter DNA quadruplexes and inhibit the growth of human cancer cells in vitro and in vivo.  The present study reports the enhancement of the pharmacol. properties of earlier ND compds. using structure-based design.  Crystal structures of three complexes with human telomeric intramol. quadruplexes demonstrate that two of the four strongly basic N-methyl-piperazine groups can be replaced by less basic morpholine groups with no loss of intermol. interactions in the grooves of the quadruplex.  The new compds. retain high affinity to human telomeric quadruplex DNA but are 10-fold more potent against the MIA PaCa-2 pancreatic cancer cell line, with IC50 values of ∼10 nM.  The lead compd. induces cellular senescence but does not inhibit telomerase activity at the nanomolar dosage levels required for inhibition of cellular proliferation.  Gene array qPCR anal. of MIA PaCa-2 cells treated with the lead compd. revealed significant dose-dependent modulation of a distinct subset of genes, including strong induction of DNA damage responsive genes CDKN1A, DDIT3, GADD45A/G, and PPM1D, and repression of genes involved in telomere maintenance, including hPOT1 and PARP1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC6B5sA4fud7Vg90H21EOLACvtfcHk0lh7Au3chnl2OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlelu74%253D&md5=0697d89813efa5f1347cbdfddeeabc78</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1021%2Fjm301899y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301899y%26sid%3Dliteratum%253Aachs%26aulast%3DMicco%26aufirst%3DM.%26aulast%3DCollie%26aufirst%3DG.%2BW.%26aulast%3DDale%26aufirst%3DA.%2BG.%26aulast%3DOhnmacht%26aufirst%3DS.%2BA.%26aulast%3DPazitna%26aufirst%3DI.%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DReszka%26aufirst%3DA.%2BP.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520and%2520evaluation%2520of%2520naphthalene%2520diimide%2520G-quadruplex%2520ligands%2520as%2520telomere%2520targeting%2520agents%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2959%26epage%3D2974%26doi%3D10.1021%2Fjm301899y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of parallel quadruplexes from human telomeric DNA</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>417</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">880</span>, <span class="refDoi"> DOI: 10.1038/nature755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnature755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=12050675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD38Xks1Wlsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2002&pages=876-880&author=G.+N.+Parkinsonauthor=M.+P.+H.+Leeauthor=S.+Neidle&title=Crystal+structure+of+parallel+quadruplexes+from+human+telomeric+DNA&doi=10.1038%2Fnature755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of parallel quadruplexes from human telomeric DNA</span></div><div class="casAuthors">Parkinson, Gary N.; Lee, Michael P. H.; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">6891</span>),
    <span class="NLM_cas:pages">876-880</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Telomeric ends of chromosomes, which comprise noncoding repeat sequences of guanine-rich DNA, are fundamental in protecting the cell from recombination and degrdn.  Disruption of telomere maintenance leads to eventual cell death, which can be exploited for therapeutic intervention in cancer.  Telomeric DNA sequences can form four-stranded (quadruplex) structures, which may be involved in the structure of telomere ends.  Here we describe the crystal structure of a quadruplex formed from four consecutive human telomeric DNA repeats and grown at a K+ concn. that approximates its intracellular concn.  K+ ions are obsd. in the structure.  The folding and appearance of the DNA in this intramol. quadruplex is fundamentally different from the published Na+-contg. quadruplex structures.  All four DNA strands are parallel, with the three linking trinucleotide loops positioned on the exterior of the quadruplex core, in a propeller-like arrangement.  The adenine in each TTA linking trinucleotide loop is swung back so that it intercalates between the two thymines.  This DNA structure suggests a straightforward path for telomere folding and unfolding, as well as ways in which it can recognize telomere-assocd. proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh0kI_FZZV_bVg90H21EOLACvtfcHk0lh7Au3chnl2OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xks1Wlsr8%253D&md5=bfe584697ec10aabc9a4aaa3fae1f3d3</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1038%2Fnature755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature755%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DG.%2BN.%26aulast%3DLee%26aufirst%3DM.%2BP.%2BH.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520parallel%2520quadruplexes%2520from%2520human%2520telomeric%2520DNA%26jtitle%3DNature%26date%3D2002%26volume%3D417%26spage%3D876%26epage%3D880%26doi%3D10.1038%2Fnature755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohnmacht, S.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besser, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Vita, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellinas-Gomez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diocou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šponer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbara Pedley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">A G-quadruplex-binding compound showing anti-tumor activity in an in vivo model for pancreatic cancer</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">11385</span>, <span class="refDoi"> DOI: 10.1038/srep11385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fsrep11385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26077929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC2MbktVSmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=11385&author=S.%0AA.+Ohnmachtauthor=C.+Marchettiauthor=M.+Gunaratnamauthor=R.+J.+Besserauthor=S.+M.+Haiderauthor=G.+Di+Vitaauthor=H.+L.+Loweauthor=M.+Mellinas-Gomezauthor=S.+Diocouauthor=M.+Robsonauthor=J.+%C5%A0ponerauthor=B.+Islamauthor=R.+Barbara+Pedleyauthor=J.+A.+Hartleyauthor=S.+Neidle&title=A+G-quadruplex-binding+compound+showing+anti-tumor+activity+in+an+in+vivo+model+for+pancreatic+cancer&doi=10.1038%2Fsrep11385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A G-quadruplex-binding compound showing anti-tumour activity in an in vivo model for pancreatic cancer</span></div><div class="casAuthors">Ohnmacht Stephan A; Marchetti Chiara; Gunaratnam Mekala; Besser Rachael J; Haider Shozeb M; Di Vita Gloria; Neidle Stephen; Lowe Helen L; Mellinas-Gomez Maria; Diocou Seckou; Robson Mathew; Pedley R Barbara; Hartley John A; Sponer Jiri; Islam Barira</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11385</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We report here that a tetra-substituted naphthalene-diimide derivative (MM41) has significant in vivo anti-tumour activity against the MIA PaCa-2 pancreatic cancer xenograft model.  IV administration with a twice-weekly 15 mg/kg dose produces ca 80% tumour growth decrease in a group of tumour-bearing animals.  Two animals survived tumour-free after 279 days.  High levels of MM41 are rapidly transported into cell nuclei and were found to accumulate in the tumour.  MM41 is a quadruplex-interactive compound which binds strongly to the quadruplexes encoded in the promoter sequences of the BCL-2 and k-RAS genes, both of which are dis-regulated in many human pancreatic cancers.  Levels of BCL-2 were reduced by ca 40% in tumours from MM41-treated animals relative to controls, consistent with BCL-2 being a target for MM41.  Molecular modelling suggests that MM41 binds to a BCL-2 quadruplex in a manner resembling that previously observed in co-crystal structures with human telomeric quadruplexes.  This supports the concept that MM41 (and by implication other quadruplex-targeting small molecules) can bind to quadruplex-forming promoter regions in a number of genes and down-regulate their transcription.  We suggest that quadruplexes within those master genes that are up-regulated drivers for particular cancers, may be selective targets for compounds such as MM41.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxgQSOJ7Hiq43yKPtYViAGfW6udTcc2eYTFOi0E4X6Fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbktVSmtQ%253D%253D&md5=ba52638803cd600a6b01dda88d1e23e5</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fsrep11385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep11385%26sid%3Dliteratum%253Aachs%26aulast%3DOhnmacht%26aufirst%3DS.%2BA.%26aulast%3DMarchetti%26aufirst%3DC.%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DBesser%26aufirst%3DR.%2BJ.%26aulast%3DHaider%26aufirst%3DS.%2BM.%26aulast%3DDi%2BVita%26aufirst%3DG.%26aulast%3DLowe%26aufirst%3DH.%2BL.%26aulast%3DMellinas-Gomez%26aufirst%3DM.%26aulast%3DDiocou%26aufirst%3DS.%26aulast%3DRobson%26aufirst%3DM.%26aulast%3D%25C5%25A0poner%26aufirst%3DJ.%26aulast%3DIslam%26aufirst%3DB.%26aulast%3DBarbara%2BPedley%26aufirst%3DR.%26aulast%3DHartley%26aufirst%3DJ.%2BA.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DA%2520G-quadruplex-binding%2520compound%2520showing%2520anti-tumor%2520activity%2520in%2520an%2520in%2520vivo%2520model%2520for%2520pancreatic%2520cancer%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D11385%26doi%3D10.1038%2Fsrep11385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gopinathan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jodrell, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, O. J.</span></span> <span> </span><span class="NLM_article-title">GEMMs as preclinical models for testing pancreatic cancer therapies</span>. <i>Dis. Models &amp; Mech.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1185</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1242/dmm.021055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1242%2Fdmm.021055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26438692" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=1185-1200&author=A.+Gopinathanauthor=J.+P.+Mortonauthor=D.+I.+Jodrellauthor=O.+J.+Sansom&title=GEMMs+as+preclinical+models+for+testing+pancreatic+cancer+therapies&doi=10.1242%2Fdmm.021055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1242%2Fdmm.021055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.021055%26sid%3Dliteratum%253Aachs%26aulast%3DGopinathan%26aufirst%3DA.%26aulast%3DMorton%26aufirst%3DJ.%2BP.%26aulast%3DJodrell%26aufirst%3DD.%2BI.%26aulast%3DSansom%26aufirst%3DO.%2BJ.%26atitle%3DGEMMs%2520as%2520preclinical%2520models%2520for%2520testing%2520pancreatic%2520cancer%2520therapies%26jtitle%3DDis.%2520Models%2520%2526amp%253B%2520Mech.%26date%3D2015%26volume%3D8%26spage%3D1185%26epage%3D1200%26doi%3D10.1242%2Fdmm.021055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huppert, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span> <span> </span><span class="NLM_article-title">Prevalence of quadruplexes in the human genome</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2908</span>– <span class="NLM_lpage">2916</span>, <span class="refDoi"> DOI: 10.1093/nar/gki609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fnar%2Fgki609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=15914667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVSgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=2908-2916&author=J.+L.+Huppertauthor=S.+Balasubramanian&title=Prevalence+of+quadruplexes+in+the+human+genome&doi=10.1093%2Fnar%2Fgki609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of quadruplexes in the human genome</span></div><div class="casAuthors">Huppert, Julian L.; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2908-2916</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Guanine-rich DNA sequences of a particular form have the ability to fold into four-stranded structures called G-quadruplexes.  In this paper, the authors present a working rule to predict which primary sequences can form this structure, and describe a search algorithm to identify such sequences in genomic DNA.  The authors count the no. of quadruplexes found in the human genome and compare that with the figure predicted by modeling DNA as a Bernoulli stream or as a Markov chain, using windows of various sizes.  The authors demonstrate that the distribution of loop lengths is significantly different from what would be expected in a random case, providing an indication of the no. of potentially relevant quadruplex-forming sequences.  In particular, the authors show that there is a significant repression of quadruplexes in the coding strand of exonic regions, which suggests that quadruplex-forming patterns are disfavored in sequences that will form RNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9b1Y1oE6MjbVg90H21EOLACvtfcHk0lgXdnZ7L2Z-ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVSgsL0%253D&md5=b3ae66e9fa59c6c074b5dd2f58b8c712</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgki609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgki609%26sid%3Dliteratum%253Aachs%26aulast%3DHuppert%26aufirst%3DJ.%2BL.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DPrevalence%2520of%2520quadruplexes%2520in%2520the%2520human%2520genome%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2005%26volume%3D33%26spage%3D2908%26epage%3D2916%26doi%3D10.1093%2Fnar%2Fgki609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Todd, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Highly prevalent putative quadruplex sequence motifs in human DNA</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2901</span>– <span class="NLM_lpage">2907</span>, <span class="refDoi"> DOI: 10.1093/nar/gki553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fnar%2Fgki553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=15914666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVSgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=2901-2907&author=A.+K.+Toddauthor=M.+Johnstonauthor=S.+Neidle&title=Highly+prevalent+putative+quadruplex+sequence+motifs+in+human+DNA&doi=10.1093%2Fnar%2Fgki553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Highly prevalent putative quadruplex sequence motifs in human DNA</span></div><div class="casAuthors">Todd, Alan K.; Johnston, Matthew; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2901-2907</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">We report here the results of a systematic search for the existence and prevalence of potential intramol. G-quadruplex forming sequences in the human genome.  We have also examd. the tendency for particular sequences of 'loop' regions to occur in particular positions with respect to the G-tracts in a quadruplex.  Using arithmetic ratio and probability techniques we have discovered frequent and systematic occurrence of certain sequence types, the most prominent being a potential quadruplex contg. CCTGT in the first 'loop' position.  Being able to highlight types of potential quadruplex sequences in G-rich regions is an important step in searching for biol. relevant sequences and finding their function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpizf5-GbnVrLVg90H21EOLACvtfcHk0lgXdnZ7L2Z-ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVSgsrw%253D&md5=53d7a1863e6a3c2f264aa291eabe893d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgki553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgki553%26sid%3Dliteratum%253Aachs%26aulast%3DTodd%26aufirst%3DA.%2BK.%26aulast%3DJohnston%26aufirst%3DM.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DHighly%2520prevalent%2520putative%2520quadruplex%2520sequence%2520motifs%2520in%2520human%2520DNA%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2005%26volume%3D33%26spage%3D2901%26epage%3D2907%26doi%3D10.1093%2Fnar%2Fgki553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Sousa Cavalcante, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, G.</span></span> <span> </span><span class="NLM_article-title">Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>741</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2014.07.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.ejphar.2014.07.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25084222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Kgsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=741&publication_year=2014&pages=8-16&author=L.+de%0ASousa+Cavalcanteauthor=G.+Monteiro&title=Gemcitabine%3A+metabolism+and+molecular+mechanisms+of+action%2C+sensitivity+and+chemoresistance+in+pancreatic+cancer&doi=10.1016%2Fj.ejphar.2014.07.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer</span></div><div class="casAuthors">de Sousa Cavalcante, Lucas; Monteiro, Gisele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">741</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8-16</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Gemcitabine is the first-line treatment for pancreatic adenocarcinoma, but is increasingly used to treat breast, bladder, and non-small cell lung cancers.  Despite such broad use, intrinsic and acquired chemoresistance is common.  In general, the underlying mechanisms of chemoresistance are poorly understood.  Here, current knowledge of gemcitabine metab., mechanisms of action, sensitivity and chemoresistance reported over the past two decades are reviewed; and we also offer new perspectives to improve gemcitabine efficacy with particular ref. to the treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKoecBhUduMLVg90H21EOLACvtfcHk0lgXdnZ7L2Z-ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Kgsr7E&md5=0454045e4cdf03cf098090f568c5647a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2014.07.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2014.07.041%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BSousa%2BCavalcante%26aufirst%3DL.%26aulast%3DMonteiro%26aufirst%3DG.%26atitle%3DGemcitabine%253A%2520metabolism%2520and%2520molecular%2520mechanisms%2520of%2520action%252C%2520sensitivity%2520and%2520chemoresistance%2520in%2520pancreatic%2520cancer%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D741%26spage%3D8%26epage%3D16%26doi%3D10.1016%2Fj.ejphar.2014.07.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Men, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, C. B.</span></span> <span> </span><span class="NLM_article-title">Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy</span>. <i>J. Drug. Target.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.3109/1061186X.2014.983522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.3109%2F1061186X.2014.983522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25470255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslSisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=125-133&author=D.+Kongauthor=Y.+Zhaoauthor=T.+Menauthor=C.+B.+Teng&title=Hippo+signaling+pathway+in+liver+and+pancreas%3A+the+potential+drug+target+for+tumor+therapy&doi=10.3109%2F1061186X.2014.983522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy</span></div><div class="casAuthors">Kong, Delin; Zhao, Yicheng; Men, Tong; Teng, Chun-Bo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-133</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1026-7158</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Cell behaviors, including proliferation, differentiation and apoptosis, are intricately controlled during organ development and tissue regeneration.  In the past 9 years, the Hippo signaling pathway has been delineated to play crit. roles in organ size control, tissue regeneration and tumorigenesis through regulating cell behaviors.  In mammals, the core modules of the Hippo signaling pathway include the MST1/2-LATS1/2 kinase cascade and the transcriptional co-activators YAP/TAZ.  The activity of YAP/TAZ is suppressed by cytoplasmic retention due to phosphorylation in the canonical MST1/2-LATS1/2 kinase cascade-dependent manner or the non-canonical MST1/2- and/or LATS1/2-independent manner.  Hippo signaling pathway, which can be activated or inactivated by cell polarity, contact inhibition, mech. stretch and extracellular factors, has been demonstrated to be involved in development and tumorigenesis of liver and pancreas.  In addn., we have summarized several small mols. currently available that can target Hippo-YAP pathway for potential treatment of hepatic and pancreatic cancers, providing clues for other YAP initiated cancers therapy as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS2c2b-wgTs7Vg90H21EOLACvtfcHk0ljBcItYaxmqlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslSisg%253D%253D&md5=4746d2ca407af4af4b9000f1fc0849c5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3109%2F1061186X.2014.983522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F1061186X.2014.983522%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DMen%26aufirst%3DT.%26aulast%3DTeng%26aufirst%3DC.%2BB.%26atitle%3DHippo%2520signaling%2520pathway%2520in%2520liver%2520and%2520pancreas%253A%2520the%2520potential%2520drug%2520target%2520for%2520tumor%2520therapy%26jtitle%3DJ.%2520Drug.%2520Target.%26date%3D2015%26volume%3D23%26spage%3D125%26epage%3D133%26doi%3D10.3109%2F1061186X.2014.983522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iriana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annamalai, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendifar, A. E.</span></span> <span> </span><span class="NLM_article-title">Targeting mTOR in pancreatic ductal adenocarcinoma</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">99</span>, <span class="refDoi"> DOI: 10.3389/fonc.2016.00099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.3389%2Ffonc.2016.00099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=27200288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FhsFKjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=99&author=S.+Irianaauthor=S.+Ahmedauthor=J.+Gongauthor=A.+A.+Annamalaiauthor=R.+Tuliauthor=A.+E.+Hendifar&title=Targeting+mTOR+in+pancreatic+ductal+adenocarcinoma&doi=10.3389%2Ffonc.2016.00099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting mTOR in Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Iriana Sentia; Ahmed Shahzad; Gong Jun; Annamalai Alagappan Anand; Tuli Richard; Hendifar Andrew Eugene</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">99</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Treatment options for advanced pancreatic ductal adenocarcinoma (PDAC) are limited; however, new therapies targeting specific tumor-related molecular characteristics may help certain patient cohorts.  Emerging preclinical data have shown that inhibition of mammalian target of rapamycin (mTOR) in specific KRAS-dependent PDAC subtypes leads to inhibition of tumorigenesis in vitro and in vivo.  Early phase II studies of mono-mTOR inhibition have not shown promise.  However, studies have shown that combined inhibition of multiple steps along the mTOR signaling pathway may lead to sustained responses by targeting mechanisms of tumor resistance.  Coordinated inhibition of mTOR along with specific KRAS-dependent mutations in molecularly defined PDAC subpopulations may offer a viable alternative for treatment in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMbUYXuVDp7K__Jf7-eMvJfW6udTcc2eZ8YzNJt55Ox7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FhsFKjsA%253D%253D&md5=9b10cb25c3663b45b225b8172df7d696</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2016.00099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2016.00099%26sid%3Dliteratum%253Aachs%26aulast%3DIriana%26aufirst%3DS.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DAnnamalai%26aufirst%3DA.%2BA.%26aulast%3DTuli%26aufirst%3DR.%26aulast%3DHendifar%26aufirst%3DA.%2BE.%26atitle%3DTargeting%2520mTOR%2520in%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DFront.%2520Oncol.%26date%3D2016%26volume%3D6%26spage%3D99%26doi%3D10.3389%2Ffonc.2016.00099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnieke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saur, D.</span></span> <span> </span><span class="NLM_article-title">Oncogenic KRAS signalling in pancreatic cancer</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">822</span>, <span class="refDoi"> DOI: 10.1038/bjc.2014.215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fbjc.2014.215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=24755884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVShs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=817-822&author=S.+Eserauthor=A.+Schniekeauthor=G.+Schneiderauthor=D.+Saur&title=Oncogenic+KRAS+signalling+in+pancreatic+cancer&doi=10.1038%2Fbjc.2014.215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic KRAS signalling in pancreatic cancer</span></div><div class="casAuthors">Eser, S.; Schnieke, A.; Schneider, G.; Saur, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">817-822</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pancreatic ductal adenocarcinoma (PDAC) is almost universally fatal.  The annual no. of deaths equals the no. of newly diagnosed cases, despite maximal treatment.  The overall 5-yr survival rate of <5% has remained stubbornly unchanged over the last 30 years, despite tremendous efforts in preclin. and clin. science.  There is unquestionably an urgent need to further improve our understanding of pancreatic cancer biol., treatment response and relapse, and to identify novel therapeutic targets.  Rigorous research in the field has uncovered genetic aberrations that occur during PDAC development and progression.  In most cases, PDAC is initiated by oncogenic mutant KRAS, which has been shown to drive pancreatic neoplasia.  However, all attempts to target KRAS directly have failed in the clinic and KRAS is widely assumed to be undruggable.  This has led to intense efforts to identify druggable crit. downstream targets and nodes orchestrated by mutationally activated KRAS.  This includes context-specific KRAS effector pathways, synthetic lethal interaction partners and KRAS-driven metabolic changes.  Here, we review recent advances in oncogenic KRAS signalling and discuss how these might benefit PDAC treatment in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmxRwu-hqhVLVg90H21EOLACvtfcHk0ljBcItYaxmqlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVShs7g%253D&md5=9e4dc9abd50852b658f6b8c1d0ddc93d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2014.215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2014.215%26sid%3Dliteratum%253Aachs%26aulast%3DEser%26aufirst%3DS.%26aulast%3DSchnieke%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DG.%26aulast%3DSaur%26aufirst%3DD.%26atitle%3DOncogenic%2520KRAS%2520signalling%2520in%2520pancreatic%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2014%26volume%3D111%26spage%3D817%26epage%3D822%26doi%3D10.1038%2Fbjc.2014.215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trajkovic-Arsic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalideris, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siveke, J. T.</span></span> <span> </span><span class="NLM_article-title">The role of insulin and IGF system in pancreatic cancer</span>. <i>J. Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">R67</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1530/JME-12-0259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1530%2FJME-12-0259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=23493758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslykt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2013&pages=R67-74&author=M.+Trajkovic-Arsicauthor=E.+Kaliderisauthor=J.+T.+Siveke&title=The+role+of+insulin+and+IGF+system+in+pancreatic+cancer&doi=10.1530%2FJME-12-0259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The role of insulin and IGF system in pancreatic cancer</span></div><div class="casAuthors">Trajkovic-Arsic, Marija; Kalideris, Evdokia; Siveke, Jens T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">R67-R74</span>CODEN:
                <span class="NLM_cas:coden">JMLEEI</span>;
        ISSN:<span class="NLM_cas:issn">0952-5041</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">A review.  The importance of the IGF system in carcinogenesis has been established for many solid cancers.  It is well known that individuals with higher circulating levels of the IGF1 ligand present an increased risk of cancer.  However, therapies with monoclonal antibodies targeting the IGF1 receptor (IGF1R) have been largely unsuccessful.  One of the potential reasons for this failure is the existence of the highly homologous insulin receptor (IR), which appears to be at least equally efficient as the IGF1R in the transition of mitogenic signals to the nucleus and promotion of cell growth.  Furthermore, IGF1 and insulin receptors can form hybrid receptors sensitive to stimulation of all three ligands of the system: insulin, IGF1, and IGF2.  Although the connection between insulin, diabetes, and cancer has been established for years now, clear evidence that demonstrate the redundancy of insulin and insulin receptors and insulin-like growth factors and their receptors in cancer is missing.  In this review, we focus on the contribution of insulin and IGFs to carcinogenesis in the insulin-producing organ, the pancreas.  We give a short summary on the complexity of insulin and the IGF system in the pancreas and their potential roles in pancreatic cancer, esp. pancreatic ductal adenocarcinoma.  Finally, we discuss drug-targeting options of this system and the rationale of simultaneous targeting of both the insulin and the IGF systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-MbwGRNVFJLVg90H21EOLACvtfcHk0ljBcItYaxmqlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslykt70%253D&md5=9614b4591498627039e76ec1c80e9115</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1530%2FJME-12-0259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FJME-12-0259%26sid%3Dliteratum%253Aachs%26aulast%3DTrajkovic-Arsic%26aufirst%3DM.%26aulast%3DKalideris%26aufirst%3DE.%26aulast%3DSiveke%26aufirst%3DJ.%2BT.%26atitle%3DThe%2520role%2520of%2520insulin%2520and%2520IGF%2520system%2520in%2520pancreatic%2520cancer%26jtitle%3DJ.%2520Mol.%2520Endocrinol.%26date%3D2013%26volume%3D50%26spage%3DR67%26epage%3D74%26doi%3D10.1530%2FJME-12-0259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arlt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehrz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mürköster, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vorndamm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folsch, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, H.</span></span> <span> </span><span class="NLM_article-title">Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3243</span>– <span class="NLM_lpage">3251</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1206390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fsj.onc.1206390" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=3243-3251&author=A.+Arltauthor=A.+Gehrzauthor=S.+M%C3%BCrk%C3%B6sterauthor=J.+Vorndammauthor=M.+L.+Kruseauthor=U.+R.+Folschauthor=H.+Schafer&title=Role+of+NF-kappaB+and+Akt%2FPI3K+in+the+resistance+of+pancreatic+carcinoma+cell+lines+against+gemcitabine-induced+cell+death&doi=10.1038%2Fsj.onc.1206390"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206390%26sid%3Dliteratum%253Aachs%26aulast%3DArlt%26aufirst%3DA.%26aulast%3DGehrz%26aufirst%3DA.%26aulast%3DM%25C3%25BCrk%25C3%25B6ster%26aufirst%3DS.%26aulast%3DVorndamm%26aufirst%3DJ.%26aulast%3DKruse%26aufirst%3DM.%2BL.%26aulast%3DFolsch%26aufirst%3DU.%2BR.%26aulast%3DSchafer%26aufirst%3DH.%26atitle%3DRole%2520of%2520NF-kappaB%2520and%2520Akt%252FPI3K%2520in%2520the%2520resistance%2520of%2520pancreatic%2520carcinoma%2520cell%2520lines%2520against%2520gemcitabine-induced%2520cell%2520death%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D3243%26epage%3D3251%26doi%3D10.1038%2Fsj.onc.1206390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Humbert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casteran, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanssens, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iovanna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertucci, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansfield, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moussy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermine, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubreuil, P.</span></span> <span> </span><span class="NLM_article-title">Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumor cell lines and ectopic mouse model</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e9430</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0009430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1371%2Fjournal.pone.0009430" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e9430&author=M.+Humbertauthor=N.+Casteranauthor=S.+Letardauthor=K.+Hanssensauthor=J.+Iovannaauthor=P.+Finettiauthor=F.+Bertucciauthor=T.+Baderauthor=C.+D.+Mansfieldauthor=A.+Moussyauthor=O.+Hermineauthor=P.+Dubreuil&title=Masitinib+combined+with+standard+gemcitabine+chemotherapy%3A+in+vitro+and+in+vivo+studies+in+human+pancreatic+tumor+cell+lines+and+ectopic+mouse+model&doi=10.1371%2Fjournal.pone.0009430"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0009430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0009430%26sid%3Dliteratum%253Aachs%26aulast%3DHumbert%26aufirst%3DM.%26aulast%3DCasteran%26aufirst%3DN.%26aulast%3DLetard%26aufirst%3DS.%26aulast%3DHanssens%26aufirst%3DK.%26aulast%3DIovanna%26aufirst%3DJ.%26aulast%3DFinetti%26aufirst%3DP.%26aulast%3DBertucci%26aufirst%3DF.%26aulast%3DBader%26aufirst%3DT.%26aulast%3DMansfield%26aufirst%3DC.%2BD.%26aulast%3DMoussy%26aufirst%3DA.%26aulast%3DHermine%26aufirst%3DO.%26aulast%3DDubreuil%26aufirst%3DP.%26atitle%3DMasitinib%2520combined%2520with%2520standard%2520gemcitabine%2520chemotherapy%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520studies%2520in%2520human%2520pancreatic%2520tumor%2520cell%2520lines%2520and%2520ectopic%2520mouse%2520model%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De9430%26doi%3D10.1371%2Fjournal.pone.0009430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forment, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oelschlaegel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xhemalce, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. P.</span></span> <span> </span><span class="NLM_article-title">Small-molecule-induced DNA damage identifies alternative DNA structures in human genes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1038/nchembio.780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnchembio.780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=22306580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=301-310&author=R.+Rodriguezauthor=K.+M.+Millerauthor=J.+V.+Formentauthor=C.+R.+Bradshawauthor=M.+Nikanauthor=S.+Brittonauthor=T.+Oelschlaegelauthor=B.+Xhemalceauthor=S.+Balasubramanianauthor=S.+P.+Jackson&title=Small-molecule-induced+DNA+damage+identifies+alternative+DNA+structures+in+human+genes&doi=10.1038%2Fnchembio.780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule-induced DNA damage identifies alternative DNA structures in human genes</span></div><div class="casAuthors">Rodriguez, Raphael; Miller, Kyle M.; Forment, Josep V.; Bradshaw, Charles R.; Nikan, Mehran; Britton, Sebastien; Oelschlaegel, Tobias; Xhemalce, Blerta; Balasubramanian, Shankar; Jackson, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">301-310</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Guanine-rich DNA sequences that can adopt non-Watson-Crick structures in vitro are prevalent in the human genome.  Whether such structures normally exist in mammalian cells has, however, been the subject of active research for decades.  Here we show that the G-quadruplex-interacting drug pyridostatin promotes growth arrest in human cancer cells by inducing replication- and transcription-dependent DNA damage.  A chromatin immunopptn. sequencing anal. of the DNA damage marker γH2AX provided the genome-wide distribution of pyridostatin-induced sites of damage and revealed that pyridostatin targets gene bodies contg. clusters of sequences with a propensity for G-quadruplex formation.  As a result, pyridostatin modulated the expression of these genes, including the proto-oncogene SRC.  We obsd. that pyridostatin reduced SRC protein abundance and SRC-dependent cellular motility in human breast cancer cells, validating SRC as a target of this drug.  Our unbiased approach to define genomic sites of action for a drug establishes a framework for discovering functional DNA-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Ffpu4Hgf7rVg90H21EOLACvtfcHk0liIHGnYryMvhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGkur0%253D&md5=60f699970eead8cabd7b3a7a260714e7</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.780%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DK.%2BM.%26aulast%3DForment%26aufirst%3DJ.%2BV.%26aulast%3DBradshaw%26aufirst%3DC.%2BR.%26aulast%3DNikan%26aufirst%3DM.%26aulast%3DBritton%26aufirst%3DS.%26aulast%3DOelschlaegel%26aufirst%3DT.%26aulast%3DXhemalce%26aufirst%3DB.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26atitle%3DSmall-molecule-induced%2520DNA%2520damage%2520identifies%2520alternative%2520DNA%2520structures%2520in%2520human%2520genes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D301%26epage%3D310%26doi%3D10.1038%2Fnchembio.780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rappold, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwabuchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Date, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Tumor suppressor P53 binding protein 1 (53bp1) is involved in DNA damage–signaling pathways</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1083/jcb.153.3.613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1083%2Fjcb.153.3.613" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2001&pages=613-620&author=I.+Rappoldauthor=K.+Iwabuchiauthor=T.+Dateauthor=J.+Chen&title=Tumor+suppressor+P53+binding+protein+1+%2853bp1%29+is+involved+in+DNA+damage%E2%80%93signaling+pathways&doi=10.1083%2Fjcb.153.3.613"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1083%2Fjcb.153.3.613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.153.3.613%26sid%3Dliteratum%253Aachs%26aulast%3DRappold%26aufirst%3DI.%26aulast%3DIwabuchi%26aufirst%3DK.%26aulast%3DDate%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DTumor%2520suppressor%2520P53%2520binding%2520protein%25201%2520%252853bp1%2529%2520is%2520involved%2520in%2520DNA%2520damage%25E2%2580%2593signaling%2520pathways%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2001%26volume%3D153%26spage%3D613%26epage%3D620%26doi%3D10.1083%2Fjcb.153.3.613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemmens, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Schendel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tijsterman, M.</span></span> <span> </span><span class="NLM_article-title">Mutagenic consequences of a single G-quadruplex demonstrate mitotic inheritance of DNA replication fork barriers</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8909</span>, <span class="refDoi"> DOI: 10.1038/ncomms9909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fncomms9909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26563448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOmsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8909&author=B.+Lemmensauthor=R.+van+Schendelauthor=M.+Tijsterman&title=Mutagenic+consequences+of+a+single+G-quadruplex+demonstrate+mitotic+inheritance+of+DNA+replication+fork+barriers&doi=10.1038%2Fncomms9909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Mutagenic consequences of a single G-quadruplex demonstrate mitotic inheritance of DNA replication fork barriers</span></div><div class="casAuthors">Lemmens, Bennie; van Schendel, Robin; Tijsterman, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8909</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Faithful DNA replication is vital to prevent disease-causing mutations, chromosomal aberrations and malignant transformation.  However, accuracy conflicts with pace and flexibility and cells rely on specialized polymerases and helicases to ensure effective and timely replication of genomes that contain DNA lesions or secondary structures.  If and how cells can tolerate a permanent barrier to replication is, however, unknown.  Here we show that a single unresolved G-quadruplexed DNA structure can persist through multiple mitotic divisions without changing conformation.  Failed replication across a G-quadruplex causes single-strand DNA gaps that give rise to DNA double-strand breaks in subsequent cell divisions, which are processed by polymerase theta (POLQ)-mediated alternative end joining.  Lineage tracing expts. further reveal that persistent G-quadruplexes cause genetic heterogeneity during organ development.  Our data demonstrate that a single lesion can cause multiple unique genomic rearrangements, and that alternative end joining enables cells to proliferate in the presence of mitotically inherited replication blocks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp8h0JCrSGUrVg90H21EOLACvtfcHk0lheKRNSJOJ5tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOmsbbK&md5=db43b84764420d505e3c6dba0bc0c70d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fncomms9909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9909%26sid%3Dliteratum%253Aachs%26aulast%3DLemmens%26aufirst%3DB.%26aulast%3Dvan%2BSchendel%26aufirst%3DR.%26aulast%3DTijsterman%26aufirst%3DM.%26atitle%3DMutagenic%2520consequences%2520of%2520a%2520single%2520G-quadruplex%2520demonstrate%2520mitotic%2520inheritance%2520of%2520DNA%2520replication%2520fork%2520barriers%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8909%26doi%3D10.1038%2Fncomms9909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hessmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsen, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siveke, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenrieder, V.</span></span> <span> </span><span class="NLM_article-title">Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1136/gutjnl-2016-312539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1136%2Fgutjnl-2016-312539" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2017&pages=168-179&author=E.+Hessmannauthor=S.+A.+Johnsenauthor=J.+T.+Sivekeauthor=V.+Ellenrieder&title=Epigenetic+treatment+of+pancreatic+cancer%3A+is+there+a+therapeutic+perspective+on+the+horizon%3F&doi=10.1136%2Fgutjnl-2016-312539"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1136%2Fgutjnl-2016-312539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgutjnl-2016-312539%26sid%3Dliteratum%253Aachs%26aulast%3DHessmann%26aufirst%3DE.%26aulast%3DJohnsen%26aufirst%3DS.%2BA.%26aulast%3DSiveke%26aufirst%3DJ.%2BT.%26aulast%3DEllenrieder%26aufirst%3DV.%26atitle%3DEpigenetic%2520treatment%2520of%2520pancreatic%2520cancer%253A%2520is%2520there%2520a%2520therapeutic%2520perspective%2520on%2520the%2520horizon%253F%26jtitle%3DGut%26date%3D2017%26volume%3D66%26spage%3D168%26epage%3D179%26doi%3D10.1136%2Fgutjnl-2016-312539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riou, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teulade-Fichou, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frickey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartig, J. S.</span></span> <span> </span><span class="NLM_article-title">Bisquinolinium compounds induce quadruplex-specific transcriptome changes in HeLa S3 cell lines</span>. <i>BMC Res. Notes</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">138</span>, <span class="refDoi"> DOI: 10.1186/1756-0500-5-138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1186%2F1756-0500-5-138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=22414013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVWgurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=138&author=R.+Halderauthor=J.+F.+Riouauthor=M.+P.+Teulade-Fichouauthor=T.+Frickeyauthor=J.+S.+Hartig&title=Bisquinolinium+compounds+induce+quadruplex-specific+transcriptome+changes+in+HeLa+S3+cell+lines&doi=10.1186%2F1756-0500-5-138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Bisquinolinium compounds induce quadruplex-specific transcriptome changes in HeLa S3 cell lines</span></div><div class="casAuthors">Halder, Rashi; Riou, Jean-Francois; Teulade-Fichou, Marie-Paule; Frickey, Tancred; Hartig, Joerg S.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Research Notes</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">138</span>CODEN:
                <span class="NLM_cas:coden">BRNMAT</span>;
        ISSN:<span class="NLM_cas:issn">1756-0500</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Guanosine rich sequences capable of forming G-quadruplex (G4) motifs are enriched near the gene transcription start site (TSS) in the human genome.  When probed at the single gene level, G-quadruplex motifs residing in promoter regions show substantial effects on gene transcription.  Moreover, further changes in transcription levels are noticed when G4-motifs are targeted with G-quadruplex-specific small mols.  Results: Global studies concerning general changes of the transcriptome via targeting promoter-based G-quadruplex motifs are very limited and have so far only been carried out with compds. displaying weak selectivity for quadruplex sequences.  Here we utilize two G-quadruplex-specific bisquinolinium derivs. PhenDC3 and 360A and investigate their effects on the expression of the HeLa S3 transcriptome.  Our results show wide-spread changes in the transcriptome with specificity for genes with G-quadruplex motifs near their transcription start sites (TSS).  Using real-time PCR we further confirmed the specificity of PhenDC3 and 360A as potent mols. to target G-quadruplex-regulated genes.  Conclusions: Specific effects on quadruplex-contg. genes have been obsd. utilizing whole-transcriptome anal. upon treatment of cultured cells with quadruplex-selective bisquinolinium compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf2sS5QZK5u7Vg90H21EOLACvtfcHk0lheKRNSJOJ5tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVWgurY%253D&md5=1fe7710c3917004e7cbe3037599ac8c6</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1186%2F1756-0500-5-138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-0500-5-138%26sid%3Dliteratum%253Aachs%26aulast%3DHalder%26aufirst%3DR.%26aulast%3DRiou%26aufirst%3DJ.%2BF.%26aulast%3DTeulade-Fichou%26aufirst%3DM.%2BP.%26aulast%3DFrickey%26aufirst%3DT.%26aulast%3DHartig%26aufirst%3DJ.%2BS.%26atitle%3DBisquinolinium%2520compounds%2520induce%2520quadruplex-specific%2520transcriptome%2520changes%2520in%2520HeLa%2520S3%2520cell%2520lines%26jtitle%3DBMC%2520Res.%2520Notes%26date%3D2012%26volume%3D5%26spage%3D138%26doi%3D10.1186%2F1756-0500-5-138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandakumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vietsch, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughlin, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadhwa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chetram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallakury, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toretsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellstein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, C.</span></span> <span> </span><span class="NLM_article-title">Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">ra42</span>, <span class="refDoi"> DOI: 10.1126/scisignal.2005049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1126%2Fscisignal.2005049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=24803537" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=ra42&author=W.+Zhangauthor=N.+Nandakumarauthor=Y.+Shiauthor=M.+Manzanoauthor=A.+Smithauthor=G.+Grahamauthor=S.+Guptaauthor=E.+E.+Vietschauthor=S.+Z.+Laughlinauthor=M.+Wadhwaauthor=M.+Chetramauthor=M.+Joshiauthor=F.+Wangauthor=B.+Kallakuryauthor=J.+Toretskyauthor=A.+Wellsteinauthor=C.+Yi&title=Downstream+of+mutant+KRAS%2C+the+transcription+regulator+YAP+is+essential+for+neoplastic+progression+to+pancreatic+ductal+adenocarcinoma&doi=10.1126%2Fscisignal.2005049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2005049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2005049%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DNandakumar%26aufirst%3DN.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DManzano%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DG.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DVietsch%26aufirst%3DE.%2BE.%26aulast%3DLaughlin%26aufirst%3DS.%2BZ.%26aulast%3DWadhwa%26aufirst%3DM.%26aulast%3DChetram%26aufirst%3DM.%26aulast%3DJoshi%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DKallakury%26aufirst%3DB.%26aulast%3DToretsky%26aufirst%3DJ.%26aulast%3DWellstein%26aufirst%3DA.%26aulast%3DYi%26aufirst%3DC.%26atitle%3DDownstream%2520of%2520mutant%2520KRAS%252C%2520the%2520transcription%2520regulator%2520YAP%2520is%2520essential%2520for%2520neoplastic%2520progression%2520to%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DSci.%2520Signaling%26date%3D2014%26volume%3D7%26spage%3Dra42%26doi%3D10.1126%2Fscisignal.2005049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ying, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liewen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadanandam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Khalil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher-Sananikone, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwitz, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettazzoni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Protopopov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffernan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draetta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePinho, R. A.</span></span> <span> </span><span class="NLM_article-title">Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2014.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.cell.2014.06.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2014&pages=185-197&author=A.+Kapoorauthor=W.+Yaoauthor=H.+Yingauthor=S.+Huaauthor=A.+Liewenauthor=Q.+Wangauthor=Y.+Zhongauthor=C.+J.+Wuauthor=A.+Sadanandamauthor=B.+Huauthor=Q.+Changauthor=G.+C.+Chuauthor=R.+Al-Khalilauthor=S.+Jiangauthor=H.+Xiaauthor=E.+Fletcher-Sananikoneauthor=C.+Limauthor=G.+I.+Horwitzauthor=A.+Vialeauthor=P.+Pettazzoniauthor=N.+Sanchezauthor=H.+Wangauthor=A.+Protopopovauthor=J.+Zhangauthor=T.+Heffernanauthor=R.+L.+Johnsonauthor=L.+Chinauthor=Y.+A.+Wangauthor=G.+Draettaauthor=R.+A.+DePinho&title=Yap1+activation+enables+bypass+of+oncogenic+Kras+addiction+in+pancreatic+cancer&doi=10.1016%2Fj.cell.2014.06.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DKapoor%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DYing%26aufirst%3DH.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DLiewen%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DC.%2BJ.%26aulast%3DSadanandam%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DChu%26aufirst%3DG.%2BC.%26aulast%3DAl-Khalil%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DH.%26aulast%3DFletcher-Sananikone%26aufirst%3DE.%26aulast%3DLim%26aufirst%3DC.%26aulast%3DHorwitz%26aufirst%3DG.%2BI.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DPettazzoni%26aufirst%3DP.%26aulast%3DSanchez%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DProtopopov%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHeffernan%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DChin%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%2BA.%26aulast%3DDraetta%26aufirst%3DG.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26atitle%3DYap1%2520activation%2520enables%2520bypass%2520of%2520oncogenic%2520Kras%2520addiction%2520in%2520pancreatic%2520cancer%26jtitle%3DCell%26date%3D2014%26volume%3D158%26spage%3D185%26epage%3D197%26doi%3D10.1016%2Fj.cell.2014.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krall, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhutkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccioni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinzel, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbluh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span> <span> </span><span class="NLM_article-title">KRAS and YAP1 converge to regulate EMT and tumor survival</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2014.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.cell.2014.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=24954536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCjtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2014&pages=171-184&author=D.+D.+Shaoauthor=W.+Xueauthor=E.+B.+Krallauthor=A.+Bhutkarauthor=F.+Piccioniauthor=X.+Wangauthor=A.+C.+Schinzelauthor=S.+Soodauthor=J.+Rosenbluhauthor=J.+W.+Kimauthor=Y.+Zwangauthor=T.+M.+Robertsauthor=D.+E.+Rootauthor=T.+Jacksauthor=W.+C.+Hahn&title=KRAS+and+YAP1+converge+to+regulate+EMT+and+tumor+survival&doi=10.1016%2Fj.cell.2014.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">KRAS and YAP1 Converge to Regulate EMT and Tumor Survival</span></div><div class="casAuthors">Shao, Diane D.; Xue, Wen; Krall, Elsa B.; Bhutkar, Arjun; Piccioni, Federica; Wang, Xiaoxing; Schinzel, Anna C.; Sood, Sabina; Rosenbluh, Joseph; Kim, Jong W.; Zwang, Yaara; Roberts, Thomas M.; Root, David E.; Jacks, Tyler; Hahn, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-184</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cancer cells that express oncogenic alleles of RAS typically require sustained expression of the mutant allele for survival, but the mol. basis of this oncogene dependency remains incompletely understood.  To identify genes that can functionally substitute for oncogenic RAS, we systematically expressed 15,294 open reading frames in a human KRAS-dependent colon cancer cell line engineered to express an inducible KRAS-specific shRNA.  We found 147 genes that promoted survival upon KRAS suppression.  In particular, the transcriptional coactivator YAP1 rescued cell viability in KRAS-dependent cells upon suppression of KRAS and was required for KRAS-induced cell transformation.  Acquired resistance to Kras suppression in a Kras-driven murine lung cancer model also involved increased YAP1 signaling.  KRAS and YAP1 converge on the transcription factor FOS and activate a transcriptional program involved in regulating the epithelial-mesenchymal transition (EMT).  Together, these findings implicate transcriptional regulation of EMT by YAP1 as a significant component of oncogenic RAS signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYcz1QvYc_z7Vg90H21EOLACvtfcHk0lhDCSEIsZXPvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCjtbfM&md5=917628c21f0bf281736e8fc9dbb9b11d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DD.%2BD.%26aulast%3DXue%26aufirst%3DW.%26aulast%3DKrall%26aufirst%3DE.%2BB.%26aulast%3DBhutkar%26aufirst%3DA.%26aulast%3DPiccioni%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DSood%26aufirst%3DS.%26aulast%3DRosenbluh%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DZwang%26aufirst%3DY.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26atitle%3DKRAS%2520and%2520YAP1%2520converge%2520to%2520regulate%2520EMT%2520and%2520tumor%2520survival%26jtitle%3DCell%26date%3D2014%26volume%3D158%26spage%3D171%26epage%3D184%26doi%3D10.1016%2Fj.cell.2014.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, K. F.</span></span> <span> </span><span class="NLM_article-title">The TEAD family and its oncogenic role in promoting tumorigenesis</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">138</span>, <span class="refDoi"> DOI: 10.3390/ijms17010138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.3390%2Fijms17010138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26805820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=138&author=Y.+Zhouauthor=T.+Huangauthor=A.+S.+Chengauthor=J.+Yuauthor=W.+Kangauthor=K.+F.+To&title=The+TEAD+family+and+its+oncogenic+role+in+promoting+tumorigenesis&doi=10.3390%2Fijms17010138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The TEAD family and its oncogenic role in promoting tumorigenesis</span></div><div class="casAuthors">Zhou, Yuhang; Huang, Tingting; Cheng, Alfred S. L.; Yu, Jun; Kang, Wei; To, Ka Fai</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">138/1-138/15</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The TEAD family of transcription factors is necessary for developmental processes.  The family members contain a TEA domain for the binding with DNA elements and a transactivation domain for the interaction with transcription coactivators.  TEAD proteins are required for the participation of coactivators to transmit the signal of pathways for the downstream signaling processes.  TEADs also play an important role in tumor initiation and facilitate cancer progression via activating a series of progression-inducing genes, such as CTGF, Cyr61, Myc and Gli2.  Recent studies have highlighted that TEADs, together with their coactivators, promote or even act as the crucial parts in the development of various malignancies, such as liver, ovarian, breast and prostate cancers.  Furthermore, TEADs are proposed to be useful prognostic biomarkers due to the ideal correlation between high expression and clinicopathol. parameters in gastric, breast, ovarian and prostate cancers.  In this review, we summarize the functional role of TEAD proteins in tumorigenesis and discuss the key role of TEAD transcription factors in the linking of signal cascade transductions.  Improved knowledge of the TEAD proteins will be helpful for deep understanding of the mol. mechanisms of tumorigenesis and identifying ideal predictive or prognostic biomarkers, even providing clin. translation for anticancer therapy in human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWR3IdQcw6YLVg90H21EOLACvtfcHk0lhziq7azeto9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOlsw%253D%253D&md5=3ca058d5405586b1397cc1e0c5b70b79</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.3390%2Fijms17010138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms17010138%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DT.%26aulast%3DCheng%26aufirst%3DA.%2BS.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DW.%26aulast%3DTo%26aufirst%3DK.%2BF.%26atitle%3DThe%2520TEAD%2520family%2520and%2520its%2520oncogenic%2520role%2520in%2520promoting%2520tumorigenesis%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2016%26volume%3D17%26spage%3D138%26doi%3D10.3390%2Fijms17010138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajurkar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jesus-Monge, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driscoll, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleman, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotton, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimstra, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, J.</span></span> <span> </span><span class="NLM_article-title">The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">E1038</span>– <span class="NLM_lpage">1047</span>, <span class="refDoi"> DOI: 10.1073/pnas.1114168109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1073%2Fpnas.1114168109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=E1038-1047&author=M.+Rajurkarauthor=W.+E.+De+Jesus-Mongeauthor=D.+R.+Driscollauthor=V.+A.+Applemanauthor=H.+Huangauthor=J.+L.+Cottonauthor=D.+S.+Klimstraauthor=L.+J.+Zhuauthor=K.+Siminauthor=L.+Xuauthor=A.+P.+McMahonauthor=B.+C.+Lewisauthor=J.+Mao&title=The+activity+of+Gli+transcription+factors+is+essential+for+Kras-induced+pancreatic+tumorigenesis&doi=10.1073%2Fpnas.1114168109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1114168109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1114168109%26sid%3Dliteratum%253Aachs%26aulast%3DRajurkar%26aufirst%3DM.%26aulast%3DDe%2BJesus-Monge%26aufirst%3DW.%2BE.%26aulast%3DDriscoll%26aufirst%3DD.%2BR.%26aulast%3DAppleman%26aufirst%3DV.%2BA.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DCotton%26aufirst%3DJ.%2BL.%26aulast%3DKlimstra%26aufirst%3DD.%2BS.%26aulast%3DZhu%26aufirst%3DL.%2BJ.%26aulast%3DSimin%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DMcMahon%26aufirst%3DA.%2BP.%26aulast%3DLewis%26aufirst%3DB.%2BC.%26aulast%3DMao%26aufirst%3DJ.%26atitle%3DThe%2520activity%2520of%2520Gli%2520transcription%2520factors%2520is%2520essential%2520for%2520Kras-induced%2520pancreatic%2520tumorigenesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3DE1038%26epage%3D1047%26doi%3D10.1073%2Fpnas.1114168109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span> <span> </span><span class="NLM_article-title">Promising molecular mechanisms responsible for gemcitabine resistance in cancer</span>. <i>Genes Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1016/j.gendis.2015.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.gendis.2015.07.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=299-306&author=Y.+Jiaauthor=J.+Xie&title=Promising+molecular+mechanisms+responsible+for+gemcitabine+resistance+in+cancer&doi=10.1016%2Fj.gendis.2015.07.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.gendis.2015.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gendis.2015.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DJ.%26atitle%3DPromising%2520molecular%2520mechanisms%2520responsible%2520for%2520gemcitabine%2520resistance%2520in%2520cancer%26jtitle%3DGenes%2520Dis.%26date%3D2015%26volume%3D2%26spage%3D299%26epage%3D306%26doi%3D10.1016%2Fj.gendis.2015.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raza, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knab, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentrem, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovic, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, H. G.</span></span> <span> </span><span class="NLM_article-title">GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">9489</span>, <span class="refDoi"> DOI: 10.1038/srep09489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fsrep09489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25807524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOjurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=9489&author=K.+Kumarauthor=S.+S.+Razaauthor=L.+M.+Knabauthor=C.+R.+Chowauthor=B.+Kwokauthor=D.+J.+Bentremauthor=R.+Popovicauthor=K.+Ebineauthor=J.+D.+Lichtauthor=H.+G.+Munshi&title=GLI2-dependent+c-MYC+upregulation+mediates+resistance+of+pancreatic+cancer+cells+to+the+BET+bromodomain+inhibitor+JQ1&doi=10.1038%2Fsrep09489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1</span></div><div class="casAuthors">Kumar, Krishan; Raza, Sania S.; Knab, Lawrence M.; Chow, Christina R.; Kwok, Benjamin; Bentrem, David J.; Popovic, Relja; Ebine, Kazumi; Licht, Jonathan D.; Munshi, Hidayatullah G.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9489</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">JQ1 and I-BET151 are selective inhibitors of BET bromodomain proteins that have efficacy against a no. of different cancers.  Since the effectiveness of targeted therapies is often limited by development of resistance, we examd. whether it was possible for cancer cells to develop resistance to the BET inhibitor JQ1.  Here we show that pancreatic cancer cells developing resistance to JQ1 demonstrate cross-resistance to I-BET151 and insensitivity to BRD4 downregulation.  The resistant cells maintain expression of c-MYC, increase expression of JQ1-target genes FOSL1 and HMGA2, and demonstrate evidence of epithelial-mesenchymal transition (EMT).  However, reverting EMT fails to sensitize the resistant cells to JQ1 treatment.  Importantly, the JQ1-resistant cells remain dependent on c-MYC that now becomes co-regulated by high levels of GLI2.  Furthermore, downregulating GLI2 re-sensitizes the resistant cells to JQ1.  Overall, these results identify a mechanism by which cancer cells develop resistance to BET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6mUgUS37czbVg90H21EOLACvtfcHk0ljGBqmo5FBxtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOjurjO&md5=c5f9dad7134441f6c7edbd6dcc7b40e8</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fsrep09489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep09489%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DRaza%26aufirst%3DS.%2BS.%26aulast%3DKnab%26aufirst%3DL.%2BM.%26aulast%3DChow%26aufirst%3DC.%2BR.%26aulast%3DKwok%26aufirst%3DB.%26aulast%3DBentrem%26aufirst%3DD.%2BJ.%26aulast%3DPopovic%26aufirst%3DR.%26aulast%3DEbine%26aufirst%3DK.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DMunshi%26aufirst%3DH.%2BG.%26atitle%3DGLI2-dependent%2520c-MYC%2520upregulation%2520mediates%2520resistance%2520of%2520pancreatic%2520cancer%2520cells%2520to%2520the%2520BET%2520bromodomain%2520inhibitor%2520JQ1%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D9489%26doi%3D10.1038%2Fsrep09489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jagadeeshan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tentu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beesetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surabhi, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mavuluri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhoopalan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitani, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chidambaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malathi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayala, S. K.</span></span> <span> </span><span class="NLM_article-title">P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1546</span>– <span class="NLM_lpage">1556</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdw184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fannonc%2Fmdw184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=27117533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC28bjs1amtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=1546-1556&author=S.+Jagadeeshanauthor=A.+Subramanianauthor=S.+Tentuauthor=S.+Beesettiauthor=M.+Singhalauthor=S.+Raghavanauthor=R.+P.+Surabhiauthor=J.+Mavuluriauthor=H.+Bhoopalanauthor=J.+Biswalauthor=R.+S.+Pitaniauthor=S.+Chidambaramauthor=S.+Sundaramauthor=R.+Malathiauthor=J.+Jeyaramanauthor=A.+S.+Nairauthor=G.+Venkatramanauthor=S.+K.+Rayala&title=P21-activated+kinase+1+%28Pak1%29+signaling+influences+therapeutic+outcome+in+pancreatic+cancer&doi=10.1093%2Fannonc%2Fmdw184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer</span></div><div class="casAuthors">Jagadeeshan S; Subramanian A; Tentu S; Beesetti S; Singhal M; Raghavan S; Mavuluri J; Rayala S K; Surabhi R P; Bhoopalan H; Venkatraman G; Biswal J; Jeyaraman J; Pitani R S; Chidambaram S; Sundaram S; Malathi R; Nair A S</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1546-56</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Therapeutic resistance to gemcitabine in pancreatic ductal adenocarcinoma (PDAC) is attributed to various cellular mechanisms and signaling molecules that influence as a single factor or in combination.  DESIGN:  In this study, utilizing in vitro p21-activated kinase 1 (Pak1) overexpression and knockdown cell line models along with in vivo athymic mouse tumor xenograft models and clinical samples, we demonstrate that Pak1 is a crucial signaling kinase in gemcitabine resistance.  RESULTS:  Pak1 kindles resistance via modulation of epithelial-mesenchymal transition and activation of pancreatic stellate cells.  Our results from gemcitabine-resistant and -sensitive cell line models showed that elevated Pak1 kinase activity is required to confer gemcitabine resistance.  This was substantiated by elevated levels of phosphorylated Pak1 and ribonucleotide reductase M1 levels in the majority of human PDAC tumors when compared with normal.  Delineation of the signaling pathway revealed that Pak1 confers resistance to gemcitabine by preventing DNA damage, inhibiting apoptosis and regulating survival signals via NF-κB.  Furthermore, we found that Pak1 is an upstream interacting substrate of transforming growth factor β-activated kinase 1-a molecule implicated in gemcitabine resistance.  Molecular mechanistic studies revealed that gemcitabine docks with the active site of Pak1; furthermore, gemcitabine treatment induces Pak1 kinase activity both in vivo and in cell-free system.  Finally, results from athymic mouse tumor models illustrated that Pak1 inhibition by IPA-3 enhances the cytotoxicity of gemcitabine and brings about pancreatic tumor regression.  CONCLUSION:  To our knowledge, this is the first study illustrating the mechanistic role of Pak1 in causing gemcitabine resistance via multiple signaling crosstalks, and hence Pak1-specific inhibitors will prove to be a better adjuvant with existing chemotherapy modality for PDAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGLmx0_3sLIbmQt-ICR3qNfW6udTcc2ebPdJguywkok7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bjs1amtQ%253D%253D&md5=23dc98cffd86c424270a2d4accd6c50c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdw184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdw184%26sid%3Dliteratum%253Aachs%26aulast%3DJagadeeshan%26aufirst%3DS.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DTentu%26aufirst%3DS.%26aulast%3DBeesetti%26aufirst%3DS.%26aulast%3DSinghal%26aufirst%3DM.%26aulast%3DRaghavan%26aufirst%3DS.%26aulast%3DSurabhi%26aufirst%3DR.%2BP.%26aulast%3DMavuluri%26aufirst%3DJ.%26aulast%3DBhoopalan%26aufirst%3DH.%26aulast%3DBiswal%26aufirst%3DJ.%26aulast%3DPitani%26aufirst%3DR.%2BS.%26aulast%3DChidambaram%26aufirst%3DS.%26aulast%3DSundaram%26aufirst%3DS.%26aulast%3DMalathi%26aufirst%3DR.%26aulast%3DJeyaraman%26aufirst%3DJ.%26aulast%3DNair%26aufirst%3DA.%2BS.%26aulast%3DVenkatraman%26aufirst%3DG.%26aulast%3DRayala%26aufirst%3DS.%2BK.%26atitle%3DP21-activated%2520kinase%25201%2520%2528Pak1%2529%2520signaling%2520influences%2520therapeutic%2520outcome%2520in%2520pancreatic%2520cancer%26jtitle%3DAnn.%2520Oncol.%26date%3D2016%26volume%3D27%26spage%3D1546%26epage%3D1556%26doi%3D10.1093%2Fannonc%2Fmdw184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span> <span> </span><span class="NLM_article-title">ROBO3 promotes growth and metastasis of pancreatic carcinoma</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2015.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.canlet.2015.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26070964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWns7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2015&pages=61-70&author=S.+Hanauthor=C.+Caoauthor=T.+Tangauthor=C.+Luauthor=J.+Xuauthor=S.+Wangauthor=L.+Xueauthor=X.+Zhangauthor=M.+Li&title=ROBO3+promotes+growth+and+metastasis+of+pancreatic+carcinoma&doi=10.1016%2Fj.canlet.2015.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">ROBO3 promotes growth and metastasis of pancreatic carcinoma</span></div><div class="casAuthors">Han, Shilong; Cao, Chuanwu; Tang, Tao; Lu, Chenhui; Xu, Jichong; Wang, Shi; Xue, Lei; Zhang, Xiaoping; Li, Maoquan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-70</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Pancreatic carcinoma is a highly lethal malignancy with an extremely poor prognosis.  Recent genome-wide studies have implicated axon guidance pathways, including the SLIT/ROBO pathway, in pancreatic tumor development and progression.  Here we showed that ROBO3 expression is up-regulated in pancreatic cancer tissue samples and cell lines.  Over-expression of ROBO3 promotes pancreatic cancer cell growth, invasion and metastasis in vitro and in mouse xenograft tumor models.  We identified miR-383 as a suppressor of ROBO3, and revealed its expression to be inversely correlated with ROBO3.  Over-expression of ROBO3 activates Wnt pathway components, β-catenin and GSK-3, and the expression of markers indicating an EMT.  By means of immunopptn., we revealed an interaction between Wnt inhibitor SFRP and ROBO3 in pancreatic cancer cell lines.  Our work suggests that ROBO3 may contribute to the progression of pancreatic cancer by sequestering Wnt inhibitor SFRP, which in turn leads to increased Wnt/β-catenin pathway activity.  We also confirmed that ROBO3 increases with clin. grade and miR-383 expression is inversely correlated to that of ROBO3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvJFg2993DebVg90H21EOLACvtfcHk0ljGBqmo5FBxtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWns7vL&md5=c4a0f2bb769800459091ce8c0bd4ad36</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DM.%26atitle%3DROBO3%2520promotes%2520growth%2520and%2520metastasis%2520of%2520pancreatic%2520carcinoma%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D366%26spage%3D61%26epage%3D70%26doi%3D10.1016%2Fj.canlet.2015.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muller, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swiercz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceyhan, G. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchler, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offermanns, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friess, H.</span></span> <span> </span><span class="NLM_article-title">Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">2421</span>– <span class="NLM_lpage">2433</span>, <span class="refDoi"> DOI: 10.1002/ijc.22949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1002%2Fijc.22949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=17631638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BD2srosVKmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=2421-2433&author=M.+W.+Mullerauthor=N.+A.+Gieseauthor=J.+M.+Swierczauthor=G.+O.+Ceyhanauthor=I.+Espositoauthor=U.+Hinzauthor=P.+Buchlerauthor=T.+Gieseauthor=M.+W.+Buchlerauthor=S.+Offermannsauthor=H.+Friess&title=Association+of+axon+guidance+factor+semaphorin+3A+with+poor+outcome+in+pancreatic+cancer&doi=10.1002%2Fijc.22949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer</span></div><div class="casAuthors">Muller Michael W; Giese Nathalia A; Swiercz Jakub M; Ceyhan Guralp O; Esposito Irene; Hinz Ulf; Buchler Peter; Giese Thomas; Buchler Markus W; Offermanns Stefan; Friess Helmut</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2421-33</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neural alterations and aberrantly expressed nerve-specific factors promoting tumor progression are known to contribute to pancreatic cancer's extremely poor prognosis.  Despite hints that axon guidance factor semaphorin 3A (SEMA3A) may function as a tumor inhibitor, its clinical importance and therapeutic potential have not yet been explored.  The present study investigated the role of SEMA3A and its receptors-plexins A1-A4 (PLXNA1-A4) and neuropilin-1 (NRP1)-in pancreatic cancer.  QRT-PCR and immunohistochemical analyses revealed overexpression of SEMA3A, NRP1 and PLXNA1 in metaplastic ducts, malignant cells and nerves of cancerous specimens, and showed that elevated levels of corresponding mRNA (6.8-fold, 2.0-fold and 1.5-fold, respectively) clearly correlated with negative clinicopathological manifestations such as shorter survival (SEMA3A and PLXNA1) and a lesser degree of tumor differentiation (NRP1) in Stages I-III patients.  High SEMA3A expression in pancreata of Stage IV M1 patients and in peritoneal metastases, and consequent functional studies indicated that poor clinical outcome might be related to the ability of SEMA3A to promote dissemination and invasiveness of pancreatic cancer cells through activation of multiple pathways involving Rac1, GSK3b or p42/p44 MAPK, but not E- to N-cadherin switch, MMP-9 or VEGF induction.  Thus, this study is the first to quantify expression of the SEMA3A system in human malignancy and to show that overexpression of SEMA3A by nerves and transformed cells leads to a SEMA3A-rich environment which may favor malignant activities of tumor cells.  Furthermore, negative clinicopathological correlations suggest that SEMA3A might represent a novel intervention target but not a treatment option for pancreatic cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8caCJH8JBWoJKJbLTgsvCfW6udTcc2eZoTAqx3cZOc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srosVKmsQ%253D%253D&md5=7cd49b071dd0d497083a152050f777dc</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fijc.22949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22949%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DM.%2BW.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26aulast%3DSwiercz%26aufirst%3DJ.%2BM.%26aulast%3DCeyhan%26aufirst%3DG.%2BO.%26aulast%3DEsposito%26aufirst%3DI.%26aulast%3DHinz%26aufirst%3DU.%26aulast%3DBuchler%26aufirst%3DP.%26aulast%3DGiese%26aufirst%3DT.%26aulast%3DBuchler%26aufirst%3DM.%2BW.%26aulast%3DOffermanns%26aufirst%3DS.%26aulast%3DFriess%26aufirst%3DH.%26atitle%3DAssociation%2520of%2520axon%2520guidance%2520factor%2520semaphorin%25203A%2520with%2520poor%2520outcome%2520in%2520pancreatic%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D121%26spage%3D2421%26epage%3D2433%26doi%3D10.1002%2Fijc.22949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gara, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganju, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yallapu, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span> <span> </span><span class="NLM_article-title">Slit/Robo pathway: a promising therapeutic target for cancer</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2014.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.drudis.2014.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25245168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Kgsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=156-164&author=R.+K.+Garaauthor=S.+Kumariauthor=A.+Ganjuauthor=M.+M.+Yallapuauthor=M.+Jaggiauthor=S.+C.+Chauhan&title=Slit%2FRobo+pathway%3A+a+promising+therapeutic+target+for+cancer&doi=10.1016%2Fj.drudis.2014.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Slit/Robo pathway: a promising therapeutic target for cancer</span></div><div class="casAuthors">Gara, Rishi K.; Kumari, Sonam; Ganju, Aditya; Yallapu, Murali M.; Jaggi, Meena; Chauhan, Subhash C.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">156-164</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Axon guidance mols., slit glycoprotein (Slit) and Roundabout receptor (Robo), have implications in the regulation of physiol. processes.  Recent studies indicate that Slit and Robo also have important roles in tumorigenesis, cancer progression and metastasis.  The Slit/Robo pathway can be considered a master regulator for multiple oncogenic signaling pathways.  Herein, we provide a comprehensive review on the role of these mols. and their assocd. signaling pathways in cancer progression and metastasis.  Overall, the current available data suggest that the Slit/Robo pathway could be a promising target for development of anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4w4gi37uqg7Vg90H21EOLACvtfcHk0lhIuvnHlZ2ogg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Kgsb3P&md5=202d17de6f0a26cc41a72832bde9034f</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DGara%26aufirst%3DR.%2BK.%26aulast%3DKumari%26aufirst%3DS.%26aulast%3DGanju%26aufirst%3DA.%26aulast%3DYallapu%26aufirst%3DM.%2BM.%26aulast%3DJaggi%26aufirst%3DM.%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26atitle%3DSlit%252FRobo%2520pathway%253A%2520a%2520promising%2520therapeutic%2520target%2520for%2520cancer%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26volume%3D20%26spage%3D156%26epage%3D164%26doi%3D10.1016%2Fj.drudis.2014.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuzillet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tijeras-Raballand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faivre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Gramont, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymond, E.</span></span> <span> </span><span class="NLM_article-title">Targeting cancer cell metabolism in pancreatic adenocarcinoma</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">16832</span>– <span class="NLM_lpage">16847</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.4160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.18632%2Foncotarget.4160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26164081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FitlGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=16832-16847&author=R.+Cohenauthor=C.+Neuzilletauthor=A.+Tijeras-Raballandauthor=S.+Faivreauthor=A.+de+Gramontauthor=E.+Raymond&title=Targeting+cancer+cell+metabolism+in+pancreatic+adenocarcinoma&doi=10.18632%2Foncotarget.4160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer cell metabolism in pancreatic adenocarcinoma</span></div><div class="casAuthors">Cohen Romain; Neuzillet Cindy; Neuzillet Cindy; Tijeras-Raballand Annemilai; Faivre Sandrine; Raymond Eric; de Gramont Armand</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">16832-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is expected to become the second leading cause of cancer death by 2030.  Current therapeutic options are limited, warranting an urgent need to explore innovative treatment strategies.  Due to specific microenvironment constraints including an extensive desmoplastic stroma reaction, PDAC faces major metabolic challenges, principally hypoxia and nutrient deprivation.  Their connection with oncogenic alterations such as KRAS mutations has brought metabolic reprogramming to the forefront of PDAC therapeutic research.  The Warburg effect, glutamine addiction, and autophagy stand as the most important adaptive metabolic mechanisms of cancer cells themselves, however metabolic reprogramming is also an important feature of the tumor microenvironment, having a major impact on epigenetic reprogramming and tumor cell interactions with its complex stroma.  We present a comprehensive overview of the main metabolic adaptations contributing to PDAC development and progression.  A review of current and future therapies targeting this range of metabolic pathways is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTP8U29TPTqVT0O18WR3iAofW6udTcc2eZoTAqx3cZOc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FitlGmsA%253D%253D&md5=437cdeb04c31a56791786a19b8f68a81</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.4160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.4160%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DR.%26aulast%3DNeuzillet%26aufirst%3DC.%26aulast%3DTijeras-Raballand%26aufirst%3DA.%26aulast%3DFaivre%26aufirst%3DS.%26aulast%3Dde%2BGramont%26aufirst%3DA.%26aulast%3DRaymond%26aufirst%3DE.%26atitle%3DTargeting%2520cancer%2520cell%2520metabolism%2520in%2520pancreatic%2520adenocarcinoma%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D16832%26epage%3D16847%26doi%3D10.18632%2Foncotarget.4160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span> <span> </span><span class="NLM_article-title">Roles of Arf6 in cancer cell invasion, metastasis and proliferation</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2017.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.lfs.2017.06.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2017&pages=80-84&author=R.+Liauthor=C.+Pengauthor=X.+Zhangauthor=Y.+Wuauthor=S.+Panauthor=Y.+Xiao&title=Roles+of+Arf6+in+cancer+cell+invasion%2C+metastasis+and+proliferation&doi=10.1016%2Fj.lfs.2017.06.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2017.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2017.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DXiao%26aufirst%3DY.%26atitle%3DRoles%2520of%2520Arf6%2520in%2520cancer%2520cell%2520invasion%252C%2520metastasis%2520and%2520proliferation%26jtitle%3DLife%2520Sci.%26date%3D2017%26volume%3D182%26spage%3D80%26epage%3D84%26doi%3D10.1016%2Fj.lfs.2017.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.canlet.2016.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28025100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFKru77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2017&pages=303-311&author=C.+Liangauthor=Y.+Qinauthor=B.+Zhangauthor=S.+Jiauthor=S.+Shiauthor=W.+Xuauthor=J.+Liuauthor=J.+Xiangauthor=D.+Liangauthor=Q.+Huauthor=Q.+Niauthor=X.+Yuauthor=J.+Xu&title=ARF6%2C+induced+by+mutant+Kras%2C+promotes+proliferation+and+Warburg+effect+in+pancreatic+cancer&doi=10.1016%2Fj.canlet.2016.12.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer</span></div><div class="casAuthors">Liang, Chen; Qin, Yi; Zhang, Bo; Ji, Shunrong; Shi, Si; Xu, Wenyan; Liu, Jiang; Xiang, Jinfeng; Liang, Dingkong; Hu, Qiangsheng; Ni, Quanxing; Yu, Xianjun; Xu, Jin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">303-311</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Though significant progress has been made in the availability of diagnostic techniques and treatment strategies, pancreatic cancer remains a disease of high mortality rates.  Therefore, there is an urgent need for a better understanding of the mol. mechanisms that governs the oncogenesis and metastasis process of pancreatic cancer.  In our study, by using the Cancer Genome Atlas (TCGA) dataset anal., we demonstrated that the small guanosine triphosphatase (GTPase) ADP-ribosylation factor 6 (ARF6) serves as a biomarker for predicting prognosis of pancreatic cancer.  In vitro studies demonstrated that silencing ARF6 expression reduced cell proliferation and attenuated the Warburg effect.  Moreover, we obsd. that ARF6 was a downstream target of Kras/ERK signaling pathway, and the strong correlation of expression between Kras and ARF6 in the TCGA dataset further confirmed this observation.  Taken together, our novel findings suggest ARF6, a target of mutant Kras, may promote pancreatic cancer development by enhancing the Warburg effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogvsszmMLgUbVg90H21EOLACvtfcHk0lhTGewZDK-yEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFKru77L&md5=93f8dc2861bdb5198e97f9e3018bcdb1</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DJi%26aufirst%3DS.%26aulast%3DShi%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DNi%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DARF6%252C%2520induced%2520by%2520mutant%2520Kras%252C%2520promotes%2520proliferation%2520and%2520Warburg%2520effect%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2017%26volume%3D388%26spage%3D303%26epage%3D311%26doi%3D10.1016%2Fj.canlet.2016.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chabu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span> <span> </span><span class="NLM_article-title">EGFR/ARF6 regulation of Hh signalling stimulates oncogenic Ras tumor overgrowth</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">14688</span>, <span class="refDoi"> DOI: 10.1038/ncomms14688</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fncomms14688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28281543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC1czltVSkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=14688&author=C.+Chabuauthor=D.+M.+Liauthor=T.+Xu&title=EGFR%2FARF6+regulation+of+Hh+signalling+stimulates+oncogenic+Ras+tumor+overgrowth&doi=10.1038%2Fncomms14688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR/ARF6 regulation of Hh signalling stimulates oncogenic Ras tumour overgrowth</span></div><div class="casAuthors">Chabu Chiswili; Li Da-Ming; Xu Tian; Xu Tian</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14688</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Multiple signalling events interact in cancer cells.  Oncogenic Ras cooperates with Egfr, which cannot be explained by the canonical signalling paradigm.  In turn, Egfr cooperates with Hedgehog signalling.  How oncogenic Ras elicits and integrates Egfr and Hedgehog signals to drive overgrowth remains unclear.  Using a Drosophila tumour model, we show that Egfr cooperates with oncogenic Ras via Arf6, which functions as a novel regulator of Hh signalling.  Oncogenic Ras induces the expression of Egfr ligands.  Egfr then signals through Arf6, which regulates Hh transport to promote Hh signalling.  Blocking any step of this signalling cascade inhibits Hh signalling and correspondingly suppresses the growth of both, fly and human cancer cells harbouring oncogenic Ras mutations.  These findings highlight a non-canonical Egfr signalling mechanism, centered on Arf6 as a novel regulator of Hh signalling.  This explains both, the puzzling requirement of Egfr in oncogenic Ras-mediated overgrowth and the cooperation between Egfr and Hedgehog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3y3tYCbMrhf_I8Jvzw4xCfW6udTcc2eZHbkDZFZxwMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czltVSkug%253D%253D&md5=103d948b1d1dade9cfe4a472bd25baff</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fncomms14688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms14688%26sid%3Dliteratum%253Aachs%26aulast%3DChabu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DD.%2BM.%26aulast%3DXu%26aufirst%3DT.%26atitle%3DEGFR%252FARF6%2520regulation%2520of%2520Hh%2520signalling%2520stimulates%2520oncogenic%2520Ras%2520tumor%2520overgrowth%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D14688%26doi%3D10.1038%2Fncomms14688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L. T.</span></span> <span> </span><span class="NLM_article-title">Down-regulation of GEP100 causes increase in E-cadherin levels and inhibits pancreatic cancer cell invasion</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e37854</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0037854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1371%2Fjournal.pone.0037854" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e37854&author=C.+G.+Xieauthor=S.+M.+Weiauthor=J.+M.+Chenauthor=X.+F.+Xuauthor=J.+T.+Caiauthor=Q.+Y.+Chenauthor=L.+T.+Jia&title=Down-regulation+of+GEP100+causes+increase+in+E-cadherin+levels+and+inhibits+pancreatic+cancer+cell+invasion&doi=10.1371%2Fjournal.pone.0037854"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0037854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0037854%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DC.%2BG.%26aulast%3DWei%26aufirst%3DS.%2BM.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DXu%26aufirst%3DX.%2BF.%26aulast%3DCai%26aufirst%3DJ.%2BT.%26aulast%3DChen%26aufirst%3DQ.%2BY.%26aulast%3DJia%26aufirst%3DL.%2BT.%26atitle%3DDown-regulation%2520of%2520GEP100%2520causes%2520increase%2520in%2520E-cadherin%2520levels%2520and%2520inhibits%2520pancreatic%2520cancer%2520cell%2520invasion%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De37854%26doi%3D10.1371%2Fjournal.pone.0037854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ying, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmelman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssiotis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher-Sananikone, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locasale, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coloff, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimaraes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hezel, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissleder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePinho, R. A.</span></span> <span> </span><span class="NLM_article-title">Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">670</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.01.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.cell.2012.01.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=22541435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Kjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=656-670&author=H.+Yingauthor=A.+C.+Kimmelmanauthor=C.+A.+Lyssiotisauthor=S.+Huaauthor=G.+C.+Chuauthor=E.+Fletcher-Sananikoneauthor=J.+W.+Locasaleauthor=J.+Sonauthor=H.+Zhangauthor=J.+L.+Coloffauthor=H.+Yanauthor=W.+Wangauthor=S.+Chenauthor=A.+Vialeauthor=H.+Zhengauthor=J.+H.+Paikauthor=C.+Limauthor=A.+R.+Guimaraesauthor=E.+S.+Martinauthor=J.+Changauthor=A.+F.+Hezelauthor=S.+R.+Perryauthor=J.+Huauthor=B.+Ganauthor=Y.+Xiaoauthor=J.+M.+Asaraauthor=R.+Weisslederauthor=Y.+A.+Wangauthor=L.+Chinauthor=L.+C.+Cantleyauthor=R.+A.+DePinho&title=Oncogenic+Kras+maintains+pancreatic+tumors+through+regulation+of+anabolic+glucose+metabolism&doi=10.1016%2Fj.cell.2012.01.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism</span></div><div class="casAuthors">Ying, Haoqiang; Kimmelman, Alec C.; Lyssiotis, Costas A.; Hua, Sujun; Chu, Gerald C.; Fletcher-Sananikone, Eliot; Locasale, Jason W.; Son, Jaekyoung; Zhang, Hailei; Coloff, Jonathan L.; Yan, Haiyan; Wang, Wei; Chen, Shujuan; Viale, Andrea; Zheng, Hongwu; Paik, Ji-hye; Lim, Carol; Guimaraes, Alexander R.; Martin, Eric S.; Chang, Jeffery; Hezel, Aram F.; Perry, Samuel R.; Hu, Jian; Gan, Boyi; Xiao, Yonghong; Asara, John M.; Weissleder, Ralph; Wang, Y. Alan; Chin, Lynda; Cantley, Lewis C.; DePinho, Ronald A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">656-670</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Tumor maintenance relies on continued activity of driver oncogenes, although their rate-limiting role is highly context dependent.  Oncogenic Kras mutation is the signature event in pancreatic ductal adenocarcinoma (PDAC), serving a crit. role in tumor initiation.  Here, an inducible KrasG12D-driven PDAC mouse model establishes that advanced PDAC remains strictly dependent on KrasG12D expression.  Transcriptome and metabolomic analyses indicate that KrasG12D serves a vital role in controlling tumor metab. through stimulation of glucose uptake and channeling of glucose intermediates into the hexosamine biosynthesis and pentose phosphate pathways (PPP).  These studies also reveal that oncogenic Kras promotes ribose biogenesis.  Unlike canonical models, we demonstrate that KrasG12D drives glycolysis intermediates into the nonoxidative PPP, thereby decoupling ribose biogenesis from NADP/NADPH-mediated redox control.  Together, this work provides in vivo mechanistic insights into how oncogenic Kras promotes metabolic reprogramming in native tumors and illuminates potential metabolic targets that can be exploited for therapeutic benefit in PDAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0n15htmLPUrVg90H21EOLACvtfcHk0liC8DXeZmCZxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Kjs7k%253D&md5=c8474034804faf04fb8bd108dd958540</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.01.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.01.058%26sid%3Dliteratum%253Aachs%26aulast%3DYing%26aufirst%3DH.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26aulast%3DLyssiotis%26aufirst%3DC.%2BA.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DChu%26aufirst%3DG.%2BC.%26aulast%3DFletcher-Sananikone%26aufirst%3DE.%26aulast%3DLocasale%26aufirst%3DJ.%2BW.%26aulast%3DSon%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DColoff%26aufirst%3DJ.%2BL.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DPaik%26aufirst%3DJ.%2BH.%26aulast%3DLim%26aufirst%3DC.%26aulast%3DGuimaraes%26aufirst%3DA.%2BR.%26aulast%3DMartin%26aufirst%3DE.%2BS.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DHezel%26aufirst%3DA.%2BF.%26aulast%3DPerry%26aufirst%3DS.%2BR.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DGan%26aufirst%3DB.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DWeissleder%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%2BA.%26aulast%3DChin%26aufirst%3DL.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26atitle%3DOncogenic%2520Kras%2520maintains%2520pancreatic%2520tumors%2520through%2520regulation%2520of%2520anabolic%2520glucose%2520metabolism%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D656%26epage%3D670%26doi%3D10.1016%2Fj.cell.2012.01.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selwan, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finicle, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edinger, A. L.</span></span> <span> </span><span class="NLM_article-title">Attacking the supply wagons to starve cancer cells to death</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>590</i></span>,  <span class="NLM_fpage">885</span>– <span class="NLM_lpage">907</span>, <span class="refDoi"> DOI: 10.1002/1873-3468.12121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1002%2F1873-3468.12121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26938658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Krur%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=590&publication_year=2016&pages=885-907&author=E.+M.+Selwanauthor=B.+T.+Finicleauthor=S.+M.+Kimauthor=A.+L.+Edinger&title=Attacking+the+supply+wagons+to+starve+cancer+cells+to+death&doi=10.1002%2F1873-3468.12121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Attacking the supply wagons to starve cancer cells to death</span></div><div class="casAuthors">Selwan, Elizabeth M.; Finicle, Brendan T.; Kim, Seong M.; Edinger, Aimee L.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">590</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">885-907</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The constitutive anabolism of cancer cells not only supports proliferation but also addicts tumor cells to a steady influx of exogenous nutrients.  Limiting access to metabolic substrates could be an effective and selective means to block cancer growth.  In this review, we define the pathways by which cancer cells acquire the raw materials for anabolism, highlight the actionable proteins in each pathway, and discuss the status of therapeutic interventions that disrupt nutrient acquisition.  Crit. open questions to be answered before apical metabolic inhibitors can be successfully and safely deployed in the clinic are also outlined.  In summary, recent studies provide strong support that substrate limitation is a powerful therapeutic strategy to effectively, and safely, starve cancer cells to death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcJvTeNv_D8LVg90H21EOLACvtfcHk0liC8DXeZmCZxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Krur%252FE&md5=6edb11a499a074c601be0749589a0525</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2F1873-3468.12121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1873-3468.12121%26sid%3Dliteratum%253Aachs%26aulast%3DSelwan%26aufirst%3DE.%2BM.%26aulast%3DFinicle%26aufirst%3DB.%2BT.%26aulast%3DKim%26aufirst%3DS.%2BM.%26aulast%3DEdinger%26aufirst%3DA.%2BL.%26atitle%3DAttacking%2520the%2520supply%2520wagons%2520to%2520starve%2520cancer%2520cells%2520to%2520death%26jtitle%3DFEBS%2520Lett.%26date%3D2016%26volume%3D590%26spage%3D885%26epage%3D907%26doi%3D10.1002%2F1873-3468.12121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scotti Buzhardt, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, N. R.</span></span> <span> </span><span class="NLM_article-title">Protein Kinase C Zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent mechanism</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e72061</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0072061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1371%2Fjournal.pone.0072061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e72061&author=A.+M.+Butlerauthor=M.+L.+Scotti+Buzhardtauthor=S.+Liauthor=K.+E.+Smithauthor=A.+P.+Fieldsauthor=N.+R.+Murray&title=Protein+Kinase+C+Zeta+regulates+human+pancreatic+cancer+cell+transformed+growth+and+invasion+through+a+STAT3-dependent+mechanism&doi=10.1371%2Fjournal.pone.0072061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0072061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0072061%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DA.%2BM.%26aulast%3DScotti%2BBuzhardt%26aufirst%3DM.%2BL.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DK.%2BE.%26aulast%3DFields%26aufirst%3DA.%2BP.%26aulast%3DMurray%26aufirst%3DN.%2BR.%26atitle%3DProtein%2520Kinase%2520C%2520Zeta%2520regulates%2520human%2520pancreatic%2520cancer%2520cell%2520transformed%2520growth%2520and%2520invasion%2520through%2520a%2520STAT3-dependent%2520mechanism%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De72061%26doi%3D10.1371%2Fjournal.pone.0072061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalari, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, A. P.</span></span> <span> </span><span class="NLM_article-title">Protein kinase Cι expression and oncogenic signaling mechanisms in cancer</span>. <i>J. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>226</i></span>,  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1002/jcp.22463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1002%2Fjcp.22463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=20945390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVaqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2011&pages=879-887&author=N.+R.+Murrayauthor=K.+R.+Kalariauthor=A.+P.+Fields&title=Protein+kinase+C%CE%B9+expression+and+oncogenic+signaling+mechanisms+in+cancer&doi=10.1002%2Fjcp.22463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase Cι expression and oncogenic signaling mechanisms in cancer</span></div><div class="casAuthors">Murray, Nicole R.; Kalari, Krishna R.; Fields, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">879-887</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Accumulating evidence demonstrates that PKCι is an oncogene and prognostic marker that is frequently targeted for genetic alteration in many major forms of human cancer.  Functional data demonstrate that PKCι is required for the transformed phenotype of lung, pancreatic, ovarian, prostate, colon, and brain cancer cells.  Future studies will be required to det. whether PKCι is also an oncogene in the many other cancer types that also overexpress PKCι.  Studies of PKCι using genetically defined models of tumorigenesis have revealed a crit. role for PKCι in multiple stages of tumorigenesis, including tumor initiation, progression, and metastasis.  Recent studies in a genetic model of lung adenocarcinoma suggest a role for PKCι in transformation of lung cancer stem cells.  These studies have important implications for the therapeutic use of aurothiomalate (ATM), a highly selective PKCι signaling inhibitor currently undergoing clin. evaluation.  Significant progress has been made in detg. the mol. mechanisms by which PKCι drives the transformed phenotype, particularly the central role played by the oncogenic PKCι-Par6 complex in transformed growth and invasion, and of several PKCι-dependent survival pathways in chemo-resistance.  Future studies will be required to det. the compn. and dynamics of the PKCι-Par6 complex, and the mechanisms by which oncogenic signaling through this complex is regulated.  Likewise, a better understanding of the crit. downstream effectors of PKCι in various human tumor types holds promise for identifying novel prognostic and surrogate markers of oncogenic PKCι activity that may be clin. useful in ongoing clin. trials of ATM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc4wV5OkXZLrVg90H21EOLACvtfcHk0liC8DXeZmCZxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVaqu7s%253D&md5=4eb7859eda072eeda723b7daa4bcaf3c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fjcp.22463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.22463%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DN.%2BR.%26aulast%3DKalari%26aufirst%3DK.%2BR.%26aulast%3DFields%26aufirst%3DA.%2BP.%26atitle%3DProtein%2520kinase%2520C%25CE%25B9%2520expression%2520and%2520oncogenic%2520signaling%2520mechanisms%2520in%2520cancer%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2011%26volume%3D226%26spage%3D879%26epage%3D887%26doi%3D10.1002%2Fjcp.22463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubbi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donahue, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, M.</span></span> <span> </span><span class="NLM_article-title">Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0128814</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0128814</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1371%2Fjournal.pone.0128814" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0128814&author=M.+J.+Thompsonauthor=L.+Rubbiauthor=D.+W.+Dawsonauthor=T.+R.+Donahueauthor=M.+Pellegrini&title=Pancreatic+cancer+patient+survival+correlates+with+DNA+methylation+of+pancreas+development+genes&doi=10.1371%2Fjournal.pone.0128814"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0128814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0128814%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DM.%2BJ.%26aulast%3DRubbi%26aufirst%3DL.%26aulast%3DDawson%26aufirst%3DD.%2BW.%26aulast%3DDonahue%26aufirst%3DT.%2BR.%26aulast%3DPellegrini%26aufirst%3DM.%26atitle%3DPancreatic%2520cancer%2520patient%2520survival%2520correlates%2520with%2520DNA%2520methylation%2520of%2520pancreas%2520development%2520genes%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0128814%26doi%3D10.1371%2Fjournal.pone.0128814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muranen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selfors, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallegos, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coloff, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoreen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brugge, J. S.</span></span> <span> </span><span class="NLM_article-title">ERK and p38 MAPK activities determine sensitivity to PI3K/mTOR inhibition via regulation of MYC and YAP</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">7168</span>– <span class="NLM_lpage">7180</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-0155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1158%2F0008-5472.CAN-16-0155" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=7168-7180&author=T.+Muranenauthor=L.+M.+Selforsauthor=J.+Hwangauthor=L.+L.+Gallegosauthor=J.+L.+Coloffauthor=C.+C.+Thoreenauthor=S.+A.+Kangauthor=D.+M.+Sabatiniauthor=G.+B.+Millsauthor=J.+S.+Brugge&title=ERK+and+p38+MAPK+activities+determine+sensitivity+to+PI3K%2FmTOR+inhibition+via+regulation+of+MYC+and+YAP&doi=10.1158%2F0008-5472.CAN-16-0155"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-0155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-0155%26sid%3Dliteratum%253Aachs%26aulast%3DMuranen%26aufirst%3DT.%26aulast%3DSelfors%26aufirst%3DL.%2BM.%26aulast%3DHwang%26aufirst%3DJ.%26aulast%3DGallegos%26aufirst%3DL.%2BL.%26aulast%3DColoff%26aufirst%3DJ.%2BL.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DBrugge%26aufirst%3DJ.%2BS.%26atitle%3DERK%2520and%2520p38%2520MAPK%2520activities%2520determine%2520sensitivity%2520to%2520PI3K%252FmTOR%2520inhibition%2520via%2520regulation%2520of%2520MYC%2520and%2520YAP%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D7168%26epage%3D7180%26doi%3D10.1158%2F0008-5472.CAN-16-0155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ireland, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rainer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaranta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weyer-Czernilofsky, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engle, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Mancera, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coupland, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taktak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogenrieder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mielgo, A.</span></span> <span> </span><span class="NLM_article-title">Chemoresistance in pancreatic cancer is driven by stroma-derived insulin-like growth factors</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">6851</span>– <span class="NLM_lpage">6863</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-1201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1158%2F0008-5472.CAN-16-1201" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=6851-6863&author=L.+Irelandauthor=A.+Santosauthor=M.+S.+Ahmedauthor=C.+Rainerauthor=S.+R.+Nielsenauthor=V.+Quarantaauthor=U.+Weyer-Czernilofskyauthor=D.+D.+Engleauthor=P.+A.+Perez-Manceraauthor=S.+E.+Couplandauthor=A.+Taktakauthor=T.+Bogenriederauthor=D.+A.+Tuvesonauthor=F.+Campbellauthor=M.+C.+Schmidauthor=A.+Mielgo&title=Chemoresistance+in+pancreatic+cancer+is+driven+by+stroma-derived+insulin-like+growth+factors&doi=10.1158%2F0008-5472.CAN-16-1201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-1201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-1201%26sid%3Dliteratum%253Aachs%26aulast%3DIreland%26aufirst%3DL.%26aulast%3DSantos%26aufirst%3DA.%26aulast%3DAhmed%26aufirst%3DM.%2BS.%26aulast%3DRainer%26aufirst%3DC.%26aulast%3DNielsen%26aufirst%3DS.%2BR.%26aulast%3DQuaranta%26aufirst%3DV.%26aulast%3DWeyer-Czernilofsky%26aufirst%3DU.%26aulast%3DEngle%26aufirst%3DD.%2BD.%26aulast%3DPerez-Mancera%26aufirst%3DP.%2BA.%26aulast%3DCoupland%26aufirst%3DS.%2BE.%26aulast%3DTaktak%26aufirst%3DA.%26aulast%3DBogenrieder%26aufirst%3DT.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DCampbell%26aufirst%3DF.%26aulast%3DSchmid%26aufirst%3DM.%2BC.%26aulast%3DMielgo%26aufirst%3DA.%26atitle%3DChemoresistance%2520in%2520pancreatic%2520cancer%2520is%2520driven%2520by%2520stroma-derived%2520insulin-like%2520growth%2520factors%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D6851%26epage%3D6863%26doi%3D10.1158%2F0008-5472.CAN-16-1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourdoncle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulé, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosh, J. R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergny, J.-L.</span></span> <span> </span><span class="NLM_article-title">G-quadruplexes and helicases</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1989</span>– <span class="NLM_lpage">2006</span>, <span class="refDoi"> DOI: 10.1093/nar/gkw079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fnar%2Fgkw079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26883636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Sqsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=1989-2006&author=O.+Mendozaauthor=A.+Bourdoncleauthor=J.-B.+Boul%C3%A9author=J.+R.+M.+Broshauthor=J.-L.+Mergny&title=G-quadruplexes+and+helicases&doi=10.1093%2Fnar%2Fgkw079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">G-quadruplexes and helicases</span></div><div class="casAuthors">Mendoza, Oscar; Bourdoncle, Anne; Boule, Jean-Baptiste; Brosh, Robert M., Jr.; Mergny, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1989-2006</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Guanine-rich DNA strands can fold in vitro into non-canonical DNA structures called G-quadruplexes.  These structures may be very stable under physiol. conditions.  Evidence suggests that G-quadruplex structures may act as 'knots' within genomic DNA, and it has been hypothesized that proteins may have evolved to remove these structures.  The first indication of how G-quadruplex structures could be unfolded enzymically came in the late 1990s with reports that some well-known duplex DNA helicases resolved these structures in vitro.  Since then, the no. of studies reporting G-quadruplex DNA unfolding by helicase enzymes has rapidly increased.  The present review aims to present a general overview of the helicase/G-quadruplex field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1DDktyH31aLVg90H21EOLACvtfcHk0ljO2rGmlbTkRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Sqsb7E&md5=0d424783aab817ee14c56597712477ba</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw079%26sid%3Dliteratum%253Aachs%26aulast%3DMendoza%26aufirst%3DO.%26aulast%3DBourdoncle%26aufirst%3DA.%26aulast%3DBoul%25C3%25A9%26aufirst%3DJ.-B.%26aulast%3DBrosh%26aufirst%3DJ.%2BR.%2BM.%26aulast%3DMergny%26aufirst%3DJ.-L.%26atitle%3DG-quadruplexes%2520and%2520helicases%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2016%26volume%3D44%26spage%3D1989%26epage%3D2006%26doi%3D10.1093%2Fnar%2Fgkw079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Day, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layer, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleary, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tivey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinzel, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izzo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doench, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, D. M.</span></span> <span> </span><span class="NLM_article-title">PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">15110</span>, <span class="refDoi"> DOI: 10.1038/ncomms15110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fncomms15110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28447610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC1crhs1altA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=15110&author=T.+A.+Dayauthor=J.+V.+Layerauthor=J.+P.+Clearyauthor=S.+Guhaauthor=K.+E.+Stevensonauthor=T.+Tiveyauthor=S.+Kimauthor=A.+C.+Schinzelauthor=F.+Izzoauthor=J.+Doenchauthor=D.+E.+Rootauthor=W.+C.+Hahnauthor=B.+D.+Priceauthor=D.+M.+Weinstock&title=PARP3+is+a+promoter+of+chromosomal+rearrangements+and+limits+G4+DNA&doi=10.1038%2Fncomms15110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA</span></div><div class="casAuthors">Day Tovah A; Layer Jacob V; Cleary J Patrick; Guha Srijoy; Tivey Trevor; Kim Sunhee; Izzo Francesca; Hahn William C; Weinstock David M; Stevenson Kristen E; Schinzel Anna C; Izzo Francesca; Doench John; Root David E; Hahn William C; Weinstock David M; Price Brendan D</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15110</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chromosomal rearrangements are essential events in the pathogenesis of both malignant and nonmalignant disorders, yet the factors affecting their formation are incompletely understood.  Here we develop a zinc-finger nuclease translocation reporter and screen for factors that modulate rearrangements in human cells.  We identify UBC9 and RAD50 as suppressors and 53BP1, DDB1 and poly(ADP)ribose polymerase 3 (PARP3) as promoters of chromosomal rearrangements across human cell types.  We focus on PARP3 as it is dispensable for murine viability and has druggable catalytic activity.  We find that PARP3 regulates G quadruplex (G4) DNA in response to DNA damage, which suppresses repair by nonhomologous end-joining and homologous recombination.  Chemical stabilization of G4 DNA in PARP3(-/-) cells leads to widespread DNA double-strand breaks and synthetic lethality.  We propose a model in which PARP3 suppresses G4 DNA and facilitates DNA repair by multiple pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWVSsEBvxNcJQHPYJuLg8TfW6udTcc2eZVEWfO47fG4rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crhs1altA%253D%253D&md5=e9258b6721793a2f2ff9e016649858b5</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fncomms15110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms15110%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DT.%2BA.%26aulast%3DLayer%26aufirst%3DJ.%2BV.%26aulast%3DCleary%26aufirst%3DJ.%2BP.%26aulast%3DGuha%26aufirst%3DS.%26aulast%3DStevenson%26aufirst%3DK.%2BE.%26aulast%3DTivey%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DIzzo%26aufirst%3DF.%26aulast%3DDoench%26aufirst%3DJ.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DPrice%26aufirst%3DB.%2BD.%26aulast%3DWeinstock%26aufirst%3DD.%2BM.%26atitle%3DPARP3%2520is%2520a%2520promoter%2520of%2520chromosomal%2520rearrangements%2520and%2520limits%2520G4%2520DNA%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D15110%26doi%3D10.1038%2Fncomms15110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collie, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Promontorio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampel, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, G. N.</span></span> <span> </span><span class="NLM_article-title">Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">2723</span>– <span class="NLM_lpage">2731</span>, <span class="refDoi"> DOI: 10.1021/ja2102423</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja2102423" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFahtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=2723-2731&author=G.+W.+Collieauthor=R.+Promontorioauthor=S.+M.+Hampelauthor=M.+Miccoauthor=S.+Neidleauthor=G.+N.+Parkinson&title=Structural+basis+for+telomeric+G-quadruplex+targeting+by+naphthalene+diimide+ligands&doi=10.1021%2Fja2102423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Telomeric G-Quadruplex Targeting by Naphthalene Diimide Ligands</span></div><div class="casAuthors">Collie, Gavin W.; Promontorio, Rossella; Hampel, Sonja M.; Micco, Marialuisa; Neidle, Stephen; Parkinson, Gary N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2723-2731</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The folding of the single-stranded 3' end of the human telomere into G-quadruplex arrangements inhibits the overhang from hybridizing with the RNA template of telomerase and halts telomere maintenance in cancer cells.  The ability to thermally stabilize human telomeric DNA as a four-stranded G-quadruplex structure by developing selective small mol. compds. is a therapeutic path to regulating telomerase activity and thereby selectively inhibit cancer cell growth.  The development of compds. with the necessary selectivity and affinity to target parallel-stranded G-quadruplex structures has proved particularly challenging to date, relying heavily upon limited structural data.  We report here on a structure-based approach to the design of quadruplex-binding ligands to enhance affinity and selectivity for human telomeric DNA.  Crystal structures have been detd. of complexes between a 22-mer intramol. human telomeric quadruplex and two potent tetra-substituted naphthalene diimide compds., functionalized with pos. charged N-methyl-piperazine side-chains.  These compds. promote parallel-stranded quadruplex topol., binding exclusively to the 3' surface of each quadruplex.  There are significant differences between the complexes in terms of ligand mobility and in the interactions with quadruplex grooves.  One of the two ligands is markedly less mobile in the crystal complex and is more quadruplex-stabilizing, forming multiple electrostatic/hydrogen bond contacts with quadruplex phosphate groups.  The data presented here provides a structural rationale for the biophys. (effects on quadruplex thermal stabilization) and biol. data (inhibition of proliferation in cancer cell lines and evidence of in vivo antitumor activity) on compds. in this series and, thus, for the concept of telomere targeting with DNA quadruplex-binding small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi4fBPG4FU0rVg90H21EOLACvtfcHk0lghas5tEu6QlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFahtA%253D%253D&md5=ccacb043644092d55fec3a75afeae0ad</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fja2102423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja2102423%26sid%3Dliteratum%253Aachs%26aulast%3DCollie%26aufirst%3DG.%2BW.%26aulast%3DPromontorio%26aufirst%3DR.%26aulast%3DHampel%26aufirst%3DS.%2BM.%26aulast%3DMicco%26aufirst%3DM.%26aulast%3DNeidle%26aufirst%3DS.%26aulast%3DParkinson%26aufirst%3DG.%2BN.%26atitle%3DStructural%2520basis%2520for%2520telomeric%2520G-quadruplex%2520targeting%2520by%2520naphthalene%2520diimide%2520ligands%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D2723%26epage%3D2731%26doi%3D10.1021%2Fja2102423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totrov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span> <span> </span><span class="NLM_article-title">ICFF: a new method to incorporate implicit flexibility into an internal coordinate force field</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">254</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1002/jcc.10091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1002%2Fjcc.10091" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=254-265&author=V.+Katritchauthor=M.+Totrovauthor=R.+Abagyan&title=ICFF%3A+a+new+method+to+incorporate+implicit+flexibility+into+an+internal+coordinate+force+field&doi=10.1002%2Fjcc.10091"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Fjcc.10091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.10091%26sid%3Dliteratum%253Aachs%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DTotrov%26aufirst%3DM.%26aulast%3DAbagyan%26aufirst%3DR.%26atitle%3DICFF%253A%2520a%2520new%2520method%2520to%2520incorporate%2520implicit%2520flexibility%2520into%2520an%2520internal%2520coordinate%2520force%2520field%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2003%26volume%3D24%26spage%3D254%26epage%3D265%26doi%3D10.1002%2Fjcc.10091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schultes, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guyen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuesta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4347</span>– <span class="NLM_lpage">4351</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.05.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.bmcl.2004.05.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=15261300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVWjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4347-4351&author=C.+M.+Schultesauthor=B.+Guyenauthor=J.+Cuestaauthor=S.+Neidle&title=Synthesis%2C+biophysical+and+biological+evaluation+of+3%2C6-bis-amidoacridines+with+extended+9-anilino+substituents+as+potent+G-quadruplex-binding+telomerase+inhibitors&doi=10.1016%2Fj.bmcl.2004.05.090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors</span></div><div class="casAuthors">Schultes, Christoph M.; Guyen, Berangere; Cuesta, Javier; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4347-4351</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Telomerase and telomere maintenance are emerging targets for the treatment of human cancers.  The authors report here on the targeting of the telomere-telomerase complex with a series of small mols. based on an acridine platform.  A series of 3,6-bisamidoacridines with extended 9-anilino sidechains were designed and synthesized as potential telomeric G-quadruplex DNA (G4) interacting compds.  G4-stabilization was assessed using a high-throughput FRET (fluorescence resonance energy transfer) assay and telomerase inhibition quantified by a modified TRAP (telomerase repeat amplification protocol) method.  Within the series, the compds. showed significant G4-stabilizing ability (ΔTm values of 25-36 °C at 1 μM concn.) and telomerase inhibition in the nanomolar region (telEC50 values of 80-318 nM).  Furthermore, a direct correlation between the FRET and TRAP assays was obsd., supporting the use of the rapid screening FRET assay for early assessment of potential G4-stabilizing telomerase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnphNjm-RlurVg90H21EOLACvtfcHk0lhzY4i6goAm9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVWjtL8%253D&md5=eb7f18784e96c4154bd6ce9ac7c8a168</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.05.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.05.090%26sid%3Dliteratum%253Aachs%26aulast%3DSchultes%26aufirst%3DC.%2BM.%26aulast%3DGuyen%26aufirst%3DB.%26aulast%3DCuesta%26aufirst%3DJ.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DSynthesis%252C%2520biophysical%2520and%2520biological%2520evaluation%2520of%25203%252C6-bis-amidoacridines%2520with%2520extended%25209-anilino%2520substituents%2520as%2520potent%2520G-quadruplex-binding%2520telomerase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4347%26epage%3D4351%26doi%3D10.1016%2Fj.bmcl.2004.05.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roehrl, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G.</span></span> <span> </span><span class="NLM_article-title">A general framework for development and data analysis of competitive high-throughput screens for small-molecule inhibitors of protein-protein interactions by fluorescence polarization</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">16056</span>– <span class="NLM_lpage">16066</span>, <span class="refDoi"> DOI: 10.1021/bi048233g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi048233g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVaisrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=16056-16066&author=M.+H.+Roehrlauthor=J.+Y.+Wangauthor=G.+Wagner&title=A+general+framework+for+development+and+data+analysis+of+competitive+high-throughput+screens+for+small-molecule+inhibitors+of+protein-protein+interactions+by+fluorescence+polarization&doi=10.1021%2Fbi048233g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A General Framework for Development and Data Analysis of Competitive High-Throughput Screens for Small-Molecule Inhibitors of Protein-Protein Interactions by Fluorescence Polarization</span></div><div class="casAuthors">Roehrl, Michael H. A.; Wang, Julia Y.; Wagner, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">16056-16066</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Equil. binding expts. are widely used for the accurate characterization of binding and competitive binding behavior in biol. systems.  Modern high-throughput discovery efforts in chem. biol. rely heavily upon this principle.  Here, we derive exact anal. expressions for general competitive binding models which can also explain a commonly encountered phenomenon in these types of expts., anticooperative incomplete displacement.  We explore the effects of nonspecific binding behavior and parameter misestimation.  All expressions are derived in terms of total concns. detd. a priori.  We discuss a general framework for high-throughput screening assays based on fluorescence polarization and strategies for assay development, sensitivity regimes, data quality control, anal., and ranking.  Theor. findings are visualized by simulations using realistic parameter sets.  Our results are the basis for the discovery of small-mol. inhibitors of the protein-protein interaction between human calcineurin and NFAT transcription factors, as discussed in the subsequent paper (31).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQB9PNnipisbVg90H21EOLACvtfcHk0lhzY4i6goAm9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVaisrzE&md5=e5d4d47155dae79903f09c083eb3ed80</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fbi048233g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi048233g%26sid%3Dliteratum%253Aachs%26aulast%3DRoehrl%26aufirst%3DM.%2BH.%26aulast%3DWang%26aufirst%3DJ.%2BY.%26aulast%3DWagner%26aufirst%3DG.%26atitle%3DA%2520general%2520framework%2520for%2520development%2520and%2520data%2520analysis%2520of%2520competitive%2520high-throughput%2520screens%2520for%2520small-molecule%2520inhibitors%2520of%2520protein-protein%2520interactions%2520by%2520fluorescence%2520polarization%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D16056%26epage%3D16066%26doi%3D10.1021%2Fbi048233g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultes, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuesta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuenca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanious, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">582</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.1021/jm050555a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050555a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=582-599&author=M.+J.+Mooreauthor=C.+M.+Schultesauthor=J.+Cuestaauthor=F.+Cuencaauthor=M.+Gunaratnamauthor=F.+A.+Taniousauthor=W.+D.+Wilsonauthor=S.+Neidle&title=Trisubstituted+acridines+as+G-quadruplex+telomere+targeting+agents.+Effects+of+extensions+of+the+3%2C6-+and+9-side+chains+on+quadruplex+binding%2C+telomerase+activity%2C+and+cell+proliferation&doi=10.1021%2Fjm050555a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm050555a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050555a%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DM.%2BJ.%26aulast%3DSchultes%26aufirst%3DC.%2BM.%26aulast%3DCuesta%26aufirst%3DJ.%26aulast%3DCuenca%26aufirst%3DF.%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DTanious%26aufirst%3DF.%2BA.%26aulast%3DWilson%26aufirst%3DW.%2BD.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DTrisubstituted%2520acridines%2520as%2520G-quadruplex%2520telomere%2520targeting%2520agents.%2520Effects%2520of%2520extensions%2520of%2520the%25203%252C6-%2520and%25209-side%2520chains%2520on%2520quadruplex%2520binding%252C%2520telomerase%2520activity%252C%2520and%2520cell%2520proliferation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D582%26epage%3D599%26doi%3D10.1021%2Fjm050555a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboagye, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balkwill, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balmain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruder, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Double, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farningham, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glennie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelland, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozer, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedge, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span> <span> </span><span class="NLM_article-title">Guidelines for the welfare and use of animals in cancer research</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">1555</span>– <span class="NLM_lpage">1577</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6605642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fsj.bjc.6605642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=20502460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=1555-1577&author=P.+Workmanauthor=E.+O.+Aboagyeauthor=F.+Balkwillauthor=A.+Balmainauthor=G.+Bruderauthor=D.+J.+Chaplinauthor=J.+A.+Doubleauthor=J.+Everittauthor=D.+A.+Farninghamauthor=M.+J.+Glennieauthor=L.+R.+Kellandauthor=V.+Robinsonauthor=I.+J.+Stratfordauthor=G.+M.+Tozerauthor=S.+Watsonauthor=S.+R.+Wedgeauthor=S.+A.+Eccles&title=Guidelines+for+the+welfare+and+use+of+animals+in+cancer+research&doi=10.1038%2Fsj.bjc.6605642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Guidelines for the welfare and use of animals in cancer research</span></div><div class="casAuthors">Workman P; Aboagye E O; Balkwill F; Balmain A; Bruder G; Chaplin D J; Double J A; Everitt J; Farningham D A H; Glennie M J; Kelland L R; Robinson V; Stratford I J; Tozer G M; Watson S; Wedge S R; Eccles S A</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1555-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer.  Excellent standards of animal care are fully consistent with the conduct of high quality cancer research.  Here we provide updated guidelines on the welfare and use of animals in cancer research.  All experiments should incorporate the 3Rs: replacement, reduction and refinement.  Focusing on animal welfare, we present recommendations on all aspects of cancer research, including: study design, statistics and pilot studies; choice of tumour models (e.g., genetically engineered, orthotopic and metastatic); therapy (including drugs and radiation); imaging (covering techniques, anaesthesia and restraint); humane endpoints (including tumour burden and site); and publication of best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkVD7D529OLg5nADWVYHg1fW6udTcc2ea2zZ672k2nzbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D&md5=55f4c62e16fb1ebaa1f05d59caba3989</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605642%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAboagye%26aufirst%3DE.%2BO.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DBruder%26aufirst%3DG.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DDouble%26aufirst%3DJ.%2BA.%26aulast%3DEveritt%26aufirst%3DJ.%26aulast%3DFarningham%26aufirst%3DD.%2BA.%26aulast%3DGlennie%26aufirst%3DM.%2BJ.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DRobinson%26aufirst%3DV.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DS.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26atitle%3DGuidelines%2520for%2520the%2520welfare%2520and%2520use%2520of%2520animals%2520in%2520cancer%2520research%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2010%26volume%3D102%26spage%3D1555%26epage%3D1577%26doi%3D10.1038%2Fsj.bjc.6605642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hingorani, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Multani, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deramaudt, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rustgi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span> <span> </span><span class="NLM_article-title">Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2005.04.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.ccr.2005.04.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=15894267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslyitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=469-483&author=S.+R.+Hingoraniauthor=L.+Wangauthor=A.+S.+Multaniauthor=C.+Combsauthor=T.+B.+Deramaudtauthor=R.+H.+Hrubanauthor=A.+K.+Rustgiauthor=S.+Changauthor=D.+A.+Tuveson&title=Trp53R172H+and+KrasG12D+cooperate+to+promote+chromosomal+instability+and+widely+metastatic+pancreatic+ductal+adenocarcinoma+in+mice&doi=10.1016%2Fj.ccr.2005.04.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice</span></div><div class="casAuthors">Hingorani, Sunil R.; Wang, Lifu; Multani, Asha S.; Combs, Chelsea; Deramaudt, Therese B.; Hruban, Ralph H.; Rustgi, Anil K.; Chang, Sandy; Tuveson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">469-483</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">To define the genetic requirements for pancreatic ductal adenocarcinoma (PDA), we have targeted concomitant endogenous expression of Trp53R172H and KrasG12D to the mouse pancreas, revealing the cooperative development of invasive and widely metastatic carcinoma that recapitulates the human disease.  The primary carcinomas and metastases demonstrate a high degree of genomic instability manifested by nonreciprocal translocations without obvious telomere erosion-hallmarks of human carcinomas not typically obsd. in mice.  No mutations were discovered in other cardinal tumor suppressor gene pathways, which, together with previous results, suggests that there are distinct genetic pathways to PDA with different biol. behaviors.  These findings have clear implications for understanding mechanisms of disease pathogenesis, and for the development of detection and targeted treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUqdYCBqe-vrVg90H21EOLACvtfcHk0lhjH3y5t2eVtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslyitLk%253D&md5=fef745f04506e9e64bbc760a1d6f8cf6</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.04.023%26sid%3Dliteratum%253Aachs%26aulast%3DHingorani%26aufirst%3DS.%2BR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMultani%26aufirst%3DA.%2BS.%26aulast%3DCombs%26aufirst%3DC.%26aulast%3DDeramaudt%26aufirst%3DT.%2BB.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DRustgi%26aufirst%3DA.%2BK.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26atitle%3DTrp53R172H%2520and%2520KrasG12D%2520cooperate%2520to%2520promote%2520chromosomal%2520instability%2520and%2520widely%2520metastatic%2520pancreatic%2520ductal%2520adenocarcinoma%2520in%2520mice%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D469%26epage%3D483%26doi%3D10.1016%2Fj.ccr.2005.04.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M.</span></span> <span> </span><span class="NLM_article-title">Cutadapt removes adapter sequences from high-throughput sequencing reads</span>. <i>EMBnet J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.14806/ej.17.1.200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.14806%2Fej.17.1.200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=10-12&author=M.+Martin&title=Cutadapt+removes+adapter+sequences+from+high-throughput+sequencing+reads&doi=10.14806%2Fej.17.1.200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.14806%2Fej.17.1.200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14806%252Fej.17.1.200%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%26atitle%3DCutadapt%2520removes%2520adapter%2520sequences%2520from%2520high-throughput%2520sequencing%2520reads%26jtitle%3DEMBnet%2520J.%26date%3D2011%26volume%3D17%26spage%3D10%26epage%3D12%26doi%3D10.14806%2Fej.17.1.200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertea, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapnell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pimentel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salzberg, S. L.</span></span> <span> </span><span class="NLM_article-title">TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</span>. <i>Genome Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">R36</span>, <span class="refDoi"> DOI: 10.1186/gb-2013-14-4-r36</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1186%2Fgb-2013-14-4-r36" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=23618408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsVSiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=R36&author=D.+Kimauthor=G.+Perteaauthor=C.+Trapnellauthor=H.+Pimentelauthor=R.+Kelleyauthor=S.+L.+Salzberg&title=TopHat2%3A+accurate+alignment+of+transcriptomes+in+the+presence+of+insertions%2C+deletions+and+gene+fusions&doi=10.1186%2Fgb-2013-14-4-r36"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</span></div><div class="casAuthors">Kim, Daehwan; Pertea, Geo; Trapnell, Cole; Pimentel, Harold; Kelley, Ryan; Salzberg, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Genome Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">R36/1-R36/13, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">GNBLFW</span>;
        ISSN:<span class="NLM_cas:issn">1474-760X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">TopHat is a popular spliced aligner for RNA-sequence (RNA-seq) expts.  In this paper, we describe TopHat2, which incorporates many significant enhancements to TopHat.  TopHat2 can align reads of various lengths produced by the latest sequencing technologies, while allowing for variable-length indels with respect to the ref. genome.  In addn. to de novo spliced alignment, TopHat2 can align reads across fusion breaks, which can occur after genomic translocations.  TopHat2 combines the ability to identify novel splice sites with direct mapping to known transcripts, producing sensitive and accurate alignments, even for highly repetitive genomes or in the presence of pseudogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmnW26zCa-EbVg90H21EOLACvtfcHk0lhjH3y5t2eVtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsVSiurc%253D&md5=49098da2937f29a5fba4b429c228c62c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1186%2Fgb-2013-14-4-r36&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2013-14-4-r36%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DPertea%26aufirst%3DG.%26aulast%3DTrapnell%26aufirst%3DC.%26aulast%3DPimentel%26aufirst%3DH.%26aulast%3DKelley%26aufirst%3DR.%26aulast%3DSalzberg%26aufirst%3DS.%2BL.%26atitle%3DTopHat2%253A%2520accurate%2520alignment%2520of%2520transcriptomes%2520in%2520the%2520presence%2520of%2520insertions%252C%2520deletions%2520and%2520gene%2520fusions%26jtitle%3DGenome%2520Biol.%26date%3D2013%26volume%3D14%26spage%3DR36%26doi%3D10.1186%2Fgb-2013-14-4-r36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anders, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyl, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, W.</span></span> <span> </span><span class="NLM_article-title">HTSeq--a Python framework to work with high-throughput sequencing data</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/btu638</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fbioinformatics%2Fbtu638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25260700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Sjt7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2015&pages=166-169&author=S.+Andersauthor=P.+T.+Pylauthor=W.+Huber&title=HTSeq%2D%2Da+Python+framework+to+work+with+high-throughput+sequencing+data&doi=10.1093%2Fbioinformatics%2Fbtu638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">HTSeq-a Python framework to work with high-throughput sequencing data</span></div><div class="casAuthors">Anders, Simon; Pyl, Paul Theodor; Huber, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">166-169</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A large choice of tools exists for many std. tasks in the anal. of high-throughput sequencing (HTS) data.  However, once a project deviates from std. workflows, custom scripts are needed.  We present HTSeq, a Python library to facilitate the rapid development of such scripts.  HTSeq offers parsers for many common data formats in HTS projects, as well as classes to represent data, such as genomic coordinates, sequences, sequencing reads, alignments, gene model information and variant calls, and provides data structures that allow for querying via genomic coordinates.  We also present htseq-count, a tool developed with HTSeq that preprocesses RNA-Seq data for differential expression anal. by counting the overlap of reads with genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsu4Wqp0zRWLVg90H21EOLACvtfcHk0lgeRrr1hYgwaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Sjt7vL&md5=d9724f89b67e37183ccafb7fa2a848a0</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtu638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtu638%26sid%3Dliteratum%253Aachs%26aulast%3DAnders%26aufirst%3DS.%26aulast%3DPyl%26aufirst%3DP.%2BT.%26aulast%3DHuber%26aufirst%3DW.%26atitle%3DHTSeq--a%2520Python%2520framework%2520to%2520work%2520with%2520high-throughput%2520sequencing%2520data%26jtitle%3DBioinformatics%26date%3D2015%26volume%3D31%26spage%3D166%26epage%3D169%26doi%3D10.1093%2Fbioinformatics%2Fbtu638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, G. K.</span></span> <span> </span><span class="NLM_article-title">edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/btp616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fbioinformatics%2Fbtp616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=19910308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1WlurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=139-140&author=M.+D.+Robinsonauthor=D.+J.+McCarthyauthor=G.+K.+Smyth&title=edgeR%3A+a+Bioconductor+package+for+differential+expression+analysis+of+digital+gene+expression+data&doi=10.1093%2Fbioinformatics%2Fbtp616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</span></div><div class="casAuthors">Robinson, Mark D.; McCarthy, Davis J.; Smyth, Gordon K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-140</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Summary: It is expected that emerging digital gene expression (DGE) technologies will overtake microarray technologies in the near future for many functional genomics applications.  One of the fundamental data anal. tasks, esp. for gene expression studies, involves detg. whether there is evidence that counts for a transcript or exon are significantly different across exptl. conditions. is a Bioconductor software package for examg. differential expression of replicated count data.  An overdispersed Poisson model is used to account for both biol. and tech. variability.  Empirical Bayes methods are used to moderate the degree of overdispersion across transcripts, improving the reliability of inference.  The methodol. can be used even with the most minimal levels of replication, provided at least one phenotype or exptl. condition is replicated.  The software may have other applications beyond sequencing data, such as proteome peptide count data.  Availability: The package is freely available under the LGPL license from the Bioconductor web site (http://bioconductor.org).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmhmmSWC6LvLVg90H21EOLACvtfcHk0lgeRrr1hYgwaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1WlurvO&md5=dd0d34f80067c1d182651dab85d8beef</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtp616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtp616%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DM.%2BD.%26aulast%3DMcCarthy%26aufirst%3DD.%2BJ.%26aulast%3DSmyth%26aufirst%3DG.%2BK.%26atitle%3DedgeR%253A%2520a%2520Bioconductor%2520package%2520for%2520differential%2520expression%2520analysis%2520of%2520digital%2520gene%2520expression%2520data%26jtitle%3DBioinformatics%26date%3D2010%26volume%3D26%26spage%3D139%26epage%3D140%26doi%3D10.1093%2Fbioinformatics%2Fbtp616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b','cit21c'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b','cit24c'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28a','cit28b','cit28c','cit28d'],'ref29':['cit29a','cit29b'],'ref30':['cit30a','cit30b','cit30c','cit30d'],'ref31':['cit31'],'ref32':['cit32a','cit32b'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 59 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chiara Platella, Ettore Napolitano, Claudia Riccardi, Domenica Musumeci, <span class="NLM_string-name hlFld-ContribAuthor">Daniela Montesarchio</span>. </span><span class="cited-content_cbyCitation_article-title">Disentangling the Structure–Activity Relationships of Naphthalene Diimides as Anticancer G-Quadruplex-Targeting Drugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 3578-3603. <a href="https://doi.org/10.1021/acs.jmedchem.1c00125" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00125%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDisentangling%252Bthe%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BNaphthalene%252BDiimides%252Bas%252BAnticancer%252BG-Quadruplex-Targeting%252BDrugs%26aulast%3DPlatella%26aufirst%3DChiara%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D22012021%26date%3D22032021%26volume%3D64%26issue%3D7%26spage%3D3578%26epage%3D3603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ahmed A. Ahmed, Richard Angell, Sally Oxenford, Jenny Worthington, Nicole Williams, Naomi Barton, Thomas G. Fowler, Daniel E. O’Flynn, Mihiro Sunose, Matthew McConville, Tam Vo, W. David Wilson, Saadia A. Karim, Jennifer P. Morton, <span class="NLM_string-name hlFld-ContribAuthor">Stephen Neidle</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetrically Substituted Quadruplex-Binding Naphthalene Diimide Showing Potent Activity in Pancreatic Cancer Models. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (8)
                                     , 1634-1644. <a href="https://doi.org/10.1021/acsmedchemlett.0c00317" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00317%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAsymmetrically%252BSubstituted%252BQuadruplex-Binding%252BNaphthalene%252BDiimide%252BShowing%252BPotent%252BActivity%252Bin%252BPancreatic%252BCancer%252BModels%26aulast%3DAhmed%26aufirst%3DAhmed%2BA.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09062020%26date%3D16072020%26date%3D20072020%26date%3D16072020%26volume%3D11%26issue%3D8%26spage%3D1634%26epage%3D1644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yufeng Liang, Shiqin Miao, Jie Mao, Chris DeSantis, <span class="NLM_string-name hlFld-ContribAuthor">Dennis Bong</span>. </span><span class="cited-content_cbyCitation_article-title">Context-Sensitive Cleavage of Folded DNAs by Loop-Targeting bPNAs. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2020,</strong> <em>59 </em>
                                    (26)
                                     , 2410-2418. <a href="https://doi.org/10.1021/acs.biochem.0c00362" title="DOI URL">https://doi.org/10.1021/acs.biochem.0c00362</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.0c00362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.0c00362%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DContext-Sensitive%252BCleavage%252Bof%252BFolded%252BDNAs%252Bby%252BLoop-Targeting%252BbPNAs%26aulast%3DLiang%26aufirst%3DYufeng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30042020%26date%3D08062020%26date%3D23062020%26date%3D10062020%26volume%3D59%26issue%3D26%26spage%3D2410%26epage%3D2418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tam Vo, Sally Oxenford, Richard Angell, Chiara Marchetti, Stephan A. Ohnmacht, W. David Wilson, <span class="NLM_string-name hlFld-ContribAuthor">Stephen Neidle</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted Naphthalenediimide Compounds Bind Selectively to Two Human Quadruplex Structures with Parallel Topology. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 991-999. <a href="https://doi.org/10.1021/acsmedchemlett.0c00041" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00041%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSubstituted%252BNaphthalenediimide%252BCompounds%252BBind%252BSelectively%252Bto%252BTwo%252BHuman%252BQuadruplex%252BStructures%252Bwith%252BParallel%252BTopology%26aulast%3DVo%26aufirst%3DTam%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28012020%26date%3D30032020%26date%3D02042020%26date%3D30032020%26volume%3D11%26issue%3D5%26spage%3D991%26epage%3D999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">V. Dhamodharan, <span class="NLM_string-name hlFld-ContribAuthor">P. I. Pradeepkumar</span>. </span><span class="cited-content_cbyCitation_article-title">Specific Recognition of Promoter G-Quadruplex DNAs by Small Molecule Ligands and Light-up Probes. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2019,</strong> <em>14 </em>
                                    (10)
                                     , 2102-2114. <a href="https://doi.org/10.1021/acschembio.9b00475" title="DOI URL">https://doi.org/10.1021/acschembio.9b00475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.9b00475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.9b00475%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DSpecific%252BRecognition%252Bof%252BPromoter%252BG-Quadruplex%252BDNAs%252Bby%252BSmall%252BMolecule%252BLigands%252Band%252BLight-up%252BProbes%26aulast%3DDhamodharan%26aufirst%3DV.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D16062019%26date%3D18092019%26date%3D04102019%26date%3D18092019%26volume%3D14%26issue%3D10%26spage%3D2102%26epage%3D2114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Martina Tassinari, Graziella Cimino-Reale, Matteo Nadai, Filippo Doria, Elena Butovskaya, Marta Recagni, Mauro Freccero, Nadia Zaffaroni, Sara N. Richter, <span class="NLM_string-name hlFld-ContribAuthor">Marco Folini</span>. </span><span class="cited-content_cbyCitation_article-title">Down-Regulation of the Androgen Receptor by G-Quadruplex Ligands Sensitizes Castration-Resistant Prostate Cancer Cells to Enzalutamide. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (19)
                                     , 8625-8638. <a href="https://doi.org/10.1021/acs.jmedchem.8b00502" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00502</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00502%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDown-Regulation%252Bof%252Bthe%252BAndrogen%252BReceptor%252Bby%252BG-Quadruplex%252BLigands%252BSensitizes%252BCastration-Resistant%252BProstate%252BCancer%252BCells%252Bto%252BEnzalutamide%26aulast%3DTassinari%26aufirst%3DMartina%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30032018%26date%3D20092018%26date%3D06092018%26volume%3D61%26issue%3D19%26spage%3D8625%26epage%3D8638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Clinton
G. Mikek, Savannah J. West, J. Cole Gwin, Neetu Dayal, Herman O. Sintim, <span class="NLM_string-name hlFld-ContribAuthor">Edwin A. Lewis</span>. </span><span class="cited-content_cbyCitation_article-title">Berenil Binds Tightly to Parallel and Mixed Parallel/Antiparallel G-Quadruplex Motifs with Varied Thermodynamic Signatures. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (9)
                                     , 11582-11591. <a href="https://doi.org/10.1021/acsomega.8b01621" title="DOI URL">https://doi.org/10.1021/acsomega.8b01621</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b01621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b01621%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DBerenil%252BBinds%252BTightly%252Bto%252BParallel%252Band%252BMixed%252BParallel%25252FAntiparallel%252BG-Quadruplex%252BMotifs%252Bwith%252BVaried%252BThermodynamic%252BSignatures%26aulast%3DMikek%26aufirst%3DClinton%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D11072018%26date%3D06092018%26volume%3D3%26issue%3D9%26spage%3D11582%26epage%3D11591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nils  Kosiol</span>, <span class="hlFld-ContribAuthor ">Stefan  Juranek</span>, <span class="hlFld-ContribAuthor ">Peter  Brossart</span>, <span class="hlFld-ContribAuthor ">Annkristin  Heine</span>, <span class="hlFld-ContribAuthor ">Katrin  Paeschke</span>. </span><span class="cited-content_cbyCitation_article-title">G-quadruplexes: a promising target for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer</span><span> <strong>2021,</strong> <em>20 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12943-021-01328-4" title="DOI URL">https://doi.org/10.1186/s12943-021-01328-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12943-021-01328-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12943-021-01328-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%26atitle%3DG-quadruplexes%25253A%252Ba%252Bpromising%252Btarget%252Bfor%252Bcancer%252Btherapy%26aulast%3DKosiol%26aufirst%3DNils%26date%3D2021%26date%3D2021%26volume%3D20%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jochen  Spiegel</span>, <span class="hlFld-ContribAuthor ">Sergio Martínez  Cuesta</span>, <span class="hlFld-ContribAuthor ">Santosh  Adhikari</span>, <span class="hlFld-ContribAuthor ">Robert  Hänsel-Hertsch</span>, <span class="hlFld-ContribAuthor ">David  Tannahill</span>, <span class="hlFld-ContribAuthor ">Shankar  Balasubramanian</span>. </span><span class="cited-content_cbyCitation_article-title">G-quadruplexes are transcription factor binding hubs in human chromatin. </span><span class="cited-content_cbyCitation_journal-name">Genome Biology</span><span> <strong>2021,</strong> <em>22 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13059-021-02324-z" title="DOI URL">https://doi.org/10.1186/s13059-021-02324-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13059-021-02324-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13059-021-02324-z%26sid%3Dliteratum%253Aachs%26jtitle%3DGenome%2520Biology%26atitle%3DG-quadruplexes%252Bare%252Btranscription%252Bfactor%252Bbinding%252Bhubs%252Bin%252Bhuman%252Bchromatin%26aulast%3DSpiegel%26aufirst%3DJochen%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amjesh  Revikumar</span>, <span class="hlFld-ContribAuthor ">Vivek  Kashyap</span>, <span class="hlFld-ContribAuthor ">Akhina  Palollathil</span>, <span class="hlFld-ContribAuthor ">Anjana  Aravind</span>, <span class="hlFld-ContribAuthor ">Rajeswari  Raguraman</span>, <span class="hlFld-ContribAuthor ">Kenkere Mallikarjunaiah Kiran  Kumar</span>, <span class="hlFld-ContribAuthor ">Manavalan  Vijayakumar</span>, <span class="hlFld-ContribAuthor ">Thottethodi Subrahmanya Keshava  Prasad</span>, <span class="hlFld-ContribAuthor ">Rajesh  Raju</span>. </span><span class="cited-content_cbyCitation_article-title">Multiple G-quadruplex binding ligand induced transcriptomic map of cancer cell lines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cell Communication and Signaling</span><span> <strong>2021,</strong> <em>10 </em><a href="https://doi.org/10.1007/s12079-021-00637-z" title="DOI URL">https://doi.org/10.1007/s12079-021-00637-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12079-021-00637-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12079-021-00637-z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cell%2520Communication%2520and%2520Signaling%26atitle%3DMultiple%252BG-quadruplex%252Bbinding%252Bligand%252Binduced%252Btranscriptomic%252Bmap%252Bof%252Bcancer%252Bcell%252Blines%26aulast%3DRevikumar%26aufirst%3DAmjesh%26date%3D2021%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ismail A.  Elhaty</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction between GW2974 and telomeric G-quadruplex DNA: a possible anticancer mechanism. </span><span class="cited-content_cbyCitation_journal-name">Chemical Papers</span><span> <strong>2021,</strong> <em>68 </em><a href="https://doi.org/10.1007/s11696-021-01801-w" title="DOI URL">https://doi.org/10.1007/s11696-021-01801-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11696-021-01801-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11696-021-01801-w%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Papers%26atitle%3DInteraction%252Bbetween%252BGW2974%252Band%252Btelomeric%252BG-quadruplex%252BDNA%25253A%252Ba%252Bpossible%252Banticancer%252Bmechanism%26aulast%3DElhaty%26aufirst%3DIsmail%2BA.%26date%3D2021%26date%3D2021%26volume%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroyuki  Seimiya</span>, <span class="hlFld-ContribAuthor ">Kazuo  Nagasawa</span>, <span class="hlFld-ContribAuthor ">Kazuo  Shin-ya</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical targeting of G-quadruplexes in telomeres and beyond for molecular cancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Antibiotics</span><span> <strong>2021,</strong> <em>52 </em><a href="https://doi.org/10.1038/s41429-021-00454-x" title="DOI URL">https://doi.org/10.1038/s41429-021-00454-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41429-021-00454-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41429-021-00454-x%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Antibiotics%26atitle%3DChemical%252Btargeting%252Bof%252BG-quadruplexes%252Bin%252Btelomeres%252Band%252Bbeyond%252Bfor%252Bmolecular%252Bcancer%252Btherapeutics%26aulast%3DSeimiya%26aufirst%3DHiroyuki%26date%3D2021%26date%3D2021%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victoria  Sanchez-Martin</span>, <span class="hlFld-ContribAuthor ">Miguel  Soriano</span>, <span class="hlFld-ContribAuthor ">Jose Antonio  Garcia-Salcedo</span>. </span><span class="cited-content_cbyCitation_article-title">Quadruplex Ligands in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (13)
                                     , 3156. <a href="https://doi.org/10.3390/cancers13133156" title="DOI URL">https://doi.org/10.3390/cancers13133156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13133156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13133156%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DQuadruplex%252BLigands%252Bin%252BCancer%252BTherapy%26aulast%3DSanchez-Martin%26aufirst%3DVictoria%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D13%26spage%3D3156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annoor  Awadasseid</span>, <span class="hlFld-ContribAuthor ">Xudong  Ma</span>, <span class="hlFld-ContribAuthor ">Yanling  Wu</span>, <span class="hlFld-ContribAuthor ">Wen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">G-quadruplex stabilization via small-molecules as a potential anti-cancer strategy. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2021,</strong> <em>139 </em>, 111550. <a href="https://doi.org/10.1016/j.biopha.2021.111550" title="DOI URL">https://doi.org/10.1016/j.biopha.2021.111550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2021.111550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2021.111550%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DG-quadruplex%252Bstabilization%252Bvia%252Bsmall-molecules%252Bas%252Ba%252Bpotential%252Banti-cancer%252Bstrategy%26aulast%3DAwadasseid%26aufirst%3DAnnoor%26date%3D2021%26volume%3D139%26spage%3D111550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaqi  Xu</span>, <span class="hlFld-ContribAuthor ">Rundong  Jiang</span>, <span class="hlFld-ContribAuthor ">Hailun  He</span>, <span class="hlFld-ContribAuthor ">Changbei  Ma</span>, <span class="hlFld-ContribAuthor ">Zhenwei  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances on G-quadruplex for biosensing, bioimaging and cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">TrAC Trends in Analytical Chemistry</span><span> <strong>2021,</strong> <em>139 </em>, 116257. <a href="https://doi.org/10.1016/j.trac.2021.116257" title="DOI URL">https://doi.org/10.1016/j.trac.2021.116257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.trac.2021.116257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.trac.2021.116257%26sid%3Dliteratum%253Aachs%26jtitle%3DTrAC%2520Trends%2520in%2520Analytical%2520Chemistry%26atitle%3DRecent%252Badvances%252Bon%252BG-quadruplex%252Bfor%252Bbiosensing%25252C%252Bbioimaging%252Band%252Bcancer%252Btherapy%26aulast%3DXu%26aufirst%3DJiaqi%26date%3D2021%26volume%3D139%26spage%3D116257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Bidula</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of putative G-quadruplex forming sequences in inflammatory mediators and their potential as targets for treating inflammatory disorders. </span><span class="cited-content_cbyCitation_journal-name">Cytokine</span><span> <strong>2021,</strong> <em>142 </em>, 155493. <a href="https://doi.org/10.1016/j.cyto.2021.155493" title="DOI URL">https://doi.org/10.1016/j.cyto.2021.155493</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cyto.2021.155493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cyto.2021.155493%26sid%3Dliteratum%253Aachs%26jtitle%3DCytokine%26atitle%3DAnalysis%252Bof%252Bputative%252BG-quadruplex%252Bforming%252Bsequences%252Bin%252Binflammatory%252Bmediators%252Band%252Btheir%252Bpotential%252Bas%252Btargets%252Bfor%252Btreating%252Binflammatory%252Bdisorders%26aulast%3DBidula%26aufirst%3DStefan%26date%3D2021%26volume%3D142%26spage%3D155493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victoria  Sanchez-Martin</span>, <span class="hlFld-ContribAuthor ">David A.  Schneider</span>, <span class="hlFld-ContribAuthor ">Matilde  Ortiz-Gonzalez</span>, <span class="hlFld-ContribAuthor ">Ana  Soriano-Lerma</span>, <span class="hlFld-ContribAuthor ">Angel  Linde-Rodriguez</span>, <span class="hlFld-ContribAuthor ">Virginia  Perez-Carrasco</span>, <span class="hlFld-ContribAuthor ">Jose  Gutierrez-Fernandez</span>, <span class="hlFld-ContribAuthor ">Marta  Cuadros</span>, <span class="hlFld-ContribAuthor ">Carlos  González</span>, <span class="hlFld-ContribAuthor ">Miguel  Soriano</span>, <span class="hlFld-ContribAuthor ">Jose A.  Garcia-Salcedo</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting ribosomal G-quadruplexes with naphthalene-diimides as RNA polymerase I inhibitors for colorectal cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.1016/j.chembiol.2021.05.021" title="DOI URL">https://doi.org/10.1016/j.chembiol.2021.05.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2021.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2021.05.021%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DTargeting%252Bribosomal%252BG-quadruplexes%252Bwith%252Bnaphthalene-diimides%252Bas%252BRNA%252Bpolymerase%252BI%252Binhibitors%252Bfor%252Bcolorectal%252Bcancer%252Btreatment%26aulast%3DSanchez-Martin%26aufirst%3DVictoria%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong  Yu</span>, <span class="hlFld-ContribAuthor ">Tengjiao  Wang</span>, <span class="hlFld-ContribAuthor ">Dong  Liang</span>, <span class="hlFld-ContribAuthor ">Yue  Mei</span>, <span class="hlFld-ContribAuthor ">Wenbin  Zou</span>, <span class="hlFld-ContribAuthor ">Shiwei  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">The Landscape of Microbial Composition and Associated Factors in Pancreatic Ductal Adenocarcinoma Using RNA-Seq Data. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.651350" title="DOI URL">https://doi.org/10.3389/fonc.2021.651350</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.651350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.651350%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DThe%252BLandscape%252Bof%252BMicrobial%252BComposition%252Band%252BAssociated%252BFactors%252Bin%252BPancreatic%252BDuctal%252BAdenocarcinoma%252BUsing%252BRNA-Seq%252BData%26aulast%3DYu%26aufirst%3DDong%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erin  Mathews</span>, <span class="hlFld-ContribAuthor ">Kevyn  Dewees</span>, <span class="hlFld-ContribAuthor ">Deborah  Diaz</span>, <span class="hlFld-ContribAuthor ">Carlita  Favero</span>. </span><span class="cited-content_cbyCitation_article-title">White matter abnormalities in fetal alcohol spectrum disorders: Focus on axon growth and guidance. </span><span class="cited-content_cbyCitation_journal-name">Experimental Biology and Medicine</span><span> <strong>2021,</strong> <em>246 </em>
                                    (7)
                                     , 812-821. <a href="https://doi.org/10.1177/1535370220980398" title="DOI URL">https://doi.org/10.1177/1535370220980398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1535370220980398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1535370220980398%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Biology%2520and%2520Medicine%26atitle%3DWhite%252Bmatter%252Babnormalities%252Bin%252Bfetal%252Balcohol%252Bspectrum%252Bdisorders%25253A%252BFocus%252Bon%252Baxon%252Bgrowth%252Band%252Bguidance%26aulast%3DMathews%26aufirst%3DErin%26date%3D2021%26date%3D2021%26volume%3D246%26issue%3D7%26spage%3D812%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shigeori  Takenaka</span>. </span><span class="cited-content_cbyCitation_article-title">Application of naphthalene diimide in biotechnology. </span><span class="cited-content_cbyCitation_journal-name">Polymer Journal</span><span> <strong>2021,</strong> <em>53 </em>
                                    (3)
                                     , 415-427. <a href="https://doi.org/10.1038/s41428-020-00434-2" title="DOI URL">https://doi.org/10.1038/s41428-020-00434-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41428-020-00434-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41428-020-00434-2%26sid%3Dliteratum%253Aachs%26jtitle%3DPolymer%2520Journal%26atitle%3DApplication%252Bof%252Bnaphthalene%252Bdiimide%252Bin%252Bbiotechnology%26aulast%3DTakenaka%26aufirst%3DShigeori%26date%3D2021%26date%3D2020%26volume%3D53%26issue%3D3%26spage%3D415%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Loukiani  Savva</span>, <span class="hlFld-ContribAuthor ">Savvas N.  Georgiades</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in Small-Molecule Ligands of Medicinal Relevance for Harnessing the Anticancer Potential of G-Quadruplexes. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 841. <a href="https://doi.org/10.3390/molecules26040841" title="DOI URL">https://doi.org/10.3390/molecules26040841</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26040841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26040841%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BDevelopments%252Bin%252BSmall-Molecule%252BLigands%252Bof%252BMedicinal%252BRelevance%252Bfor%252BHarnessing%252Bthe%252BAnticancer%252BPotential%252Bof%252BG-Quadruplexes%26aulast%3DSavva%26aufirst%3DLoukiani%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentina  Pirota</span>, <span class="hlFld-ContribAuthor ">Chiara  Platella</span>, <span class="hlFld-ContribAuthor ">Domenica  Musumeci</span>, <span class="hlFld-ContribAuthor ">Alessandra  Benassi</span>, <span class="hlFld-ContribAuthor ">Jussara  Amato</span>, <span class="hlFld-ContribAuthor ">Bruno  Pagano</span>, <span class="hlFld-ContribAuthor ">Giorgio  Colombo</span>, <span class="hlFld-ContribAuthor ">Mauro  Freccero</span>, <span class="hlFld-ContribAuthor ">Filippo  Doria</span>, <span class="hlFld-ContribAuthor ">Daniela  Montesarchio</span>. </span><span class="cited-content_cbyCitation_article-title">On the binding of naphthalene diimides to a human telomeric G-quadruplex multimer model. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2021,</strong> <em>166 </em>, 1320-1334. <a href="https://doi.org/10.1016/j.ijbiomac.2020.11.013" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2020.11.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2020.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2020.11.013%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DOn%252Bthe%252Bbinding%252Bof%252Bnaphthalene%252Bdiimides%252Bto%252Ba%252Bhuman%252Btelomeric%252BG-quadruplex%252Bmultimer%252Bmodel%26aulast%3DPirota%26aufirst%3DValentina%26date%3D2021%26volume%3D166%26spage%3D1320%26epage%3D1334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheshanath V.  Bhosale</span>, <span class="hlFld-ContribAuthor ">Mohammad  Al Kobaisi</span>, <span class="hlFld-ContribAuthor ">Ratan W.  Jadhav</span>, <span class="hlFld-ContribAuthor ">Pranay P.  Morajkar</span>, <span class="hlFld-ContribAuthor ">Lathe A.  Jones</span>, <span class="hlFld-ContribAuthor ">Subi  George</span>. </span><span class="cited-content_cbyCitation_article-title">Naphthalene diimides: perspectives and promise. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>23 </em><a href="https://doi.org/10.1039/D0CS00239A" title="DOI URL">https://doi.org/10.1039/D0CS00239A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CS00239A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CS00239A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DNaphthalene%252Bdiimides%25253A%252Bperspectives%252Band%252Bpromise%26aulast%3DBhosale%26aufirst%3DSheshanath%2BV.%26date%3D2021%26date%3D2021%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Platella</span>, <span class="hlFld-ContribAuthor ">Marko  Trajkovski</span>, <span class="hlFld-ContribAuthor ">Filippo  Doria</span>, <span class="hlFld-ContribAuthor ">Mauro  Freccero</span>, <span class="hlFld-ContribAuthor ">Janez  Plavec</span>, <span class="hlFld-ContribAuthor ">Daniela  Montesarchio</span>. </span><span class="cited-content_cbyCitation_article-title">On the interaction of an anticancer trisubstituted naphthalene diimide with G-quadruplexes of different topologies: a structural insight. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2020,</strong> <em>48 </em>
                                    (21)
                                     , 12380-12393. <a href="https://doi.org/10.1093/nar/gkaa1001" title="DOI URL">https://doi.org/10.1093/nar/gkaa1001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkaa1001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkaa1001%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DOn%252Bthe%252Binteraction%252Bof%252Ban%252Banticancer%252Btrisubstituted%252Bnaphthalene%252Bdiimide%252Bwith%252BG-quadruplexes%252Bof%252Bdifferent%252Btopologies%25253A%252Ba%252Bstructural%252Binsight%26aulast%3DPlatella%26aufirst%3DChiara%26date%3D2020%26date%3D2020%26volume%3D48%26issue%3D21%26spage%3D12380%26epage%3D12393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Miglietta</span>, <span class="hlFld-ContribAuthor ">Marco  Russo</span>, <span class="hlFld-ContribAuthor ">Giovanni  Capranico</span>. </span><span class="cited-content_cbyCitation_article-title">G-quadruplex–R-loop interactions and the mechanism of anticancer G-quadruplex binders. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2020,</strong> <em>48 </em>
                                    (21)
                                     , 11942-11957. <a href="https://doi.org/10.1093/nar/gkaa944" title="DOI URL">https://doi.org/10.1093/nar/gkaa944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkaa944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkaa944%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DG-quadruplex%2525E2%252580%252593R-loop%252Binteractions%252Band%252Bthe%252Bmechanism%252Bof%252Banticancer%252BG-quadruplex%252Bbinders%26aulast%3DMiglietta%26aufirst%3DGiulia%26date%3D2020%26date%3D2020%26volume%3D48%26issue%3D21%26spage%3D11942%26epage%3D11957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neha</span>, <span class="hlFld-ContribAuthor ">Parimal  Das</span>, <span class="hlFld-ContribAuthor ">Shiv Prakash  Verma</span>. </span><span class="cited-content_cbyCitation_article-title">Dual role of G-quadruplex in translocation renal cell carcinoma: Exploring plausible Cancer therapeutic innovation. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - General Subjects</span><span> <strong>2020,</strong> <em>1864 </em>
                                    (12)
                                     , 129719. <a href="https://doi.org/10.1016/j.bbagen.2020.129719" title="DOI URL">https://doi.org/10.1016/j.bbagen.2020.129719</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbagen.2020.129719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbagen.2020.129719%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520General%2520Subjects%26atitle%3DDual%252Brole%252Bof%252BG-quadruplex%252Bin%252Btranslocation%252Brenal%252Bcell%252Bcarcinoma%25253A%252BExploring%252Bplausible%252BCancer%252Btherapeutic%252Binnovation%26aulast%3DNeha%26date%3D2020%26volume%3D1864%26issue%3D12%26spage%3D129719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victoria  Sanchez-Martin</span>, <span class="hlFld-ContribAuthor ">Carmen  Lopez-Pujante</span>, <span class="hlFld-ContribAuthor ">Miguel  Soriano-Rodriguez</span>, <span class="hlFld-ContribAuthor ">Jose A.  Garcia-Salcedo</span>. </span><span class="cited-content_cbyCitation_article-title">An Updated Focus on Quadruplex Structures as Potential Therapeutic Targets in Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (23)
                                     , 8900. <a href="https://doi.org/10.3390/ijms21238900" title="DOI URL">https://doi.org/10.3390/ijms21238900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21238900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21238900%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DAn%252BUpdated%252BFocus%252Bon%252BQuadruplex%252BStructures%252Bas%252BPotential%252BTherapeutic%252BTargets%252Bin%252BCancer%26aulast%3DSanchez-Martin%26aufirst%3DVictoria%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D23%26spage%3D8900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed Abdullah  Ahmed</span>, <span class="hlFld-ContribAuthor ">Chiara  Marchetti</span>, <span class="hlFld-ContribAuthor ">Stephan A.  Ohnmacht</span>, <span class="hlFld-ContribAuthor ">Stephen  Neidle</span>. </span><span class="cited-content_cbyCitation_article-title">A G-quadruplex-binding compound shows potent activity in human gemcitabine-resistant pancreatic cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-68944-w" title="DOI URL">https://doi.org/10.1038/s41598-020-68944-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-68944-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-68944-w%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252BG-quadruplex-binding%252Bcompound%252Bshows%252Bpotent%252Bactivity%252Bin%252Bhuman%252Bgemcitabine-resistant%252Bpancreatic%252Bcancer%252Bcells%26aulast%3DAhmed%26aufirst%3DAhmed%2BAbdullah%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed Abdullah  Ahmed</span>, <span class="hlFld-ContribAuthor ">Stephen  Neidle</span>. </span><span class="cited-content_cbyCitation_article-title">A G-Quadruplex-Binding Small Molecule and the HDAC Inhibitor SAHA (Vorinostat) Act Synergistically in Gemcitabine-Sensitive and Resistant Pancreatic Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (22)
                                     , 5407. <a href="https://doi.org/10.3390/molecules25225407" title="DOI URL">https://doi.org/10.3390/molecules25225407</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25225407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25225407%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DA%252BG-Quadruplex-Binding%252BSmall%252BMolecule%252Band%252Bthe%252BHDAC%252BInhibitor%252BSAHA%252B%252528Vorinostat%252529%252BAct%252BSynergistically%252Bin%252BGemcitabine-Sensitive%252Band%252BResistant%252BPancreatic%252BCancer%252BCells%26aulast%3DAhmed%26aufirst%3DAhmed%2BAbdullah%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D22%26spage%3D5407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mizuho  Yasuda</span>, <span class="hlFld-ContribAuthor ">Yue  Ma</span>, <span class="hlFld-ContribAuthor ">Sachiko  Okabe</span>, <span class="hlFld-ContribAuthor ">Yuki  Wakabayashi</span>, <span class="hlFld-ContribAuthor ">Dongdong  Su</span>, <span class="hlFld-ContribAuthor ">Young-Tae  Chang</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Seimiya</span>, <span class="hlFld-ContribAuthor ">Masayuki  Tera</span>, <span class="hlFld-ContribAuthor ">Kazuo  Nagasawa</span>. </span><span class="cited-content_cbyCitation_article-title">Target identification of a macrocyclic hexaoxazole G-quadruplex ligand using post-target-binding visualization. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (85)
                                     , 12905-12908. <a href="https://doi.org/10.1039/D0CC04957C" title="DOI URL">https://doi.org/10.1039/D0CC04957C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC04957C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC04957C%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DTarget%252Bidentification%252Bof%252Ba%252Bmacrocyclic%252Bhexaoxazole%252BG-quadruplex%252Bligand%252Busing%252Bpost-target-binding%252Bvisualization%26aulast%3DYasuda%26aufirst%3DMizuho%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D85%26spage%3D12905%26epage%3D12908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fallon K.  Noto</span>, <span class="hlFld-ContribAuthor ">Jaya  Sangodkar</span>, <span class="hlFld-ContribAuthor ">Bisoye Towobola  Adedeji</span>, <span class="hlFld-ContribAuthor ">Sam  Moody</span>, <span class="hlFld-ContribAuthor ">Christopher B.  McClain</span>, <span class="hlFld-ContribAuthor ">Ming  Tong</span>, <span class="hlFld-ContribAuthor ">Eric  Ostertag</span>, <span class="hlFld-ContribAuthor ">Jack  Crawford</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Gao</span>, <span class="hlFld-ContribAuthor ">Lauren  Hurst</span>, <span class="hlFld-ContribAuthor ">Caitlin M.  O’Connor</span>, <span class="hlFld-ContribAuthor ">Erika N.  Hanson</span>, <span class="hlFld-ContribAuthor ">Sudeh  Izadmehr</span>, <span class="hlFld-ContribAuthor ">Rita  Tohmé</span>, <span class="hlFld-ContribAuthor ">Jyothsna  Narla</span>, <span class="hlFld-ContribAuthor ">Kristin  LeSueur</span>, <span class="hlFld-ContribAuthor ">Kajari  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Amit  Rupani</span>, <span class="hlFld-ContribAuthor ">Marwan K.  Tayeh</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Innis</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Galsky</span>, <span class="hlFld-ContribAuthor ">B. Mark  Evers</span>, <span class="hlFld-ContribAuthor ">Analisa  DiFeo</span>, <span class="hlFld-ContribAuthor ">Goutham  Narla</span>, <span class="hlFld-ContribAuthor ">Tseten Y.  Jamling</span>, . </span><span class="cited-content_cbyCitation_article-title">The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2020,</strong> <em>15 </em>
                                    (10)
                                     , e0240169. <a href="https://doi.org/10.1371/journal.pone.0240169" title="DOI URL">https://doi.org/10.1371/journal.pone.0240169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0240169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0240169%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DThe%252BSRG%252Brat%25252C%252Ba%252BSprague-Dawley%252BRag2%25252FIl2rg%252Bdouble-knockout%252Bvalidated%252Bfor%252Bhuman%252Btumor%252Boncology%252Bstudies%26aulast%3DNoto%26aufirst%3DFallon%2BK.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D10%26spage%3De0240169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuya  Nakanishi</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Seimiya</span>. </span><span class="cited-content_cbyCitation_article-title">G-quadruplex in cancer biology and drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2020,</strong> <em>531 </em>
                                    (1)
                                     , 45-50. <a href="https://doi.org/10.1016/j.bbrc.2020.03.178" title="DOI URL">https://doi.org/10.1016/j.bbrc.2020.03.178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2020.03.178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2020.03.178%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DG-quadruplex%252Bin%252Bcancer%252Bbiology%252Band%252Bdrug%252Bdiscovery%26aulast%3DNakanishi%26aufirst%3DChuya%26date%3D2020%26volume%3D531%26issue%3D1%26spage%3D45%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Ma</span>, <span class="hlFld-ContribAuthor ">Keisuke  Iida</span>, <span class="hlFld-ContribAuthor ">Kazuo  Nagasawa</span>. </span><span class="cited-content_cbyCitation_article-title">Topologies of G-quadruplex: Biological functions and regulation by ligands. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2020,</strong> <em>531 </em>
                                    (1)
                                     , 3-17. <a href="https://doi.org/10.1016/j.bbrc.2019.12.103" title="DOI URL">https://doi.org/10.1016/j.bbrc.2019.12.103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2019.12.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2019.12.103%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DTopologies%252Bof%252BG-quadruplex%25253A%252BBiological%252Bfunctions%252Band%252Bregulation%252Bby%252Bligands%26aulast%3DMa%26aufirst%3DYue%26date%3D2020%26volume%3D531%26issue%3D1%26spage%3D3%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroyuki  Seimiya</span>. </span><span class="cited-content_cbyCitation_article-title">Crossroads of telomere biology and anticancer drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2020,</strong> <em>111 </em>
                                    (9)
                                     , 3089-3099. <a href="https://doi.org/10.1111/cas.14540" title="DOI URL">https://doi.org/10.1111/cas.14540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.14540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.14540%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DCrossroads%252Bof%252Btelomere%252Bbiology%252Band%252Banticancer%252Bdrug%252Bdiscovery%26aulast%3DSeimiya%26aufirst%3DHiroyuki%26date%3D2020%26date%3D2020%26volume%3D111%26issue%3D9%26spage%3D3089%26epage%3D3099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhaval  Varshney</span>, <span class="hlFld-ContribAuthor ">Jochen  Spiegel</span>, <span class="hlFld-ContribAuthor ">Katherine  Zyner</span>, <span class="hlFld-ContribAuthor ">David  Tannahill</span>, <span class="hlFld-ContribAuthor ">Shankar  Balasubramanian</span>. </span><span class="cited-content_cbyCitation_article-title">The regulation and functions of DNA and RNA G-quadruplexes. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Molecular Cell Biology</span><span> <strong>2020,</strong> <em>21 </em>
                                    (8)
                                     , 459-474. <a href="https://doi.org/10.1038/s41580-020-0236-x" title="DOI URL">https://doi.org/10.1038/s41580-020-0236-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41580-020-0236-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41580-020-0236-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Molecular%2520Cell%2520Biology%26atitle%3DThe%252Bregulation%252Band%252Bfunctions%252Bof%252BDNA%252Band%252BRNA%252BG-quadruplexes%26aulast%3DVarshney%26aufirst%3DDhaval%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D8%26spage%3D459%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imlimaong  Aier</span>, <span class="hlFld-ContribAuthor ">Rahul  Semwal</span>, <span class="hlFld-ContribAuthor ">Anju  Sharma</span>, <span class="hlFld-ContribAuthor ">Pritish Kumar  Varadwaj</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              identification of therapeutic compounds against microRNA targets in drug-resistant pancreatic ductal adenocarcinoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>14 </em>, 1-9. <a href="https://doi.org/10.1080/07391102.2020.1782262" title="DOI URL">https://doi.org/10.1080/07391102.2020.1782262</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1782262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1782262%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIn%252Bsilico%252Bidentification%252Bof%252Btherapeutic%252Bcompounds%252Bagainst%252BmicroRNA%252Btargets%252Bin%252Bdrug-resistant%252Bpancreatic%252Bductal%252Badenocarcinoma%26aulast%3DAier%26aufirst%3DImlimaong%26date%3D2020%26date%3D2020%26volume%3D14%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrey M.  Zhirov</span>, <span class="hlFld-ContribAuthor ">Dmitry A.  Kovalev</span>, <span class="hlFld-ContribAuthor ">Diana V.  Ulshina</span>, <span class="hlFld-ContribAuthor ">Sergey V.  Pisarenko</span>, <span class="hlFld-ContribAuthor ">Oleg P.  Demidov</span>, <span class="hlFld-ContribAuthor ">Ivan V.  Borovlev</span>. </span><span class="cited-content_cbyCitation_article-title">Diazapyrenes: interaction with nucleic acids and biological activity. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2020,</strong> <em>56 </em>
                                    (6)
                                     , 674-693. <a href="https://doi.org/10.1007/s10593-020-02717-1" title="DOI URL">https://doi.org/10.1007/s10593-020-02717-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-020-02717-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-020-02717-1%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DDiazapyrenes%25253A%252Binteraction%252Bwith%252Bnucleic%252Bacids%252Band%252Bbiological%252Bactivity%26aulast%3DZhirov%26aufirst%3DAndrey%2BM.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D6%26spage%3D674%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xing  Chen</span>, <span class="hlFld-ContribAuthor ">Wen‐Jian  Tang</span>, <span class="hlFld-ContribAuthor ">Jing Bo  Shi</span>, <span class="hlFld-ContribAuthor ">Ming Ming  Liu</span>, <span class="hlFld-ContribAuthor ">Xin‐Hua  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic strategies for targeting telomerase in cancer. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (2)
                                     , 532-585. <a href="https://doi.org/10.1002/med.21626" title="DOI URL">https://doi.org/10.1002/med.21626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21626%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTherapeutic%252Bstrategies%252Bfor%252Btargeting%252Btelomerase%252Bin%252Bcancer%26aulast%3DChen%26aufirst%3DXing%26date%3D2020%26volume%3D40%26issue%3D2%26spage%3D532%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Platella</span>, <span class="hlFld-ContribAuthor ">Valentina  Pirota</span>, <span class="hlFld-ContribAuthor ">Domenica  Musumeci</span>, <span class="hlFld-ContribAuthor ">Federica  Rizzi</span>, <span class="hlFld-ContribAuthor ">Sara  Iachettini</span>, <span class="hlFld-ContribAuthor ">Pasquale  Zizza</span>, <span class="hlFld-ContribAuthor ">Annamaria  Biroccio</span>, <span class="hlFld-ContribAuthor ">Mauro  Freccero</span>, <span class="hlFld-ContribAuthor ">Daniela  Montesarchio</span>, <span class="hlFld-ContribAuthor ">Filippo  Doria</span>. </span><span class="cited-content_cbyCitation_article-title">Trifunctionalized Naphthalene Diimides and Dimeric Analogues as G-Quadruplex-Targeting Anticancer Agents Selected by Affinity Chromatography. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (6)
                                     , 1964. <a href="https://doi.org/10.3390/ijms21061964" title="DOI URL">https://doi.org/10.3390/ijms21061964</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21061964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21061964%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DTrifunctionalized%252BNaphthalene%252BDiimides%252Band%252BDimeric%252BAnalogues%252Bas%252BG-Quadruplex-Targeting%252BAnticancer%252BAgents%252BSelected%252Bby%252BAffinity%252BChromatography%26aulast%3DPlatella%26aufirst%3DChiara%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D6%26spage%3D1964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Karam  Chand</span>, <span class="hlFld-ContribAuthor ">Sudipta  Bhowmik</span>, <span class="hlFld-ContribAuthor ">Rabindra Nath  Das</span>, <span class="hlFld-ContribAuthor ">Snehasish  Bhattacharjee</span>, <span class="hlFld-ContribAuthor ">Mattias  Hedenström</span>, <span class="hlFld-ContribAuthor ">Erik  Chorell</span>. </span><span class="cited-content_cbyCitation_article-title">Subtle structural alterations in G-quadruplex DNA regulate site specificity of fluorescence light-up probes. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2020,</strong> <em>48 </em>
                                    (3)
                                     , 1108-1119. <a href="https://doi.org/10.1093/nar/gkz1205" title="DOI URL">https://doi.org/10.1093/nar/gkz1205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkz1205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkz1205%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DSubtle%252Bstructural%252Balterations%252Bin%252BG-quadruplex%252BDNA%252Bregulate%252Bsite%252Bspecificity%252Bof%252Bfluorescence%252Blight-up%252Bprobes%26aulast%3DKumar%26aufirst%3DRajendra%26date%3D2020%26date%3D2020%26volume%3D48%26issue%3D3%26spage%3D1108%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jochen  Spiegel</span>, <span class="hlFld-ContribAuthor ">Santosh  Adhikari</span>, <span class="hlFld-ContribAuthor ">Shankar  Balasubramanian</span>. </span><span class="cited-content_cbyCitation_article-title">The Structure and Function of DNA G-Quadruplexes. </span><span class="cited-content_cbyCitation_journal-name">Trends in Chemistry</span><span> <strong>2020,</strong> <em>2 </em>
                                    (2)
                                     , 123-136. <a href="https://doi.org/10.1016/j.trechm.2019.07.002" title="DOI URL">https://doi.org/10.1016/j.trechm.2019.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.trechm.2019.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.trechm.2019.07.002%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Chemistry%26atitle%3DThe%252BStructure%252Band%252BFunction%252Bof%252BDNA%252BG-Quadruplexes%26aulast%3DSpiegel%26aufirst%3DJochen%26date%3D2020%26volume%3D2%26issue%3D2%26spage%3D123%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sefan  Asamitsu</span>. </span><span class="cited-content_cbyCitation_article-title">Introduction. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-44. <a href="https://doi.org/10.1007/978-981-15-7716-1_1" title="DOI URL">https://doi.org/10.1007/978-981-15-7716-1_1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-15-7716-1_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-15-7716-1_1%26sid%3Dliteratum%253Aachs%26atitle%3DIntroduction%26aulast%3DAsamitsu%26aufirst%3DSefan%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D44%26pub%3DSpringer%2520Singapore%26atitle%3DDevelopment%252Bof%252BSelective%252BDNA-Interacting%252BLigands%26aulast%3DAsamitsu%26aufirst%3DSefan%26date%3D2020%26volume%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen  Neidle</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges in developing small-molecule quadruplex therapeutics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 517-546. <a href="https://doi.org/10.1016/bs.armc.2020.05.005" title="DOI URL">https://doi.org/10.1016/bs.armc.2020.05.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.armc.2020.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.armc.2020.05.005%26sid%3Dliteratum%253Aachs%26atitle%3DChallenges%252Bin%252Bdeveloping%252Bsmall-molecule%252Bquadruplex%252Btherapeutics%26aulast%3DNeidle%26aufirst%3DStephen%26date%3D2020%26spage%3D517%26epage%3D546%26pub%3DElsevier%26atitle%3DQuadruplex%252BNucleic%252BAcids%252BAs%252BTargets%252BFor%252BMedicinal%252BChemistry%26date%3D2020%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imlimaong  Aier</span>, <span class="hlFld-ContribAuthor ">Pritish K.  Varadwaj</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding the Mechanism of Cell Death in Gemcitabine Resistant Pancreatic Ductal Adenocarcinoma: A Systems Biology Approach. </span><span class="cited-content_cbyCitation_journal-name">Current Genomics</span><span> <strong>2020,</strong> <em>20 </em>
                                    (7)
                                     , 483-490. <a href="https://doi.org/10.2174/1389202920666191025102726" title="DOI URL">https://doi.org/10.2174/1389202920666191025102726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389202920666191025102726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389202920666191025102726%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Genomics%26atitle%3DUnderstanding%252Bthe%252BMechanism%252Bof%252BCell%252BDeath%252Bin%252BGemcitabine%252BResistant%252BPancreatic%252BDuctal%252BAdenocarcinoma%25253A%252BA%252BSystems%252BBiology%252BApproach%26aulast%3DAier%26aufirst%3DImlimaong%26date%3D2020%26volume%3D20%26issue%3D7%26spage%3D483%26epage%3D490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucas T.  Gray</span>, <span class="hlFld-ContribAuthor ">Emilia  Puig Lombardi</span>, <span class="hlFld-ContribAuthor ">Daniela  Verga</span>, <span class="hlFld-ContribAuthor ">Alain  Nicolas</span>, <span class="hlFld-ContribAuthor ">Marie-Paule  Teulade-Fichou</span>, <span class="hlFld-ContribAuthor ">Arturo  Londoño-Vallejo</span>, <span class="hlFld-ContribAuthor ">Nancy  Maizels</span>. </span><span class="cited-content_cbyCitation_article-title">G-quadruplexes Sequester Free Heme in Living Cells. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2019,</strong> <em>26 </em>
                                    (12)
                                     , 1681-1691.e5. <a href="https://doi.org/10.1016/j.chembiol.2019.10.003" title="DOI URL">https://doi.org/10.1016/j.chembiol.2019.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2019.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2019.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DG-quadruplexes%252BSequester%252BFree%252BHeme%252Bin%252BLiving%252BCells%26aulast%3DGray%26aufirst%3DLucas%2BT.%26date%3D2019%26volume%3D26%26issue%3D12%26spage%3D1681%26epage%3D1691.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stepan A.  Kremis</span>, <span class="hlFld-ContribAuthor ">Dmitry S.  Baev</span>, <span class="hlFld-ContribAuthor ">Alla V.  Lipeeva</span>, <span class="hlFld-ContribAuthor ">Elvira E.  Shults</span>, <span class="hlFld-ContribAuthor ">Tatiana G.  Tolstikova</span>, <span class="hlFld-ContribAuthor ">Olga I.  Sinitsyna</span>, <span class="hlFld-ContribAuthor ">Alexey V.  Kochetov</span>, <span class="hlFld-ContribAuthor ">Tatiana S.  Frolova</span>. </span><span class="cited-content_cbyCitation_article-title">Genotoxic activity of 1,2,3‐triazolyl modified furocoumarins and 2,3‐dihydrofurocoumarins. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biochemical and Molecular Toxicology</span><span> <strong>2019,</strong> <em>33 </em>
                                    (11)
                                     <a href="https://doi.org/10.1002/jbt.22396" title="DOI URL">https://doi.org/10.1002/jbt.22396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jbt.22396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjbt.22396%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biochemical%2520and%2520Molecular%2520Toxicology%26atitle%3DGenotoxic%252Bactivity%252Bof%252B1%25252C2%25252C3%2525E2%252580%252590triazolyl%252Bmodified%252Bfurocoumarins%252Band%252B2%25252C3%2525E2%252580%252590dihydrofurocoumarins%26aulast%3DKremis%26aufirst%3DStepan%2BA.%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangyuan  Li</span>, <span class="hlFld-ContribAuthor ">Dan  Guo</span>, <span class="hlFld-ContribAuthor ">Lin  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Study on the recognition of G-quadruplexes by two stereoisomers of alkaloids. </span><span class="cited-content_cbyCitation_journal-name">Analytical and Bioanalytical Chemistry</span><span> <strong>2019,</strong> <em>411 </em>
                                    (21)
                                     , 5555-5561. <a href="https://doi.org/10.1007/s00216-019-01937-5" title="DOI URL">https://doi.org/10.1007/s00216-019-01937-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00216-019-01937-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00216-019-01937-5%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520and%2520Bioanalytical%2520Chemistry%26atitle%3DStudy%252Bon%252Bthe%252Brecognition%252Bof%252BG-quadruplexes%252Bby%252Btwo%252Bstereoisomers%252Bof%252Balkaloids%26aulast%3DLi%26aufirst%3DFangyuan%26date%3D2019%26date%3D2019%26volume%3D411%26issue%3D21%26spage%3D5555%26epage%3D5561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eduarda  Mendes</span>, <span class="hlFld-ContribAuthor ">Enrico  Cadoni</span>, <span class="hlFld-ContribAuthor ">Filipa  Carneiro</span>, <span class="hlFld-ContribAuthor ">Marta B.  Afonso</span>, <span class="hlFld-ContribAuthor ">Hugo  Brito</span>, <span class="hlFld-ContribAuthor ">João  Lavrado</span>, <span class="hlFld-ContribAuthor ">Daniel J. V. A.  dos Santos</span>, <span class="hlFld-ContribAuthor ">Jorge B.  Vítor</span>, <span class="hlFld-ContribAuthor ">Stephen  Neidle</span>, <span class="hlFld-ContribAuthor ">Cecília M. P.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Alexandra  Paulo</span>. </span><span class="cited-content_cbyCitation_article-title">Combining 1,3‐Ditriazolylbenzene and Quinoline to Discover a New G‐Quadruplex‐Interactive Small Molecule Active against Cancer Stem‐Like Cells. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (14)
                                     , 1325-1328. <a href="https://doi.org/10.1002/cmdc.201900243" title="DOI URL">https://doi.org/10.1002/cmdc.201900243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900243%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DCombining%252B1%25252C3%2525E2%252580%252590Ditriazolylbenzene%252Band%252BQuinoline%252Bto%252BDiscover%252Ba%252BNew%252BG%2525E2%252580%252590Quadruplex%2525E2%252580%252590Interactive%252BSmall%252BMolecule%252BActive%252Bagainst%252BCancer%252BStem%2525E2%252580%252590Like%252BCells%26aulast%3DMendes%26aufirst%3DEduarda%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D14%26spage%3D1325%26epage%3D1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhize  Ou</span>, <span class="hlFld-ContribAuthor ">Zhiyuan  Li</span>, <span class="hlFld-ContribAuthor ">Yunyan  Gao</span>, <span class="hlFld-ContribAuthor ">Wenli  Xing</span>, <span class="hlFld-ContribAuthor ">Hongdan  Jia</span>, <span class="hlFld-ContribAuthor ">Huan  Zhang</span>, <span class="hlFld-ContribAuthor ">Na  Yi</span>. </span><span class="cited-content_cbyCitation_article-title">Novel triazole and morpholine substituted bisnaphthalimide: Synthesis, photophysical and G-quadruplex binding properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1185 </em>, 27-37. <a href="https://doi.org/10.1016/j.molstruc.2019.02.073" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.02.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.02.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.02.073%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DNovel%252Btriazole%252Band%252Bmorpholine%252Bsubstituted%252Bbisnaphthalimide%25253A%252BSynthesis%25252C%252Bphotophysical%252Band%252BG-quadruplex%252Bbinding%252Bproperties%26aulast%3DOu%26aufirst%3DZhize%26date%3D2019%26volume%3D1185%26spage%3D27%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanni  Marsico</span>, <span class="hlFld-ContribAuthor ">Vicki S  Chambers</span>, <span class="hlFld-ContribAuthor ">Aleksandr B  Sahakyan</span>, <span class="hlFld-ContribAuthor ">Patrick  McCauley</span>, <span class="hlFld-ContribAuthor ">Jonathan M  Boutell</span>, <span class="hlFld-ContribAuthor ">Marco Di  Antonio</span>, <span class="hlFld-ContribAuthor ">Shankar  Balasubramanian</span>. </span><span class="cited-content_cbyCitation_article-title">Whole genome experimental maps of DNA G-quadruplexes in multiple species. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2019,</strong> <em>47 </em>
                                    (8)
                                     , 3862-3874. <a href="https://doi.org/10.1093/nar/gkz179" title="DOI URL">https://doi.org/10.1093/nar/gkz179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkz179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkz179%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DWhole%252Bgenome%252Bexperimental%252Bmaps%252Bof%252BDNA%252BG-quadruplexes%252Bin%252Bmultiple%252Bspecies%26aulast%3DMarsico%26aufirst%3DGiovanni%26date%3D2019%26date%3D2019%26volume%3D47%26issue%3D8%26spage%3D3862%26epage%3D3874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dora M.  Răsădean</span>, <span class="hlFld-ContribAuthor ">Samuel W. O.  Harrison</span>, <span class="hlFld-ContribAuthor ">Isobel R.  Owens</span>, <span class="hlFld-ContribAuthor ">Aucéanne  Miramont</span>, <span class="hlFld-ContribAuthor ">Frances M.  Bromley</span>, <span class="hlFld-ContribAuthor ">G. Dan  Pantoș</span>. </span><span class="cited-content_cbyCitation_article-title">Importance of Chiral Recognition in Designing Metal-Free Ligands for G-Quadruplex DNA. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (8)
                                     , 1473. <a href="https://doi.org/10.3390/molecules24081473" title="DOI URL">https://doi.org/10.3390/molecules24081473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24081473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24081473%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DImportance%252Bof%252BChiral%252BRecognition%252Bin%252BDesigning%252BMetal-Free%252BLigands%252Bfor%252BG-Quadruplex%252BDNA%26aulast%3DR%25C4%2583s%25C4%2583dean%26aufirst%3DDora%2BM.%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D8%26spage%3D1473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jussara  Amato</span>, <span class="hlFld-ContribAuthor ">Chiara  Platella</span>, <span class="hlFld-ContribAuthor ">Sara  Iachettini</span>, <span class="hlFld-ContribAuthor ">Pasquale  Zizza</span>, <span class="hlFld-ContribAuthor ">Domenica  Musumeci</span>, <span class="hlFld-ContribAuthor ">Sandro  Cosconati</span>, <span class="hlFld-ContribAuthor ">Alessia  Pagano</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Annamaria  Biroccio</span>, <span class="hlFld-ContribAuthor ">Antonio  Randazzo</span>, <span class="hlFld-ContribAuthor ">Bruno  Pagano</span>, <span class="hlFld-ContribAuthor ">Daniela  Montesarchio</span>. </span><span class="cited-content_cbyCitation_article-title">Tailoring a lead-like compound targeting multiple G-quadruplex structures. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 295-306. <a href="https://doi.org/10.1016/j.ejmech.2018.11.058" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.11.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.11.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.11.058%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTailoring%252Ba%252Blead-like%252Bcompound%252Btargeting%252Bmultiple%252BG-quadruplex%252Bstructures%26aulast%3DAmato%26aufirst%3DJussara%26date%3D2019%26volume%3D163%26spage%3D295%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Yin  Sun</span>, <span class="hlFld-ContribAuthor ">Xiao-Na  Wang</span>, <span class="hlFld-ContribAuthor ">Sui-Qi  Cheng</span>, <span class="hlFld-ContribAuthor ">Xiao-Xuan  Su</span>, <span class="hlFld-ContribAuthor ">Tian-Miao  Ou</span>. </span><span class="cited-content_cbyCitation_article-title">Developing Novel G-Quadruplex Ligands: from Interaction with Nucleic Acids to Interfering with Nucleic Acid–Protein Interaction. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (3)
                                     , 396. <a href="https://doi.org/10.3390/molecules24030396" title="DOI URL">https://doi.org/10.3390/molecules24030396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24030396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24030396%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDeveloping%252BNovel%252BG-Quadruplex%252BLigands%25253A%252Bfrom%252BInteraction%252Bwith%252BNucleic%252BAcids%252Bto%252BInterfering%252Bwith%252BNucleic%252BAcid%2525E2%252580%252593Protein%252BInteraction%26aulast%3DSun%26aufirst%3DZhi-Yin%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D3%26spage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentina  Pirota</span>, <span class="hlFld-ContribAuthor ">Matteo  Nadai</span>, <span class="hlFld-ContribAuthor ">Filippo  Doria</span>, <span class="hlFld-ContribAuthor ">Sara  Richter</span>. </span><span class="cited-content_cbyCitation_article-title">Naphthalene Diimides as Multimodal G-Quadruplex-Selective Ligands. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (3)
                                     , 426. <a href="https://doi.org/10.3390/molecules24030426" title="DOI URL">https://doi.org/10.3390/molecules24030426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24030426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24030426%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNaphthalene%252BDiimides%252Bas%252BMultimodal%252BG-Quadruplex-Selective%252BLigands%26aulast%3DPirota%26aufirst%3DValentina%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D3%26spage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sefan  Asamitsu</span>, <span class="hlFld-ContribAuthor ">Shunsuke  Obata</span>, <span class="hlFld-ContribAuthor ">Zutao  Yu</span>, <span class="hlFld-ContribAuthor ">Toshikazu  Bando</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Sugiyama</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress of Targeted G-Quadruplex-Preferred Ligands Toward Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (3)
                                     , 429. <a href="https://doi.org/10.3390/molecules24030429" title="DOI URL">https://doi.org/10.3390/molecules24030429</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24030429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24030429%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BProgress%252Bof%252BTargeted%252BG-Quadruplex-Preferred%252BLigands%252BToward%252BCancer%252BTherapy%26aulast%3DAsamitsu%26aufirst%3DSefan%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D3%26spage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pallavi  Chilka</span>, <span class="hlFld-ContribAuthor ">Nakshi  Desai</span>, <span class="hlFld-ContribAuthor ">Bhaskar  Datta</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Fluorescent Probes for G- Quadruplex Visualization as Potential Cancer Theranostic Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (4)
                                     , 752. <a href="https://doi.org/10.3390/molecules24040752" title="DOI URL">https://doi.org/10.3390/molecules24040752</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24040752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24040752%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSmall%252BMolecule%252BFluorescent%252BProbes%252Bfor%252BG-%252BQuadruplex%252BVisualization%252Bas%252BPotential%252BCancer%252BTheranostic%252BAgents%26aulast%3DChilka%26aufirst%3DPallavi%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D4%26spage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleonora  Zorzan</span>, <span class="hlFld-ContribAuthor ">Ramy  Elgendy</span>, <span class="hlFld-ContribAuthor ">Mery  Giantin</span>, <span class="hlFld-ContribAuthor ">Mauro  Dacasto</span>, <span class="hlFld-ContribAuthor ">Claudia  Sissi</span>. </span><span class="cited-content_cbyCitation_article-title">Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-35516-y" title="DOI URL">https://doi.org/10.1038/s41598-018-35516-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-35516-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-35516-y%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DWhole-Transcriptome%252BProfiling%252Bof%252BCanine%252Band%252BHuman%252Bin%252BVitro%252BModels%252BExposed%252Bto%252Ba%252BG-Quadruplex%252BBinding%252BSmall%252BMolecule%26aulast%3DZorzan%26aufirst%3DEleonora%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mekala  Gunaratnam</span>, <span class="hlFld-ContribAuthor ">Gavin W.  Collie</span>, <span class="hlFld-ContribAuthor ">Anthony P.  Reszka</span>, <span class="hlFld-ContribAuthor ">Alan K.  Todd</span>, <span class="hlFld-ContribAuthor ">Gary N.  Parkinson</span>, <span class="hlFld-ContribAuthor ">Stephen  Neidle</span>. </span><span class="cited-content_cbyCitation_article-title">A naphthalene diimide G-quadruplex ligand inhibits cell growth and down-regulates BCL-2 expression in an imatinib-resistant gastrointestinal cancer cell line. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (11)
                                     , 2958-2964. <a href="https://doi.org/10.1016/j.bmc.2018.04.050" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DA%252Bnaphthalene%252Bdiimide%252BG-quadruplex%252Bligand%252Binhibits%252Bcell%252Bgrowth%252Band%252Bdown-regulates%252BBCL-2%252Bexpression%252Bin%252Ban%252Bimatinib-resistant%252Bgastrointestinal%252Bcancer%252Bcell%252Bline%26aulast%3DGunaratnam%26aufirst%3DMekala%26date%3D2018%26volume%3D26%26issue%3D11%26spage%3D2958%26epage%3D2964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuela  Ruggiero</span>, <span class="hlFld-ContribAuthor ">Sara N  Richter</span>. </span><span class="cited-content_cbyCitation_article-title">G-quadruplexes and G-quadruplex ligands: targets and tools in antiviral therapy. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2018,</strong> <em>46 </em>
                                    (7)
                                     , 3270-3283. <a href="https://doi.org/10.1093/nar/gky187" title="DOI URL">https://doi.org/10.1093/nar/gky187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gky187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgky187%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DG-quadruplexes%252Band%252BG-quadruplex%252Bligands%25253A%252Btargets%252Band%252Btools%252Bin%252Bantiviral%252Btherapy%26aulast%3DRuggiero%26aufirst%3DEmanuela%26date%3D2018%26date%3D2018%26volume%3D46%26issue%3D7%26spage%3D3270%26epage%3D3283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01781&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. G4 modeling, FRET, and cell line growth inhibition studies of the trisubstituted naphthalene diimide derivatives MM41 and CM03. (a) MM41 structure and (b) molecular model of MM41 bound to a human telomeric G4, following docking and minimization and using the co-crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UYH">3UYH</a>)<a onclick="showRef(event, 'cit32a'); return false;" href="javascript:void(0);" class="ref cit32a">(32a)</a> as a starting point. The red dotted circle highlights the fourth pyrrolidino side chain substituent of MM41, which is not buried in a G4 groove, by contrast with the other three side chains. (c) CM03 structure and (d) molecular model of CM03 bound to the native parallel human telomeric G4 structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KF1">1KF1</a>)<a onclick="showRef(event, 'cit32b'); return false;" href="javascript:void(0);" class="ref cit32b">(32b)</a> following docking and minimization. MM41 and CM03 are shown in ball-and-stick representation and the G4 in surface representation, with electrostatic interaction regions colored yellow. (e) Table showing melting temperature changes (Δ<i>T</i><sub>m</sub>) in °C, for CM03 and MM41 with a panel of G4s, determined using a FRET procedure performed in solution containing 50 mM K<sup>+</sup> ion. Ligands were used at 1 μM concentration. Standard deviations are from triplicate measurements. (f) Growth inhibition assays. Short-term 96 h IC<sub>50</sub> values (in nM) for the two compounds in cancer and normal fibroblast cell line panel. Average growth inhibition is shown with standard deviations from >3 individual determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01781&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound CM03 (<b>4</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01781&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(i) 5,5-Dimethyl-1,3-dibromohydantoin, H<sub>2</sub>SO<sub>4</sub>, 80° C, 72 h; (ii) 3-morpholinopropylamine, acetic acid, microwave, 130 °C, 25 min (The intermediate <b>3b</b> was not isolated); (iii) amine, NMP, microwave, 125 °C, 30 min. For CM03, n = 2, R = pyrrolidino. The overall yield of the synthesis for steps i to iii (compound <b>4</b>: CM03) was 26%. The yield for steps i and ii (from compound <b>1</b> to compound <b>3a</b>) was 35%; the yield for final step (iii) (compound <b>3a</b> to compound <b>4</b> (CM03)) was 75%.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CM03 treatment reduces tumor volume in a MIA PaCa-2 xenograft model of PDAC. (a) Plot showing the tumor volume of MIA PaCa-2 xenografts treated with CM03, MM41, gemcitabine, or saline (control) over 62 days. There are eight CD-1 mice per condition and dosing for all cohorts was stopped on day 28, shown by the red arrow. Standard error of the mean (SEM) is indicated for all growth curves for each tumor volume. * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 (Student <i>t</i> test). (b) A plot of weight for the eight mice in the 15 mg/kg CM03 cohort of this xenograft experiment, for the first 40 days of the experiment. (c) Table showing changes in tumor volume (TV), in cm<sup>3</sup>, relative to the control cohort at the selected three time points (MTV represents mean tumor volume). Statistical analysis between the average tumor volume of treated versus control mice cohorts at the given time points was performed using the Student <i>t</i> test * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001. (d) Sections of hematoxylin and eosin-stained organ tissue, taken from animals at the termination of the xenograft experiment. In each case, images from a single animal are shown. No differences between animals in a cohort were observed. Sections through (i) kidneys and (ii) livers taken from a control (untreated) and a CM03-treated mouse. (e) (i) IVIS images of a saline (control) untreated mouse and a 10 mg/kg CM03 treated mouse with tumors on their flank, 4 h after administration; (ii) IVIS images of the excised tumor from each animal (untreated control and 10 mg/kg CM03 treated) 4 h after administration. (f) Kaplan–Meier plot showing survival of PDAC-bearing KPC mice post onset of treatment (CM03, <i>n</i> = 7, control, <i>n</i> = 5, Mann–Whitney, <i>p</i> = 0.217).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01781&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Differentially down-regulated genes common to both PANC-1 and MIA PaCa-2 are enriched in PQs after treatment with 400 nM CM03. (a,b) MIA PaCa-2 and PANC-1 cells were treated with 400 nM CM03 for 6 and 24 h and mRNA extracted for analysis by RNA-Seq. Genes were split into four subgroups according to their fold change upon CM03 treatment versus untreated: Down (Log<sub>2</sub> FC < 0.5, FDR < 0.1), Up (Log<sub>2</sub> FC > 0.5, FDR < 0.1), Down strong (Log<sub>2</sub> FC ≤ 1.0, FDR < 0.05) and Up strong (Log<sub>2</sub> FC ≥ 1.0, FDR < 0.05) and analyzed for PQs occurrence in both (a) promoter (100 bp downstream and 2 kb upstream of the TSS) and (b) gene bodies (exons and introns). See Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf" class="ext-link">Table 3</a> for median and IQR for box and whisker plots. Significance between differentially deregulated gene sets was calculated using the Wilcox statistical test via R software. *<i>p</i> < 0.05, ** <i>p</i> < 1 × 10<sup>–10</sup>, *** <i>p</i> < 1 × 10<sup>–25</sup>. PQs mean number is significantly lower (red asterisks) or higher (black asterisks) than the no differential expression group (NO). (c,d) enriched KEGG pathways (<i>p</i> < 0.05 with Bonferroni correction) and associated down-regulated genes (Log<sub>2</sub> FC < 0.5, FDR < 0.1) common to both PANC-1 and MIA PaCa-2 cell lines after (c) 6 h and (d) 24 h CM03 treatment using the ClueGO Cytoscape App. (e) Scatter plot of significant down-regulated KEGG pathways (p-EASE ≤ 0.05) upon 6 and 24 h CM03 treatment. (f,g) Common (f) down-regulated KEGG pathways after 6 h CM03 treatment are also enriched in promoter and gene body PQs compared to (g) common-up regulated KEGG pathways at 6 h. The significance threshold of 0.05 is represented by the dotted line on the graph.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01781&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. CM03 treatment induces DNA damage and increases the presence of nuclear G4. (a) Following 6 and 24 h treatment with 400 nM CM03, PANC-1 cells were fixed with paraformaldehyde and stained with antibodies against G4s (BG4, green) and the DNA damage marker 53BP1 (red). <i>Z</i>-Stack images (11 μm × 0.3 μm spacing) were captured using a Nikon wide-field microscope and deconvolved using Hugyens Professional software. The central slice of the <i>Z</i>-stack is shown in the representative images. White scale bar is 10 μm. Zoom panel represents increased magnification of the highlighted section of the nucleus (dotted square) in the Merge panel. Yellow scale bar is 2.5 μm. Detection and co-localization between BG4 and 53BP1 foci (white arrows) were performed using a custom protocol in the ICY software, which utilizes the spot detector and co-localization studio plugins with the wavelet and Ripley’s K functions (see <a class="ref internalNav" href="#sec4" aria-label="Methods">Methods</a>). (b–e) The graphs show the mean number of (b) BG4 foci, (c) 53BP1 foci, (d) BG4-53BP1 co-localizations, or (e) percentage of total BG4 co-localizing with 53BP1 per nucleus with the standard deviation from three biological replicates. A two-tailed Student’s <i>t</i> test was used to determine statistical significance across each condition (<i>p</i> < 0.05 = *, <i>p</i> < 0.01 = **; n.s. = not significant). Each biological replicate represents 50–100 nuclei.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01781&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/medium/jm-2017-017813_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Validation of mRNA down regulation by qRT-PCR for a subset of down-regulated genes, selected from RNA-Seq experiments. (a–d) MIA PaCa-2 and PANC-1 cells were treated (a and b) with 400 nM CM03 and (c and d) with 400 nM gemcitabine, all for 6 and 24 h. Total mRNA was extracted, reverse transcribed into cDNA, and then qRT-PCR was performed. The <i>C</i><sub>t</sub> values were normalized to the genomic mean of three housekeeping genes (<i>ACTB</i>, <i>GAPDH</i>, and <i>TUBB</i>), and the relative gene expression was determined using the Livak method, 2<sup>–ΔΔ<i>C</i>t</sup>. The log-fold expression changes (Log<sub>2</sub> FC) for each gene are shown relative to vehicle-treated controls (PBS for CM03 and DMSO for gemcitabine). Student’s <i>t</i> test along with 2<sup>–Δ<i>C</i>t</sup> values were used to determine the statistical significance of the observed changes, which are the mean of in each case at least three determinations. Those genes with changes in expression with <i>p</i> < 0.05 have been marked *.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01781/20180315/images/large/jm-2017-017813_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01781&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81438" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81438" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 84 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamisawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaori, K.</span></span> <span> </span><span class="NLM_article-title">Pancreatic cancer</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(16)00141-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2FS0140-6736%2816%2900141-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26830752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2mtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2016&pages=73-85&author=T.+Kamisawaauthor=L.+D.+Woodauthor=T.+Itoiauthor=K.+Takaori&title=Pancreatic+cancer&doi=10.1016%2FS0140-6736%2816%2900141-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer</span></div><div class="casAuthors">Kamisawa, Terumi; Wood, Laura D.; Itoi, Takao; Takaori, Kyoichi</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">10039</span>),
    <span class="NLM_cas:pages">73-85</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pancreatic cancer is a highly lethal disease, for which mortality closely parallels incidence.  Most patients with pancreatic cancer remain asymptomatic until the disease reaches an advanced stage.  There is no std. program for screening patients at high risk of pancreatic cancer (eg, those with a family history of pancreatic cancer and chronic pancreatitis).  Most pancreatic cancers arise from microscopic non-invasive epithelial proliferations within the pancreatic ducts, referred to as pancreatic intraepithelial neoplasias.  There are four major driver genes for pancreatic cancer: KRAS, CDKN2A, TP53, and SMAD4.  KRAS mutation and alterations in CDKN2A are early events in pancreatic tumorigenesis.  Endoscopic ultrasonog. and endoscopic ultrasonog.-guided fine-needle aspiration offer high diagnostic ability for pancreatic cancer.  Surgical resection is regarded as the only potentially curative treatment, and adjuvant chemotherapy with gemcitabine or S-1, an oral fluoropyrimidine deriv., is given after surgery.  FOLFIRINOX (fluorouracil, folinic acid [leucovorin], irinotecan, and oxaliplatin) and gemcitabine plus nanoparticle albumin-bound paclitaxel (nab-paclitaxel) are the treatments of choice for patients who are not surgical candidates but have good performance status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowv4Kc18l117Vg90H21EOLACvtfcHk0lhJipqlMBkC4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2mtb8%253D&md5=008fad5f1be8c3c6f3534c5bc3c3ea3a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2816%2900141-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252816%252900141-0%26sid%3Dliteratum%253Aachs%26aulast%3DKamisawa%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DL.%2BD.%26aulast%3DItoi%26aufirst%3DT.%26aulast%3DTakaori%26aufirst%3DK.%26atitle%3DPancreatic%2520cancer%26jtitle%3DLancet%26date%3D2016%26volume%3D388%26spage%3D73%26epage%3D85%26doi%3D10.1016%2FS0140-6736%2816%2900141-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nones, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patch, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingras, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruxner, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nourse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murtaugh, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harliwong, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idrisoglu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nourbakhsh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakoff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloonan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassahn, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mincarelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colvin, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagrial, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantrill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarlett, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinho, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giry-Laterriere, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samra, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kench, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrett, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toon, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeps, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran-Jones, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duthie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oien, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hair, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grutzmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfgang, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawlor, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rusev, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munzy, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karim, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilarsky, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musgrove, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biankin, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimmond, S. M.</span></span> <span> </span><span class="NLM_article-title">Genomic analyses identify molecular subtypes of pancreatic cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>531</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1038/nature16965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnature16965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26909576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFOisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=531&publication_year=2016&pages=47-52&author=P.+Baileyauthor=D.+K.+Changauthor=K.+Nonesauthor=A.+L.+Johnsauthor=A.+M.+Patchauthor=M.+C.+Gingrasauthor=D.+K.+Millerauthor=A.+N.+Christauthor=T.+J.+Bruxnerauthor=M.+C.+Quinnauthor=C.+Nourseauthor=L.+C.+Murtaughauthor=I.+Harliwongauthor=S.+Idrisogluauthor=S.+Manningauthor=E.+Nourbakhshauthor=S.+Waniauthor=L.+Finkauthor=O.+Holmesauthor=V.+Chinauthor=M.+J.+Andersonauthor=S.+Kazakoffauthor=C.+Leonardauthor=F.+Newellauthor=N.+Waddellauthor=S.+Woodauthor=Q.+Xuauthor=P.+J.+Wilsonauthor=N.+Cloonanauthor=K.+S.+Kassahnauthor=D.+Taylorauthor=K.+Quekauthor=A.+Robertsonauthor=L.+Pantanoauthor=L.+Mincarelliauthor=L.+N.+Sanchezauthor=L.+Eversauthor=J.+Wuauthor=M.+Pineseauthor=M.+J.+Cowleyauthor=M.+D.+Jonesauthor=E.+K.+Colvinauthor=A.+M.+Nagrialauthor=E.+S.+Humphreyauthor=L.+A.+Chantrillauthor=A.+Mawsonauthor=J.+Humphrisauthor=A.+Chouauthor=M.+Pajicauthor=C.+J.+Scarlettauthor=A.+V.+Pinhoauthor=M.+Giry-Laterriereauthor=I.+Roomanauthor=J.+S.+Samraauthor=J.+G.+Kenchauthor=J.+A.+Lovellauthor=N.+D.+Merrettauthor=C.+W.+Toonauthor=K.+Epariauthor=N.+Q.+Nguyenauthor=A.+Barbourauthor=N.+Zepsauthor=K.+Moran-Jonesauthor=N.+B.+Jamiesonauthor=J.+S.+Grahamauthor=F.+Duthieauthor=K.+Oienauthor=J.+Hairauthor=R.+Grutzmannauthor=A.+Maitraauthor=C.+A.+Iacobuzio-Donahueauthor=C.+L.+Wolfgangauthor=R.+A.+Morganauthor=R.+T.+Lawlorauthor=V.+Corboauthor=C.+Bassiauthor=B.+Rusevauthor=P.+Capelliauthor=R.+Salviaauthor=G.+Tortoraauthor=D.+Mukhopadhyayauthor=G.+M.+Petersenauthor=D.+M.+Munzyauthor=W.+E.+Fisherauthor=S.+A.+Karimauthor=J.+R.+Eshlemanauthor=R.+H.+Hrubanauthor=C.+Pilarskyauthor=J.+P.+Mortonauthor=O.+J.+Sansomauthor=A.+Scarpaauthor=E.+A.+Musgroveauthor=U.+M.+Baileyauthor=O.+Hofmannauthor=R.+L.+Sutherlandauthor=D.+A.+Wheelerauthor=A.+J.+Gillauthor=R.+A.+Gibbsauthor=J.+V.+Pearsonauthor=N.+Waddellauthor=A.+V.+Biankinauthor=S.+M.+Grimmond&title=Genomic+analyses+identify+molecular+subtypes+of+pancreatic+cancer&doi=10.1038%2Fnature16965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Genomic analyses identify molecular subtypes of pancreatic cancer</span></div><div class="casAuthors">Bailey, Peter; Chang, David K.; Nones, Katia; Johns, Amber L.; Patch, Ann-Marie; Gingras, Marie-Claude; Miller, David K.; Christ, Angelika N.; Bruxner, Tim J. C.; Quinn, Michael C.; Nourse, Craig; Murtaugh, L. Charles; Harliwong, Ivon; Idrisoglu, Senel; Manning, Suzanne; Nourbakhsh, Ehsan; Wani, Shivangi; Fink, Lynn; Holmes, Oliver; Chin, Venessa; Anderson, Matthew J.; Kazakoff, Stephen; Leonard, Conrad; Newell, Felicity; Waddell, Nick; Wood, Scott; Xu, Qinying; Wilson, Peter J.; Cloonan, Nicole; Kassahn, Karin S.; Taylor, Darrin; Quek, Kelly; Robertson, Alan; Pantano, Lorena; Mincarelli, Laura; Sanchez, Luis N.; Evers, Lisa; Wu, Jianmin; Pinese, Mark; Cowley, Mark J.; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chantrill, Lorraine A.; Mawson, Amanda; Humphris, Jeremy; Chou, Angela; Pajic, Marina; Scarlett, Christopher J.; Pinho, Andreia V.; Giry-Laterriere, Marc; Rooman, Ilse; Samra, Jaswinder S.; Kench, James G.; Lovell, Jessica A.; Merrett, Neil D.; Toon, Christopher W.; Epari, Krishna; Nguyen, Nam Q.; Barbour, Andrew; Zeps, Nikolajs; Moran-Jones, Kim; Jamieson, Nigel B.; Graham, Janet S.; Duthie, Fraser; Oien, Karin; Hair, Jane; Grutzmann, Robert; Maitra, Anirban; Iacobuzio-Donahue, Christine A.; Wolfgang, Christopher L.; Morgan, Richard A.; Lawlor, Rita T.; Corbo, Vincenzo; Bassi, Claudio; Rusev, Borislav; Capelli, Paola; Salvia, Roberto; Tortora, Giampaolo; Mukhopadhyay, Debabrata; Petersen, Gloria M.; Munzy, Donna M.; Fisher, William E.; Karim, Saadia A.; Eshleman, James R.; Hruban, Ralph H.; Pilarsky, Christian; Morton, Jennifer P.; Sansom, Owen J.; Scarpa, Aldo; Musgrove, Elizabeth A.; Bailey, Ulla-Maja Hagbo; Hofmann, Oliver; Sutherland, Robert L.; Wheeler, David A.; Gill, Anthony J.; Gibbs, Richard A.; Pearson, John V.; Waddell, Nicola; Biankin, Andrew V.; Grimmond, Sean M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">531</span>
        (<span class="NLM_cas:issue">7592</span>),
    <span class="NLM_cas:pages">47-52</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Integrated genomic anal. of 456 pancreatic ductal adenocarcinomas identified 32 recurrently mutated genes that aggregate into 10 pathways: KRAS, TGF-β, WNT, NOTCH, ROBO/SLIT signaling, G1/S transition, SWI-SNF, chromatin modification, DNA repair and RNA processing.  Expression anal. defined 4 subtypes: (1) squamous; (2) pancreatic progenitor; (3) immunogenic; and (4) aberrantly differentiated endocrine exocrine (ADEX) that correlate with histopathol. characteristics.  Squamous tumors are enriched for TP53 and KDM6A mutations, upregulation of the TP63ΔN transcriptional network, hypermethylation of pancreatic endodermal cell-fate detg. genes and have a poor prognosis.  Pancreatic progenitor tumors preferentially express genes involved in early pancreatic development (FOXA2/3, PDX1 and MNX1).  ADEX tumors displayed upregulation of genes that regulate networks involved in KRAS activation, exocrine (NR5A2 and RBPJL), and endocrine differentiation (NEUROD1 and NKX2-2).  Immunogenic tumors contained upregulated immune networks including pathways involved in acquired immune suppression.  These data infer differences in the mol. evolution of pancreatic cancer subtypes and identify opportunities for therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDwApQBihoOLVg90H21EOLACvtfcHk0lhiJE3jx3wPHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFOisr0%253D&md5=6bc3da87878717d45460a164f970638a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature16965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature16965%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DD.%2BK.%26aulast%3DNones%26aufirst%3DK.%26aulast%3DJohns%26aufirst%3DA.%2BL.%26aulast%3DPatch%26aufirst%3DA.%2BM.%26aulast%3DGingras%26aufirst%3DM.%2BC.%26aulast%3DMiller%26aufirst%3DD.%2BK.%26aulast%3DChrist%26aufirst%3DA.%2BN.%26aulast%3DBruxner%26aufirst%3DT.%2BJ.%26aulast%3DQuinn%26aufirst%3DM.%2BC.%26aulast%3DNourse%26aufirst%3DC.%26aulast%3DMurtaugh%26aufirst%3DL.%2BC.%26aulast%3DHarliwong%26aufirst%3DI.%26aulast%3DIdrisoglu%26aufirst%3DS.%26aulast%3DManning%26aufirst%3DS.%26aulast%3DNourbakhsh%26aufirst%3DE.%26aulast%3DWani%26aufirst%3DS.%26aulast%3DFink%26aufirst%3DL.%26aulast%3DHolmes%26aufirst%3DO.%26aulast%3DChin%26aufirst%3DV.%26aulast%3DAnderson%26aufirst%3DM.%2BJ.%26aulast%3DKazakoff%26aufirst%3DS.%26aulast%3DLeonard%26aufirst%3DC.%26aulast%3DNewell%26aufirst%3DF.%26aulast%3DWaddell%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DWilson%26aufirst%3DP.%2BJ.%26aulast%3DCloonan%26aufirst%3DN.%26aulast%3DKassahn%26aufirst%3DK.%2BS.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DQuek%26aufirst%3DK.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DPantano%26aufirst%3DL.%26aulast%3DMincarelli%26aufirst%3DL.%26aulast%3DSanchez%26aufirst%3DL.%2BN.%26aulast%3DEvers%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DPinese%26aufirst%3DM.%26aulast%3DCowley%26aufirst%3DM.%2BJ.%26aulast%3DJones%26aufirst%3DM.%2BD.%26aulast%3DColvin%26aufirst%3DE.%2BK.%26aulast%3DNagrial%26aufirst%3DA.%2BM.%26aulast%3DHumphrey%26aufirst%3DE.%2BS.%26aulast%3DChantrill%26aufirst%3DL.%2BA.%26aulast%3DMawson%26aufirst%3DA.%26aulast%3DHumphris%26aufirst%3DJ.%26aulast%3DChou%26aufirst%3DA.%26aulast%3DPajic%26aufirst%3DM.%26aulast%3DScarlett%26aufirst%3DC.%2BJ.%26aulast%3DPinho%26aufirst%3DA.%2BV.%26aulast%3DGiry-Laterriere%26aufirst%3DM.%26aulast%3DRooman%26aufirst%3DI.%26aulast%3DSamra%26aufirst%3DJ.%2BS.%26aulast%3DKench%26aufirst%3DJ.%2BG.%26aulast%3DLovell%26aufirst%3DJ.%2BA.%26aulast%3DMerrett%26aufirst%3DN.%2BD.%26aulast%3DToon%26aufirst%3DC.%2BW.%26aulast%3DEpari%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DN.%2BQ.%26aulast%3DBarbour%26aufirst%3DA.%26aulast%3DZeps%26aufirst%3DN.%26aulast%3DMoran-Jones%26aufirst%3DK.%26aulast%3DJamieson%26aufirst%3DN.%2BB.%26aulast%3DGraham%26aufirst%3DJ.%2BS.%26aulast%3DDuthie%26aufirst%3DF.%26aulast%3DOien%26aufirst%3DK.%26aulast%3DHair%26aufirst%3DJ.%26aulast%3DGrutzmann%26aufirst%3DR.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%2BA.%26aulast%3DWolfgang%26aufirst%3DC.%2BL.%26aulast%3DMorgan%26aufirst%3DR.%2BA.%26aulast%3DLawlor%26aufirst%3DR.%2BT.%26aulast%3DCorbo%26aufirst%3DV.%26aulast%3DBassi%26aufirst%3DC.%26aulast%3DRusev%26aufirst%3DB.%26aulast%3DCapelli%26aufirst%3DP.%26aulast%3DSalvia%26aufirst%3DR.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3DMukhopadhyay%26aufirst%3DD.%26aulast%3DPetersen%26aufirst%3DG.%2BM.%26aulast%3DMunzy%26aufirst%3DD.%2BM.%26aulast%3DFisher%26aufirst%3DW.%2BE.%26aulast%3DKarim%26aufirst%3DS.%2BA.%26aulast%3DEshleman%26aufirst%3DJ.%2BR.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DPilarsky%26aufirst%3DC.%26aulast%3DMorton%26aufirst%3DJ.%2BP.%26aulast%3DSansom%26aufirst%3DO.%2BJ.%26aulast%3DScarpa%26aufirst%3DA.%26aulast%3DMusgrove%26aufirst%3DE.%2BA.%26aulast%3DBailey%26aufirst%3DU.%2BM.%26aulast%3DHofmann%26aufirst%3DO.%26aulast%3DSutherland%26aufirst%3DR.%2BL.%26aulast%3DWheeler%26aufirst%3DD.%2BA.%26aulast%3DGill%26aufirst%3DA.%2BJ.%26aulast%3DGibbs%26aufirst%3DR.%2BA.%26aulast%3DPearson%26aufirst%3DJ.%2BV.%26aulast%3DWaddell%26aufirst%3DN.%26aulast%3DBiankin%26aufirst%3DA.%2BV.%26aulast%3DGrimmond%26aufirst%3DS.%2BM.%26atitle%3DGenomic%2520analyses%2520identify%2520molecular%2520subtypes%2520of%2520pancreatic%2520cancer%26jtitle%3DNature%26date%3D2016%26volume%3D531%26spage%3D47%26epage%3D52%26doi%3D10.1038%2Fnature16965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, P.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yachida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mudie, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleasance, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stebbings, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morsberger, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latimer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaren, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nik-Zainal, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzies, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swerdlow, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futreal, P. A.</span></span> <span> </span><span class="NLM_article-title">The patterns and dynamics of genomic instability in metastatic pancreatic cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>467</i></span>,  <span class="NLM_fpage">1109</span>– <span class="NLM_lpage">1113</span>, <span class="refDoi"> DOI: 10.1038/nature09460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnature09460" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=467&publication_year=2010&pages=1109-1113&author=P.%0AJ.+Campbellauthor=S.+Yachidaauthor=L.+J.+Mudieauthor=P.+J.+Stephensauthor=E.+D.+Pleasanceauthor=L.+A.+Stebbingsauthor=L.+A.+Morsbergerauthor=C.+Latimerauthor=S.+McLarenauthor=M.+L.+Linauthor=D.+J.+McBrideauthor=I.+Varelaauthor=S.+A.+Nik-Zainalauthor=C.+Leroyauthor=M.+Jiaauthor=A.+Menziesauthor=A.+P.+Butlerauthor=J.+W.+Teagueauthor=C.+A.+Griffinauthor=J.+Burtonauthor=H.+Swerdlowauthor=M.+A.+Quailauthor=M.+R.+Strattonauthor=C.+Iacobuzio-Donahueauthor=P.+A.+Futreal&title=The+patterns+and+dynamics+of+genomic+instability+in+metastatic+pancreatic+cancer&doi=10.1038%2Fnature09460"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature09460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09460%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DP.%2BJ.%26aulast%3DYachida%26aufirst%3DS.%26aulast%3DMudie%26aufirst%3DL.%2BJ.%26aulast%3DStephens%26aufirst%3DP.%2BJ.%26aulast%3DPleasance%26aufirst%3DE.%2BD.%26aulast%3DStebbings%26aufirst%3DL.%2BA.%26aulast%3DMorsberger%26aufirst%3DL.%2BA.%26aulast%3DLatimer%26aufirst%3DC.%26aulast%3DMcLaren%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DM.%2BL.%26aulast%3DMcBride%26aufirst%3DD.%2BJ.%26aulast%3DVarela%26aufirst%3DI.%26aulast%3DNik-Zainal%26aufirst%3DS.%2BA.%26aulast%3DLeroy%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DM.%26aulast%3DMenzies%26aufirst%3DA.%26aulast%3DButler%26aufirst%3DA.%2BP.%26aulast%3DTeague%26aufirst%3DJ.%2BW.%26aulast%3DGriffin%26aufirst%3DC.%2BA.%26aulast%3DBurton%26aufirst%3DJ.%26aulast%3DSwerdlow%26aufirst%3DH.%26aulast%3DQuail%26aufirst%3DM.%2BA.%26aulast%3DStratton%26aufirst%3DM.%2BR.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%26aulast%3DFutreal%26aufirst%3DP.%2BA.%26atitle%3DThe%2520patterns%2520and%2520dynamics%2520of%2520genomic%2520instability%2520in%2520metastatic%2520pancreatic%2520cancer%26jtitle%3DNature%26date%3D2010%26volume%3D467%26spage%3D1109%26epage%3D1113%26doi%3D10.1038%2Fnature09460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patch, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassahn, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nones, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, M. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadlullah, M. Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruxner, T. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harliwong, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idrisoglu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nourse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nourbakhsh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloonan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakoff, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poudel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagrial, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantrill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmann, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colvin, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarlett, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinho, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giry-Laterriere, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samra, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kench, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettitt, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrett, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeps, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niclou, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjerkvig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grutzmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aust, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfgang, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawlor, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falconi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempero, M. A.</span></span>; <span class="NLM_contrib-group">Australian Pancreatic Cancer</span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genome, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilarsky, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musgrove, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biankin, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimmond, S. M.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Whole genomes redefine the mutational landscape of pancreatic cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>518</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1038/nature14169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnature14169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25719666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsVagurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=518&publication_year=2015&pages=495-501&author=N.+Waddellauthor=M.+Pajicauthor=A.-M.+Patchauthor=D.+K.+Changauthor=K.+S.+Kassahnauthor=P.+Baileyauthor=A.+L.+Johnsauthor=D.+Millerauthor=K.+Nonesauthor=K.+Quekauthor=M.+C.+J.+Quinnauthor=A.+J.+Robertsonauthor=M.+Z.+H.+Fadlullahauthor=T.+J.+C.+Bruxnerauthor=A.+N.+Christauthor=I.+Harliwongauthor=S.+Idrisogluauthor=S.+Manningauthor=C.+Nourseauthor=E.+Nourbakhshauthor=S.+Waniauthor=P.+J.+Wilsonauthor=E.+Markhamauthor=N.+Cloonanauthor=M.+J.+Andersonauthor=J.+L.+Finkauthor=O.+Holmesauthor=S.+H.+Kazakoffauthor=C.+Leonardauthor=F.+Newellauthor=B.+Poudelauthor=S.+Songauthor=D.+Taylorauthor=N.+Waddellauthor=S.+Woodauthor=Q.+Xuauthor=J.+Wuauthor=M.+Pineseauthor=M.+J.+Cowleyauthor=H.+C.+Leeauthor=M.+D.+Jonesauthor=A.+M.+Nagrialauthor=J.+Humphrisauthor=L.+A.+Chantrillauthor=V.+Chinauthor=A.+M.+Steinmannauthor=A.+Mawsonauthor=E.+S.+Humphreyauthor=E.+K.+Colvinauthor=A.+Chouauthor=C.+J.+Scarlettauthor=A.+V.+Pinhoauthor=M.+Giry-Laterriereauthor=I.+Roomanauthor=J.+S.+Samraauthor=J.+G.+Kenchauthor=J.+A.+Pettittauthor=N.+D.+Merrettauthor=C.+Toonauthor=K.+Epariauthor=N.+Q.+Nguyenauthor=A.+Barbourauthor=N.+Zepsauthor=N.+B.+Jamiesonauthor=J.+S.+Grahamauthor=S.+P.+Niclouauthor=R.+Bjerkvigauthor=R.+Grutzmannauthor=D.+Austauthor=R.+H.+Hrubanauthor=A.+Maitraauthor=C.+A.+Iacobuzio-Donahueauthor=C.+L.+Wolfgangauthor=R.+A.+Morganauthor=R.+T.+Lawlorauthor=V.+Corboauthor=C.+Bassiauthor=M.+Falconiauthor=G.+Zamboniauthor=G.+Tortoraauthor=M.+A.+Temperoauthor=Australian+Pancreatic+Cancerauthor=I.+Genomeauthor=A.+J.+Gillauthor=J.+R.+Eshlemanauthor=C.+Pilarskyauthor=A.+Scarpaauthor=E.+A.+Musgroveauthor=J.+V.+Pearsonauthor=A.+V.+Biankinauthor=S.+M.+Grimmond&title=Whole+genomes+redefine+the+mutational+landscape+of+pancreatic+cancer&doi=10.1038%2Fnature14169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Whole genomes redefine the mutational landscape of pancreatic cancer</span></div><div class="casAuthors">Waddell, Nicola; Pajic, Marina; Patch, Ann-Marie; Chang, David K.; Kassahn, Karin S.; Bailey, Peter; Johns, Amber L.; Miller, David K.; Nones, Katia; Quek, Kelly; Quinn, Michael C. J.; Robertson, Alan J.; Fadlullah, Muhammad Z. H.; Bruxner, Tim J. C.; Christ, Angelika N.; Harliwong, Ivon; Idrisoglu, Senel; Manning, Suzanne; Nourse, Craig; Nourbakhsh, Ehsan; Wani, Shivangi; Wilson, Peter J.; Markham, Emma; Cloonan, Nicole; Anderson, Matthew J.; Fink, J. Lynn; Holmes, Oliver; Kazakoff, Stephen H.; Leonard, Conrad; Newell, Felicity; Poudel, Barsha; Song, Sarah; Taylor, Darrin; Waddell, Nick; Wood, Scott; Xu, Qinying; Wu, Jianmin; Pinese, Mark; Cowley, Mark J.; Lee, Hong C.; Jones, Marc D.; Nagrial, Adnan M.; Humphris, Jeremy; Chantrill, Lorraine A.; Chin, Venessa T.; Steinmann, Angela M.; Mawson, Amanda; Humphrey, Emily S.; Colvin, Emily K.; Chou, Angela; Scarlett, Christopher J.; Pinho, Andreia V.; Giry-Laterriere, Marc; Rooman, Ilse; Samra, Jaswinder S.; Kench, James G.; Pettitt, Jessica A.; Merrett, Neil D.; Toon, Christopher; Epari, Krishna P.; Nguyen, Nam Q.; Barbour, Andrew P.; Zeps, Nikolajs; Jamieson, Nigel B.; Graham, Janet S.; Niclou, Simone P.; Bjerkvig, Rolf; Grutzmann, Robert; Aust, Daniela; Hruban, Ralph H.; Maitra, Anirban; Iacobuzio-Donahue, Christine A.; Wolfgang, Christopher L.; Morgan, Richard A.; Lawlor, Rita T.; Corbo, Vincenzo; Bassi, Claudio; Falconi, Massimo; Zamboni, Giuseppe; Tortora, Giampaolo; Tempero, Margaret A.; Biankin, Andrew V.; Brancato, Mary-Anne L.; Rowe, Sarah J.; Simpson, Skye H.; Martyn-Smith, Mona; Thomas, Michelle T.; Chou, Angela; Mead, R. Scott; Pettit, Jessica; Tao, Jiang; Di Pietro, Renee; Watson, Clare; Lee, Hong Ching; Wong, Rachel; Giry-Laterriere, Marc; Daly, Roger J.; Musgrove, Elizabeth A.; Sutherland, Robert L.; Patch, Ann-Marie; Gongora, Milena; Xu, Christina; Lynn Fink, J.; Bruxner, Tim; Pearson, John V.; Nagaraj, Shivashankar; Krisnan, Keerthana; Wood, David; Gill, Anthony J.; Pavlakis, Nick; Guminski, Alex; Asghari, Ray; Pavey, Darren; Das, Amitabha; Cosman, Peter H.; Ismail, Kasim; O'Connnor, Chelsie; Lam Duncan McLeod, Vincent W.; Pleass, Henry C.; Richardson, Arthur; James, Virginia; Cooper, Caroline L.; Joseph, David; Sandroussi, Charbel; Crawford, Michael; Gallagher, James; Texler, Michael; Forest, Cindy; Laycock, Andrew; Ballal, Mo; Fletcher, David R.; Mukhedkar, Sanjay; Spry, Nigel A.; De Boer, Bastiaan; Chai, Ming; Beilin, Maria; Feeney, Kynan; Nguyen, Nan Q.; Ruszkiewicz, Andrew R.; Worthley, Chris; Tan, Chuan P.; Debrencini, Tamara; Chen, John; Brooke-Smith, Mark E.; Papangelis, Virginia; Tang, Henry; Clouston, Andrew D.; Martin, Patrick; O'Rourke, Thomas J.; Chiang, Amy; Fawcett, Jonathan W.; Slater, Kellee; Yeung, Shinn; Hatzifotis, Michael; Hodgkinson, Peter; Christophi, Christopher; Nikfarjam, Mehrdad; Mountain, Angela; Eshleman, James R.; Schulick, Richard D.; Hodgin, Mary; Scarpa, Aldo; Beghelli, Stefania; Scardoni, Maria; Grimmond, Sean M.; Oien, Karen; Hair, Jane; Pilarsky, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">518</span>
        (<span class="NLM_cas:issue">7540</span>),
    <span class="NLM_cas:pages">495-501</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pancreatic cancer remains one of the most lethal of malignancies and a major health burden.  We performed whole-genome sequencing and copy no. variation (CNV) anal. of 100 pancreatic ductal adenocarcinomas (PDACs).  Chromosomal rearrangements leading to gene disruption were prevalent, affecting genes known to be important in pancreatic cancer (TP53, SMAD4, CDKN2A, ARID1A and ROBO2) and new candidate drivers of pancreatic carcinogenesis (KDM6A and PREX2).  Patterns of structural variation (variation in chromosomal structure) classified PDACs into 4 subtypes with potential clin. utility: the subtypes were termed stable, locally rearranged, scattered and unstable.  A significant proportion harbored focal amplifications, many of which contained druggable oncogenes (ERBB2, MET, FGFR1, CDK6, PIK3R3 and PIK3CA), but at low individual patient prevalence.  Genomic instability co-segregated with inactivation of DNA maintenance genes (BRCA1, BRCA2 or PALB2) and a mutational signature of DNA damage repair deficiency.  Of 8 patients who received platinum therapy, 4 of 5 individuals with these measures of defective DNA maintenance responded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVXQXYMEyD4bVg90H21EOLACvtfcHk0lhQAuWWkGx0uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsVagurc%253D&md5=8e517355c91236f9f1717c21e4cfafe6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature14169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14169%26sid%3Dliteratum%253Aachs%26aulast%3DWaddell%26aufirst%3DN.%26aulast%3DPajic%26aufirst%3DM.%26aulast%3DPatch%26aufirst%3DA.-M.%26aulast%3DChang%26aufirst%3DD.%2BK.%26aulast%3DKassahn%26aufirst%3DK.%2BS.%26aulast%3DBailey%26aufirst%3DP.%26aulast%3DJohns%26aufirst%3DA.%2BL.%26aulast%3DMiller%26aufirst%3DD.%26aulast%3DNones%26aufirst%3DK.%26aulast%3DQuek%26aufirst%3DK.%26aulast%3DQuinn%26aufirst%3DM.%2BC.%2BJ.%26aulast%3DRobertson%26aufirst%3DA.%2BJ.%26aulast%3DFadlullah%26aufirst%3DM.%2BZ.%2BH.%26aulast%3DBruxner%26aufirst%3DT.%2BJ.%2BC.%26aulast%3DChrist%26aufirst%3DA.%2BN.%26aulast%3DHarliwong%26aufirst%3DI.%26aulast%3DIdrisoglu%26aufirst%3DS.%26aulast%3DManning%26aufirst%3DS.%26aulast%3DNourse%26aufirst%3DC.%26aulast%3DNourbakhsh%26aufirst%3DE.%26aulast%3DWani%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DP.%2BJ.%26aulast%3DMarkham%26aufirst%3DE.%26aulast%3DCloonan%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DM.%2BJ.%26aulast%3DFink%26aufirst%3DJ.%2BL.%26aulast%3DHolmes%26aufirst%3DO.%26aulast%3DKazakoff%26aufirst%3DS.%2BH.%26aulast%3DLeonard%26aufirst%3DC.%26aulast%3DNewell%26aufirst%3DF.%26aulast%3DPoudel%26aufirst%3DB.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DWaddell%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DPinese%26aufirst%3DM.%26aulast%3DCowley%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BC.%26aulast%3DJones%26aufirst%3DM.%2BD.%26aulast%3DNagrial%26aufirst%3DA.%2BM.%26aulast%3DHumphris%26aufirst%3DJ.%26aulast%3DChantrill%26aufirst%3DL.%2BA.%26aulast%3DChin%26aufirst%3DV.%26aulast%3DSteinmann%26aufirst%3DA.%2BM.%26aulast%3DMawson%26aufirst%3DA.%26aulast%3DHumphrey%26aufirst%3DE.%2BS.%26aulast%3DColvin%26aufirst%3DE.%2BK.%26aulast%3DChou%26aufirst%3DA.%26aulast%3DScarlett%26aufirst%3DC.%2BJ.%26aulast%3DPinho%26aufirst%3DA.%2BV.%26aulast%3DGiry-Laterriere%26aufirst%3DM.%26aulast%3DRooman%26aufirst%3DI.%26aulast%3DSamra%26aufirst%3DJ.%2BS.%26aulast%3DKench%26aufirst%3DJ.%2BG.%26aulast%3DPettitt%26aufirst%3DJ.%2BA.%26aulast%3DMerrett%26aufirst%3DN.%2BD.%26aulast%3DToon%26aufirst%3DC.%26aulast%3DEpari%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DN.%2BQ.%26aulast%3DBarbour%26aufirst%3DA.%26aulast%3DZeps%26aufirst%3DN.%26aulast%3DJamieson%26aufirst%3DN.%2BB.%26aulast%3DGraham%26aufirst%3DJ.%2BS.%26aulast%3DNiclou%26aufirst%3DS.%2BP.%26aulast%3DBjerkvig%26aufirst%3DR.%26aulast%3DGrutzmann%26aufirst%3DR.%26aulast%3DAust%26aufirst%3DD.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%2BA.%26aulast%3DWolfgang%26aufirst%3DC.%2BL.%26aulast%3DMorgan%26aufirst%3DR.%2BA.%26aulast%3DLawlor%26aufirst%3DR.%2BT.%26aulast%3DCorbo%26aufirst%3DV.%26aulast%3DBassi%26aufirst%3DC.%26aulast%3DFalconi%26aufirst%3DM.%26aulast%3DZamboni%26aufirst%3DG.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3DTempero%26aufirst%3DM.%2BA.%26aulast%3D%26aulast%3DGenome%26aufirst%3DI.%26aulast%3DGill%26aufirst%3DA.%2BJ.%26aulast%3DEshleman%26aufirst%3DJ.%2BR.%26aulast%3DPilarsky%26aufirst%3DC.%26aulast%3DScarpa%26aufirst%3DA.%26aulast%3DMusgrove%26aufirst%3DE.%2BA.%26aulast%3DPearson%26aufirst%3DJ.%2BV.%26aulast%3DBiankin%26aufirst%3DA.%2BV.%26aulast%3DGrimmond%26aufirst%3DS.%2BM.%26atitle%3DWhole%2520genomes%2520redefine%2520the%2520mutational%2520landscape%2520of%2520pancreatic%2520cancer%26jtitle%3DNature%26date%3D2015%26volume%3D518%26spage%3D495%26epage%3D501%26doi%3D10.1038%2Fnature14169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makohon-Moore, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohutek, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attiyeh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C. A.</span></span> <span> </span><span class="NLM_article-title">Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.1038/ng.3764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fng.3764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28092682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2017&pages=358-366&author=A.+P.+Makohon-Mooreauthor=M.+Zhangauthor=J.+G.+Reiterauthor=I.+Bozicauthor=B.+Allenauthor=D.+Kunduauthor=K.+Chatterjeeauthor=F.+Wongauthor=Y.+Jiaoauthor=Z.+A.+Kohutekauthor=J.+Hongauthor=M.+Attiyehauthor=B.+Javierauthor=L.+D.+Woodauthor=R.+H.+Hrubanauthor=M.+A.+Nowakauthor=N.+Papadopoulosauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=C.+A.+Iacobuzio-Donahue&title=Limited+heterogeneity+of+known+driver+gene+mutations+among+the+metastases+of+individual+patients+with+pancreatic+cancer&doi=10.1038%2Fng.3764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer</span></div><div class="casAuthors">Makohon-Moore, Alvin P.; Zhang, Ming; Reiter, Johannes G.; Bozic, Ivana; Allen, Benjamin; Kundu, Deepanjan; Chatterjee, Krishnendu; Wong, Fay; Jiao, Yuchen; Kohutek, Zachary A.; Hong, Jungeui; Attiyeh, Marc; Javier, Breanna; Wood, Laura D.; Hruban, Ralph H.; Nowak, Martin A.; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Iacobuzio-Donahue, Christine A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">358-366</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The extent of heterogeneity among driver gene mutations present in naturally occurring metastases-i.e., treatment-naive metastatic disease-is largely unknown.  To address this issue, we carried out 60× whole-genome sequencing of 26 metastases from four patients with pancreatic cancer.  We found that identical mutations in known driver genes were present in every metastatic lesion for each patient studied.  Passenger gene mutations, which do not have known or predicted functional consequences, accounted for all intratumoral heterogeneity.  Even with respect to these passenger mutations, our anal. suggests that the genetic similarity among the founding cells of metastases was higher than that expected for any two cells randomly taken from a normal tissue.  The uniformity of known driver gene mutations among metastases in the same patient has crit. and encouraging implications for the success of future targeted therapies in advanced-stage disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriVIIRrBsoCbVg90H21EOLACvtfcHk0lhEhRaxKJ5UMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCls7Y%253D&md5=82eb3061ea531307627bed2a6f1be543</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fng.3764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.3764%26sid%3Dliteratum%253Aachs%26aulast%3DMakohon-Moore%26aufirst%3DA.%2BP.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DReiter%26aufirst%3DJ.%2BG.%26aulast%3DBozic%26aufirst%3DI.%26aulast%3DAllen%26aufirst%3DB.%26aulast%3DKundu%26aufirst%3DD.%26aulast%3DChatterjee%26aufirst%3DK.%26aulast%3DWong%26aufirst%3DF.%26aulast%3DJiao%26aufirst%3DY.%26aulast%3DKohutek%26aufirst%3DZ.%2BA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DAttiyeh%26aufirst%3DM.%26aulast%3DJavier%26aufirst%3DB.%26aulast%3DWood%26aufirst%3DL.%2BD.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DNowak%26aufirst%3DM.%2BA.%26aulast%3DPapadopoulos%26aufirst%3DN.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%2BA.%26atitle%3DLimited%2520heterogeneity%2520of%2520known%2520driver%2520gene%2520mutations%2520among%2520the%2520metastases%2520of%2520individual%2520patients%2520with%2520pancreatic%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D2017%26volume%3D49%26spage%3D358%26epage%3D366%26doi%3D10.1038%2Fng.3764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leary, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angenendt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankoo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimeno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calhoun, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolskaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolsky, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartigan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffee, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karchin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmigiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velculescu, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span> <span> </span><span class="NLM_article-title">Core signaling pathways in human pancreatic cancers revealed by global genomic analyses</span>. <i>Science (Washington, DC, U. S.)</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>321</i></span>,  <span class="NLM_fpage">1801</span>– <span class="NLM_lpage">1806</span>, <span class="refDoi"> DOI: 10.1126/science.1164368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1126%2Fscience.1164368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=18772397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2008&pages=1801-1806&author=S.+Jonesauthor=X.+Zhangauthor=D.+W.+Parsonsauthor=J.+C.-H.+Linauthor=R.+J.+Learyauthor=P.+Angenendtauthor=P.+Mankooauthor=H.+Carterauthor=H.+Kamiyamaauthor=A.+Jimenoauthor=S.-M.+Hongauthor=B.+Fuauthor=M.-T.+Linauthor=E.+S.+Calhounauthor=M.+Kamiyamaauthor=K.+Walterauthor=T.+Nikolskayaauthor=Y.+Nikolskyauthor=J.+Hartiganauthor=D.+R.+Smithauthor=M.+Hidalgoauthor=S.+D.+Leachauthor=A.+P.+Kleinauthor=E.+M.+Jaffeeauthor=M.+Gogginsauthor=A.+Maitraauthor=C.+Iacobuzio-Donahueauthor=J.+R.+Eshlemanauthor=S.+E.+Kernauthor=R.+H.+Hrubanauthor=R.+Karchinauthor=N.+Papadopoulosauthor=G.+Parmigianiauthor=B.+Vogelsteinauthor=V.+E.+Velculescuauthor=K.+W.+Kinzler&title=Core+signaling+pathways+in+human+pancreatic+cancers+revealed+by+global+genomic+analyses&doi=10.1126%2Fscience.1164368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses</span></div><div class="casAuthors">Jones, Sian; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Leary, Rebecca J.; Angenendt, Philipp; Mankoo, Parminder; Carter, Hannah; Kamiyama, Hirohiko; Jimeno, Antonio; Hong, Seung-Mo; Fu, Baojin; Lin, Ming-Tseh; Calhoun, Eric S.; Kamiyama, Mihoko; Walter, Kimberly; Nikolskaya, Tatiana; Nikolsky, Yuri; Hartigan, James; Smith, Douglas R.; Hidalgo, Manuel; Leach, Steven D.; Klein, Alison P.; Jaffee, Elizabeth M.; Goggins, Michael; Maitra, Anirban; Iacobuzio-Donahue, Christine; Eshleman, James R.; Kern, Scott E.; Hruban, Ralph H.; Karchin, Rachel; Papadopoulos, Nickolas; Parmigiani, Giovanni; Vogelstein, Bert; Velculescu, Victor E.; Kinzler, Kenneth W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">5897</span>),
    <span class="NLM_cas:pages">1801-1806</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">There are currently few therapeutic options for patients with pancreatic cancer, and new insights into the pathogenesis of this lethal disease are urgently needed.  Toward this end, the authors performed a comprehensive genetic anal. of 24 pancreatic cancers.  The authors first detd. the sequences of 23,219 transcripts, representing 20,661 protein-coding genes, in these samples.  Then, the authors searched for homozygous deletions and amplifications in the tumor DNA by using microarrays contg. probes for ~106 single-nucleotide polymorphisms.  It was found that pancreatic cancers contain an av. of 63 genetic alterations, the majority of which are point mutations.  These alterations defined a core set of 12 cellular signaling pathways and processes that were each genetically altered in 67 to 100% of the tumors.  Anal. of these tumors' transcriptomes with next-generation sequencing-by-synthesis technologies provided independent evidence for the importance of these pathways and processes.  These data indicate that genetically altered core pathways and regulatory processes only become evident once the coding regions of the genome are analyzed in depth.  Dysregulation of these core pathways and processes through mutation can explain the major features of pancreatic tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopWEan4wZjSLVg90H21EOLACvtfcHk0lhgQChy5YZc6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtLrL&md5=62aa344f0bd3ba335cf6a8263ebbf29a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1164368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1164368%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DLin%26aufirst%3DJ.%2BC.-H.%26aulast%3DLeary%26aufirst%3DR.%2BJ.%26aulast%3DAngenendt%26aufirst%3DP.%26aulast%3DMankoo%26aufirst%3DP.%26aulast%3DCarter%26aufirst%3DH.%26aulast%3DKamiyama%26aufirst%3DH.%26aulast%3DJimeno%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DS.-M.%26aulast%3DFu%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DM.-T.%26aulast%3DCalhoun%26aufirst%3DE.%2BS.%26aulast%3DKamiyama%26aufirst%3DM.%26aulast%3DWalter%26aufirst%3DK.%26aulast%3DNikolskaya%26aufirst%3DT.%26aulast%3DNikolsky%26aufirst%3DY.%26aulast%3DHartigan%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%2BR.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DLeach%26aufirst%3DS.%2BD.%26aulast%3DKlein%26aufirst%3DA.%2BP.%26aulast%3DJaffee%26aufirst%3DE.%2BM.%26aulast%3DGoggins%26aufirst%3DM.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%26aulast%3DEshleman%26aufirst%3DJ.%2BR.%26aulast%3DKern%26aufirst%3DS.%2BE.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DKarchin%26aufirst%3DR.%26aulast%3DPapadopoulos%26aufirst%3DN.%26aulast%3DParmigiani%26aufirst%3DG.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26atitle%3DCore%2520signaling%2520pathways%2520in%2520human%2520pancreatic%2520cancers%2520revealed%2520by%2520global%2520genomic%2520analyses%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D2008%26volume%3D321%26spage%3D1801%26epage%3D1806%26doi%3D10.1126%2Fscience.1164368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biankin, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingras, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthuswamy, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patch, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harliwong, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idrisoglu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nourse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nourbakhsh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gongora, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarlett, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinho, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nones, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruxner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloonan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mead, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphris, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colvin, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagrial, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantrill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samra, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kench, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrett, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeps, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakkar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzny, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunicardi, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodges, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhay, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timms, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Borja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denroche, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yung, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onetto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulick, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfgang, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawlor, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scardoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempero, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Mancera, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Largaespada, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wessels, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rust, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musgrove, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimmond, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassahn, K. S.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>491</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1038/nature11547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnature11547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=23103869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOmt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=491&publication_year=2012&pages=399-405&author=A.+V.+Biankinauthor=N.+Waddellauthor=M.+C.+Gingrasauthor=L.+B.+Muthuswamyauthor=A.+L.+Johnsauthor=D.+K.+Millerauthor=P.+J.+Wilsonauthor=A.+M.+Patchauthor=J.+Wuauthor=D.+K.+Changauthor=M.+J.+Cowleyauthor=B.+B.+Gardinerauthor=S.+Songauthor=I.+Harliwongauthor=S.+Idrisogluauthor=C.+Nourseauthor=E.+Nourbakhshauthor=S.+Manningauthor=S.+Waniauthor=M.+Gongoraauthor=M.+Pajicauthor=C.+J.+Scarlettauthor=A.+J.+Gillauthor=A.+V.+Pinhoauthor=I.+Roomanauthor=M.+Andersonauthor=O.+Holmesauthor=C.+Leonardauthor=D.+Taylorauthor=S.+Woodauthor=Q.+Xuauthor=K.+Nonesauthor=J.+L.+Finkauthor=A.+Christauthor=T.+Bruxnerauthor=N.+Cloonanauthor=G.+Kolleauthor=F.+Newellauthor=M.+Pineseauthor=R.+S.+Meadauthor=J.+L.+Humphrisauthor=W.+Kaplanauthor=M.+D.+Jonesauthor=E.+K.+Colvinauthor=A.+M.+Nagrialauthor=E.+S.+Humphreyauthor=A.+Chouauthor=V.+T.+Chinauthor=L.+A.+Chantrillauthor=A.+Mawsonauthor=J.+S.+Samraauthor=J.+G.+Kenchauthor=J.+A.+Lovellauthor=R.+J.+Dalyauthor=N.+D.+Merrettauthor=C.+Toonauthor=K.+Epariauthor=N.+Q.+Nguyenauthor=A.+Barbourauthor=N.+Zepsauthor=N.+Kakkarauthor=F.+Zhaoauthor=Y.+Q.+Wuauthor=M.+Wangauthor=D.+M.+Muznyauthor=W.+E.+Fisherauthor=F.+C.+Brunicardiauthor=S.+E.+Hodgesauthor=J.+G.+Reidauthor=J.+Drummondauthor=K.+Changauthor=Y.+Hanauthor=L.+R.+Lewisauthor=H.+Dinhauthor=C.+J.+Buhayauthor=T.+Beckauthor=L.+Timmsauthor=M.+Samauthor=K.+Begleyauthor=A.+Brownauthor=D.+Paiauthor=A.+Panchalauthor=N.+Buchnerauthor=R.+De+Borjaauthor=R.+E.+Denrocheauthor=C.+K.+Yungauthor=S.+Serraauthor=N.+Onettoauthor=D.+Mukhopadhyayauthor=M.+S.+Tsaoauthor=P.+A.+Shawauthor=G.+M.+Petersenauthor=S.+Gallingerauthor=R.+H.+Hrubanauthor=A.+Maitraauthor=C.+A.+Iacobuzio-Donahueauthor=R.+D.+Schulickauthor=C.+L.+Wolfgangauthor=R.+A.+Morganauthor=R.+T.+Lawlorauthor=P.+Capelliauthor=V.+Corboauthor=M.+Scardoniauthor=G.+Tortoraauthor=M.+A.+Temperoauthor=K.+M.+Mannauthor=N.+A.+Jenkinsauthor=P.+A.+Perez-Manceraauthor=D.+J.+Adamsauthor=D.+A.+Largaespadaauthor=L.+F.+Wesselsauthor=A.+G.+Rustauthor=L.+D.+Steinauthor=D.+A.+Tuvesonauthor=N.+G.+Copelandauthor=E.+A.+Musgroveauthor=A.+Scarpaauthor=J.+R.+Eshlemanauthor=T.+J.+Hudsonauthor=R.+L.+Sutherlandauthor=D.+A.+Wheelerauthor=J.+V.+Pearsonauthor=J.+D.+McPhersonauthor=R.+A.+Gibbsauthor=S.+M.+Grimmondauthor=K.+S.+Kassahn&title=Pancreatic+cancer+genomes+reveal+aberrations+in+axon+guidance+pathway+genes&doi=10.1038%2Fnature11547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes</span></div><div class="casAuthors">Biankin, Andrew V.; Waddell, Nicola; Kassahn, Karin S.; Gingras, Marie-Claude; Muthuswamy, Lakshmi B.; Johns, Amber L.; Miller, David K.; Wilson, Peter J.; Patch, Ann-Marie; Wu, Jianmin; Chang, David K.; Cowley, Mark J.; Gardiner, Brooke B.; Song, Sarah; Harliwong, Ivon; Idrisoglu, Senel; Nourse, Craig; Nourbakhsh, Ehsan; Manning, Suzanne; Wani, Shivangi; Gongora, Milena; Pajic, Marina; Scarlett, Christopher J.; Gill, Anthony J.; Pinho, Andreia V.; Rooman, Ilse; Anderson, Matthew; Holmes, Oliver; Leonard, Conrad; Taylor, Darrin; Wood, Scott; Xu, Christina; Nones, Katia; Lynn Fink, J.; Christ, Angelika; Bruxner, Tim; Cloonan, Nicole; Kolle, Gabriel; Newell, Felicity; Pinese, Mark; Scott Mead, R.; Humphris, Jeremy L.; Kaplan, Warren; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chou, Angela; Chin, Venessa T.; Chantrill, Lorraine A.; Mawson, Amanda; Samra, Jaswinder S.; Kench, James G.; Lovell, Jessica A.; Daly, Roger J.; Merrett, Neil D.; Toon, Christopher; Epari, Krishna P.; Nguyen, Nam Q.; Barbour, Andrew P.; Zeps, Nikolajs; Brancato, Mary-Anne L.; Rowe, Sarah J.; Simpson, Skye L.; Martyn-Smith, Mona; Thomas, Michelle T.; Pettit, Jessica; Tao, Jiang; DiPietro, Renee; Watson, Clare; Wong, Rachel; Giry-Laterriere, Marc; Musgrove, Elizabeth A.; Sutherland, Robert L.; Grimmond, Sean M.; Patch, Ann-Marie; Nourse, Craig; Anderson, Matthew; Pavlakis, Nick; Guminski, Alex; Asghari, Ray; Pavey, Darren A.; Das, Amitabha; Cosman, Peter H.; Ismail, Kasim; O'Connor, Chelsie; Lam, Vincent W.; McLeod, Duncan; Pleass, Henry C.; Richardson, Arthur; James, Virginia; Cooper, Caroline L.; Joseph, David; Sandroussi, Charbel; Crawford, Michael; Gallagher, James; Texler, Michael; Forrest, Cindy; Laycock, Andrew; Ballal, Mo; Fletcher, David R.; Mukhedkar, Sanjay; Spry, Nigel A.; DeBoer, Bastiaan; Chai, Ming; Beilin, Maria; Feeney, Kynan; Ruszkiewicz, Andrew R.; Worthley, Chris; Tan, Chuan P.; Debrencini, Tamara; Chen, John; Brooke-Smith, Mark E.; Papangelis, Virginia; Tang, Henry; Clouston, Andrew D.; Martin, Patrick; O'Rourke, Thomas J.; Chiang, Amy; Fawcett, Jonathan W.; Slater, Kellee; Yeung, Shinn; Hatzifotis, Michael; Hodgkinson, Peter; Christophi, Christopher; Nikfarjam, Mehrdad; Eshleman, James R.; Hruban, Ralph H.; Maitra, Anirban; Iacobuzio-Donahue, Christine A.; Schulick, Richard D.; Wolfgang, Christopher L.; Morgan, Richard A.; Hodgin, Mary B.; Scarpa, Aldo; Lawlor, Rita T.; Capelli, Paola; Beghelli, Stefania; Corbo, Vincenzo; Scardoni, Maria; Pederzoli, Paolo; Tortora, Giampaolo; Bassi, Claudio; Tempero, Margaret A.; Kakkar, Nipun; Zhao, Fengmei; Wu, Yuan Qing; Wang, Min; Muzny, Donna M.; Fisher, William E.; Charles Brunicardi, F.; Hodges, Sally E.; Reid, Jeffrey G.; Drummond, Jennifer; Chang, Kyle; Han, Yi; Lewis, Lora R.; Dinh, Huyen; Buhay, Christian J.; Beck, Timothy; Timms, Lee; Sam, Michelle; Begley, Kimberly; Brown, Andrew; Pai, Deepa; Panchal, Ami; Buchner, Nicholas; De Borja, Richard; Denroche, Robert E.; Yung, Christina K.; Serra, Stefano; Onetto, Nicole; Mukhopadhyay, Debabrata; Tsao, Ming-Sound; Shaw, Patricia A.; Petersen, Gloria M.; Gallinger, Steven; Iacobuzio-Donahue, Christine A.; Mann, Karen M.; Jenkins, Nancy A.; Perez-Mancera, Pedro A.; Adams, David J.; Largaespada, David A.; Wessels, Lodewyk F. A.; Rust, Alistair G.; Stein, Lincoln D.; Tuveson, David A.; Copeland, Neal G.; Hudson, Thomas J.; Wheeler, David A.; McPherson, John D.; Gibbs, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">491</span>
        (<span class="NLM_cas:issue">7424</span>),
    <span class="NLM_cas:pages">399-405</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pancreatic cancer is a highly lethal malignancy with few effective therapies.  We performed exome sequencing and copy no. anal. to define genomic aberrations in a prospectively accrued clin. cohort (n = 142) of early (stage I and II) sporadic pancreatic ductal adenocarcinoma.  Detailed anal. of 99 informative tumors identified substantial heterogeneity with 2,016 non-silent mutations and 1,628 copy-no. variations.  We define 16 significantly mutated genes, reaffirming known mutations (KRAS, TP53, CDKN2A, SMAD4, MLL3, TGFBR2, ARID1A and SF3B1), and uncover novel mutated genes including addnl. genes involved in chromatin modification (EPC1 and ARID2), DNA damage repair (ATM) and other mechanisms (ZIM2, MAP2K4, NALCN, SLC16A4 and MAGEA6).  Integrative anal. with in vitro functional data and animal models provided supportive evidence for potential roles for these genetic aberrations in carcinogenesis.  Pathway-based anal. of recurrently mutated genes recapitulated clustering in core signalling pathways in pancreatic ductal adenocarcinoma, and identified new mutated genes in each pathway.  We also identified frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, which was also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement of axon guidance genes in pancreatic carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6I8TIAplbi7Vg90H21EOLACvtfcHk0lgi_mAh_NyVxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOmt7jN&md5=482b61e2d2caec25b5b68aa955f2fb74</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature11547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11547%26sid%3Dliteratum%253Aachs%26aulast%3DBiankin%26aufirst%3DA.%2BV.%26aulast%3DWaddell%26aufirst%3DN.%26aulast%3DGingras%26aufirst%3DM.%2BC.%26aulast%3DMuthuswamy%26aufirst%3DL.%2BB.%26aulast%3DJohns%26aufirst%3DA.%2BL.%26aulast%3DMiller%26aufirst%3DD.%2BK.%26aulast%3DWilson%26aufirst%3DP.%2BJ.%26aulast%3DPatch%26aufirst%3DA.%2BM.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DD.%2BK.%26aulast%3DCowley%26aufirst%3DM.%2BJ.%26aulast%3DGardiner%26aufirst%3DB.%2BB.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DHarliwong%26aufirst%3DI.%26aulast%3DIdrisoglu%26aufirst%3DS.%26aulast%3DNourse%26aufirst%3DC.%26aulast%3DNourbakhsh%26aufirst%3DE.%26aulast%3DManning%26aufirst%3DS.%26aulast%3DWani%26aufirst%3DS.%26aulast%3DGongora%26aufirst%3DM.%26aulast%3DPajic%26aufirst%3DM.%26aulast%3DScarlett%26aufirst%3DC.%2BJ.%26aulast%3DGill%26aufirst%3DA.%2BJ.%26aulast%3DPinho%26aufirst%3DA.%2BV.%26aulast%3DRooman%26aufirst%3DI.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DHolmes%26aufirst%3DO.%26aulast%3DLeonard%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DNones%26aufirst%3DK.%26aulast%3DFink%26aufirst%3DJ.%2BL.%26aulast%3DChrist%26aufirst%3DA.%26aulast%3DBruxner%26aufirst%3DT.%26aulast%3DCloonan%26aufirst%3DN.%26aulast%3DKolle%26aufirst%3DG.%26aulast%3DNewell%26aufirst%3DF.%26aulast%3DPinese%26aufirst%3DM.%26aulast%3DMead%26aufirst%3DR.%2BS.%26aulast%3DHumphris%26aufirst%3DJ.%2BL.%26aulast%3DKaplan%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DM.%2BD.%26aulast%3DColvin%26aufirst%3DE.%2BK.%26aulast%3DNagrial%26aufirst%3DA.%2BM.%26aulast%3DHumphrey%26aufirst%3DE.%2BS.%26aulast%3DChou%26aufirst%3DA.%26aulast%3DChin%26aufirst%3DV.%2BT.%26aulast%3DChantrill%26aufirst%3DL.%2BA.%26aulast%3DMawson%26aufirst%3DA.%26aulast%3DSamra%26aufirst%3DJ.%2BS.%26aulast%3DKench%26aufirst%3DJ.%2BG.%26aulast%3DLovell%26aufirst%3DJ.%2BA.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26aulast%3DMerrett%26aufirst%3DN.%2BD.%26aulast%3DToon%26aufirst%3DC.%26aulast%3DEpari%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DN.%2BQ.%26aulast%3DBarbour%26aufirst%3DA.%26aulast%3DZeps%26aufirst%3DN.%26aulast%3DKakkar%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DY.%2BQ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DMuzny%26aufirst%3DD.%2BM.%26aulast%3DFisher%26aufirst%3DW.%2BE.%26aulast%3DBrunicardi%26aufirst%3DF.%2BC.%26aulast%3DHodges%26aufirst%3DS.%2BE.%26aulast%3DReid%26aufirst%3DJ.%2BG.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DK.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DLewis%26aufirst%3DL.%2BR.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DBuhay%26aufirst%3DC.%2BJ.%26aulast%3DBeck%26aufirst%3DT.%26aulast%3DTimms%26aufirst%3DL.%26aulast%3DSam%26aufirst%3DM.%26aulast%3DBegley%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DPai%26aufirst%3DD.%26aulast%3DPanchal%26aufirst%3DA.%26aulast%3DBuchner%26aufirst%3DN.%26aulast%3DDe%2BBorja%26aufirst%3DR.%26aulast%3DDenroche%26aufirst%3DR.%2BE.%26aulast%3DYung%26aufirst%3DC.%2BK.%26aulast%3DSerra%26aufirst%3DS.%26aulast%3DOnetto%26aufirst%3DN.%26aulast%3DMukhopadhyay%26aufirst%3DD.%26aulast%3DTsao%26aufirst%3DM.%2BS.%26aulast%3DShaw%26aufirst%3DP.%2BA.%26aulast%3DPetersen%26aufirst%3DG.%2BM.%26aulast%3DGallinger%26aufirst%3DS.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%2BA.%26aulast%3DSchulick%26aufirst%3DR.%2BD.%26aulast%3DWolfgang%26aufirst%3DC.%2BL.%26aulast%3DMorgan%26aufirst%3DR.%2BA.%26aulast%3DLawlor%26aufirst%3DR.%2BT.%26aulast%3DCapelli%26aufirst%3DP.%26aulast%3DCorbo%26aufirst%3DV.%26aulast%3DScardoni%26aufirst%3DM.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3DTempero%26aufirst%3DM.%2BA.%26aulast%3DMann%26aufirst%3DK.%2BM.%26aulast%3DJenkins%26aufirst%3DN.%2BA.%26aulast%3DPerez-Mancera%26aufirst%3DP.%2BA.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DLargaespada%26aufirst%3DD.%2BA.%26aulast%3DWessels%26aufirst%3DL.%2BF.%26aulast%3DRust%26aufirst%3DA.%2BG.%26aulast%3DStein%26aufirst%3DL.%2BD.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DCopeland%26aufirst%3DN.%2BG.%26aulast%3DMusgrove%26aufirst%3DE.%2BA.%26aulast%3DScarpa%26aufirst%3DA.%26aulast%3DEshleman%26aufirst%3DJ.%2BR.%26aulast%3DHudson%26aufirst%3DT.%2BJ.%26aulast%3DSutherland%26aufirst%3DR.%2BL.%26aulast%3DWheeler%26aufirst%3DD.%2BA.%26aulast%3DPearson%26aufirst%3DJ.%2BV.%26aulast%3DMcPherson%26aufirst%3DJ.%2BD.%26aulast%3DGibbs%26aufirst%3DR.%2BA.%26aulast%3DGrimmond%26aufirst%3DS.%2BM.%26aulast%3DKassahn%26aufirst%3DK.%2BS.%26atitle%3DPancreatic%2520cancer%2520genomes%2520reveal%2520aberrations%2520in%2520axon%2520guidance%2520pathway%2520genes%26jtitle%3DNature%26date%3D2012%26volume%3D491%26spage%3D399%26epage%3D405%26doi%3D10.1038%2Fnature11547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2016</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.3322/caac.21332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.3322%2Fcaac.21332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26742998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC28rot1Kjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2016&pages=7-30&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2016&doi=10.3322%2Fcaac.21332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2016</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries.  Mortality data were collected by the National Center for Health Statistics.  In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States.  Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009-2012), much of which is because of recent rapid declines in prostate cancer diagnoses.  The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012.  Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease.  Among children and adolescents (aged birth-19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia.  Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKAn5ROFAaRS86Js-BCLiifW6udTcc2eZMoZqtxAHv-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rot1Kjug%253D%253D&md5=2d4030a531945c5ebaaab181bfd80457</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21332%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202016%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2016%26volume%3D66%26spage%3D7%26epage%3D30%26doi%3D10.3322%2Fcaac.21332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span> <i>Statistics
by Cancer Type</i>; <span class="NLM_publisher-name">Cancer Research</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2017</span>; <a href="http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer_-_heading-Two" class="extLink">http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer_-_heading-Two</a> (accessed January 6, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Statistics%0Aby+Cancer+Type%3B+Cancer+Research%3A+London%2C+2017%3B+http%3A%2F%2Fwww.cancerresearchuk.org%2Fhealth-professional%2Fcancer-statistics%2Fstatistics-by-cancer-type%2Fpancreatic-cancer_-_heading-Two+%28accessed+January+6%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DStatistics%250Aby%2520Cancer%2520Type%26pub%3DCancer%2520Research%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carmichael, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spittle, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiessi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatter, J.</span></span> <span> </span><span class="NLM_article-title">Phase II study of gemcitabine in patients with advanced pancreatic cancer</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1038/bjc.1996.18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fbjc.1996.18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=8554969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADyaK28Xht12iurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1996&pages=101-105&author=J.+Carmichaelauthor=U.+Finkauthor=R.+C.+Russellauthor=M.+F.+Spittleauthor=A.+L.+Harrisauthor=G.+Spiessiauthor=J.+Blatter&title=Phase+II+study+of+gemcitabine+in+patients+with+advanced+pancreatic+cancer&doi=10.1038%2Fbjc.1996.18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II study of gemcitabine in patients with advanced pancreatic cancer</span></div><div class="casAuthors">Carmichael, J; Fink, U; Russell, RCG; Spittle, MF; Harris, AL; Spiessi, G; Blatter, J</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-5</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The efficacy and safety of gemcitabine at a starting dose of 800 mg/m2 administered once a week for 3 wk with 1 wk's rest was investigated in chemonaive patients with advanced and/or metastatic pancreatic cancer.  Of 34 patients, 32 were evaluable for efficacy, 20 patients had metastatic stage IV disease, 25 had a performance status of 1 and 26 (76%) patients has significant pain on presentation.  All responses were independently validated by an external oncol. review board: two patients achieved a partial response that lasted 5.8 and 5.2 mo (6.3%) and six patients were stable for at least 4 wk.  The median duration of survival for evaluable patients was 6.3 mo (range 1.6-19.2 mo).  The tumor markers, CEA, CA 19-9 and CA 195 were serially measured in 16 patients.  There was a good correlation with tumor response when all three markers were significantly decreased.  In 4 of 16 patients, tumor marker levels decreased by ≈60%, including the two responders, one patient who survived for 12 mo and one patient who showed objective tumor shrinkage but was deemed ineligible for response evaluation because the disease was considered not to be bidimensionally measurable.  Symptomatic benefits included improvement in performance status (17.2%), analgesic requirement (7.4%), pain score (28.6%) and nausea (27.3%).  The mean no. of cycles administered was 2.5 and the mean dosage received was 890 mg/m2 per injection.  Seventy-four per cent of dose administrations were given on schedule.  Toxicity, particularly hematol. toxicity, reported as the max. WHO grade experienced by patients was mild.  Infective episodes were rare and limited to WHO grade 2 (6.7%).  Nausea and vomiting was generally modest (WHO grade 3, 26.7%).  Other side-effects included mild transient flu-like symptoms (seven patients) and peripheral edema (three patients), which was not assocd. with abnormal cardiac hepatic or renal function.  Gemcitabine has modest activity in pancreatic cancer, a limited pos. improvement on a range of patient benefit parameters and has a mild toxicity profile.  For these reasons and because of its novel mode of action, gemcitabine warrants further investigation in combination studies in pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJnn1RADnTt7Vg90H21EOLACvtfcHk0lgLhvJz7GHhTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xht12iurc%253D&md5=32651c020bdac10da4e6d082222b0e24</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1996.18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1996.18%26sid%3Dliteratum%253Aachs%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DFink%26aufirst%3DU.%26aulast%3DRussell%26aufirst%3DR.%2BC.%26aulast%3DSpittle%26aufirst%3DM.%2BF.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26aulast%3DSpiessi%26aufirst%3DG.%26aulast%3DBlatter%26aufirst%3DJ.%26atitle%3DPhase%2520II%2520study%2520of%2520gemcitabine%2520in%2520patients%2520with%2520advanced%2520pancreatic%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1996%26volume%3D73%26spage%3D101%26epage%3D105%26doi%3D10.1038%2Fbjc.1996.18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Von
Hoff, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ervin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiorean, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjulandin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleh, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laheru, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahary, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabernero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Cutsem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iglesias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renschler, M. F.</span></span> <span> </span><span class="NLM_article-title">Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1703</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1304369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1056%2FNEJMoa1304369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=24131140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCjsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=1691-1703&author=D.+D.+Von%0AHoffauthor=T.+Ervinauthor=F.+P.+Arenaauthor=E.+G.+Chioreanauthor=J.+Infanteauthor=M.+Mooreauthor=T.+Seayauthor=S.+A.+Tjulandinauthor=W.+W.+Maauthor=M.+N.+Salehauthor=M.+Harrisauthor=M.+Reniauthor=S.+Dowdenauthor=D.+Laheruauthor=N.+Baharyauthor=R.+K.+Ramanathanauthor=J.+Taberneroauthor=M.+Hidalgoauthor=D.+Goldsteinauthor=E.+Van+Cutsemauthor=X.+Weiauthor=J.+Iglesiasauthor=M.+F.+Renschler&title=Increased+survival+in+pancreatic+cancer+with+nab-paclitaxel+plus+gemcitabine&doi=10.1056%2FNEJMoa1304369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine</span></div><div class="casAuthors">Von Hoff, Daniel D.; Ervin, Thomas; Arena, Francis P.; Chiorean, E. Gabriela; Infante, Jeffrey; Moore, Malcolm; Seay, Thomas; Tjulandin, Sergei A.; Ma, Wen Wee; Saleh, Mansoor N.; Harris, Marion; Reni, Michele; Dowden, Scot; Laheru, Daniel; Bahary, Nathan; Ramanathan, Ramesh K.; Tabernero, Josep; Hidalgo, Manuel; Goldstein, David; Van Cutsem, Eric; Wei, Xinyu; Iglesias, Jose; Renschler, Markus F.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1691-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: In a phase 1-2 trial of albumin-bound paclitaxel (nab-paclitaxel) plus gemcitabine, substantial clin. activity was noted in patients with advanced pancreatic cancer.  We conducted a phase 3 study of the efficacy and safety of the combination vs. gemcitabine monotherapy in patients with metastatic pancreatic cancer.  METHODS: We randomly assigned patients with a Karnofsky performance-status score of 70 or more (on a scale from 0 to 100, with higher scores indicating better performance status) to nab-paclitaxel (125 mg per square meter of body-surface area) followed by gemcitabine (1000 mg per square meter) on days 1, 8, and 15 every 4 wk or gemcitabine monotherapy (1000 mg per square meter) weekly for 7 of 8 wk (cycle 1) and then on days 1, 8, and 15 every 4 wk (cycle 2 and subsequent cycles).  Patients received the study treatment until disease progression.  The primary end point was overall survival; secondary end points were progression-free survival and overall response rate.  RESULTS: A total of 861 patients were randomly assigned to nab-paclitaxel plus gemcitabine (431 patients) or gemcitabine (430).  The median overall survival was 8.5 mo in the nab-paclitaxel-gemcitabine group as compared with 6.7 mo in the gemcitabine group (hazard ratio for death, 0.72; 95% confidence interval [CI], 0.62 to 0.83; P<0.001).  The survival rate was 35% in the nab-paclitaxel-gemcitabine group vs. 22% in the gemcitabine group at 1 yr, and 9% vs. 4% at 2 years.  The median progression-free survival was 5.5 mo in the nab-paclitaxel-gemcitabine group, as compared with 3.7 mo in the gemcitabine group (hazard ratio for disease progression or death, 0.69; 95% CI, 0.58 to 0.82; P<0.001); the response rate according to independent review was 23% vs. 7% in the two groups (P<0.001).  The most common adverse events of grade 3 or higher were neutropenia (38% in the nab-paclitaxel-gemcitabine group vs. 27% in the gemcitabine group), fatigue (17% vs. 7%), and neuropathy (17% vs. 1%).  Febrile neutropenia occurred in 3% vs. 1% of the patients in the two groups.  In the nab-paclitaxel-gemcitabine group, neuropathy of grade 3 or higher improved to grade 1 or lower in a median of 29 days.  CONCLUSIONS: In patients with metastatic pancreatic adenocarcinoma, nab-paclitaxel plus gemcitabine significantly improved overall survival, progression-free survival, and response rate, but rates of peripheral neuropathy and myelosuppression were increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCXpODbQZ6dLVg90H21EOLACvtfcHk0ljhQmLgMShAgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCjsb7I&md5=b1169c7e9879c08061dd9e9389dc36fe</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1304369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1304369%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DErvin%26aufirst%3DT.%26aulast%3DArena%26aufirst%3DF.%2BP.%26aulast%3DChiorean%26aufirst%3DE.%2BG.%26aulast%3DInfante%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DSeay%26aufirst%3DT.%26aulast%3DTjulandin%26aufirst%3DS.%2BA.%26aulast%3DMa%26aufirst%3DW.%2BW.%26aulast%3DSaleh%26aufirst%3DM.%2BN.%26aulast%3DHarris%26aufirst%3DM.%26aulast%3DReni%26aufirst%3DM.%26aulast%3DDowden%26aufirst%3DS.%26aulast%3DLaheru%26aufirst%3DD.%26aulast%3DBahary%26aufirst%3DN.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DVan%2BCutsem%26aufirst%3DE.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DIglesias%26aufirst%3DJ.%26aulast%3DRenschler%26aufirst%3DM.%2BF.%26atitle%3DIncreased%2520survival%2520in%2520pancreatic%2520cancer%2520with%2520nab-paclitaxel%2520plus%2520gemcitabine%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D1691%26epage%3D1703%26doi%3D10.1056%2FNEJMoa1304369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desseigne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ychou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouche, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimbaud, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becouarn, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adenis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raoul, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourgou-Bourgade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Fouchardiere, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennouna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachet, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khemissa-Akouz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pere-Verge, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assenat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauffert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoto-Grillot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducreux, M.</span></span> <span> </span><span class="NLM_article-title">FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>364</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1825</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1011923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1056%2FNEJMoa1011923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=21561347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvF2jsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=1817-1825&author=T.+Conroyauthor=F.+Desseigneauthor=M.+Ychouauthor=O.+Boucheauthor=R.+Guimbaudauthor=Y.+Becouarnauthor=A.+Adenisauthor=J.+L.+Raoulauthor=S.+Gourgou-Bourgadeauthor=C.+de+la+Fouchardiereauthor=J.+Bennounaauthor=J.+B.+Bachetauthor=F.+Khemissa-Akouzauthor=D.+Pere-Vergeauthor=C.+Delbaldoauthor=E.+Assenatauthor=B.+Chauffertauthor=P.+Michelauthor=C.+Montoto-Grillotauthor=M.+Ducreux&title=FOLFIRINOX+versus+gemcitabine+for+metastatic+pancreatic+cancer&doi=10.1056%2FNEJMoa1011923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">FOLFIRINOX versus gemcitabine or metastatic pancreatic cancer</span></div><div class="casAuthors">Conroy, Thierry; Desseigne, Francoise; Ychou, Marc; Bouche, Olivier; Guimbaud, Rosine; Becouarn, Yves; Adenis, Antoine; Raoul, Jean-Luc; Gourgou-Bourgade, Sophie; de la Fouchardiere, Christelle; Bennouna, Jaafar; Bachet, Jean-Baptiste; Khemissa-Akouz, Faiza; Pere-Verge, Denis; Delbaldo, Catherine; Assenat, Eric; Chauffert, Bruno; Michel, Pierre; Montoto-Grillot, Christine; Ducreux, Michel</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1817-1825</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Data are lacking on the efficacy and safety of a combination chemotherapy regimen consisting of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) as compared with gemcitabine as first-line therapy in patients with metastatic pancreatic cancer.  METHODS We randomly assigned 342 patients with an Eastern Cooperative Oncol. Group performance status score of 0 or 1 (on a scale of 0 to 5, with higher scores indicating a greater severity of illness) to receive FOLFIRINOX (oxaliplatin, 85 mg per square meter of body-surface area; irinotecan, 180 mg per square meter; leucovorin, 400 mg per square meter; and fluorouracil, 400 mg per square meter given as a bolus followed by 2400 mg per square meter given as a 46-h continuous infusion, every 2 wk) or gemcitabine at a dose of 1000 mg per square meter weekly for 7 of 8 wk and then weekly for 3 of 4 wk.  Six months of chemotherapy were recommended in both groups in patients who had a response.  The primary end point was overall survival.  RESULTS The median overall survival was 11.1 mo in the FOLFIRINOX group as compared with 6.8 mo in the gemcitabine group (hazard ratio for death, 0.57; 95% confidence interval [CI], 0.45 to 0.73; P < 0.001).  Median progression-free survival was 6.4 mo in the FOLFIRINOX group and 3.3 mo in the gemcitabine group (hazard ratio for disease progression, 0.47; 95% CI, 0.37 to 0.59; P < 0.001).  The objective response rate was 31.60% in the FOLFIRINOX group vs. 9.4% in the gemcitabine group (P < 0.001).  More adverse events were noted in the FOLFIRINOX group; 5.4% of patients in this group had febrile neutropenia.  At 6 mo, 31% of the patients in the FOLFIRINOX group had a definitive degrdn. of the quality of life vs. 66% in the gemcitabine group (hazard ratio, 0.47; 95% CI, 0.30 to 0.70; P < 0.001).  CONCLUSIONS As compared with gemcitabine, FOLFIRINOX was assocd. with a survival advantage and had increased toxicity.  FOLFIRINOX is an option for the treatment of patients with metastatic pancreatic cancer and good performance status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGyDR85GUgOrVg90H21EOLACvtfcHk0ljhQmLgMShAgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvF2jsrw%253D&md5=a1a7135a6c97c4dc47233465ce0defd5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1011923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1011923%26sid%3Dliteratum%253Aachs%26aulast%3DConroy%26aufirst%3DT.%26aulast%3DDesseigne%26aufirst%3DF.%26aulast%3DYchou%26aufirst%3DM.%26aulast%3DBouche%26aufirst%3DO.%26aulast%3DGuimbaud%26aufirst%3DR.%26aulast%3DBecouarn%26aufirst%3DY.%26aulast%3DAdenis%26aufirst%3DA.%26aulast%3DRaoul%26aufirst%3DJ.%2BL.%26aulast%3DGourgou-Bourgade%26aufirst%3DS.%26aulast%3Dde%2Bla%2BFouchardiere%26aufirst%3DC.%26aulast%3DBennouna%26aufirst%3DJ.%26aulast%3DBachet%26aufirst%3DJ.%2BB.%26aulast%3DKhemissa-Akouz%26aufirst%3DF.%26aulast%3DPere-Verge%26aufirst%3DD.%26aulast%3DDelbaldo%26aufirst%3DC.%26aulast%3DAssenat%26aufirst%3DE.%26aulast%3DChauffert%26aufirst%3DB.%26aulast%3DMichel%26aufirst%3DP.%26aulast%3DMontoto-Grillot%26aufirst%3DC.%26aulast%3DDucreux%26aufirst%3DM.%26atitle%3DFOLFIRINOX%2520versus%2520gemcitabine%2520for%2520metastatic%2520pancreatic%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D1817%26epage%3D1825%26doi%3D10.1056%2FNEJMoa1011923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismail, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vartak, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittinghofer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastiaens, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibition of the KRAS-PDEdelta interaction impairs oncogenic KRAS signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>497</i></span>,  <span class="NLM_fpage">638</span>– <span class="NLM_lpage">642</span>, <span class="refDoi"> DOI: 10.1038/nature12205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnature12205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=23698361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFSgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=497&publication_year=2013&pages=638-642&author=G.+Zimmermannauthor=B.+Papkeauthor=S.+Ismailauthor=N.+Vartakauthor=A.+Chandraauthor=M.+Hoffmannauthor=S.+A.+Hahnauthor=G.+Triolaauthor=A.+Wittinghoferauthor=P.+I.+Bastiaensauthor=H.+Waldmann&title=Small+molecule+inhibition+of+the+KRAS-PDEdelta+interaction+impairs+oncogenic+KRAS+signalling&doi=10.1038%2Fnature12205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling</span></div><div class="casAuthors">Zimmermann, Gunther; Papke, Bjoern; Ismail, Shehab; Vartak, Nachiket; Chandra, Anchal; Hoffmann, Maike; Hahn, Stephan A.; Triola, Gemma; Wittinghofer, Alfred; Bastiaens, Philippe I. H.; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">497</span>
        (<span class="NLM_cas:issue">7451</span>),
    <span class="NLM_cas:pages">638-642</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The KRAS oncogene product is considered a major target in anticancer drug discovery.  However, direct interference with KRAS signalling has not yet led to clin. useful drugs.  Correct localization and signalling by farnesylated KRAS is regulated by the prenyl-binding protein PDEδ, which sustains the spatial organization of KRAS by facilitating its diffusion in the cytoplasm.  Here we report that interfering with binding of mammalian PDEδ to KRAS by means of small mols. provides a novel opportunity to suppress oncogenic RAS signalling by altering its localization to endomembranes.  Biochem. screening and subsequent structure-based hit optimization yielded inhibitors of the KRAS-PDEδ interaction that selectively bind to the prenyl-binding pocket of PDEδ with nanomolar affinity, inhibit oncogenic RAS signalling and suppress in vitro and in vivo proliferation of human pancreatic ductal adenocarcinoma cells that are dependent on oncogenic KRAS.  Our findings may inspire novel drug discovery efforts aimed at the development of drugs targeting oncogenic RAS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj4LMNyMIV4LVg90H21EOLACvtfcHk0lg0_PkZg3xeVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFSgtbs%253D&md5=e8dfd498bfd4dafbebf07fee9128e6b0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature12205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12205%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DG.%26aulast%3DPapke%26aufirst%3DB.%26aulast%3DIsmail%26aufirst%3DS.%26aulast%3DVartak%26aufirst%3DN.%26aulast%3DChandra%26aufirst%3DA.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DHahn%26aufirst%3DS.%2BA.%26aulast%3DTriola%26aufirst%3DG.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DBastiaens%26aufirst%3DP.%2BI.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DSmall%2520molecule%2520inhibition%2520of%2520the%2520KRAS-PDEdelta%2520interaction%2520impairs%2520oncogenic%2520KRAS%2520signalling%26jtitle%3DNature%26date%3D2013%26volume%3D497%26spage%3D638%26epage%3D642%26doi%3D10.1038%2Fnature12205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Quadruplex nucleic acids as novel therapeutic targets</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5987</span>– <span class="NLM_lpage">6011</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01835</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01835" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5987-6011&author=S.+Neidle&title=Quadruplex+nucleic+acids+as+novel+therapeutic+targets&doi=10.1021%2Facs.jmedchem.5b01835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Quadruplex Nucleic Acids as Novel Therapeutic Targets</span></div><div class="casAuthors">Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5987-6011</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quadruplex-forming sequences are widely prevalent in human and other genomes, including bacterial ones.  These sequences are over-represented in eukaryotic telomeres, promoters, and 5' untranslated regions.  They can form quadruplex structures, which may be transient in many situations in normal cells since they can be effectively resolved by helicase action.  Mutated helicases in cancer cells are unable to unwind quadruplexes, which are impediments to transcription, translation, or replication, depending on their location within a particular gene.  Small mols. that can stabilize quadruplex structures augment these effects and produce cell and proliferation growth inhibition.  This article surveys the chem. biol. of quadruplexes.  It critically examines the major classes of quadruplex-binding small mols. that have been developed to date and the various approaches to discovering selective agents.  The challenges of requiring (and achieving) small-mol. targeted selectivity for a particular quadruplex are discussed in relation to the potential of these small mols. as clin. useful therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZLAJfhJHYjrVg90H21EOLACvtfcHk0lg0_PkZg3xeVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOlsr0%253D&md5=73a5a4b3ba0b33128500a3f9420700ed</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01835%26sid%3Dliteratum%253Aachs%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DQuadruplex%2520nucleic%2520acids%2520as%2520novel%2520therapeutic%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5987%26epage%3D6011%26doi%3D10.1021%2Facs.jmedchem.5b01835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huppert, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span> <span> </span><span class="NLM_article-title">G-quadruplexes in promoters throughout the human genome</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">406</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1093/nar/gkl1057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fnar%2Fgkl1057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=17169996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=406-413&author=J.+L.+Huppertauthor=S.+Balasubramanian&title=G-quadruplexes+in+promoters+throughout+the+human+genome&doi=10.1093%2Fnar%2Fgkl1057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">G-quadruplexes in promoters throughout the human genome</span></div><div class="casAuthors">Huppert, Julian L.; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">406-413</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Certain G-rich DNA sequences readily form four-stranded structures called G-quadruplexes.  These sequence motifs are located in telomeres as a repeated unit, and elsewhere in the genome, where their function is currently unknown.  It has been proposed that G-quadruplexes may be directly involved in gene regulation at the level of transcription.  In support of this hypothesis, we show that the promoter regions (1 kb upstream of the transcription start site TSS) of genes are significantly enriched in quadruplex motifs relative to the rest of the genome, with >40% of human gene promoters contg. one or more quadruplex motif.  Furthermore, these promoter quadruplexes strongly assoc. with nuclease hypersensitive sites identified throughout the genome via biochem. measurement.  Regions of the human genome that are both nuclease hypersensitive and within promoters show a remarkable (230-fold) enrichment of quadruplex elements, compared to the rest of the genome.  These quadruplex motifs identified in promoter regions also show an interesting structural bias towards more stable forms.  These observations support the proposal that promoter G-quadruplexes are directly involved in the regulation of gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofaKOSq_qjKrVg90H21EOLACvtfcHk0lg0_PkZg3xeVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOls74%253D&md5=626903207653e1c97d568b9b50c093bd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkl1057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkl1057%26sid%3Dliteratum%253Aachs%26aulast%3DHuppert%26aufirst%3DJ.%2BL.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DG-quadruplexes%2520in%2520promoters%2520throughout%2520the%2520human%2520genome%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3D406%26epage%3D413%26doi%3D10.1093%2Fnar%2Fgkl1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansel-Hertsch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beraldi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lensing, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsico, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zyner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Antonio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannahill, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span> <span> </span><span class="NLM_article-title">G-quadruplex structures mark human regulatory chromatin</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1267</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1038/ng.3662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fng.3662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=27618450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFSgurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=1267-1272&author=R.+Hansel-Hertschauthor=D.+Beraldiauthor=S.+V.+Lensingauthor=G.+Marsicoauthor=K.+Zynerauthor=A.+Parryauthor=M.+Di+Antonioauthor=J.+Pikeauthor=H.+Kimuraauthor=M.+Naritaauthor=D.+Tannahillauthor=S.+Balasubramanian&title=G-quadruplex+structures+mark+human+regulatory+chromatin&doi=10.1038%2Fng.3662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">G-quadruplex structures mark human regulatory chromatin</span></div><div class="casAuthors">Hansel-Hertsch, Robert; Beraldi, Dario; Lensing, Stefanie V.; Marsico, Giovanni; Zyner, Katherine; Parry, Aled; Di Antonio, Marco; Pike, Jeremy; Kimura, Hiroshi; Narita, Masashi; Tannahill, David; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1267-1272</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G-quadruplex (G4) structural motifs have been linked to transcription, replication and genome instability and are implicated in cancer and other diseases.  However, it is crucial to demonstrate the bona fide formation of G4 structures within an endogenous chromatin context.  Herein we address this through the development of G4 ChIP-seq, an antibody-based G4 chromatin immunopptn. and high-throughput sequencing approach.  We find ∼10,000 G4 structures in human chromatin, predominantly in regulatory, nucleosome-depleted regions.  G4 structures are enriched in the promoters and 5' UTRs of highly transcribed genes, particularly in genes related to cancer and in somatic copy no. amplifications, such as MYC.  Strikingly, de novo and enhanced G4 formation are assocd. with increased transcriptional activity, as shown by HDAC inhibitor-induced chromatin relaxation and obsd. in immortalized as compared to normal cellular states.  Our findings show that regulatory, nucleosome-depleted chromatin and elevated transcription shape the endogenous human G4 DNA landscape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYo8vsZd_UZLVg90H21EOLACvtfcHk0ljCa3WPZRplKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFSgurvP&md5=898d19559a9ccbc0ff468558a653fc43</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fng.3662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.3662%26sid%3Dliteratum%253Aachs%26aulast%3DHansel-Hertsch%26aufirst%3DR.%26aulast%3DBeraldi%26aufirst%3DD.%26aulast%3DLensing%26aufirst%3DS.%2BV.%26aulast%3DMarsico%26aufirst%3DG.%26aulast%3DZyner%26aufirst%3DK.%26aulast%3DParry%26aufirst%3DA.%26aulast%3DDi%2BAntonio%26aufirst%3DM.%26aulast%3DPike%26aufirst%3DJ.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DTannahill%26aufirst%3DD.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DG-quadruplex%2520structures%2520mark%2520human%2520regulatory%2520chromatin%26jtitle%3DNat.%2520Genet.%26date%3D2016%26volume%3D48%26spage%3D1267%26epage%3D1272%26doi%3D10.1038%2Fng.3662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, V.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsico, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Antonio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span> <span> </span><span class="NLM_article-title">High-throughput sequencing of DNA G-quadruplex structures in the human genome</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">881</span>, <span class="refDoi"> DOI: 10.1038/nbt.3295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnbt.3295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26192317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FksFOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=877-881&author=V.%0AS.+Chambersauthor=G.+Marsicoauthor=J.+M.+Boutellauthor=M.+Di+Antonioauthor=G.+P.+Smithauthor=S.+Balasubramanian&title=High-throughput+sequencing+of+DNA+G-quadruplex+structures+in+the+human+genome&doi=10.1038%2Fnbt.3295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput sequencing of DNA G-quadruplex structures in the human genome</span></div><div class="casAuthors">Chambers Vicki S; Marsico Giovanni; Boutell Jonathan M; Smith Geoffrey P; Di Antonio Marco; Balasubramanian Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nature biotechnology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">877-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">G-quadruplexes (G4s) are nucleic acid secondary structures that form within guanine-rich DNA or RNA sequences.  G4 formation can affect chromatin architecture and gene regulation and has been associated with genomic instability, genetic diseases and cancer progression.  Here we present a high-resolution sequencing-based method to detect G4s in the human genome.  We identified 716,310 distinct G4 structures, 451,646 of which were not predicted by computational methods.  These included previously uncharacterized noncanonical long loop and bulged structures.  We observed a high G4 density in functional regions, such as 5' untranslated regions and splicing sites, as well as in genes previously not predicted to contain these structures (such as BRCA2).  G4 formation was significantly associated with oncogenes, tumor suppressors and somatic copy number alterations related to cancer development.  The G4s identified in this study may therefore represent promising targets for cancer intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTr_GulKgy_aSjiVMCqkKxVfW6udTcc2ebQ-qFEDInpz7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FksFOltA%253D%253D&md5=e8b1e1dcb44cc030cd843817f507f92e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnbt.3295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.3295%26sid%3Dliteratum%253Aachs%26aulast%3DChambers%26aufirst%3DV.%2BS.%26aulast%3DMarsico%26aufirst%3DG.%26aulast%3DBoutell%26aufirst%3DJ.%2BM.%26aulast%3DDi%2BAntonio%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DG.%2BP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DHigh-throughput%2520sequencing%2520of%2520DNA%2520G-quadruplex%2520structures%2520in%2520the%2520human%2520genome%26jtitle%3DNat.%2520Biotechnol.%26date%3D2015%26volume%3D33%26spage%3D877%26epage%3D881%26doi%3D10.1038%2Fnbt.3295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biffi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannahill, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCafferty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span> <span> </span><span class="NLM_article-title">Quantitative visualization of DNA G-quadruplex structures in human cells</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1038/nchem.1548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnchem.1548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=23422559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=182-186&author=G.+Biffiauthor=D.+Tannahillauthor=J.+McCaffertyauthor=S.+Balasubramanian&title=Quantitative+visualization+of+DNA+G-quadruplex+structures+in+human+cells&doi=10.1038%2Fnchem.1548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative visualization of DNA G-quadruplex structures in human cells</span></div><div class="casAuthors">Biffi, Giulia; Tannahill, David; McCafferty, John; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">182-186</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Four-stranded G-quadruplex nucleic acid structures are of great interest as their high thermodn. stability under near-physiol. conditions suggests that they could form in cells.  Here we report the generation and application of an engineered, structure-specific antibody employed to quant. visualize DNA G-quadruplex structures in human cells.  We show explicitly that G-quadruplex formation in DNA is modulated during cell-cycle progression and that endogenous G-quadruplex DNA structures can be stabilized by a small-mol. ligand.  Together these findings provide substantive evidence for the formation of G-quadruplex structures in the genome of mammalian cells and corroborate the application of stabilizing ligands in a cellular context to target G-quadruplexes and intervene with their function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhn6OP0CwcSLVg90H21EOLACvtfcHk0liSnIfbvsy0Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSms7o%253D&md5=1721b2fba0fd65bfedd758b273c80f21</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1548%26sid%3Dliteratum%253Aachs%26aulast%3DBiffi%26aufirst%3DG.%26aulast%3DTannahill%26aufirst%3DD.%26aulast%3DMcCafferty%26aufirst%3DJ.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DQuantitative%2520visualization%2520of%2520DNA%2520G-quadruplex%2520structures%2520in%2520human%2520cells%26jtitle%3DNat.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D182%26epage%3D186%26doi%3D10.1038%2Fnchem.1548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosh, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansdorp, P. M.</span></span> <span> </span><span class="NLM_article-title">Detection of G-quadruplex DNA in mammalian cells</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">860</span>– <span class="NLM_lpage">869</span>, <span class="refDoi"> DOI: 10.1093/nar/gkt957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fnar%2Fgkt957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=24163102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlShsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=860-869&author=A.+Hendersonauthor=Y.+Wuauthor=Y.+C.+Huangauthor=E.+A.+Chavezauthor=J.+Plattauthor=F.+B.+Johnsonauthor=R.+M.+Broshauthor=D.+Senauthor=P.+M.+Lansdorp&title=Detection+of+G-quadruplex+DNA+in+mammalian+cells&doi=10.1093%2Fnar%2Fgkt957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of G-quadruplex DNA in mammalian cells</span></div><div class="casAuthors">Henderson, Alexander; Wu, Yuliang; Huang, Yu Chuan; Chavez, Elizabeth A.; Platt, Jesse; Johnson, F. Brad; Brosh, Robert M., Jr.; Sen, Dipankar; Lansdorp, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">860-869</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">It has been proposed that guanine-rich DNA forms four-stranded structures in vivo called G-quadruplexes or G4 DNA.  G4 DNA has been implicated in several biol. processes, but tools to study G4 DNA structures in cells are limited.  Here we report the development of novel murine monoclonal antibodies specific for different G4 DNA structures.  We show that one of these antibodies designated 1H6 exhibits strong nuclear staining in most human and murine cells.  Staining intensity increased on treatment of cells with agents that stabilize G4 DNA and, strikingly, cells deficient in FANCJ, a G4 DNA-specific helicase, showed stronger nuclear staining than controls.  Our data strongly support the existence of G4 DNA structures in mammalian cells and indicate that the abundance of such structures is increased in the absence of FANCJ.  We conclude that monoclonal antibody 1H6 is a valuable tool for further studies on the role of G4 DNA in cell and mol. biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrli0PqZbZA3bVg90H21EOLACvtfcHk0liSnIfbvsy0Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlShsrw%253D&md5=a16e8096cfaa3f7d8d7d045294a6fa3f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt957%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.%2BC.%26aulast%3DChavez%26aufirst%3DE.%2BA.%26aulast%3DPlatt%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DF.%2BB.%26aulast%3DBrosh%26aufirst%3DR.%2BM.%26aulast%3DSen%26aufirst%3DD.%26aulast%3DLansdorp%26aufirst%3DP.%2BM.%26atitle%3DDetection%2520of%2520G-quadruplex%2520DNA%2520in%2520mammalian%2520cells%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26spage%3D860%26epage%3D869%26doi%3D10.1093%2Fnar%2Fgkt957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biffi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannahill, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howat, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span> <span> </span><span class="NLM_article-title">Elevated levels of G-quadruplex formation in human stomach and liver cancer tissues</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e102711</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0102711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1371%2Fjournal.pone.0102711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25033211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ehur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e102711&author=G.+Biffiauthor=D.+Tannahillauthor=J.+Millerauthor=W.+J.+Howatauthor=S.+Balasubramanian&title=Elevated+levels+of+G-quadruplex+formation+in+human+stomach+and+liver+cancer+tissues&doi=10.1371%2Fjournal.pone.0102711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated levels of G-quadruplex formation in human stomach and liver cancer tissues</span></div><div class="casAuthors">Biffi, Giulia; Tannahill, David; Miller, Jodi; Howat, William J.; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e102711/1-e102711/9, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Four-stranded G-quadruplex DNA secondary structures have recently been visualized in the nuclei of human cultured cells.  Here, we show that BG4, a G-quadruplex-specific antibody, can be used to stain DNA G-quadruplex structures in patient-derived tissues using immunohistochem.  We observe a significantly elevated no. of G-quadruplex-pos. nuclei in human cancers of the liver and stomach as compared to background non-neoplastic tissue.  Our results suggest that G-quadruplex formation can be detected and measured in patient-derived material and that elevated G-quadruplex formation may be a characteristic of some cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNw8M-YLkC47Vg90H21EOLACvtfcHk0liSnIfbvsy0Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ehur7P&md5=25c316d253cfb80c0f5195ee524a0fe6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0102711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0102711%26sid%3Dliteratum%253Aachs%26aulast%3DBiffi%26aufirst%3DG.%26aulast%3DTannahill%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DJ.%26aulast%3DHowat%26aufirst%3DW.%2BJ.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DElevated%2520levels%2520of%2520G-quadruplex%2520formation%2520in%2520human%2520stomach%2520and%2520liver%2520cancer%2520tissues%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De102711%26doi%3D10.1371%2Fjournal.pone.0102711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Monchaud, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teulade-Fichou, M. P.</span></span> <span> </span><span class="NLM_article-title">A hitchhiker’s guide to G-quadruplex ligands</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">636</span>, <span class="refDoi"> DOI: 10.1039/B714772B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1039%2FB714772B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=18264563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1yksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=627-636&author=D.+Monchaudauthor=M.+P.+Teulade-Fichou&title=A+hitchhiker%E2%80%99s+guide+to+G-quadruplex+ligands&doi=10.1039%2FB714772B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">A hitchhiker's guide to G-quadruplex ligands</span></div><div class="casAuthors">Monchaud, David; Teulade-Fichou, Marie-Paule</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">627-636</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Over the past decade, nucleic acid chemists have seen the spectacular emergence of mols. designed to interact efficiently and selectively with a peculiar DNA structure named G-quadruplex.  Initially derived from classical DNA intercalators, these G-quadruplex ligands progressively became the focal point of new excitement since they appear to inhibit selectively the growth of cancer cells thereby opening interesting perspectives towards the development of novel anti-cancer drugs.  The present review article aims to help researchers enter this exciting research field, and to highlight recent advances in the design of G-quadruplex ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocJwqI1pO4abVg90H21EOLACvtfcHk0liSnIfbvsy0Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1yksLs%253D&md5=6fb7438f6a893ab816818d5799e3ef62</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1039%2FB714772B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB714772B%26sid%3Dliteratum%253Aachs%26aulast%3DMonchaud%26aufirst%3DD.%26aulast%3DTeulade-Fichou%26aufirst%3DM.%2BP.%26atitle%3DA%2520hitchhiker%25E2%2580%2599s%2520guide%2520to%2520G-quadruplex%2520ligands%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D627%26epage%3D636%26doi%3D10.1039%2FB714772B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="note"><p class="first last">29</p></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, R.</span></span> <span> </span><span class="NLM_article-title">G-quadruplex interacting small molecules and drugs: from bench towards bedside</span>. <i>Expert Rev. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">679</span>, <span class="refDoi"> DOI: 10.1586/17512433.2014.945909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1586%2F17512433.2014.945909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25089820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlequ7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=663-679&author=S.+M%C3%BCllerauthor=R.+Rodriguez&title=G-quadruplex+interacting+small+molecules+and+drugs%3A+from+bench+towards+bedside&doi=10.1586%2F17512433.2014.945909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">G-quadruplex interacting small molecules and drugs: from bench toward bedside</span></div><div class="casAuthors">Mueller, Sebastian; Rodriguez, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">663-679</span>CODEN:
                <span class="NLM_cas:coden">ERCPAG</span>;
        ISSN:<span class="NLM_cas:issn">1751-2433</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  G-quadruplexes are non-Watson-Crick four-stranded nucleic acid structures.  Recent evidence points toward their existence in vivo and their implication in various biol. processes.  Over the past two decades, small mols. have been developed to specifically and selectively target these structures in order to dissect mechanisms they have been linked to.  This has led to the development of potential therapeutic agents, particularly for anti-carcinogenic activity.  Here, we first present how major biol. roles of G-quadruplexes have been uncovered by the use of specifically designed small mol. probes.  We use this to highlight how fundamental research has contributed to identifying biol. functions of G-quadruplexes and their potential as therapeutic targets.  We then discuss the development of G-quadruplex interacting small mols. as potential drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe7SVTmBTFjLVg90H21EOLACvtfcHk0ljMa6pfyVUZCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlequ7vM&md5=1fd176d2c918892fbb45e8b5e4e2f064</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1586%2F17512433.2014.945909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F17512433.2014.945909%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DRodriguez%26aufirst%3DR.%26atitle%3DG-quadruplex%2520interacting%2520small%2520molecules%2520and%2520drugs%253A%2520from%2520bench%2520towards%2520bedside%26jtitle%3DExpert%2520Rev.%2520Clin.%2520Pharmacol.%26date%3D2014%26volume%3D7%26spage%3D663%26epage%3D679%26doi%3D10.1586%2F17512433.2014.945909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurston, D. E.</span></span> <span> </span><span class="NLM_article-title">Recent advances in targeting the telomeric G-quadruplex DNA sequence with small molecules as a strategy for anticancer therapies</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1259</span>– <span class="NLM_lpage">1290</span>, <span class="refDoi"> DOI: 10.4155/fmc-2015-0017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.4155%2Ffmc-2015-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=27442231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1GitbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1259-1290&author=M.+K.+Islamauthor=P.+J.+Jacksonauthor=K.+M.+Rahmanauthor=D.+E.+Thurston&title=Recent+advances+in+targeting+the+telomeric+G-quadruplex+DNA+sequence+with+small+molecules+as+a+strategy+for+anticancer+therapies&doi=10.4155%2Ffmc-2015-0017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in targeting the telomeric G-quadruplex DNA sequence with small molecules as a strategy for anticancer therapies</span></div><div class="casAuthors">Islam, Mohammad K.; Jackson, Paul JM; Rahman, Khondaker M.; Thurston, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1259-1290</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Human telomeric DNA (hTelo), present at the ends of chromosomes to protect their integrity during cell division, comprises tandem repeats of the sequence d(TTAGGG) which is known to form a G-quadruplex secondary structure.  This unique structural formation of DNA is distinct from the well-known helical structure that most genomic DNA is thought to adopt, and has recently gained prominence as a mol. target for new types of anticancer agents.  In particular, compds. that can stabilize the intramol. G-quadruplex formed within the human telomeric DNA sequence can inhibit the activity of the enzyme telomerase which is known to be upregulated in tumor cells and is a major contributor to their immortality.  This provides the basis for the discovery and development of small mols. with the potential for selective toxicity toward tumor cells.  This review summarizes the various families of small mols. reported in the literature that have telomeric quadruplex stabilizing properties, and assesses the potential for compds. of this type to be developed as novel anticancer therapies.  A future perspective is also presented, emphasizing the need for researchers to adopt approaches that will allow the discovery of mols. with more drug-like properties in order to improve the chances of lead mols. reaching the clinic in the next decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdBY7z5P_hnrVg90H21EOLACvtfcHk0ljMa6pfyVUZCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1GitbvN&md5=e4958c74af6d2859a6d997d7d1c0d22b</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2015-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2015-0017%26sid%3Dliteratum%253Aachs%26aulast%3DIslam%26aufirst%3DM.%2BK.%26aulast%3DJackson%26aufirst%3DP.%2BJ.%26aulast%3DRahman%26aufirst%3DK.%2BM.%26aulast%3DThurston%26aufirst%3DD.%2BE.%26atitle%3DRecent%2520advances%2520in%2520targeting%2520the%2520telomeric%2520G-quadruplex%2520DNA%2520sequence%2520with%2520small%2520molecules%2520as%2520a%2520strategy%2520for%2520anticancer%2520therapies%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D1259%26epage%3D1290%26doi%3D10.4155%2Ffmc-2015-0017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grand, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bearss, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, L. H.</span></span> <span> </span><span class="NLM_article-title">Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">11593</span>– <span class="NLM_lpage">11598</span>, <span class="refDoi"> DOI: 10.1073/pnas.182256799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1073%2Fpnas.182256799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=12195017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFWqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11593-11598&author=A.+Siddiqui-Jainauthor=C.+L.+Grandauthor=D.+J.+Bearssauthor=L.+H.+Hurley&title=Direct+evidence+for+a+G-quadruplex+in+a+promoter+region+and+its+targeting+with+a+small+molecule+to+repress+c-MYC+transcription&doi=10.1073%2Fpnas.182256799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription</span></div><div class="casAuthors">Siddiqui-Jain, Adam; Grand, Cory L.; Bearss, David J.; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">11593-11598</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The nuclease hypersensitivity element III1 upstream of the P1 promoter of c-MYC controls 85-90% of the transcriptional activation of this gene.  We have demonstrated that the purine-rich strand of the DNA in this region can form two different intramol. G-quadruplex structures, only one of which seems to be biol. relevant.  This biol. relevant structure is the kinetically favored chairform G-quadruplex, which is destabilized when mutated with a single G → A transition, resulting in a 3-fold increase in basal transcriptional activity of the c-MYC promoter.  The cationic porphyrin TMPyP4, which has been shown to stabilize this G-quadruplex structure, is able to suppress further c-MYC transcriptional activation.  These results provide compelling evidence that a specific G-quadruplex structure formed in the c-MYC promoter region functions as a transcriptional repressor element.  Furthermore, we establish the principle that c-MYC transcription can be controlled by ligand-mediated G-quadruplex stabilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzMKd0v3rpM7Vg90H21EOLACvtfcHk0ljMa6pfyVUZCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFWqsL4%253D&md5=5f2767891816e2364405e1a4b37eba48</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.182256799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.182256799%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DGrand%26aufirst%3DC.%2BL.%26aulast%3DBearss%26aufirst%3DD.%2BJ.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DDirect%2520evidence%2520for%2520a%2520G-quadruplex%2520in%2520a%2520promoter%2520region%2520and%2520its%2520targeting%2520with%2520a%2520small%2520molecule%2520to%2520repress%2520c-MYC%2520transcription%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D11593%26epage%3D11598%26doi%3D10.1073%2Fpnas.182256799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rigo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sissi, C.</span></span> <span> </span><span class="NLM_article-title">G-quadruplexes in human promoters: A challenge for therapeutic applications</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1861</i></span>,  <span class="NLM_fpage">1399</span>– <span class="NLM_lpage">1413</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2016.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.bbagen.2016.12.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28025083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltlShug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1861&publication_year=2017&pages=1399-1413&author=R.+Rigoauthor=M.+Palumboauthor=C.+Sissi&title=G-quadruplexes+in+human+promoters%3A+A+challenge+for+therapeutic+applications&doi=10.1016%2Fj.bbagen.2016.12.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">G-quadruplexes in human promoters: A challenge for therapeutic applications</span></div><div class="casAuthors">Rigo, Riccardo; Palumbo, Manlio; Sissi, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1861</span>
        (<span class="NLM_cas:issue">5_Part_B</span>),
    <span class="NLM_cas:pages">1399-1413</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  G-rich sequences undergo unique structural equil. to form G-quadruplexes (G4) both in vitro and in cell systems.  Several pathologies emerged to be directly related to G4 occurrence at defined genomic portions.  Addnl., G-rich sequences are significantly represented around transcription start sites (TSS) thus leading to the hypothesis of a gene regulatory function for G4.  Thus, the tuning of G4 formation has been proposed as a new powerful tool to regulate gene expression to treat related pathologies.  However, up-to date this approach did not provide any new really efficient treatment.  Here, we summarize the most recent advances on the correlation between the structural features of G4 in human promoters and the role these systems physiol. exert.  In particular we focus on the effect of G4 localization among cell compartments and along the promoters in correlation with protein interaction networks and epigenetic state.  Finally the intrinsic structural features of G4 at promoters are discussed to unveil the contribution of different G4 structural modules in this complex architecture.  It emerges that G4s play several roles in the intriguing and complex mechanism of gene expression, being able to produce opposite effects on the same target.  This reflects the occurrence of a highly variegate network of several components working simultaneously.  The resulting picture is still fuzzy but some points of strength are definitely emerging, which prompts all of us to strengthen our efforts in view of a selective control of gene expression through G4 modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx7Z5yaojLhbVg90H21EOLACvtfcHk0linV9VSQoa56w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltlShug%253D%253D&md5=82140fbd55b29ecddf9586d6d9d6701e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2016.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2016.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DRigo%26aufirst%3DR.%26aulast%3DPalumbo%26aufirst%3DM.%26aulast%3DSissi%26aufirst%3DC.%26atitle%3DG-quadruplexes%2520in%2520human%2520promoters%253A%2520A%2520challenge%2520for%2520therapeutic%2520applications%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2017%26volume%3D1861%26spage%3D1399%26epage%3D1413%26doi%3D10.1016%2Fj.bbagen.2016.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Boddupally, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhale, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, L. H.</span></span> <span> </span><span class="NLM_article-title">Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6076</span>– <span class="NLM_lpage">6086</span>, <span class="refDoi"> DOI: 10.1021/jm300282c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300282c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC38Xotlemu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6076-6086&author=P.+V.+Boddupallyauthor=S.+Hahnauthor=C.+Bemanauthor=B.+Deauthor=T.+A.+Brooksauthor=V.+Gokhaleauthor=L.+H.+Hurley&title=Anticancer+activity+and+cellular+repression+of+c-MYC+by+the+G-quadruplex-stabilizing+11-piperazinylquindoline+is+not+dependent+on+direct+targeting+of+the+G-quadruplex+in+the+c-MYC+promoter&doi=10.1021%2Fjm300282c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Activity and Cellular Repression of c-MYC by the G-Quadruplex-Stabilizing 11-Piperazinylquindoline Is Not Dependent on Direct Targeting of the G-Quadruplex in the c-MYC Promoter</span></div><div class="casAuthors">Boddupally, Peda V. L.; Hahn, Seongmin; Beman, Cristina; De, Biswanath; Brooks, Tracy A.; Gokhale, Vijay; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6076-6086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This G-rich region of the c-MYC promoter has been shown to form a G-quadruplex structure that acts as a silencer element for c-MYC transcriptional control.  In the present work, we have synthesized a series of 11-substituted quindoline analogs as c-MYC G-quadruplex-stabilizing compds., and the cell-free and in vitro activity of these compds. were evaluated.  Two lead compds. (4 and 12) demonstrated good cell-free profiles, and compd. 4 (2-(4-(10H-indolo[3,2-b]quinolin-11-yl)piperazin-1-yl)-N,N-dimethylethanamine) significantly down-regulated c-MYC expression.  However, despite the good cell-free activity and the effect of these compds. on c-MYC gene expression, we have demonstrated, using a cellular assay in a Burkitt's lymphoma cell line (CA46-specific), that these effects were not mediated through targeting of the c-MYC G-quadruplex.  Thus, caution should be used in assigning the effects of G-quadruplex-interactive compds. that lower c-MYC to direct targeting of these promoter elements unless this assay, or similar ones, demonstrates direct targeting of the G-quadruplex in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaQnhUeWAjMLVg90H21EOLACvtfcHk0linV9VSQoa56w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xotlemu7Y%253D&md5=fb167ae59f4bffbac5bd48672ae4a319</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm300282c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300282c%26sid%3Dliteratum%253Aachs%26aulast%3DBoddupally%26aufirst%3DP.%2BV.%26aulast%3DHahn%26aufirst%3DS.%26aulast%3DBeman%26aufirst%3DC.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DBrooks%26aufirst%3DT.%2BA.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DAnticancer%2520activity%2520and%2520cellular%2520repression%2520of%2520c-MYC%2520by%2520the%2520G-quadruplex-stabilizing%252011-piperazinylquindoline%2520is%2520not%2520dependent%2520on%2520direct%2520targeting%2520of%2520the%2520G-quadruplex%2520in%2520the%2520c-MYC%2520promoter%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6076%26epage%3D6086%26doi%3D10.1021%2Fjm300282c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danford, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhale, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, T. A.</span></span> <span> </span><span class="NLM_article-title">Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">41018</span>– <span class="NLM_lpage">41027</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.274720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1074%2Fjbc.M111.274720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=21956115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOqu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=41018-41027&author=R.+V.+Brownauthor=F.+L.+Danfordauthor=V.+Gokhaleauthor=L.+H.+Hurleyauthor=T.+A.+Brooks&title=Demonstration+that+drug-targeted+down-regulation+of+MYC+in+non-Hodgkins+lymphoma+is+directly+mediated+through+the+promoter+G-quadruplex&doi=10.1074%2Fjbc.M111.274720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Demonstration that drug-targeted down-regulation of MYC in Non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex</span></div><div class="casAuthors">Brown, Robert V.; Danford, Forest L.; Gokhale, Vijay; Hurley, Laurence H.; Brooks, Tracy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">41018-41027</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Most transcription of the MYC proto-oncogene initiates in the near upstream promoter, within which lies the nuclease hypersensitive element (NHE) III1 region contg. the CT-element.  This dynamic stretch of DNA can form at least three different topologies: single-stranded DNA, double-stranded DNA, or higher order secondary structures that silence transcription.  In the current report, we identify the ellipticine analog GQC-05 (NSC338258) as a high affinity, potent, and selective stabilizer of the MYC G-quadruplex (G4).  In cells, GQC-05 induced cytotoxicity with corresponding decreased MYC mRNA and altered protein binding to the NHE III1 region, in agreement with a G4 stabilizing compd.  We further describe a unique feature of the Burkitt's lymphoma cell line CA46 that allowed us to clearly demonstrate the mechanism and location of action of GQC-05 within this region of DNA and through the G4.  Most importantly, these data present, as far as we are aware, the most direct evidence of intracellular G4-mediated control of a particular promoter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg8phSNhEgRrVg90H21EOLACvtfcHk0linV9VSQoa56w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOqu7fO&md5=62ecbb643265e2b4e0e7bc051043b46f</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.274720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.274720%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BV.%26aulast%3DDanford%26aufirst%3DF.%2BL.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26aulast%3DBrooks%26aufirst%3DT.%2BA.%26atitle%3DDemonstration%2520that%2520drug-targeted%2520down-regulation%2520of%2520MYC%2520in%2520non-Hodgkins%2520lymphoma%2520is%2520directly%2520mediated%2520through%2520the%2520promoter%2520G-quadruplex%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D41018%26epage%3D41027%26doi%3D10.1074%2Fjbc.M111.274720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit24c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Felsenstein, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gareiss, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneekloth, J. S.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Small molecule microarrays enable the identification of a selective, quadruplex-binding inhibitor of MYC expression</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00577</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00577" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Cqtr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=139-148&author=K.+M.+Felsensteinauthor=L.+B.+Saundersauthor=J.+K.+Simmonsauthor=E.+Leonauthor=D.+R.+Calabreseauthor=S.+Zhangauthor=A.+Michalowskiauthor=P.+Gareissauthor=B.+A.+Mockauthor=J.+S.+Schneekloth&title=Small+molecule+microarrays+enable+the+identification+of+a+selective%2C+quadruplex-binding+inhibitor+of+MYC+expression&doi=10.1021%2Facschembio.5b00577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24cR"><div class="casContent"><span class="casTitleNuber">24c</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression</span></div><div class="casAuthors">Felsenstein, Kenneth M.; Saunders, Lindsey B.; Simmons, John K.; Leon, Elena; Calabrese, David R.; Zhang, Shuling; Michalowski, Aleksandra; Gareiss, Peter; Mock, Beverly A.; Schneekloth, John S., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-148</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transcription factor MYC plays a pivotal role in cancer initiation, progression, and maintenance.  However, it has proven difficult to develop small mol. inhibitors of MYC.  One attractive route to pharmacol. inhibition of MYC has been the prevention of its expression through small mol.-mediated stabilization of the G-quadruplex (G4) present in its promoter.  Although mols. that bind globally to quadruplex DNA and influence gene expression are well-known, the identification of new chem. scaffolds that selectively modulate G4-driven genes remains a challenge.  Here, we report an approach for the identification of G4-binding small mols. using small mol. microarrays (SMMs).  We use the SMM screening platform to identify a novel G4-binding small mol. that inhibits MYC expression in cell models, with minimal impact on the expression of other G4-assocd. genes.  Surface plasmon resonance (SPR) and thermal melt assays demonstrated that this mol. binds reversibly to the MYC G4 with single digit micromolar affinity, and with weaker or no measurable binding to other G4s.  Biochem. and cell-based assays demonstrated that the compd. effectively silenced MYC transcription and translation via a G4-dependent mechanism of action.  The compd. induced G1 arrest and was selectively toxic to MYC-driven cancer cell lines contg. the G4 in the promoter but had minimal effects in peripheral blood mononucleocytes or a cell line lacking the G4 in its MYC promoter.  As a measure of selectivity, gene expression anal. and qPCR expts. demonstrated that MYC and several MYC target genes were downregulated upon treatment with this compd., while the expression of several other G4-driven genes was not affected.  In addn. to providing a novel chem. scaffold that modulates MYC expression through G4 binding, this work suggests that the SMM screening approach may be broadly useful as an approach for the identification of new G4-binding small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc_vBHrAhtdrVg90H21EOLACvtfcHk0ljH4XU3MnJXsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Cqtr7J&md5=2987c07be00c2d7c20e2e991c332a71f</span></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00577%26sid%3Dliteratum%253Aachs%26aulast%3DFelsenstein%26aufirst%3DK.%2BM.%26aulast%3DSaunders%26aufirst%3DL.%2BB.%26aulast%3DSimmons%26aufirst%3DJ.%2BK.%26aulast%3DLeon%26aufirst%3DE.%26aulast%3DCalabrese%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DMichalowski%26aufirst%3DA.%26aulast%3DGareiss%26aufirst%3DP.%26aulast%3DMock%26aufirst%3DB.%2BA.%26aulast%3DSchneekloth%26aufirst%3DJ.%2BS.%26atitle%3DSmall%2520molecule%2520microarrays%2520enable%2520the%2520identification%2520of%2520a%2520selective%252C%2520quadruplex-binding%2520inhibitor%2520of%2520MYC%2520expression%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D139%26epage%3D148%26doi%3D10.1021%2Facschembio.5b00577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drygin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaebe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bliesath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proffitt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trent, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitten, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, W. G.</span></span> <span> </span><span class="NLM_article-title">Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">7653</span>– <span class="NLM_lpage">7661</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-1304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1158%2F0008-5472.CAN-09-1304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=19738048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Skt7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=7653-7661&author=D.+Dryginauthor=A.+Siddiqui-Jainauthor=S.+O%E2%80%99Brienauthor=M.+Schwaebeauthor=A.+Linauthor=J.+Bliesathauthor=C.+B.+Hoauthor=C.+Proffittauthor=K.+Trentauthor=J.+P.+Whittenauthor=J.+K.+Limauthor=D.+Von+Hoffauthor=K.+Anderesauthor=W.+G.+Rice&title=Anticancer+activity+of+CX-3543%3A+a+direct+inhibitor+of+rRNA+biogenesis&doi=10.1158%2F0008-5472.CAN-09-1304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis</span></div><div class="casAuthors">Drygin, Denis; Siddiqui-Jain, Adam; O'Brien, Sean; Schwaebe, Michael; Lin, Amy; Bliesath, Josh; Ho, Caroline B.; Proffitt, Chris; Trent, Katy; Whitten, Jeffrey P.; Lim, John K. C.; Von Hoff, Daniel; Anderes, Kenna; Rice, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7653-7661</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hallmark deregulated signaling in cancer cells drives excessive ribosome biogenesis within the nucleolus, which elicits unbridled cell growth and proliferation.  The rate-limiting step of ribosome biogenesis is synthesis of rRNA (building blocks of ribosomes) by RNA Polymerase I (Pol I).  Numerous kinase pathways and products of proto-oncogenes can up-regulate Pol I, whereas tumor suppressor proteins can inhibit rRNA synthesis.  In tumorigenesis, activating mutations in certain cancer-assocd. kinases and loss-of-function mutations in tumor suppressors lead to deregulated signaling that stimulates Pol I transcription with resultant increases in ribosome biogenesis, protein synthesis, cell growth, and proliferation.  Certain anticancer therapeutics, such as cisplatin and 5-fluorouracil, reportedly exert, at least partially, their activity through disruption of ribosome biogenesis, yet many prime targets for anticancer drugs within the ribosome synthetic machinery of the nucleolus remain largely unexploited.  Herein, we describe CX-3543, a small mol. nucleolus-targeting agent that selectively disrupts nucleolin/rDNA G-quadruplex complexes in the nucleolus, thereby inhibiting Pol I transcription and inducing apoptosis in cancer cells.  CX-3543 is the first G-quadruplex interactive agent to enter human clin. trials, and it is currently under evaluation against carcinoid/neuroendocrine tumors in a phase II clin. trial. [Cancer Res 2009;69(19):7653-61].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkebihaes9wbVg90H21EOLACvtfcHk0ljH4XU3MnJXsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Skt7vF&md5=5608400f3cd64d937a5e3773f9a2caed</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-1304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-1304%26sid%3Dliteratum%253Aachs%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%26aulast%3DSchwaebe%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DBliesath%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DC.%2BB.%26aulast%3DProffitt%26aufirst%3DC.%26aulast%3DTrent%26aufirst%3DK.%26aulast%3DWhitten%26aufirst%3DJ.%2BP.%26aulast%3DLim%26aufirst%3DJ.%2BK.%26aulast%3DVon%2BHoff%26aufirst%3DD.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRice%26aufirst%3DW.%2BG.%26atitle%3DAnticancer%2520activity%2520of%2520CX-3543%253A%2520a%2520direct%2520inhibitor%2520of%2520rRNA%2520biogenesis%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D7653%26epage%3D7661%26doi%3D10.1158%2F0008-5472.CAN-09-1304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Antonio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvester, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabeer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yap, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osako, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Algara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bally, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenton, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cescon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stirling, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hieter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aparicio, S.</span></span> <span> </span><span class="NLM_article-title">CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumors</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">14432</span>, <span class="refDoi"> DOI: 10.1038/ncomms14432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fncomms14432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28211448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVKms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=14432&author=H.+Xuauthor=M.+Di+Antonioauthor=S.+McKinneyauthor=V.+Mathewauthor=B.+Hoauthor=N.+J.+O%E2%80%99Neilauthor=N.+D.+Santosauthor=J.+Silvesterauthor=V.+Weiauthor=J.+Garciaauthor=F.+Kabeerauthor=D.+Laiauthor=P.+Sorianoauthor=J.+Banathauthor=D.+S.+Chiuauthor=D.+Yapauthor=D.+D.+Leauthor=F.+B.+Yeauthor=A.+Zhangauthor=K.+Thuauthor=J.+Soongauthor=S.+C.+Linauthor=A.+H.+Tsaiauthor=T.+Osakoauthor=T.+Algaraauthor=D.+N.+Saundersauthor=J.+Wongauthor=J.+Xianauthor=M.+B.+Ballyauthor=J.+D.+Brentonauthor=G.+W.+Brownauthor=S.+P.+Shahauthor=D.+Cesconauthor=T.+W.+Makauthor=C.+Caldasauthor=P.+C.+Stirlingauthor=P.+Hieterauthor=S.+Balasubramanianauthor=S.+Aparicio&title=CX-5461+is+a+DNA+G-quadruplex+stabilizer+with+selective+lethality+in+BRCA1%2F2+deficient+tumors&doi=10.1038%2Fncomms14432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours</span></div><div class="casAuthors">Xu, Hong; Di Antonio, Marco; McKinney, Steven; Mathew, Veena; Ho, Brandon; O'Neil, Nigel J.; Dos Santos, Nancy; Silvester, Jennifer; Wei, Vivien; Garcia, Jessica; Kabeer, Farhia; Lai, Daniel; Soriano, Priscilla; Banath, Judit; Chiu, Derek S.; Yap, Damian; Le, Daniel D.; Ye, Frank B.; Zhang, Anni; Thu, Kelsie; Soong, John; Lin, Shu-chuan; Tsai, Angela Hsin Chin; Osako, Tomo; Algara, Teresa; Saunders, Darren N.; Wong, Jason; Xian, Jian; Bally, Marcel B.; Brenton, James D.; Brown, Grant W.; Shah, Sohrab P.; Cescon, David; Mak, Tak W.; Caldas, Carlos; Stirling, Peter C.; Hieter, Phil; Balasubramanian, Shankar; Aparicio, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14432</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G-quadruplex DNAs form four-stranded helical structures and are proposed to play key roles in different cellular processes.  Targeting G-quadruplex DNAs for cancer treatment is a very promising prospect.  Here, we show that CX-5461 is a G-quadruplex stabilizer, with specific toxicity against BRCA deficiencies in cancer cells and polyclonal patient-derived xenograft models, including tumors resistant to PARP inhibition.  Exposure to CX-5461, and its related drug CX-3543, blocks replication forks and induces ssDNA gaps or breaks.  The BRCA and NHEJ pathways are required for the repair of CX-5461 and CX-3543-induced DNA damage and failure to do so leads to lethality.  These data strengthen the concept of G4 targeting as a therapeutic approach, specifically for targeting HR and NHEJ deficient cancers and other tumors deficient for DNA damage repair.  CX-5461 is now in advanced phase I clin. trial for patients with BRCA1/2 deficient tumors (Canadian trial, NCT02719977, opened May 2016).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppKJRejuN5X7Vg90H21EOLACvtfcHk0ljH4XU3MnJXsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVKms7s%253D&md5=8e496952f88642ff05eaf136fe6856d6</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fncomms14432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms14432%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DDi%2BAntonio%26aufirst%3DM.%26aulast%3DMcKinney%26aufirst%3DS.%26aulast%3DMathew%26aufirst%3DV.%26aulast%3DHo%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DN.%2BJ.%26aulast%3DSantos%26aufirst%3DN.%2BD.%26aulast%3DSilvester%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DV.%26aulast%3DGarcia%26aufirst%3DJ.%26aulast%3DKabeer%26aufirst%3DF.%26aulast%3DLai%26aufirst%3DD.%26aulast%3DSoriano%26aufirst%3DP.%26aulast%3DBanath%26aufirst%3DJ.%26aulast%3DChiu%26aufirst%3DD.%2BS.%26aulast%3DYap%26aufirst%3DD.%26aulast%3DLe%26aufirst%3DD.%2BD.%26aulast%3DYe%26aufirst%3DF.%2BB.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DThu%26aufirst%3DK.%26aulast%3DSoong%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DS.%2BC.%26aulast%3DTsai%26aufirst%3DA.%2BH.%26aulast%3DOsako%26aufirst%3DT.%26aulast%3DAlgara%26aufirst%3DT.%26aulast%3DSaunders%26aufirst%3DD.%2BN.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DXian%26aufirst%3DJ.%26aulast%3DBally%26aufirst%3DM.%2BB.%26aulast%3DBrenton%26aufirst%3DJ.%2BD.%26aulast%3DBrown%26aufirst%3DG.%2BW.%26aulast%3DShah%26aufirst%3DS.%2BP.%26aulast%3DCescon%26aufirst%3DD.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DCaldas%26aufirst%3DC.%26aulast%3DStirling%26aufirst%3DP.%2BC.%26aulast%3DHieter%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DAparicio%26aufirst%3DS.%26atitle%3DCX-5461%2520is%2520a%2520DNA%2520G-quadruplex%2520stabilizer%2520with%2520selective%2520lethality%2520in%2520BRCA1%252F2%2520deficient%2520tumors%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D14432%26doi%3D10.1038%2Fncomms14432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span> </span><span class="NLM_article-title">A Phase I/II Study of CX5461</span>.  <i>ClinicalTrials.gov</i>; <span class="NLM_publisher-name">U.S. National
Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2016</span>; <a href="https://clinicaltrials.gov/ct2/show/NCT02719977" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02719977</a> (accessed Jan 7, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Phase+I%2FII+Study+of+CX5461.+ClinicalTrials.gov%3B+U.S.+National%0AInstitutes+of+Health%3A+Bethesda%2C+MD%2C+2016%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02719977+%28accessed+Jan+7%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Phase%2520I%252FII%2520Study%2520of%2520CX5461%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%250AInstitutes%2520of%2520Health%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Doria, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasotti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freccero, M.</span></span> <span> </span><span class="NLM_article-title">Water soluble extended naphthalene diimides as pH fluorescent sensors and G-quadruplex ligands</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3830</span>– <span class="NLM_lpage">3840</span>, <span class="refDoi"> DOI: 10.1039/c2ob07006e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1039%2Fc2ob07006e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=22469919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFGhtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=3830-3840&author=F.+Doriaauthor=M.+Nadaiauthor=G.+Sattinauthor=L.+Pasottiauthor=S.+N.+Richterauthor=M.+Freccero&title=Water+soluble+extended+naphthalene+diimides+as+pH+fluorescent+sensors+and+G-quadruplex+ligands&doi=10.1039%2Fc2ob07006e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">Water soluble extended naphthalene diimides as pH fluorescent sensors and G-quadruplex ligands</span></div><div class="casAuthors">Doria, Filippo; Nadai, Matteo; Sattin, Giovanna; Pasotti, Luca; Richter, Sara N.; Freccero, Mauro</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3830-3840</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Extended naphthalene diimides (NDIs) fused to 1,4-dihydropyrazine-2,3-dione, contg. two solubilizing moieties, have been synthesized.  Fluorescence spectra of the new NDIs were remarkably affected by pH, as the second deprotonation of the dihydropyrazinedione moiety (pKa 6.9) switched off the emission.  Binding to a G-quadruplex folded oligonucleotide and stoichiometry were evaluated by FRET melting assay and CD anal.  G-quadruplex binding was strongly enhanced shifting from pH 7.4 to pH 6.0 as a consequence of the dihydropyrazinedione moiety protonation.  Cytotoxicity studies using two human telomerase-pos. cell lines (HT29 and A549) revealed that the best G-quadruplex ligand was very active against the colon cell line, with an EC50 of 300 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCoDZL-SHlDbVg90H21EOLACvtfcHk0ljI_Lm3ZmrPCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFGhtr0%253D&md5=9fa4f30354167482c7a7011491166940</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1039%2Fc2ob07006e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob07006e%26sid%3Dliteratum%253Aachs%26aulast%3DDoria%26aufirst%3DF.%26aulast%3DNadai%26aufirst%3DM.%26aulast%3DSattin%26aufirst%3DG.%26aulast%3DPasotti%26aufirst%3DL.%26aulast%3DRichter%26aufirst%3DS.%2BN.%26aulast%3DFreccero%26aufirst%3DM.%26atitle%3DWater%2520soluble%2520extended%2520naphthalene%2520diimides%2520as%2520pH%2520fluorescent%2520sensors%2520and%2520G-quadruplex%2520ligands%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26spage%3D3830%26epage%3D3840%26doi%3D10.1039%2Fc2ob07006e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Spinello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunenberg, J.</span></span> <span> </span><span class="NLM_article-title">Molecular recognition of naphthalene diimide ligands by telomeric quadruplex-DNA: the importance of the protonation state and mediated hydrogen bonds</span>. <i>Phys. Chem. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2871</span>– <span class="NLM_lpage">2877</span>, <span class="refDoi"> DOI: 10.1039/C5CP05576H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1039%2FC5CP05576H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26733046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVajt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=2871-2877&author=A.+Spinelloauthor=G.+Baroneauthor=J.+Grunenberg&title=Molecular+recognition+of+naphthalene+diimide+ligands+by+telomeric+quadruplex-DNA%3A+the+importance+of+the+protonation+state+and+mediated+hydrogen+bonds&doi=10.1039%2FC5CP05576H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of naphthalene diimide ligands by telomeric quadruplex-DNA: the importance of the protonation state and mediated hydrogen bonds</span></div><div class="casAuthors">Spinello, A.; Barone, G.; Grunenberg, J.</div><div class="citationInfo"><span class="NLM_cas:title">Physical Chemistry Chemical Physics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2871-2877</span>CODEN:
                <span class="NLM_cas:coden">PPCPFQ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9076</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In depth Monte Carlo conformational scans in combination with mol. dynamics (MD) simulations and electronic structure calcns. were applied in order to study the mol. recognition process between tetrasubstituted naphthalene diimide (ND) guests and G-quadruplex (G4) DNA receptors.  ND guests are a promising class of telomere stabilizers due to which they are used in novel anticancer therapeutics.  Though several ND guests have been studied exptl. in the past, the protonation state under physiol. conditions is still unclear.  Based on chem. intuition, in the case of N-methyl-piperazine substitution, different protonation states are possible and might play a crucial role in the mol. recognition process by G4-DNA.  Depending on the proton concn., different nitrogen atoms of the N-methyl-piperazine might (or might not) be protonated.  This fact was considered in our simulation in terms of a case by case anal., since the process of mol. recognition is detd. by possible donor or acceptor positions.  The results of our simulations show that the electrostatic interactions between the ND ligands and the G4 receptor are maximized in the case of the protonation of the terminal nitrogen atoms, forming compact ND G4 complexes inside the grooves.  The influence of different protonation states in terms of the ability to form hydrogen bonds with the sugar-phosphate backbone, as well as the importance of mediated vs. direct hydrogen bonding, was analyzed in detail by MD and relaxed force const. (compliance const.) simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Et1eGmdZXrVg90H21EOLACvtfcHk0ljI_Lm3ZmrPCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVajt7nJ&md5=ccb7e76763d3ffa74fbab6e4ce13eed7</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1039%2FC5CP05576H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CP05576H%26sid%3Dliteratum%253Aachs%26aulast%3DSpinello%26aufirst%3DA.%26aulast%3DBarone%26aufirst%3DG.%26aulast%3DGrunenberg%26aufirst%3DJ.%26atitle%3DMolecular%2520recognition%2520of%2520naphthalene%2520diimide%2520ligands%2520by%2520telomeric%2520quadruplex-DNA%253A%2520the%2520importance%2520of%2520the%2520protonation%2520state%2520and%2520mediated%2520hydrogen%2520bonds%26jtitle%3DPhys.%2520Chem.%2520Chem.%2520Phys.%26date%3D2016%26volume%3D18%26spage%3D2871%26epage%3D2877%26doi%3D10.1039%2FC5CP05576H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit28c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Răsădean, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantoş, G. D.</span></span> <span> </span><span class="NLM_article-title">Amino-acid-derived naphthalenediimides as versatile G-quadruplex binders</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">8491</span>– <span class="NLM_lpage">8499</span>, <span class="refDoi"> DOI: 10.1002/chem.201700957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1002%2Fchem.201700957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28409867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2sXot12itrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=8491-8499&author=D.+M.+R%C4%83s%C4%83deanauthor=B.+Shengauthor=J.+Dashauthor=G.+D.+Panto%C5%9F&title=Amino-acid-derived+naphthalenediimides+as+versatile+G-quadruplex+binders&doi=10.1002%2Fchem.201700957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28cR"><div class="casContent"><span class="casTitleNuber">28c</span><div class="casTitle"><span class="NLM_cas:atitle">Amino-Acid-Derived Naphthalenediimides as Versatile G-Quadruplex Binders</span></div><div class="casAuthors">Rasadean, Dora M.; Sheng, Bin; Dash, Jyotirmayee; Pantos, G. Dan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">8491-8499</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The design and synthesis of water sol., amino-acid-functionalized naphthalenediimides (NDIs) as potential ligands of native G-quadruplexes is reported.  The NDIs were tested on a panel of oncogene promoters, on the human telomeric sequence h-telo, and on double-stranded DNA.  Out of the ligands tested, NDI 3 (Nε-Boc-L-lysine NDI) exhibited a highly discriminating nature by only stabilizing the oncogene promoter c-kit2, which is up-regulated up to 80% in ovarian, gastrointestinal, and breast malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobOnRf0TMJK7Vg90H21EOLACvtfcHk0ljI_Lm3ZmrPCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXot12itrY%253D&md5=a6d12d6fa83e767147d3770bc3fc3993</span></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=10.1002%2Fchem.201700957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201700957%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C4%2583s%25C4%2583dean%26aufirst%3DD.%2BM.%26aulast%3DSheng%26aufirst%3DB.%26aulast%3DDash%26aufirst%3DJ.%26aulast%3DPanto%25C5%259F%26aufirst%3DG.%2BD.%26atitle%3DAmino-acid-derived%2520naphthalenediimides%2520as%2520versatile%2520G-quadruplex%2520binders%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D8491%26epage%3D8499%26doi%3D10.1002%2Fchem.201700957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit28d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Street, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingworth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, M. C.</span></span> <span> </span><span class="NLM_article-title">Divalent naphthalene diimide ligands display high selectivity for the human telomeric G-quadruplex in K<sup>+</sup> buffer</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6953</span>– <span class="NLM_lpage">6958</span>, <span class="refDoi"> DOI: 10.1002/chem.201700140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1002%2Fchem.201700140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28257554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVahtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=6953-6958&author=S.+Streetauthor=D.+Chinauthor=G.+Hollingworthauthor=M.+Berryauthor=J.+C.+Moralesauthor=M.+C.+Galan&title=Divalent+naphthalene+diimide+ligands+display+high+selectivity+for+the+human+telomeric+G-quadruplex+in+K%2B+buffer&doi=10.1002%2Fchem.201700140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28dR"><div class="casContent"><span class="casTitleNuber">28d</span><div class="casTitle"><span class="NLM_cas:atitle">Divalent Naphthalene Diimide Ligands Display High Selectivity for the Human Telomeric G-quadruplex in K+ Buffer</span></div><div class="casAuthors">Street, Steven T. G.; Chin, Donovan N.; Hollingworth, Gregory J.; Berry, Monica; Morales, Juan C.; Galan, M. Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">6953-6958</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Selective G-quadruplex ligands offer great promise for the development of anti-cancer therapies.  A novel series of divalent cationic naphthalene diimide ligands that selectively bind to the hybrid form of the human telomeric G-quadruplex in K+ buffer are described herein.  We demonstrate that an imidazolium-bearing mannoside-conjugate is the most selective ligand to date for this quadruplex against several other quadruplex and duplex structures.  We also show that a similarly selective methylpiperazine-bearing ligand was more toxic to HeLa cancer cells than doxorubicin, while exhibiting three times less toxicity towards fetal lung fibroblasts WI-38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY8kTU_XkfH7Vg90H21EOLACvtfcHk0lgG5J23FmsGDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVahtLw%253D&md5=c0a249d79e3c76292c7fb54affd1b9fb</span></div><a href="/servlet/linkout?suffix=cit28d&amp;dbid=16384&amp;doi=10.1002%2Fchem.201700140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201700140%26sid%3Dliteratum%253Aachs%26aulast%3DStreet%26aufirst%3DS.%26aulast%3DChin%26aufirst%3DD.%26aulast%3DHollingworth%26aufirst%3DG.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DMorales%26aufirst%3DJ.%2BC.%26aulast%3DGalan%26aufirst%3DM.%2BC.%26atitle%3DDivalent%2520naphthalene%2520diimide%2520ligands%2520display%2520high%2520selectivity%2520for%2520the%2520human%2520telomeric%2520G-quadruplex%2520in%2520K%252B%2520buffer%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D6953%26epage%3D6958%26doi%3D10.1002%2Fchem.201700140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nadai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimino-Reale, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doria, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butovskaya, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freccero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folini, M.</span></span> <span> </span><span class="NLM_article-title">Assessment of gene promoter Gquadruplex binding and modulation by a naphthalene diimide derivative in tumor cells</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">380</span>, <span class="refDoi"> DOI: 10.3892/ijo.2014.2723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.3892%2Fijo.2014.2723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25370864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovVylsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2015&pages=369-380&author=M.+Nadaiauthor=G.+Cimino-Realeauthor=G.+Sattinauthor=F.+Doriaauthor=E.+Butovskayaauthor=N.+Zaffaroniauthor=M.+Frecceroauthor=M.+Palumboauthor=S.+N.+Richterauthor=M.+Folini&title=Assessment+of+gene+promoter+Gquadruplex+binding+and+modulation+by+a+naphthalene+diimide+derivative+in+tumor+cells&doi=10.3892%2Fijo.2014.2723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of gene promoter G-quadruplex binding and modulation by a naphthalene diimide derivative in tumor cells</span></div><div class="casAuthors">Nadai, Matteo; Cimino-Reale, Graziella; Sattin, Giovanna; Doria, Filippo; Butovskaya, Elena; Zaffaroni, Nadia; Freccero, Mauro; Palumbo, Manlio; Richter, Sara N.; Folini, Marco</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">369-380</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Naphthalene diimide (NDI) derivs. have shown high affinity for telomeric guanine (G)-quadruplexes and good antiproliferative activity in different human tumor exptl. models.  A trisubstituted compd. (H-NDI-NMe2) has been reported to stabilize the telomeric G-quadruplex and to cause telomere dysfunction and downregulation of telomerase expression.  We further investigated its mechanism of action by analyzing the capability of the mol. to interfere with the expression levels of oncogenes, such as MYC, telomerase reverse transcriptase (TERT), KIT and BCL2, known to bear G-quadruplex-forming sequences within their promoters, in human tumor cell lines of different histol. origin.  Exposure to H-NDI-NMe2 resulted in a cell type-dependent perturbation of the expression levels of the four selected genes.  Biophys. and mol. analyses revealed that H-NDI-NMe2 bound with high affinity and effectively stabilized mainly MYC and BCL2, which share long sequences and the possibility of multiple G-quadruplex folding.  The mRNA levels of both genes, but not protein amts. were affected by NDI treatment.  Global gene expression anal. showed modulation of genes implicated in telomere function and mechanisms of cancer; however, G-quadruplex-mediated regulation of gene expression by H-NDI-NMe2 was largely dependent on the cell context.  These data indicate that a deeper knowledge on the mol. mechanisms and biol. effects of G-quadruplex structures is still needed to help developing new effective anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolgiCQ2scOAbVg90H21EOLACvtfcHk0lhkItVp22oPRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovVylsrk%253D&md5=1824a62814f486e47a3173e65a5095d6</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.3892%2Fijo.2014.2723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2014.2723%26sid%3Dliteratum%253Aachs%26aulast%3DNadai%26aufirst%3DM.%26aulast%3DCimino-Reale%26aufirst%3DG.%26aulast%3DSattin%26aufirst%3DG.%26aulast%3DDoria%26aufirst%3DF.%26aulast%3DButovskaya%26aufirst%3DE.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DFreccero%26aufirst%3DM.%26aulast%3DPalumbo%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DS.%2BN.%26aulast%3DFolini%26aufirst%3DM.%26atitle%3DAssessment%2520of%2520gene%2520promoter%2520Gquadruplex%2520binding%2520and%2520modulation%2520by%2520a%2520naphthalene%2520diimide%2520derivative%2520in%2520tumor%2520cells%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2015%26volume%3D46%26spage%3D369%26epage%3D380%26doi%3D10.3892%2Fijo.2014.2723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lopergolo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortoreto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doria, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beretta, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuco, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freccero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrello, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folini, M.</span></span> <span> </span><span class="NLM_article-title">Targeting of RET oncogene by naphthalene diimide-mediated gene promoter G-quadruplex stabilization exerts anti-tumor activity in oncogene-addicted human medullary thyroid cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">49649</span>– <span class="NLM_lpage">49663</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.10105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.18632%2Foncotarget.10105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=27351133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC2s7ksFWntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=49649-49663&author=A.+Lopergoloauthor=R.+Perroneauthor=M.+Tortoretoauthor=F.+Doriaauthor=G.+L.+Berettaauthor=V.+Zucoauthor=M.+Frecceroauthor=M.+G.+Borrelloauthor=C.+Lanziauthor=S.+N.+Richterauthor=N.+Zaffaroniauthor=M.+Folini&title=Targeting+of+RET+oncogene+by+naphthalene+diimide-mediated+gene+promoter+G-quadruplex+stabilization+exerts+anti-tumor+activity+in+oncogene-addicted+human+medullary+thyroid+cancer&doi=10.18632%2Foncotarget.10105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting of RET oncogene by naphthalene diimide-mediated gene promoter G-quadruplex stabilization exerts anti-tumor activity in oncogene-addicted human medullary thyroid cancer</span></div><div class="casAuthors">Lopergolo Alessia; Tortoreto Monica; Beretta Giovanni L; Zuco Valentina; Borrello Maria Grazia; Lanzi Cinzia; Zaffaroni Nadia; Folini Marco; Perrone Rosalba; Richter Sara N; Doria Filippo; Freccero Mauro</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">49649-49663</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Medullary thyroid cancer (MTC) relies on the aberrant activation of RET proto-oncogene.  Though targeted approaches (i.e., tyrosine kinase inhibitors) are available, the absence of complete responses and the onset of resistance mechanisms indicate the need for novel therapeutic interventions.  Due to their role in regulation of gene expression, G-quadruplexes (G4) represent attractive targets amenable to be recognized or stabilized by small molecules.  Here, we report that exposure of MTC cells to a tri-substituted naphthalene diimide (NDI) resulted in a significant antiproliferative activity paralleled by inhibition of RET expression.  Biophysical analysis and gene reporter assays showed that impairment of RET expression was consequent to the NDI-mediated stabilization of the G4 forming within the gene promoter.  We also showed for the first time that systemic administration of the NDI in mice xenotransplanted with MTC cells resulted in a remarkable inhibition of tumor growth in vivo.  Overall, our findings indicate that NDI-dependent RET G4 stabilization represents a suitable approach to control RET transcription and delineate the rationale for the development of G4 stabilizing-based treatments for MTC as well as for other tumors in which RET may have functional and therapeutic implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnc_DupHv-_ApJitSxOdIlfW6udTcc2eZUyYLwqjPDwbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7ksFWntw%253D%253D&md5=10918d79c3869f35b2c695b5d81176ae</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.10105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.10105%26sid%3Dliteratum%253Aachs%26aulast%3DLopergolo%26aufirst%3DA.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DDoria%26aufirst%3DF.%26aulast%3DBeretta%26aufirst%3DG.%2BL.%26aulast%3DZuco%26aufirst%3DV.%26aulast%3DFreccero%26aufirst%3DM.%26aulast%3DBorrello%26aufirst%3DM.%2BG.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DRichter%26aufirst%3DS.%2BN.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DFolini%26aufirst%3DM.%26atitle%3DTargeting%2520of%2520RET%2520oncogene%2520by%2520naphthalene%2520diimide-mediated%2520gene%2520promoter%2520G-quadruplex%2520stabilization%2520exerts%2520anti-tumor%2520activity%2520in%2520oncogene-addicted%2520human%2520medullary%2520thyroid%2520cancer%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D49649%26epage%3D49663%26doi%3D10.18632%2Foncotarget.10105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cuenca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greciano, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munnur, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanjunda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Tri- and tetra-substituted naphthalene diimides as potent G-quadruplex ligands</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1668</span>– <span class="NLM_lpage">1673</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.01.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.bmcl.2008.01.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=18243701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1Cktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1668-1673&author=F.+Cuencaauthor=O.+Grecianoauthor=M.+Gunaratnamauthor=S.+Haiderauthor=D.+Munnurauthor=R.+Nanjundaauthor=W.+D.+Wilsonauthor=S.+Neidle&title=Tri-+and+tetra-substituted+naphthalene+diimides+as+potent+G-quadruplex+ligands&doi=10.1016%2Fj.bmcl.2008.01.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Tri- and tetra-substituted naphthalene diimides as potent G-quadruplex ligands</span></div><div class="casAuthors">Cuenca, Francisco; Greciano, Olga; Gunaratnam, Mekala; Haider, Shozeb; Munnur, Deeksha; Nanjunda, Rupesh; Wilson, W. David; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1668-1673</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of tri- and tetra-substituted naphthalene diimides, e.g. I, have been designed and synthesized.  Several compds. show exceptional affinity for telomeric G-quadruplex DNA in classical and competition FRET assays and SPR studies.  They inhibit telomerase in the TRAP assay, and show potent senescence-based short-term anti-proliferative effects on MCF7 and A549 cancer cell lines, and localize in the nucleus and particularly the nucleolus of MCF7 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkbDMZFc0FpbVg90H21EOLACvtfcHk0ljTC5YQtmYY0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1Cktbs%253D&md5=e52c4feda254b7221da45882bea1cc7c</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.01.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.01.050%26sid%3Dliteratum%253Aachs%26aulast%3DCuenca%26aufirst%3DF.%26aulast%3DGreciano%26aufirst%3DO.%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DHaider%26aufirst%3DS.%26aulast%3DMunnur%26aufirst%3DD.%26aulast%3DNanjunda%26aufirst%3DR.%26aulast%3DWilson%26aufirst%3DW.%2BD.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DTri-%2520and%2520tetra-substituted%2520naphthalene%2520diimides%2520as%2520potent%2520G-quadruplex%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1668%26epage%3D1673%26doi%3D10.1016%2Fj.bmcl.2008.01.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swank, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galesa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reszka, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuenca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Targeting human gastrointestinal stromal tumor cells with a quadruplex-binding small molecule</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3774</span>– <span class="NLM_lpage">3783</span>, <span class="refDoi"> DOI: 10.1021/jm900424a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900424a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVegsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3774-3783&author=M.+Gunaratnamauthor=S.+Swankauthor=S.+M.+Haiderauthor=K.+Galesaauthor=A.+P.+Reszkaauthor=M.+Beltranauthor=F.+Cuencaauthor=J.+A.+Fletcherauthor=S.+Neidle&title=Targeting+human+gastrointestinal+stromal+tumor+cells+with+a+quadruplex-binding+small+molecule&doi=10.1021%2Fjm900424a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Human Gastrointestinal Stromal Tumor Cells with a Quadruplex-Binding Small Molecule</span></div><div class="casAuthors">Gunaratnam, Mekala; Swank, Stephen; Haider, Shozeb M.; Galesa, Katja; Reszka, Anthony P.; Beltran, Monica; Cuenca, Francisco; Fletcher, Jonathan A.; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3774-3783</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Most of human gastrointestinal stromal tumors (GIST) are driven by activating mutations in the proto-oncogene KIT, a tyrosine kinase receptor.  Clin. treatment with imatinib targets the kinase domain of KIT, but tumor regrowth occurs as a result of the development of resistant mutations in the kinase active site.  An alternative small-mol. approach to GIST therapy is described, in which the KIT gene is directly targeted, and thus, kinase resistance may be circumvented.  A naphthalene diimide deriv. has been used to demonstrate the concept of dual quadruplex targeting.  This compd. strongly stabilizes both telomeric quadruplex DNA and quadruplex sites in the KIT promoter in vitro.  It is shown here that the compd. is a potent inducer of growth arrest in a patient-derived GIST cell line at a concn. (∼1 μM) that also results in effective inhibition of telomerase activity and almost complete suppression of KIT mRNA and KIT protein expression.  Mol. modeling studies with a telomeric quadruplex have been used to rationalize aspects of the exptl. quadruplex melting data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqPRQUnx-G7bVg90H21EOLACvtfcHk0ljTC5YQtmYY0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVegsbc%253D&md5=4784d55409f53593bd924165555524b4</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1021%2Fjm900424a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900424a%26sid%3Dliteratum%253Aachs%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DSwank%26aufirst%3DS.%26aulast%3DHaider%26aufirst%3DS.%2BM.%26aulast%3DGalesa%26aufirst%3DK.%26aulast%3DReszka%26aufirst%3DA.%2BP.%26aulast%3DBeltran%26aufirst%3DM.%26aulast%3DCuenca%26aufirst%3DF.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DTargeting%2520human%2520gastrointestinal%2520stromal%2520tumor%2520cells%2520with%2520a%2520quadruplex-binding%2520small%2520molecule%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3774%26epage%3D3783%26doi%3D10.1021%2Fjm900424a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit30c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hampel, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidibe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riou, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Tetrasubstituted naphthalene diimide ligands with selectivity for telomeric G-quadruplexes and cancer cells</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6459</span>– <span class="NLM_lpage">6463</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.09.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.bmcl.2010.09.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=20932753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSms7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6459-6463&author=S.+M.+Hampelauthor=A.+Sidibeauthor=M.+Gunaratnamauthor=J.-F.+Riouauthor=S.+Neidle&title=Tetrasubstituted+naphthalene+diimide+ligands+with+selectivity+for+telomeric+G-quadruplexes+and+cancer+cells&doi=10.1016%2Fj.bmcl.2010.09.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30cR"><div class="casContent"><span class="casTitleNuber">30c</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrasubstituted naphthalene diimide ligands with selectivity for telomeric G-quadruplexes and cancer cells</span></div><div class="casAuthors">Hampel, Sonja M.; Sidibe, Assitan; Gunaratnam, Mekala; Riou, Jean-Francois; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6459-6463</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of tetrasubstituted naphthalene diimide compds. I (n = 2-4) with N-methylpiperazine end groups has been synthesized and evaluated as G-quadruplex ligands.  They have high affinity and selectivity for telomeric G-quadruplex DNA over duplex DNA.  CD studies show that they induce formation of a parallel G-quadruplex topol.  They inhibit the binding of hPOT1 and topoisomerase IIIα to telomeric DNA and inhibit telomerase activity in MCF7 cells.  I has potent activity in a panel of cancer cell lines, with typical IC50 values of ∼0.1 μM, and up to 100-fold lower toxicity in a normal human fibroblast cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9XMkHrRF7p7Vg90H21EOLACvtfcHk0ljTC5YQtmYY0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSms7nJ&md5=9f6b2316116b7d42492641e80a95fc6a</span></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.066%26sid%3Dliteratum%253Aachs%26aulast%3DHampel%26aufirst%3DS.%2BM.%26aulast%3DSidibe%26aufirst%3DA.%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DRiou%26aufirst%3DJ.-F.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DTetrasubstituted%2520naphthalene%2520diimide%2520ligands%2520with%2520selectivity%2520for%2520telomeric%2520G-quadruplexes%2520and%2520cancer%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6459%26epage%3D6463%26doi%3D10.1016%2Fj.bmcl.2010.09.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit30d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Fuente, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampel, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reszka, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schatzlein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Targeting pancreatic cancer with a G-quadruplex ligand</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">7151</span>– <span class="NLM_lpage">7157</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.09.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.bmc.2011.09.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=22041170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVehsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=7151-7157&author=M.+Gunaratnamauthor=M.+de+la+Fuenteauthor=S.+M.+Hampelauthor=A.+K.+Toddauthor=A.+P.+Reszkaauthor=A.+Schatzleinauthor=S.+Neidle&title=Targeting+pancreatic+cancer+with+a+G-quadruplex+ligand&doi=10.1016%2Fj.bmc.2011.09.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30dR"><div class="casContent"><span class="casTitleNuber">30d</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting pancreatic cancer with a G-quadruplex ligand</span></div><div class="casAuthors">Gunaratnam, Mekala; de la Fuente, Maria; Hampel, Sonja M.; Todd, Alan K.; Reszka, Anthony P.; Schaetzlein, Andreas; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7151-7157</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The integrity of telomeres in most cancer cells is maintained by the action of the telomerase enzyme complex, which catalyzes the synthesis of telomeric DNA repeats in order to replace those lost during replication.  Telomerase is esp. up-regulated in metastatic cancer and is thus emerging as a major therapeutic target.  One approach to telomerase inhibition involves the sequestration of the single-stranded 3' ends of telomeric DNA into higher-order quadruplex structures.  We have recently shown that tetra-substituted naphthalene diimide compds. are potent quadruplex-stabilizing mols. with telomerase inhibitory activity in cells.  We show here that one such compd., BMSG-SH-3, which has been optimized by computer modeling, has significant in vivo antitumor activity against a model for pancreatic cancer, a cancer that is esp. resistant to current therapies.  A large redn. in telomerase activity in treated tumors was obsd. and the naphthalene diimide compd. was found to be selectively localized in the treated tumors.  We find that the expression of the therapeutically important chaperone protein HSP90, a regulator of telomerase is also reduced in vivo by BMSG-SH-3 treatment.  The compd. is a potent stabilizer of two G-quadruplex sequences found in the promoter region of the HSP90 gene, as well as a G-quadruplex from human telomeric DNA.  It is proposed that the simultaneous targeting of these quadruplexes may be an effective anti-tumor strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzs1OhYf4VxLVg90H21EOLACvtfcHk0ljRlsYOAw3F7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVehsr%252FJ&md5=d40adb1e679a5939c181d7989fb60107</span></div><a href="/servlet/linkout?suffix=cit30d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.09.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.09.055%26sid%3Dliteratum%253Aachs%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3Dde%2Bla%2BFuente%26aufirst%3DM.%26aulast%3DHampel%26aufirst%3DS.%2BM.%26aulast%3DTodd%26aufirst%3DA.%2BK.%26aulast%3DReszka%26aufirst%3DA.%2BP.%26aulast%3DSchatzlein%26aufirst%3DA.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DTargeting%2520pancreatic%2520cancer%2520with%2520a%2520G-quadruplex%2520ligand%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D7151%26epage%3D7157%26doi%3D10.1016%2Fj.bmc.2011.09.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span>; <span class="NLM_string-name">Cuenca, F.</span>; <span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Naphthalene diimide compounds interacting with G-quadruplex regions in DNA</span>. U.S. Patent <span class="NLM_patent">8,796,456</span>, August 14, <span class="NLM_year">2014</span>; Eur. Patent <span class="NLM_patent">2227470</span>, March 5, <span class="NLM_year">2014</span>; Jap. Patent <span class="NLM_patent">5366968</span>, August 29, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+Gunaratnam&author=F.+Cuenca&author=S.+Neidle&title=Naphthalene+diimide+compounds+interacting+with+G-quadruplex+regions+in+DNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGunaratnam%26aufirst%3DM.%26atitle%3DNaphthalene%2520diimide%2520compounds%2520interacting%2520with%2520G-quadruplex%2520regions%2520in%2520DNA%26date%3D2014%26date%3D2014%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Micco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collie, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnmacht, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazitna, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reszka, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design and evaluation of naphthalene diimide G-quadruplex ligands as telomere targeting agents in pancreatic cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2959</span>– <span class="NLM_lpage">2974</span>, <span class="refDoi"> DOI: 10.1021/jm301899y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301899y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlelu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2959-2974&author=M.+Miccoauthor=G.+W.+Collieauthor=A.+G.+Daleauthor=S.+A.+Ohnmachtauthor=I.+Pazitnaauthor=M.+Gunaratnamauthor=A.+P.+Reszkaauthor=S.+Neidle&title=Structure-based+design+and+evaluation+of+naphthalene+diimide+G-quadruplex+ligands+as+telomere+targeting+agents+in+pancreatic+cancer+cells&doi=10.1021%2Fjm301899y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Evaluation of Naphthalene Diimide G-Quadruplex Ligands As Telomere Targeting Agents in Pancreatic Cancer Cells</span></div><div class="casAuthors">Micco, Marialuisa; Collie, Gavin W.; Dale, Aaron G.; Ohnmacht, Stephan A.; Pazitna, Ingrida; Gunaratnam, Mekala; Reszka, Anthony P.; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2959-2974</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tetra-substituted naphthalene diimide (ND) derivs. with pos. charged termini are potent stabilizers of human telomeric and gene promoter DNA quadruplexes and inhibit the growth of human cancer cells in vitro and in vivo.  The present study reports the enhancement of the pharmacol. properties of earlier ND compds. using structure-based design.  Crystal structures of three complexes with human telomeric intramol. quadruplexes demonstrate that two of the four strongly basic N-methyl-piperazine groups can be replaced by less basic morpholine groups with no loss of intermol. interactions in the grooves of the quadruplex.  The new compds. retain high affinity to human telomeric quadruplex DNA but are 10-fold more potent against the MIA PaCa-2 pancreatic cancer cell line, with IC50 values of ∼10 nM.  The lead compd. induces cellular senescence but does not inhibit telomerase activity at the nanomolar dosage levels required for inhibition of cellular proliferation.  Gene array qPCR anal. of MIA PaCa-2 cells treated with the lead compd. revealed significant dose-dependent modulation of a distinct subset of genes, including strong induction of DNA damage responsive genes CDKN1A, DDIT3, GADD45A/G, and PPM1D, and repression of genes involved in telomere maintenance, including hPOT1 and PARP1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC6B5sA4fud7Vg90H21EOLACvtfcHk0ljRlsYOAw3F7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlelu74%253D&md5=0697d89813efa5f1347cbdfddeeabc78</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1021%2Fjm301899y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301899y%26sid%3Dliteratum%253Aachs%26aulast%3DMicco%26aufirst%3DM.%26aulast%3DCollie%26aufirst%3DG.%2BW.%26aulast%3DDale%26aufirst%3DA.%2BG.%26aulast%3DOhnmacht%26aufirst%3DS.%2BA.%26aulast%3DPazitna%26aufirst%3DI.%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DReszka%26aufirst%3DA.%2BP.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520and%2520evaluation%2520of%2520naphthalene%2520diimide%2520G-quadruplex%2520ligands%2520as%2520telomere%2520targeting%2520agents%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2959%26epage%3D2974%26doi%3D10.1021%2Fjm301899y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of parallel quadruplexes from human telomeric DNA</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>417</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">880</span>, <span class="refDoi"> DOI: 10.1038/nature755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnature755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=12050675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD38Xks1Wlsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2002&pages=876-880&author=G.+N.+Parkinsonauthor=M.+P.+H.+Leeauthor=S.+Neidle&title=Crystal+structure+of+parallel+quadruplexes+from+human+telomeric+DNA&doi=10.1038%2Fnature755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of parallel quadruplexes from human telomeric DNA</span></div><div class="casAuthors">Parkinson, Gary N.; Lee, Michael P. H.; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">6891</span>),
    <span class="NLM_cas:pages">876-880</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Telomeric ends of chromosomes, which comprise noncoding repeat sequences of guanine-rich DNA, are fundamental in protecting the cell from recombination and degrdn.  Disruption of telomere maintenance leads to eventual cell death, which can be exploited for therapeutic intervention in cancer.  Telomeric DNA sequences can form four-stranded (quadruplex) structures, which may be involved in the structure of telomere ends.  Here we describe the crystal structure of a quadruplex formed from four consecutive human telomeric DNA repeats and grown at a K+ concn. that approximates its intracellular concn.  K+ ions are obsd. in the structure.  The folding and appearance of the DNA in this intramol. quadruplex is fundamentally different from the published Na+-contg. quadruplex structures.  All four DNA strands are parallel, with the three linking trinucleotide loops positioned on the exterior of the quadruplex core, in a propeller-like arrangement.  The adenine in each TTA linking trinucleotide loop is swung back so that it intercalates between the two thymines.  This DNA structure suggests a straightforward path for telomere folding and unfolding, as well as ways in which it can recognize telomere-assocd. proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh0kI_FZZV_bVg90H21EOLACvtfcHk0ljRlsYOAw3F7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xks1Wlsr8%253D&md5=bfe584697ec10aabc9a4aaa3fae1f3d3</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1038%2Fnature755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature755%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DG.%2BN.%26aulast%3DLee%26aufirst%3DM.%2BP.%2BH.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520parallel%2520quadruplexes%2520from%2520human%2520telomeric%2520DNA%26jtitle%3DNature%26date%3D2002%26volume%3D417%26spage%3D876%26epage%3D880%26doi%3D10.1038%2Fnature755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohnmacht, S.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besser, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Vita, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellinas-Gomez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diocou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šponer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbara Pedley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">A G-quadruplex-binding compound showing anti-tumor activity in an in vivo model for pancreatic cancer</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">11385</span>, <span class="refDoi"> DOI: 10.1038/srep11385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fsrep11385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26077929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC2MbktVSmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=11385&author=S.%0AA.+Ohnmachtauthor=C.+Marchettiauthor=M.+Gunaratnamauthor=R.+J.+Besserauthor=S.+M.+Haiderauthor=G.+Di+Vitaauthor=H.+L.+Loweauthor=M.+Mellinas-Gomezauthor=S.+Diocouauthor=M.+Robsonauthor=J.+%C5%A0ponerauthor=B.+Islamauthor=R.+Barbara+Pedleyauthor=J.+A.+Hartleyauthor=S.+Neidle&title=A+G-quadruplex-binding+compound+showing+anti-tumor+activity+in+an+in+vivo+model+for+pancreatic+cancer&doi=10.1038%2Fsrep11385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A G-quadruplex-binding compound showing anti-tumour activity in an in vivo model for pancreatic cancer</span></div><div class="casAuthors">Ohnmacht Stephan A; Marchetti Chiara; Gunaratnam Mekala; Besser Rachael J; Haider Shozeb M; Di Vita Gloria; Neidle Stephen; Lowe Helen L; Mellinas-Gomez Maria; Diocou Seckou; Robson Mathew; Pedley R Barbara; Hartley John A; Sponer Jiri; Islam Barira</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11385</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We report here that a tetra-substituted naphthalene-diimide derivative (MM41) has significant in vivo anti-tumour activity against the MIA PaCa-2 pancreatic cancer xenograft model.  IV administration with a twice-weekly 15 mg/kg dose produces ca 80% tumour growth decrease in a group of tumour-bearing animals.  Two animals survived tumour-free after 279 days.  High levels of MM41 are rapidly transported into cell nuclei and were found to accumulate in the tumour.  MM41 is a quadruplex-interactive compound which binds strongly to the quadruplexes encoded in the promoter sequences of the BCL-2 and k-RAS genes, both of which are dis-regulated in many human pancreatic cancers.  Levels of BCL-2 were reduced by ca 40% in tumours from MM41-treated animals relative to controls, consistent with BCL-2 being a target for MM41.  Molecular modelling suggests that MM41 binds to a BCL-2 quadruplex in a manner resembling that previously observed in co-crystal structures with human telomeric quadruplexes.  This supports the concept that MM41 (and by implication other quadruplex-targeting small molecules) can bind to quadruplex-forming promoter regions in a number of genes and down-regulate their transcription.  We suggest that quadruplexes within those master genes that are up-regulated drivers for particular cancers, may be selective targets for compounds such as MM41.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxgQSOJ7Hiq43yKPtYViAGfW6udTcc2eaSwqympJ1L3bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbktVSmtQ%253D%253D&md5=ba52638803cd600a6b01dda88d1e23e5</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fsrep11385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep11385%26sid%3Dliteratum%253Aachs%26aulast%3DOhnmacht%26aufirst%3DS.%2BA.%26aulast%3DMarchetti%26aufirst%3DC.%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DBesser%26aufirst%3DR.%2BJ.%26aulast%3DHaider%26aufirst%3DS.%2BM.%26aulast%3DDi%2BVita%26aufirst%3DG.%26aulast%3DLowe%26aufirst%3DH.%2BL.%26aulast%3DMellinas-Gomez%26aufirst%3DM.%26aulast%3DDiocou%26aufirst%3DS.%26aulast%3DRobson%26aufirst%3DM.%26aulast%3D%25C5%25A0poner%26aufirst%3DJ.%26aulast%3DIslam%26aufirst%3DB.%26aulast%3DBarbara%2BPedley%26aufirst%3DR.%26aulast%3DHartley%26aufirst%3DJ.%2BA.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DA%2520G-quadruplex-binding%2520compound%2520showing%2520anti-tumor%2520activity%2520in%2520an%2520in%2520vivo%2520model%2520for%2520pancreatic%2520cancer%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D11385%26doi%3D10.1038%2Fsrep11385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gopinathan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jodrell, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, O. J.</span></span> <span> </span><span class="NLM_article-title">GEMMs as preclinical models for testing pancreatic cancer therapies</span>. <i>Dis. Models &amp; Mech.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1185</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1242/dmm.021055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1242%2Fdmm.021055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26438692" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=1185-1200&author=A.+Gopinathanauthor=J.+P.+Mortonauthor=D.+I.+Jodrellauthor=O.+J.+Sansom&title=GEMMs+as+preclinical+models+for+testing+pancreatic+cancer+therapies&doi=10.1242%2Fdmm.021055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1242%2Fdmm.021055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.021055%26sid%3Dliteratum%253Aachs%26aulast%3DGopinathan%26aufirst%3DA.%26aulast%3DMorton%26aufirst%3DJ.%2BP.%26aulast%3DJodrell%26aufirst%3DD.%2BI.%26aulast%3DSansom%26aufirst%3DO.%2BJ.%26atitle%3DGEMMs%2520as%2520preclinical%2520models%2520for%2520testing%2520pancreatic%2520cancer%2520therapies%26jtitle%3DDis.%2520Models%2520%2526amp%253B%2520Mech.%26date%3D2015%26volume%3D8%26spage%3D1185%26epage%3D1200%26doi%3D10.1242%2Fdmm.021055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huppert, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span> <span> </span><span class="NLM_article-title">Prevalence of quadruplexes in the human genome</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2908</span>– <span class="NLM_lpage">2916</span>, <span class="refDoi"> DOI: 10.1093/nar/gki609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fnar%2Fgki609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=15914667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVSgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=2908-2916&author=J.+L.+Huppertauthor=S.+Balasubramanian&title=Prevalence+of+quadruplexes+in+the+human+genome&doi=10.1093%2Fnar%2Fgki609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of quadruplexes in the human genome</span></div><div class="casAuthors">Huppert, Julian L.; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2908-2916</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Guanine-rich DNA sequences of a particular form have the ability to fold into four-stranded structures called G-quadruplexes.  In this paper, the authors present a working rule to predict which primary sequences can form this structure, and describe a search algorithm to identify such sequences in genomic DNA.  The authors count the no. of quadruplexes found in the human genome and compare that with the figure predicted by modeling DNA as a Bernoulli stream or as a Markov chain, using windows of various sizes.  The authors demonstrate that the distribution of loop lengths is significantly different from what would be expected in a random case, providing an indication of the no. of potentially relevant quadruplex-forming sequences.  In particular, the authors show that there is a significant repression of quadruplexes in the coding strand of exonic regions, which suggests that quadruplex-forming patterns are disfavored in sequences that will form RNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9b1Y1oE6MjbVg90H21EOLACvtfcHk0lifKD1QQz1MlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVSgsL0%253D&md5=b3ae66e9fa59c6c074b5dd2f58b8c712</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgki609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgki609%26sid%3Dliteratum%253Aachs%26aulast%3DHuppert%26aufirst%3DJ.%2BL.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DPrevalence%2520of%2520quadruplexes%2520in%2520the%2520human%2520genome%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2005%26volume%3D33%26spage%3D2908%26epage%3D2916%26doi%3D10.1093%2Fnar%2Fgki609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Todd, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Highly prevalent putative quadruplex sequence motifs in human DNA</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2901</span>– <span class="NLM_lpage">2907</span>, <span class="refDoi"> DOI: 10.1093/nar/gki553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fnar%2Fgki553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=15914666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVSgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=2901-2907&author=A.+K.+Toddauthor=M.+Johnstonauthor=S.+Neidle&title=Highly+prevalent+putative+quadruplex+sequence+motifs+in+human+DNA&doi=10.1093%2Fnar%2Fgki553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Highly prevalent putative quadruplex sequence motifs in human DNA</span></div><div class="casAuthors">Todd, Alan K.; Johnston, Matthew; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2901-2907</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">We report here the results of a systematic search for the existence and prevalence of potential intramol. G-quadruplex forming sequences in the human genome.  We have also examd. the tendency for particular sequences of 'loop' regions to occur in particular positions with respect to the G-tracts in a quadruplex.  Using arithmetic ratio and probability techniques we have discovered frequent and systematic occurrence of certain sequence types, the most prominent being a potential quadruplex contg. CCTGT in the first 'loop' position.  Being able to highlight types of potential quadruplex sequences in G-rich regions is an important step in searching for biol. relevant sequences and finding their function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpizf5-GbnVrLVg90H21EOLACvtfcHk0lifKD1QQz1MlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVSgsrw%253D&md5=53d7a1863e6a3c2f264aa291eabe893d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgki553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgki553%26sid%3Dliteratum%253Aachs%26aulast%3DTodd%26aufirst%3DA.%2BK.%26aulast%3DJohnston%26aufirst%3DM.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DHighly%2520prevalent%2520putative%2520quadruplex%2520sequence%2520motifs%2520in%2520human%2520DNA%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2005%26volume%3D33%26spage%3D2901%26epage%3D2907%26doi%3D10.1093%2Fnar%2Fgki553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Sousa Cavalcante, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, G.</span></span> <span> </span><span class="NLM_article-title">Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>741</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2014.07.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.ejphar.2014.07.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25084222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Kgsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=741&publication_year=2014&pages=8-16&author=L.+de%0ASousa+Cavalcanteauthor=G.+Monteiro&title=Gemcitabine%3A+metabolism+and+molecular+mechanisms+of+action%2C+sensitivity+and+chemoresistance+in+pancreatic+cancer&doi=10.1016%2Fj.ejphar.2014.07.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer</span></div><div class="casAuthors">de Sousa Cavalcante, Lucas; Monteiro, Gisele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">741</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8-16</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Gemcitabine is the first-line treatment for pancreatic adenocarcinoma, but is increasingly used to treat breast, bladder, and non-small cell lung cancers.  Despite such broad use, intrinsic and acquired chemoresistance is common.  In general, the underlying mechanisms of chemoresistance are poorly understood.  Here, current knowledge of gemcitabine metab., mechanisms of action, sensitivity and chemoresistance reported over the past two decades are reviewed; and we also offer new perspectives to improve gemcitabine efficacy with particular ref. to the treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKoecBhUduMLVg90H21EOLACvtfcHk0liCbF1pJs8Mlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Kgsr7E&md5=0454045e4cdf03cf098090f568c5647a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2014.07.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2014.07.041%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BSousa%2BCavalcante%26aufirst%3DL.%26aulast%3DMonteiro%26aufirst%3DG.%26atitle%3DGemcitabine%253A%2520metabolism%2520and%2520molecular%2520mechanisms%2520of%2520action%252C%2520sensitivity%2520and%2520chemoresistance%2520in%2520pancreatic%2520cancer%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D741%26spage%3D8%26epage%3D16%26doi%3D10.1016%2Fj.ejphar.2014.07.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Men, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, C. B.</span></span> <span> </span><span class="NLM_article-title">Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy</span>. <i>J. Drug. Target.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.3109/1061186X.2014.983522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.3109%2F1061186X.2014.983522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25470255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslSisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=125-133&author=D.+Kongauthor=Y.+Zhaoauthor=T.+Menauthor=C.+B.+Teng&title=Hippo+signaling+pathway+in+liver+and+pancreas%3A+the+potential+drug+target+for+tumor+therapy&doi=10.3109%2F1061186X.2014.983522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy</span></div><div class="casAuthors">Kong, Delin; Zhao, Yicheng; Men, Tong; Teng, Chun-Bo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-133</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1026-7158</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Cell behaviors, including proliferation, differentiation and apoptosis, are intricately controlled during organ development and tissue regeneration.  In the past 9 years, the Hippo signaling pathway has been delineated to play crit. roles in organ size control, tissue regeneration and tumorigenesis through regulating cell behaviors.  In mammals, the core modules of the Hippo signaling pathway include the MST1/2-LATS1/2 kinase cascade and the transcriptional co-activators YAP/TAZ.  The activity of YAP/TAZ is suppressed by cytoplasmic retention due to phosphorylation in the canonical MST1/2-LATS1/2 kinase cascade-dependent manner or the non-canonical MST1/2- and/or LATS1/2-independent manner.  Hippo signaling pathway, which can be activated or inactivated by cell polarity, contact inhibition, mech. stretch and extracellular factors, has been demonstrated to be involved in development and tumorigenesis of liver and pancreas.  In addn., we have summarized several small mols. currently available that can target Hippo-YAP pathway for potential treatment of hepatic and pancreatic cancers, providing clues for other YAP initiated cancers therapy as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS2c2b-wgTs7Vg90H21EOLACvtfcHk0liCbF1pJs8Mlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslSisg%253D%253D&md5=4746d2ca407af4af4b9000f1fc0849c5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3109%2F1061186X.2014.983522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F1061186X.2014.983522%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DMen%26aufirst%3DT.%26aulast%3DTeng%26aufirst%3DC.%2BB.%26atitle%3DHippo%2520signaling%2520pathway%2520in%2520liver%2520and%2520pancreas%253A%2520the%2520potential%2520drug%2520target%2520for%2520tumor%2520therapy%26jtitle%3DJ.%2520Drug.%2520Target.%26date%3D2015%26volume%3D23%26spage%3D125%26epage%3D133%26doi%3D10.3109%2F1061186X.2014.983522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iriana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annamalai, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendifar, A. E.</span></span> <span> </span><span class="NLM_article-title">Targeting mTOR in pancreatic ductal adenocarcinoma</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">99</span>, <span class="refDoi"> DOI: 10.3389/fonc.2016.00099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.3389%2Ffonc.2016.00099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=27200288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FhsFKjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=99&author=S.+Irianaauthor=S.+Ahmedauthor=J.+Gongauthor=A.+A.+Annamalaiauthor=R.+Tuliauthor=A.+E.+Hendifar&title=Targeting+mTOR+in+pancreatic+ductal+adenocarcinoma&doi=10.3389%2Ffonc.2016.00099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting mTOR in Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Iriana Sentia; Ahmed Shahzad; Gong Jun; Annamalai Alagappan Anand; Tuli Richard; Hendifar Andrew Eugene</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">99</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Treatment options for advanced pancreatic ductal adenocarcinoma (PDAC) are limited; however, new therapies targeting specific tumor-related molecular characteristics may help certain patient cohorts.  Emerging preclinical data have shown that inhibition of mammalian target of rapamycin (mTOR) in specific KRAS-dependent PDAC subtypes leads to inhibition of tumorigenesis in vitro and in vivo.  Early phase II studies of mono-mTOR inhibition have not shown promise.  However, studies have shown that combined inhibition of multiple steps along the mTOR signaling pathway may lead to sustained responses by targeting mechanisms of tumor resistance.  Coordinated inhibition of mTOR along with specific KRAS-dependent mutations in molecularly defined PDAC subpopulations may offer a viable alternative for treatment in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMbUYXuVDp7K__Jf7-eMvJfW6udTcc2eaoDWDseYmOgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FhsFKjsA%253D%253D&md5=9b10cb25c3663b45b225b8172df7d696</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2016.00099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2016.00099%26sid%3Dliteratum%253Aachs%26aulast%3DIriana%26aufirst%3DS.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DAnnamalai%26aufirst%3DA.%2BA.%26aulast%3DTuli%26aufirst%3DR.%26aulast%3DHendifar%26aufirst%3DA.%2BE.%26atitle%3DTargeting%2520mTOR%2520in%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DFront.%2520Oncol.%26date%3D2016%26volume%3D6%26spage%3D99%26doi%3D10.3389%2Ffonc.2016.00099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnieke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saur, D.</span></span> <span> </span><span class="NLM_article-title">Oncogenic KRAS signalling in pancreatic cancer</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">822</span>, <span class="refDoi"> DOI: 10.1038/bjc.2014.215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fbjc.2014.215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=24755884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVShs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=817-822&author=S.+Eserauthor=A.+Schniekeauthor=G.+Schneiderauthor=D.+Saur&title=Oncogenic+KRAS+signalling+in+pancreatic+cancer&doi=10.1038%2Fbjc.2014.215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic KRAS signalling in pancreatic cancer</span></div><div class="casAuthors">Eser, S.; Schnieke, A.; Schneider, G.; Saur, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">817-822</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pancreatic ductal adenocarcinoma (PDAC) is almost universally fatal.  The annual no. of deaths equals the no. of newly diagnosed cases, despite maximal treatment.  The overall 5-yr survival rate of <5% has remained stubbornly unchanged over the last 30 years, despite tremendous efforts in preclin. and clin. science.  There is unquestionably an urgent need to further improve our understanding of pancreatic cancer biol., treatment response and relapse, and to identify novel therapeutic targets.  Rigorous research in the field has uncovered genetic aberrations that occur during PDAC development and progression.  In most cases, PDAC is initiated by oncogenic mutant KRAS, which has been shown to drive pancreatic neoplasia.  However, all attempts to target KRAS directly have failed in the clinic and KRAS is widely assumed to be undruggable.  This has led to intense efforts to identify druggable crit. downstream targets and nodes orchestrated by mutationally activated KRAS.  This includes context-specific KRAS effector pathways, synthetic lethal interaction partners and KRAS-driven metabolic changes.  Here, we review recent advances in oncogenic KRAS signalling and discuss how these might benefit PDAC treatment in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmxRwu-hqhVLVg90H21EOLACvtfcHk0lgWWPTuf7eocw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVShs7g%253D&md5=9e4dc9abd50852b658f6b8c1d0ddc93d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2014.215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2014.215%26sid%3Dliteratum%253Aachs%26aulast%3DEser%26aufirst%3DS.%26aulast%3DSchnieke%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DG.%26aulast%3DSaur%26aufirst%3DD.%26atitle%3DOncogenic%2520KRAS%2520signalling%2520in%2520pancreatic%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2014%26volume%3D111%26spage%3D817%26epage%3D822%26doi%3D10.1038%2Fbjc.2014.215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trajkovic-Arsic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalideris, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siveke, J. T.</span></span> <span> </span><span class="NLM_article-title">The role of insulin and IGF system in pancreatic cancer</span>. <i>J. Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">R67</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1530/JME-12-0259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1530%2FJME-12-0259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=23493758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslykt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2013&pages=R67-74&author=M.+Trajkovic-Arsicauthor=E.+Kaliderisauthor=J.+T.+Siveke&title=The+role+of+insulin+and+IGF+system+in+pancreatic+cancer&doi=10.1530%2FJME-12-0259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The role of insulin and IGF system in pancreatic cancer</span></div><div class="casAuthors">Trajkovic-Arsic, Marija; Kalideris, Evdokia; Siveke, Jens T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">R67-R74</span>CODEN:
                <span class="NLM_cas:coden">JMLEEI</span>;
        ISSN:<span class="NLM_cas:issn">0952-5041</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">A review.  The importance of the IGF system in carcinogenesis has been established for many solid cancers.  It is well known that individuals with higher circulating levels of the IGF1 ligand present an increased risk of cancer.  However, therapies with monoclonal antibodies targeting the IGF1 receptor (IGF1R) have been largely unsuccessful.  One of the potential reasons for this failure is the existence of the highly homologous insulin receptor (IR), which appears to be at least equally efficient as the IGF1R in the transition of mitogenic signals to the nucleus and promotion of cell growth.  Furthermore, IGF1 and insulin receptors can form hybrid receptors sensitive to stimulation of all three ligands of the system: insulin, IGF1, and IGF2.  Although the connection between insulin, diabetes, and cancer has been established for years now, clear evidence that demonstrate the redundancy of insulin and insulin receptors and insulin-like growth factors and their receptors in cancer is missing.  In this review, we focus on the contribution of insulin and IGFs to carcinogenesis in the insulin-producing organ, the pancreas.  We give a short summary on the complexity of insulin and the IGF system in the pancreas and their potential roles in pancreatic cancer, esp. pancreatic ductal adenocarcinoma.  Finally, we discuss drug-targeting options of this system and the rationale of simultaneous targeting of both the insulin and the IGF systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-MbwGRNVFJLVg90H21EOLACvtfcHk0lgWWPTuf7eocw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslykt70%253D&md5=9614b4591498627039e76ec1c80e9115</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1530%2FJME-12-0259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FJME-12-0259%26sid%3Dliteratum%253Aachs%26aulast%3DTrajkovic-Arsic%26aufirst%3DM.%26aulast%3DKalideris%26aufirst%3DE.%26aulast%3DSiveke%26aufirst%3DJ.%2BT.%26atitle%3DThe%2520role%2520of%2520insulin%2520and%2520IGF%2520system%2520in%2520pancreatic%2520cancer%26jtitle%3DJ.%2520Mol.%2520Endocrinol.%26date%3D2013%26volume%3D50%26spage%3DR67%26epage%3D74%26doi%3D10.1530%2FJME-12-0259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arlt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehrz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mürköster, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vorndamm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folsch, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, H.</span></span> <span> </span><span class="NLM_article-title">Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3243</span>– <span class="NLM_lpage">3251</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1206390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fsj.onc.1206390" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=3243-3251&author=A.+Arltauthor=A.+Gehrzauthor=S.+M%C3%BCrk%C3%B6sterauthor=J.+Vorndammauthor=M.+L.+Kruseauthor=U.+R.+Folschauthor=H.+Schafer&title=Role+of+NF-kappaB+and+Akt%2FPI3K+in+the+resistance+of+pancreatic+carcinoma+cell+lines+against+gemcitabine-induced+cell+death&doi=10.1038%2Fsj.onc.1206390"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206390%26sid%3Dliteratum%253Aachs%26aulast%3DArlt%26aufirst%3DA.%26aulast%3DGehrz%26aufirst%3DA.%26aulast%3DM%25C3%25BCrk%25C3%25B6ster%26aufirst%3DS.%26aulast%3DVorndamm%26aufirst%3DJ.%26aulast%3DKruse%26aufirst%3DM.%2BL.%26aulast%3DFolsch%26aufirst%3DU.%2BR.%26aulast%3DSchafer%26aufirst%3DH.%26atitle%3DRole%2520of%2520NF-kappaB%2520and%2520Akt%252FPI3K%2520in%2520the%2520resistance%2520of%2520pancreatic%2520carcinoma%2520cell%2520lines%2520against%2520gemcitabine-induced%2520cell%2520death%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D3243%26epage%3D3251%26doi%3D10.1038%2Fsj.onc.1206390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Humbert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casteran, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanssens, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iovanna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertucci, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansfield, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moussy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermine, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubreuil, P.</span></span> <span> </span><span class="NLM_article-title">Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumor cell lines and ectopic mouse model</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e9430</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0009430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1371%2Fjournal.pone.0009430" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e9430&author=M.+Humbertauthor=N.+Casteranauthor=S.+Letardauthor=K.+Hanssensauthor=J.+Iovannaauthor=P.+Finettiauthor=F.+Bertucciauthor=T.+Baderauthor=C.+D.+Mansfieldauthor=A.+Moussyauthor=O.+Hermineauthor=P.+Dubreuil&title=Masitinib+combined+with+standard+gemcitabine+chemotherapy%3A+in+vitro+and+in+vivo+studies+in+human+pancreatic+tumor+cell+lines+and+ectopic+mouse+model&doi=10.1371%2Fjournal.pone.0009430"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0009430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0009430%26sid%3Dliteratum%253Aachs%26aulast%3DHumbert%26aufirst%3DM.%26aulast%3DCasteran%26aufirst%3DN.%26aulast%3DLetard%26aufirst%3DS.%26aulast%3DHanssens%26aufirst%3DK.%26aulast%3DIovanna%26aufirst%3DJ.%26aulast%3DFinetti%26aufirst%3DP.%26aulast%3DBertucci%26aufirst%3DF.%26aulast%3DBader%26aufirst%3DT.%26aulast%3DMansfield%26aufirst%3DC.%2BD.%26aulast%3DMoussy%26aufirst%3DA.%26aulast%3DHermine%26aufirst%3DO.%26aulast%3DDubreuil%26aufirst%3DP.%26atitle%3DMasitinib%2520combined%2520with%2520standard%2520gemcitabine%2520chemotherapy%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520studies%2520in%2520human%2520pancreatic%2520tumor%2520cell%2520lines%2520and%2520ectopic%2520mouse%2520model%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De9430%26doi%3D10.1371%2Fjournal.pone.0009430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forment, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oelschlaegel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xhemalce, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. P.</span></span> <span> </span><span class="NLM_article-title">Small-molecule-induced DNA damage identifies alternative DNA structures in human genes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1038/nchembio.780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fnchembio.780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=22306580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=301-310&author=R.+Rodriguezauthor=K.+M.+Millerauthor=J.+V.+Formentauthor=C.+R.+Bradshawauthor=M.+Nikanauthor=S.+Brittonauthor=T.+Oelschlaegelauthor=B.+Xhemalceauthor=S.+Balasubramanianauthor=S.+P.+Jackson&title=Small-molecule-induced+DNA+damage+identifies+alternative+DNA+structures+in+human+genes&doi=10.1038%2Fnchembio.780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule-induced DNA damage identifies alternative DNA structures in human genes</span></div><div class="casAuthors">Rodriguez, Raphael; Miller, Kyle M.; Forment, Josep V.; Bradshaw, Charles R.; Nikan, Mehran; Britton, Sebastien; Oelschlaegel, Tobias; Xhemalce, Blerta; Balasubramanian, Shankar; Jackson, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">301-310</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Guanine-rich DNA sequences that can adopt non-Watson-Crick structures in vitro are prevalent in the human genome.  Whether such structures normally exist in mammalian cells has, however, been the subject of active research for decades.  Here we show that the G-quadruplex-interacting drug pyridostatin promotes growth arrest in human cancer cells by inducing replication- and transcription-dependent DNA damage.  A chromatin immunopptn. sequencing anal. of the DNA damage marker γH2AX provided the genome-wide distribution of pyridostatin-induced sites of damage and revealed that pyridostatin targets gene bodies contg. clusters of sequences with a propensity for G-quadruplex formation.  As a result, pyridostatin modulated the expression of these genes, including the proto-oncogene SRC.  We obsd. that pyridostatin reduced SRC protein abundance and SRC-dependent cellular motility in human breast cancer cells, validating SRC as a target of this drug.  Our unbiased approach to define genomic sites of action for a drug establishes a framework for discovering functional DNA-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Ffpu4Hgf7rVg90H21EOLACvtfcHk0ljxmb8aqLOfZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGkur0%253D&md5=60f699970eead8cabd7b3a7a260714e7</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.780%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DK.%2BM.%26aulast%3DForment%26aufirst%3DJ.%2BV.%26aulast%3DBradshaw%26aufirst%3DC.%2BR.%26aulast%3DNikan%26aufirst%3DM.%26aulast%3DBritton%26aufirst%3DS.%26aulast%3DOelschlaegel%26aufirst%3DT.%26aulast%3DXhemalce%26aufirst%3DB.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26atitle%3DSmall-molecule-induced%2520DNA%2520damage%2520identifies%2520alternative%2520DNA%2520structures%2520in%2520human%2520genes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D301%26epage%3D310%26doi%3D10.1038%2Fnchembio.780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rappold, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwabuchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Date, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Tumor suppressor P53 binding protein 1 (53bp1) is involved in DNA damage–signaling pathways</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1083/jcb.153.3.613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1083%2Fjcb.153.3.613" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2001&pages=613-620&author=I.+Rappoldauthor=K.+Iwabuchiauthor=T.+Dateauthor=J.+Chen&title=Tumor+suppressor+P53+binding+protein+1+%2853bp1%29+is+involved+in+DNA+damage%E2%80%93signaling+pathways&doi=10.1083%2Fjcb.153.3.613"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1083%2Fjcb.153.3.613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.153.3.613%26sid%3Dliteratum%253Aachs%26aulast%3DRappold%26aufirst%3DI.%26aulast%3DIwabuchi%26aufirst%3DK.%26aulast%3DDate%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DTumor%2520suppressor%2520P53%2520binding%2520protein%25201%2520%252853bp1%2529%2520is%2520involved%2520in%2520DNA%2520damage%25E2%2580%2593signaling%2520pathways%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2001%26volume%3D153%26spage%3D613%26epage%3D620%26doi%3D10.1083%2Fjcb.153.3.613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemmens, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Schendel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tijsterman, M.</span></span> <span> </span><span class="NLM_article-title">Mutagenic consequences of a single G-quadruplex demonstrate mitotic inheritance of DNA replication fork barriers</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8909</span>, <span class="refDoi"> DOI: 10.1038/ncomms9909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fncomms9909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26563448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOmsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8909&author=B.+Lemmensauthor=R.+van+Schendelauthor=M.+Tijsterman&title=Mutagenic+consequences+of+a+single+G-quadruplex+demonstrate+mitotic+inheritance+of+DNA+replication+fork+barriers&doi=10.1038%2Fncomms9909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Mutagenic consequences of a single G-quadruplex demonstrate mitotic inheritance of DNA replication fork barriers</span></div><div class="casAuthors">Lemmens, Bennie; van Schendel, Robin; Tijsterman, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8909</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Faithful DNA replication is vital to prevent disease-causing mutations, chromosomal aberrations and malignant transformation.  However, accuracy conflicts with pace and flexibility and cells rely on specialized polymerases and helicases to ensure effective and timely replication of genomes that contain DNA lesions or secondary structures.  If and how cells can tolerate a permanent barrier to replication is, however, unknown.  Here we show that a single unresolved G-quadruplexed DNA structure can persist through multiple mitotic divisions without changing conformation.  Failed replication across a G-quadruplex causes single-strand DNA gaps that give rise to DNA double-strand breaks in subsequent cell divisions, which are processed by polymerase theta (POLQ)-mediated alternative end joining.  Lineage tracing expts. further reveal that persistent G-quadruplexes cause genetic heterogeneity during organ development.  Our data demonstrate that a single lesion can cause multiple unique genomic rearrangements, and that alternative end joining enables cells to proliferate in the presence of mitotically inherited replication blocks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp8h0JCrSGUrVg90H21EOLACvtfcHk0ljxmb8aqLOfZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOmsbbK&md5=db43b84764420d505e3c6dba0bc0c70d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fncomms9909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9909%26sid%3Dliteratum%253Aachs%26aulast%3DLemmens%26aufirst%3DB.%26aulast%3Dvan%2BSchendel%26aufirst%3DR.%26aulast%3DTijsterman%26aufirst%3DM.%26atitle%3DMutagenic%2520consequences%2520of%2520a%2520single%2520G-quadruplex%2520demonstrate%2520mitotic%2520inheritance%2520of%2520DNA%2520replication%2520fork%2520barriers%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8909%26doi%3D10.1038%2Fncomms9909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hessmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsen, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siveke, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenrieder, V.</span></span> <span> </span><span class="NLM_article-title">Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1136/gutjnl-2016-312539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1136%2Fgutjnl-2016-312539" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2017&pages=168-179&author=E.+Hessmannauthor=S.+A.+Johnsenauthor=J.+T.+Sivekeauthor=V.+Ellenrieder&title=Epigenetic+treatment+of+pancreatic+cancer%3A+is+there+a+therapeutic+perspective+on+the+horizon%3F&doi=10.1136%2Fgutjnl-2016-312539"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1136%2Fgutjnl-2016-312539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgutjnl-2016-312539%26sid%3Dliteratum%253Aachs%26aulast%3DHessmann%26aufirst%3DE.%26aulast%3DJohnsen%26aufirst%3DS.%2BA.%26aulast%3DSiveke%26aufirst%3DJ.%2BT.%26aulast%3DEllenrieder%26aufirst%3DV.%26atitle%3DEpigenetic%2520treatment%2520of%2520pancreatic%2520cancer%253A%2520is%2520there%2520a%2520therapeutic%2520perspective%2520on%2520the%2520horizon%253F%26jtitle%3DGut%26date%3D2017%26volume%3D66%26spage%3D168%26epage%3D179%26doi%3D10.1136%2Fgutjnl-2016-312539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riou, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teulade-Fichou, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frickey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartig, J. S.</span></span> <span> </span><span class="NLM_article-title">Bisquinolinium compounds induce quadruplex-specific transcriptome changes in HeLa S3 cell lines</span>. <i>BMC Res. Notes</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">138</span>, <span class="refDoi"> DOI: 10.1186/1756-0500-5-138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1186%2F1756-0500-5-138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=22414013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVWgurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=138&author=R.+Halderauthor=J.+F.+Riouauthor=M.+P.+Teulade-Fichouauthor=T.+Frickeyauthor=J.+S.+Hartig&title=Bisquinolinium+compounds+induce+quadruplex-specific+transcriptome+changes+in+HeLa+S3+cell+lines&doi=10.1186%2F1756-0500-5-138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Bisquinolinium compounds induce quadruplex-specific transcriptome changes in HeLa S3 cell lines</span></div><div class="casAuthors">Halder, Rashi; Riou, Jean-Francois; Teulade-Fichou, Marie-Paule; Frickey, Tancred; Hartig, Joerg S.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Research Notes</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">138</span>CODEN:
                <span class="NLM_cas:coden">BRNMAT</span>;
        ISSN:<span class="NLM_cas:issn">1756-0500</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Guanosine rich sequences capable of forming G-quadruplex (G4) motifs are enriched near the gene transcription start site (TSS) in the human genome.  When probed at the single gene level, G-quadruplex motifs residing in promoter regions show substantial effects on gene transcription.  Moreover, further changes in transcription levels are noticed when G4-motifs are targeted with G-quadruplex-specific small mols.  Results: Global studies concerning general changes of the transcriptome via targeting promoter-based G-quadruplex motifs are very limited and have so far only been carried out with compds. displaying weak selectivity for quadruplex sequences.  Here we utilize two G-quadruplex-specific bisquinolinium derivs. PhenDC3 and 360A and investigate their effects on the expression of the HeLa S3 transcriptome.  Our results show wide-spread changes in the transcriptome with specificity for genes with G-quadruplex motifs near their transcription start sites (TSS).  Using real-time PCR we further confirmed the specificity of PhenDC3 and 360A as potent mols. to target G-quadruplex-regulated genes.  Conclusions: Specific effects on quadruplex-contg. genes have been obsd. utilizing whole-transcriptome anal. upon treatment of cultured cells with quadruplex-selective bisquinolinium compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf2sS5QZK5u7Vg90H21EOLACvtfcHk0liFEZKSbyhGgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVWgurY%253D&md5=1fe7710c3917004e7cbe3037599ac8c6</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1186%2F1756-0500-5-138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-0500-5-138%26sid%3Dliteratum%253Aachs%26aulast%3DHalder%26aufirst%3DR.%26aulast%3DRiou%26aufirst%3DJ.%2BF.%26aulast%3DTeulade-Fichou%26aufirst%3DM.%2BP.%26aulast%3DFrickey%26aufirst%3DT.%26aulast%3DHartig%26aufirst%3DJ.%2BS.%26atitle%3DBisquinolinium%2520compounds%2520induce%2520quadruplex-specific%2520transcriptome%2520changes%2520in%2520HeLa%2520S3%2520cell%2520lines%26jtitle%3DBMC%2520Res.%2520Notes%26date%3D2012%26volume%3D5%26spage%3D138%26doi%3D10.1186%2F1756-0500-5-138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandakumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vietsch, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughlin, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadhwa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chetram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallakury, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toretsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellstein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, C.</span></span> <span> </span><span class="NLM_article-title">Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">ra42</span>, <span class="refDoi"> DOI: 10.1126/scisignal.2005049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1126%2Fscisignal.2005049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=24803537" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=ra42&author=W.+Zhangauthor=N.+Nandakumarauthor=Y.+Shiauthor=M.+Manzanoauthor=A.+Smithauthor=G.+Grahamauthor=S.+Guptaauthor=E.+E.+Vietschauthor=S.+Z.+Laughlinauthor=M.+Wadhwaauthor=M.+Chetramauthor=M.+Joshiauthor=F.+Wangauthor=B.+Kallakuryauthor=J.+Toretskyauthor=A.+Wellsteinauthor=C.+Yi&title=Downstream+of+mutant+KRAS%2C+the+transcription+regulator+YAP+is+essential+for+neoplastic+progression+to+pancreatic+ductal+adenocarcinoma&doi=10.1126%2Fscisignal.2005049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2005049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2005049%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DNandakumar%26aufirst%3DN.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DManzano%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DG.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DVietsch%26aufirst%3DE.%2BE.%26aulast%3DLaughlin%26aufirst%3DS.%2BZ.%26aulast%3DWadhwa%26aufirst%3DM.%26aulast%3DChetram%26aufirst%3DM.%26aulast%3DJoshi%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DKallakury%26aufirst%3DB.%26aulast%3DToretsky%26aufirst%3DJ.%26aulast%3DWellstein%26aufirst%3DA.%26aulast%3DYi%26aufirst%3DC.%26atitle%3DDownstream%2520of%2520mutant%2520KRAS%252C%2520the%2520transcription%2520regulator%2520YAP%2520is%2520essential%2520for%2520neoplastic%2520progression%2520to%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DSci.%2520Signaling%26date%3D2014%26volume%3D7%26spage%3Dra42%26doi%3D10.1126%2Fscisignal.2005049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ying, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liewen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadanandam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Khalil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher-Sananikone, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwitz, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettazzoni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Protopopov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffernan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draetta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePinho, R. A.</span></span> <span> </span><span class="NLM_article-title">Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2014.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.cell.2014.06.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2014&pages=185-197&author=A.+Kapoorauthor=W.+Yaoauthor=H.+Yingauthor=S.+Huaauthor=A.+Liewenauthor=Q.+Wangauthor=Y.+Zhongauthor=C.+J.+Wuauthor=A.+Sadanandamauthor=B.+Huauthor=Q.+Changauthor=G.+C.+Chuauthor=R.+Al-Khalilauthor=S.+Jiangauthor=H.+Xiaauthor=E.+Fletcher-Sananikoneauthor=C.+Limauthor=G.+I.+Horwitzauthor=A.+Vialeauthor=P.+Pettazzoniauthor=N.+Sanchezauthor=H.+Wangauthor=A.+Protopopovauthor=J.+Zhangauthor=T.+Heffernanauthor=R.+L.+Johnsonauthor=L.+Chinauthor=Y.+A.+Wangauthor=G.+Draettaauthor=R.+A.+DePinho&title=Yap1+activation+enables+bypass+of+oncogenic+Kras+addiction+in+pancreatic+cancer&doi=10.1016%2Fj.cell.2014.06.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DKapoor%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DYing%26aufirst%3DH.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DLiewen%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DC.%2BJ.%26aulast%3DSadanandam%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DChu%26aufirst%3DG.%2BC.%26aulast%3DAl-Khalil%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DH.%26aulast%3DFletcher-Sananikone%26aufirst%3DE.%26aulast%3DLim%26aufirst%3DC.%26aulast%3DHorwitz%26aufirst%3DG.%2BI.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DPettazzoni%26aufirst%3DP.%26aulast%3DSanchez%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DProtopopov%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHeffernan%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DChin%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%2BA.%26aulast%3DDraetta%26aufirst%3DG.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26atitle%3DYap1%2520activation%2520enables%2520bypass%2520of%2520oncogenic%2520Kras%2520addiction%2520in%2520pancreatic%2520cancer%26jtitle%3DCell%26date%3D2014%26volume%3D158%26spage%3D185%26epage%3D197%26doi%3D10.1016%2Fj.cell.2014.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krall, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhutkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccioni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinzel, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbluh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span> <span> </span><span class="NLM_article-title">KRAS and YAP1 converge to regulate EMT and tumor survival</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2014.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.cell.2014.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=24954536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCjtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2014&pages=171-184&author=D.+D.+Shaoauthor=W.+Xueauthor=E.+B.+Krallauthor=A.+Bhutkarauthor=F.+Piccioniauthor=X.+Wangauthor=A.+C.+Schinzelauthor=S.+Soodauthor=J.+Rosenbluhauthor=J.+W.+Kimauthor=Y.+Zwangauthor=T.+M.+Robertsauthor=D.+E.+Rootauthor=T.+Jacksauthor=W.+C.+Hahn&title=KRAS+and+YAP1+converge+to+regulate+EMT+and+tumor+survival&doi=10.1016%2Fj.cell.2014.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">KRAS and YAP1 Converge to Regulate EMT and Tumor Survival</span></div><div class="casAuthors">Shao, Diane D.; Xue, Wen; Krall, Elsa B.; Bhutkar, Arjun; Piccioni, Federica; Wang, Xiaoxing; Schinzel, Anna C.; Sood, Sabina; Rosenbluh, Joseph; Kim, Jong W.; Zwang, Yaara; Roberts, Thomas M.; Root, David E.; Jacks, Tyler; Hahn, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-184</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cancer cells that express oncogenic alleles of RAS typically require sustained expression of the mutant allele for survival, but the mol. basis of this oncogene dependency remains incompletely understood.  To identify genes that can functionally substitute for oncogenic RAS, we systematically expressed 15,294 open reading frames in a human KRAS-dependent colon cancer cell line engineered to express an inducible KRAS-specific shRNA.  We found 147 genes that promoted survival upon KRAS suppression.  In particular, the transcriptional coactivator YAP1 rescued cell viability in KRAS-dependent cells upon suppression of KRAS and was required for KRAS-induced cell transformation.  Acquired resistance to Kras suppression in a Kras-driven murine lung cancer model also involved increased YAP1 signaling.  KRAS and YAP1 converge on the transcription factor FOS and activate a transcriptional program involved in regulating the epithelial-mesenchymal transition (EMT).  Together, these findings implicate transcriptional regulation of EMT by YAP1 as a significant component of oncogenic RAS signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYcz1QvYc_z7Vg90H21EOLACvtfcHk0liFEZKSbyhGgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCjtbfM&md5=917628c21f0bf281736e8fc9dbb9b11d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DD.%2BD.%26aulast%3DXue%26aufirst%3DW.%26aulast%3DKrall%26aufirst%3DE.%2BB.%26aulast%3DBhutkar%26aufirst%3DA.%26aulast%3DPiccioni%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DSood%26aufirst%3DS.%26aulast%3DRosenbluh%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DZwang%26aufirst%3DY.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26atitle%3DKRAS%2520and%2520YAP1%2520converge%2520to%2520regulate%2520EMT%2520and%2520tumor%2520survival%26jtitle%3DCell%26date%3D2014%26volume%3D158%26spage%3D171%26epage%3D184%26doi%3D10.1016%2Fj.cell.2014.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, K. F.</span></span> <span> </span><span class="NLM_article-title">The TEAD family and its oncogenic role in promoting tumorigenesis</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">138</span>, <span class="refDoi"> DOI: 10.3390/ijms17010138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.3390%2Fijms17010138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26805820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=138&author=Y.+Zhouauthor=T.+Huangauthor=A.+S.+Chengauthor=J.+Yuauthor=W.+Kangauthor=K.+F.+To&title=The+TEAD+family+and+its+oncogenic+role+in+promoting+tumorigenesis&doi=10.3390%2Fijms17010138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The TEAD family and its oncogenic role in promoting tumorigenesis</span></div><div class="casAuthors">Zhou, Yuhang; Huang, Tingting; Cheng, Alfred S. L.; Yu, Jun; Kang, Wei; To, Ka Fai</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">138/1-138/15</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The TEAD family of transcription factors is necessary for developmental processes.  The family members contain a TEA domain for the binding with DNA elements and a transactivation domain for the interaction with transcription coactivators.  TEAD proteins are required for the participation of coactivators to transmit the signal of pathways for the downstream signaling processes.  TEADs also play an important role in tumor initiation and facilitate cancer progression via activating a series of progression-inducing genes, such as CTGF, Cyr61, Myc and Gli2.  Recent studies have highlighted that TEADs, together with their coactivators, promote or even act as the crucial parts in the development of various malignancies, such as liver, ovarian, breast and prostate cancers.  Furthermore, TEADs are proposed to be useful prognostic biomarkers due to the ideal correlation between high expression and clinicopathol. parameters in gastric, breast, ovarian and prostate cancers.  In this review, we summarize the functional role of TEAD proteins in tumorigenesis and discuss the key role of TEAD transcription factors in the linking of signal cascade transductions.  Improved knowledge of the TEAD proteins will be helpful for deep understanding of the mol. mechanisms of tumorigenesis and identifying ideal predictive or prognostic biomarkers, even providing clin. translation for anticancer therapy in human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWR3IdQcw6YLVg90H21EOLACvtfcHk0lg8V6m4kkBUfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOlsw%253D%253D&md5=3ca058d5405586b1397cc1e0c5b70b79</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.3390%2Fijms17010138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms17010138%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DT.%26aulast%3DCheng%26aufirst%3DA.%2BS.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DW.%26aulast%3DTo%26aufirst%3DK.%2BF.%26atitle%3DThe%2520TEAD%2520family%2520and%2520its%2520oncogenic%2520role%2520in%2520promoting%2520tumorigenesis%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2016%26volume%3D17%26spage%3D138%26doi%3D10.3390%2Fijms17010138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajurkar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jesus-Monge, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driscoll, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleman, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotton, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimstra, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, J.</span></span> <span> </span><span class="NLM_article-title">The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">E1038</span>– <span class="NLM_lpage">1047</span>, <span class="refDoi"> DOI: 10.1073/pnas.1114168109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1073%2Fpnas.1114168109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=E1038-1047&author=M.+Rajurkarauthor=W.+E.+De+Jesus-Mongeauthor=D.+R.+Driscollauthor=V.+A.+Applemanauthor=H.+Huangauthor=J.+L.+Cottonauthor=D.+S.+Klimstraauthor=L.+J.+Zhuauthor=K.+Siminauthor=L.+Xuauthor=A.+P.+McMahonauthor=B.+C.+Lewisauthor=J.+Mao&title=The+activity+of+Gli+transcription+factors+is+essential+for+Kras-induced+pancreatic+tumorigenesis&doi=10.1073%2Fpnas.1114168109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1114168109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1114168109%26sid%3Dliteratum%253Aachs%26aulast%3DRajurkar%26aufirst%3DM.%26aulast%3DDe%2BJesus-Monge%26aufirst%3DW.%2BE.%26aulast%3DDriscoll%26aufirst%3DD.%2BR.%26aulast%3DAppleman%26aufirst%3DV.%2BA.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DCotton%26aufirst%3DJ.%2BL.%26aulast%3DKlimstra%26aufirst%3DD.%2BS.%26aulast%3DZhu%26aufirst%3DL.%2BJ.%26aulast%3DSimin%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DMcMahon%26aufirst%3DA.%2BP.%26aulast%3DLewis%26aufirst%3DB.%2BC.%26aulast%3DMao%26aufirst%3DJ.%26atitle%3DThe%2520activity%2520of%2520Gli%2520transcription%2520factors%2520is%2520essential%2520for%2520Kras-induced%2520pancreatic%2520tumorigenesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3DE1038%26epage%3D1047%26doi%3D10.1073%2Fpnas.1114168109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span> <span> </span><span class="NLM_article-title">Promising molecular mechanisms responsible for gemcitabine resistance in cancer</span>. <i>Genes Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1016/j.gendis.2015.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.gendis.2015.07.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=299-306&author=Y.+Jiaauthor=J.+Xie&title=Promising+molecular+mechanisms+responsible+for+gemcitabine+resistance+in+cancer&doi=10.1016%2Fj.gendis.2015.07.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.gendis.2015.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gendis.2015.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DJ.%26atitle%3DPromising%2520molecular%2520mechanisms%2520responsible%2520for%2520gemcitabine%2520resistance%2520in%2520cancer%26jtitle%3DGenes%2520Dis.%26date%3D2015%26volume%3D2%26spage%3D299%26epage%3D306%26doi%3D10.1016%2Fj.gendis.2015.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raza, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knab, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentrem, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovic, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, H. G.</span></span> <span> </span><span class="NLM_article-title">GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">9489</span>, <span class="refDoi"> DOI: 10.1038/srep09489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fsrep09489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25807524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOjurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=9489&author=K.+Kumarauthor=S.+S.+Razaauthor=L.+M.+Knabauthor=C.+R.+Chowauthor=B.+Kwokauthor=D.+J.+Bentremauthor=R.+Popovicauthor=K.+Ebineauthor=J.+D.+Lichtauthor=H.+G.+Munshi&title=GLI2-dependent+c-MYC+upregulation+mediates+resistance+of+pancreatic+cancer+cells+to+the+BET+bromodomain+inhibitor+JQ1&doi=10.1038%2Fsrep09489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1</span></div><div class="casAuthors">Kumar, Krishan; Raza, Sania S.; Knab, Lawrence M.; Chow, Christina R.; Kwok, Benjamin; Bentrem, David J.; Popovic, Relja; Ebine, Kazumi; Licht, Jonathan D.; Munshi, Hidayatullah G.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9489</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">JQ1 and I-BET151 are selective inhibitors of BET bromodomain proteins that have efficacy against a no. of different cancers.  Since the effectiveness of targeted therapies is often limited by development of resistance, we examd. whether it was possible for cancer cells to develop resistance to the BET inhibitor JQ1.  Here we show that pancreatic cancer cells developing resistance to JQ1 demonstrate cross-resistance to I-BET151 and insensitivity to BRD4 downregulation.  The resistant cells maintain expression of c-MYC, increase expression of JQ1-target genes FOSL1 and HMGA2, and demonstrate evidence of epithelial-mesenchymal transition (EMT).  However, reverting EMT fails to sensitize the resistant cells to JQ1 treatment.  Importantly, the JQ1-resistant cells remain dependent on c-MYC that now becomes co-regulated by high levels of GLI2.  Furthermore, downregulating GLI2 re-sensitizes the resistant cells to JQ1.  Overall, these results identify a mechanism by which cancer cells develop resistance to BET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6mUgUS37czbVg90H21EOLACvtfcHk0lg8V6m4kkBUfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOjurjO&md5=c5f9dad7134441f6c7edbd6dcc7b40e8</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fsrep09489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep09489%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DRaza%26aufirst%3DS.%2BS.%26aulast%3DKnab%26aufirst%3DL.%2BM.%26aulast%3DChow%26aufirst%3DC.%2BR.%26aulast%3DKwok%26aufirst%3DB.%26aulast%3DBentrem%26aufirst%3DD.%2BJ.%26aulast%3DPopovic%26aufirst%3DR.%26aulast%3DEbine%26aufirst%3DK.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DMunshi%26aufirst%3DH.%2BG.%26atitle%3DGLI2-dependent%2520c-MYC%2520upregulation%2520mediates%2520resistance%2520of%2520pancreatic%2520cancer%2520cells%2520to%2520the%2520BET%2520bromodomain%2520inhibitor%2520JQ1%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D9489%26doi%3D10.1038%2Fsrep09489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jagadeeshan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tentu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beesetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surabhi, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mavuluri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhoopalan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitani, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chidambaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malathi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayala, S. K.</span></span> <span> </span><span class="NLM_article-title">P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1546</span>– <span class="NLM_lpage">1556</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdw184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fannonc%2Fmdw184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=27117533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC28bjs1amtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=1546-1556&author=S.+Jagadeeshanauthor=A.+Subramanianauthor=S.+Tentuauthor=S.+Beesettiauthor=M.+Singhalauthor=S.+Raghavanauthor=R.+P.+Surabhiauthor=J.+Mavuluriauthor=H.+Bhoopalanauthor=J.+Biswalauthor=R.+S.+Pitaniauthor=S.+Chidambaramauthor=S.+Sundaramauthor=R.+Malathiauthor=J.+Jeyaramanauthor=A.+S.+Nairauthor=G.+Venkatramanauthor=S.+K.+Rayala&title=P21-activated+kinase+1+%28Pak1%29+signaling+influences+therapeutic+outcome+in+pancreatic+cancer&doi=10.1093%2Fannonc%2Fmdw184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer</span></div><div class="casAuthors">Jagadeeshan S; Subramanian A; Tentu S; Beesetti S; Singhal M; Raghavan S; Mavuluri J; Rayala S K; Surabhi R P; Bhoopalan H; Venkatraman G; Biswal J; Jeyaraman J; Pitani R S; Chidambaram S; Sundaram S; Malathi R; Nair A S</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1546-56</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Therapeutic resistance to gemcitabine in pancreatic ductal adenocarcinoma (PDAC) is attributed to various cellular mechanisms and signaling molecules that influence as a single factor or in combination.  DESIGN:  In this study, utilizing in vitro p21-activated kinase 1 (Pak1) overexpression and knockdown cell line models along with in vivo athymic mouse tumor xenograft models and clinical samples, we demonstrate that Pak1 is a crucial signaling kinase in gemcitabine resistance.  RESULTS:  Pak1 kindles resistance via modulation of epithelial-mesenchymal transition and activation of pancreatic stellate cells.  Our results from gemcitabine-resistant and -sensitive cell line models showed that elevated Pak1 kinase activity is required to confer gemcitabine resistance.  This was substantiated by elevated levels of phosphorylated Pak1 and ribonucleotide reductase M1 levels in the majority of human PDAC tumors when compared with normal.  Delineation of the signaling pathway revealed that Pak1 confers resistance to gemcitabine by preventing DNA damage, inhibiting apoptosis and regulating survival signals via NF-κB.  Furthermore, we found that Pak1 is an upstream interacting substrate of transforming growth factor β-activated kinase 1-a molecule implicated in gemcitabine resistance.  Molecular mechanistic studies revealed that gemcitabine docks with the active site of Pak1; furthermore, gemcitabine treatment induces Pak1 kinase activity both in vivo and in cell-free system.  Finally, results from athymic mouse tumor models illustrated that Pak1 inhibition by IPA-3 enhances the cytotoxicity of gemcitabine and brings about pancreatic tumor regression.  CONCLUSION:  To our knowledge, this is the first study illustrating the mechanistic role of Pak1 in causing gemcitabine resistance via multiple signaling crosstalks, and hence Pak1-specific inhibitors will prove to be a better adjuvant with existing chemotherapy modality for PDAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGLmx0_3sLIbmQt-ICR3qNfW6udTcc2eYALtMspzzHLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bjs1amtQ%253D%253D&md5=23dc98cffd86c424270a2d4accd6c50c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdw184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdw184%26sid%3Dliteratum%253Aachs%26aulast%3DJagadeeshan%26aufirst%3DS.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DTentu%26aufirst%3DS.%26aulast%3DBeesetti%26aufirst%3DS.%26aulast%3DSinghal%26aufirst%3DM.%26aulast%3DRaghavan%26aufirst%3DS.%26aulast%3DSurabhi%26aufirst%3DR.%2BP.%26aulast%3DMavuluri%26aufirst%3DJ.%26aulast%3DBhoopalan%26aufirst%3DH.%26aulast%3DBiswal%26aufirst%3DJ.%26aulast%3DPitani%26aufirst%3DR.%2BS.%26aulast%3DChidambaram%26aufirst%3DS.%26aulast%3DSundaram%26aufirst%3DS.%26aulast%3DMalathi%26aufirst%3DR.%26aulast%3DJeyaraman%26aufirst%3DJ.%26aulast%3DNair%26aufirst%3DA.%2BS.%26aulast%3DVenkatraman%26aufirst%3DG.%26aulast%3DRayala%26aufirst%3DS.%2BK.%26atitle%3DP21-activated%2520kinase%25201%2520%2528Pak1%2529%2520signaling%2520influences%2520therapeutic%2520outcome%2520in%2520pancreatic%2520cancer%26jtitle%3DAnn.%2520Oncol.%26date%3D2016%26volume%3D27%26spage%3D1546%26epage%3D1556%26doi%3D10.1093%2Fannonc%2Fmdw184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span> <span> </span><span class="NLM_article-title">ROBO3 promotes growth and metastasis of pancreatic carcinoma</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2015.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.canlet.2015.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26070964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWns7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2015&pages=61-70&author=S.+Hanauthor=C.+Caoauthor=T.+Tangauthor=C.+Luauthor=J.+Xuauthor=S.+Wangauthor=L.+Xueauthor=X.+Zhangauthor=M.+Li&title=ROBO3+promotes+growth+and+metastasis+of+pancreatic+carcinoma&doi=10.1016%2Fj.canlet.2015.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">ROBO3 promotes growth and metastasis of pancreatic carcinoma</span></div><div class="casAuthors">Han, Shilong; Cao, Chuanwu; Tang, Tao; Lu, Chenhui; Xu, Jichong; Wang, Shi; Xue, Lei; Zhang, Xiaoping; Li, Maoquan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-70</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Pancreatic carcinoma is a highly lethal malignancy with an extremely poor prognosis.  Recent genome-wide studies have implicated axon guidance pathways, including the SLIT/ROBO pathway, in pancreatic tumor development and progression.  Here we showed that ROBO3 expression is up-regulated in pancreatic cancer tissue samples and cell lines.  Over-expression of ROBO3 promotes pancreatic cancer cell growth, invasion and metastasis in vitro and in mouse xenograft tumor models.  We identified miR-383 as a suppressor of ROBO3, and revealed its expression to be inversely correlated with ROBO3.  Over-expression of ROBO3 activates Wnt pathway components, β-catenin and GSK-3, and the expression of markers indicating an EMT.  By means of immunopptn., we revealed an interaction between Wnt inhibitor SFRP and ROBO3 in pancreatic cancer cell lines.  Our work suggests that ROBO3 may contribute to the progression of pancreatic cancer by sequestering Wnt inhibitor SFRP, which in turn leads to increased Wnt/β-catenin pathway activity.  We also confirmed that ROBO3 increases with clin. grade and miR-383 expression is inversely correlated to that of ROBO3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvJFg2993DebVg90H21EOLACvtfcHk0li4BucItktmtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWns7vL&md5=c4a0f2bb769800459091ce8c0bd4ad36</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DM.%26atitle%3DROBO3%2520promotes%2520growth%2520and%2520metastasis%2520of%2520pancreatic%2520carcinoma%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D366%26spage%3D61%26epage%3D70%26doi%3D10.1016%2Fj.canlet.2015.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muller, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swiercz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceyhan, G. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchler, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offermanns, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friess, H.</span></span> <span> </span><span class="NLM_article-title">Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">2421</span>– <span class="NLM_lpage">2433</span>, <span class="refDoi"> DOI: 10.1002/ijc.22949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1002%2Fijc.22949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=17631638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BD2srosVKmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=2421-2433&author=M.+W.+Mullerauthor=N.+A.+Gieseauthor=J.+M.+Swierczauthor=G.+O.+Ceyhanauthor=I.+Espositoauthor=U.+Hinzauthor=P.+Buchlerauthor=T.+Gieseauthor=M.+W.+Buchlerauthor=S.+Offermannsauthor=H.+Friess&title=Association+of+axon+guidance+factor+semaphorin+3A+with+poor+outcome+in+pancreatic+cancer&doi=10.1002%2Fijc.22949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer</span></div><div class="casAuthors">Muller Michael W; Giese Nathalia A; Swiercz Jakub M; Ceyhan Guralp O; Esposito Irene; Hinz Ulf; Buchler Peter; Giese Thomas; Buchler Markus W; Offermanns Stefan; Friess Helmut</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2421-33</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neural alterations and aberrantly expressed nerve-specific factors promoting tumor progression are known to contribute to pancreatic cancer's extremely poor prognosis.  Despite hints that axon guidance factor semaphorin 3A (SEMA3A) may function as a tumor inhibitor, its clinical importance and therapeutic potential have not yet been explored.  The present study investigated the role of SEMA3A and its receptors-plexins A1-A4 (PLXNA1-A4) and neuropilin-1 (NRP1)-in pancreatic cancer.  QRT-PCR and immunohistochemical analyses revealed overexpression of SEMA3A, NRP1 and PLXNA1 in metaplastic ducts, malignant cells and nerves of cancerous specimens, and showed that elevated levels of corresponding mRNA (6.8-fold, 2.0-fold and 1.5-fold, respectively) clearly correlated with negative clinicopathological manifestations such as shorter survival (SEMA3A and PLXNA1) and a lesser degree of tumor differentiation (NRP1) in Stages I-III patients.  High SEMA3A expression in pancreata of Stage IV M1 patients and in peritoneal metastases, and consequent functional studies indicated that poor clinical outcome might be related to the ability of SEMA3A to promote dissemination and invasiveness of pancreatic cancer cells through activation of multiple pathways involving Rac1, GSK3b or p42/p44 MAPK, but not E- to N-cadherin switch, MMP-9 or VEGF induction.  Thus, this study is the first to quantify expression of the SEMA3A system in human malignancy and to show that overexpression of SEMA3A by nerves and transformed cells leads to a SEMA3A-rich environment which may favor malignant activities of tumor cells.  Furthermore, negative clinicopathological correlations suggest that SEMA3A might represent a novel intervention target but not a treatment option for pancreatic cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8caCJH8JBWoJKJbLTgsvCfW6udTcc2eYALtMspzzHLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srosVKmsQ%253D%253D&md5=7cd49b071dd0d497083a152050f777dc</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fijc.22949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22949%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DM.%2BW.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26aulast%3DSwiercz%26aufirst%3DJ.%2BM.%26aulast%3DCeyhan%26aufirst%3DG.%2BO.%26aulast%3DEsposito%26aufirst%3DI.%26aulast%3DHinz%26aufirst%3DU.%26aulast%3DBuchler%26aufirst%3DP.%26aulast%3DGiese%26aufirst%3DT.%26aulast%3DBuchler%26aufirst%3DM.%2BW.%26aulast%3DOffermanns%26aufirst%3DS.%26aulast%3DFriess%26aufirst%3DH.%26atitle%3DAssociation%2520of%2520axon%2520guidance%2520factor%2520semaphorin%25203A%2520with%2520poor%2520outcome%2520in%2520pancreatic%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D121%26spage%3D2421%26epage%3D2433%26doi%3D10.1002%2Fijc.22949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gara, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganju, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yallapu, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span> <span> </span><span class="NLM_article-title">Slit/Robo pathway: a promising therapeutic target for cancer</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2014.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.drudis.2014.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25245168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Kgsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=156-164&author=R.+K.+Garaauthor=S.+Kumariauthor=A.+Ganjuauthor=M.+M.+Yallapuauthor=M.+Jaggiauthor=S.+C.+Chauhan&title=Slit%2FRobo+pathway%3A+a+promising+therapeutic+target+for+cancer&doi=10.1016%2Fj.drudis.2014.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Slit/Robo pathway: a promising therapeutic target for cancer</span></div><div class="casAuthors">Gara, Rishi K.; Kumari, Sonam; Ganju, Aditya; Yallapu, Murali M.; Jaggi, Meena; Chauhan, Subhash C.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">156-164</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Axon guidance mols., slit glycoprotein (Slit) and Roundabout receptor (Robo), have implications in the regulation of physiol. processes.  Recent studies indicate that Slit and Robo also have important roles in tumorigenesis, cancer progression and metastasis.  The Slit/Robo pathway can be considered a master regulator for multiple oncogenic signaling pathways.  Herein, we provide a comprehensive review on the role of these mols. and their assocd. signaling pathways in cancer progression and metastasis.  Overall, the current available data suggest that the Slit/Robo pathway could be a promising target for development of anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4w4gi37uqg7Vg90H21EOLACvtfcHk0liWWJ9CaEVDdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Kgsb3P&md5=202d17de6f0a26cc41a72832bde9034f</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DGara%26aufirst%3DR.%2BK.%26aulast%3DKumari%26aufirst%3DS.%26aulast%3DGanju%26aufirst%3DA.%26aulast%3DYallapu%26aufirst%3DM.%2BM.%26aulast%3DJaggi%26aufirst%3DM.%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26atitle%3DSlit%252FRobo%2520pathway%253A%2520a%2520promising%2520therapeutic%2520target%2520for%2520cancer%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26volume%3D20%26spage%3D156%26epage%3D164%26doi%3D10.1016%2Fj.drudis.2014.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuzillet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tijeras-Raballand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faivre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Gramont, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymond, E.</span></span> <span> </span><span class="NLM_article-title">Targeting cancer cell metabolism in pancreatic adenocarcinoma</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">16832</span>– <span class="NLM_lpage">16847</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.4160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.18632%2Foncotarget.4160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26164081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FitlGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=16832-16847&author=R.+Cohenauthor=C.+Neuzilletauthor=A.+Tijeras-Raballandauthor=S.+Faivreauthor=A.+de+Gramontauthor=E.+Raymond&title=Targeting+cancer+cell+metabolism+in+pancreatic+adenocarcinoma&doi=10.18632%2Foncotarget.4160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer cell metabolism in pancreatic adenocarcinoma</span></div><div class="casAuthors">Cohen Romain; Neuzillet Cindy; Neuzillet Cindy; Tijeras-Raballand Annemilai; Faivre Sandrine; Raymond Eric; de Gramont Armand</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">16832-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is expected to become the second leading cause of cancer death by 2030.  Current therapeutic options are limited, warranting an urgent need to explore innovative treatment strategies.  Due to specific microenvironment constraints including an extensive desmoplastic stroma reaction, PDAC faces major metabolic challenges, principally hypoxia and nutrient deprivation.  Their connection with oncogenic alterations such as KRAS mutations has brought metabolic reprogramming to the forefront of PDAC therapeutic research.  The Warburg effect, glutamine addiction, and autophagy stand as the most important adaptive metabolic mechanisms of cancer cells themselves, however metabolic reprogramming is also an important feature of the tumor microenvironment, having a major impact on epigenetic reprogramming and tumor cell interactions with its complex stroma.  We present a comprehensive overview of the main metabolic adaptations contributing to PDAC development and progression.  A review of current and future therapies targeting this range of metabolic pathways is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTP8U29TPTqVT0O18WR3iAofW6udTcc2eYAvjB6WUIqiLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FitlGmsA%253D%253D&md5=437cdeb04c31a56791786a19b8f68a81</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.4160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.4160%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DR.%26aulast%3DNeuzillet%26aufirst%3DC.%26aulast%3DTijeras-Raballand%26aufirst%3DA.%26aulast%3DFaivre%26aufirst%3DS.%26aulast%3Dde%2BGramont%26aufirst%3DA.%26aulast%3DRaymond%26aufirst%3DE.%26atitle%3DTargeting%2520cancer%2520cell%2520metabolism%2520in%2520pancreatic%2520adenocarcinoma%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D16832%26epage%3D16847%26doi%3D10.18632%2Foncotarget.4160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span> <span> </span><span class="NLM_article-title">Roles of Arf6 in cancer cell invasion, metastasis and proliferation</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2017.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.lfs.2017.06.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2017&pages=80-84&author=R.+Liauthor=C.+Pengauthor=X.+Zhangauthor=Y.+Wuauthor=S.+Panauthor=Y.+Xiao&title=Roles+of+Arf6+in+cancer+cell+invasion%2C+metastasis+and+proliferation&doi=10.1016%2Fj.lfs.2017.06.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2017.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2017.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DXiao%26aufirst%3DY.%26atitle%3DRoles%2520of%2520Arf6%2520in%2520cancer%2520cell%2520invasion%252C%2520metastasis%2520and%2520proliferation%26jtitle%3DLife%2520Sci.%26date%3D2017%26volume%3D182%26spage%3D80%26epage%3D84%26doi%3D10.1016%2Fj.lfs.2017.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.canlet.2016.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28025100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFKru77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2017&pages=303-311&author=C.+Liangauthor=Y.+Qinauthor=B.+Zhangauthor=S.+Jiauthor=S.+Shiauthor=W.+Xuauthor=J.+Liuauthor=J.+Xiangauthor=D.+Liangauthor=Q.+Huauthor=Q.+Niauthor=X.+Yuauthor=J.+Xu&title=ARF6%2C+induced+by+mutant+Kras%2C+promotes+proliferation+and+Warburg+effect+in+pancreatic+cancer&doi=10.1016%2Fj.canlet.2016.12.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer</span></div><div class="casAuthors">Liang, Chen; Qin, Yi; Zhang, Bo; Ji, Shunrong; Shi, Si; Xu, Wenyan; Liu, Jiang; Xiang, Jinfeng; Liang, Dingkong; Hu, Qiangsheng; Ni, Quanxing; Yu, Xianjun; Xu, Jin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">303-311</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Though significant progress has been made in the availability of diagnostic techniques and treatment strategies, pancreatic cancer remains a disease of high mortality rates.  Therefore, there is an urgent need for a better understanding of the mol. mechanisms that governs the oncogenesis and metastasis process of pancreatic cancer.  In our study, by using the Cancer Genome Atlas (TCGA) dataset anal., we demonstrated that the small guanosine triphosphatase (GTPase) ADP-ribosylation factor 6 (ARF6) serves as a biomarker for predicting prognosis of pancreatic cancer.  In vitro studies demonstrated that silencing ARF6 expression reduced cell proliferation and attenuated the Warburg effect.  Moreover, we obsd. that ARF6 was a downstream target of Kras/ERK signaling pathway, and the strong correlation of expression between Kras and ARF6 in the TCGA dataset further confirmed this observation.  Taken together, our novel findings suggest ARF6, a target of mutant Kras, may promote pancreatic cancer development by enhancing the Warburg effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogvsszmMLgUbVg90H21EOLACvtfcHk0liWWJ9CaEVDdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFKru77L&md5=93f8dc2861bdb5198e97f9e3018bcdb1</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DJi%26aufirst%3DS.%26aulast%3DShi%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DNi%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DARF6%252C%2520induced%2520by%2520mutant%2520Kras%252C%2520promotes%2520proliferation%2520and%2520Warburg%2520effect%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2017%26volume%3D388%26spage%3D303%26epage%3D311%26doi%3D10.1016%2Fj.canlet.2016.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chabu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span> <span> </span><span class="NLM_article-title">EGFR/ARF6 regulation of Hh signalling stimulates oncogenic Ras tumor overgrowth</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">14688</span>, <span class="refDoi"> DOI: 10.1038/ncomms14688</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fncomms14688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28281543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC1czltVSkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=14688&author=C.+Chabuauthor=D.+M.+Liauthor=T.+Xu&title=EGFR%2FARF6+regulation+of+Hh+signalling+stimulates+oncogenic+Ras+tumor+overgrowth&doi=10.1038%2Fncomms14688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR/ARF6 regulation of Hh signalling stimulates oncogenic Ras tumour overgrowth</span></div><div class="casAuthors">Chabu Chiswili; Li Da-Ming; Xu Tian; Xu Tian</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14688</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Multiple signalling events interact in cancer cells.  Oncogenic Ras cooperates with Egfr, which cannot be explained by the canonical signalling paradigm.  In turn, Egfr cooperates with Hedgehog signalling.  How oncogenic Ras elicits and integrates Egfr and Hedgehog signals to drive overgrowth remains unclear.  Using a Drosophila tumour model, we show that Egfr cooperates with oncogenic Ras via Arf6, which functions as a novel regulator of Hh signalling.  Oncogenic Ras induces the expression of Egfr ligands.  Egfr then signals through Arf6, which regulates Hh transport to promote Hh signalling.  Blocking any step of this signalling cascade inhibits Hh signalling and correspondingly suppresses the growth of both, fly and human cancer cells harbouring oncogenic Ras mutations.  These findings highlight a non-canonical Egfr signalling mechanism, centered on Arf6 as a novel regulator of Hh signalling.  This explains both, the puzzling requirement of Egfr in oncogenic Ras-mediated overgrowth and the cooperation between Egfr and Hedgehog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3y3tYCbMrhf_I8Jvzw4xCfW6udTcc2ebe2yTejTy0zrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czltVSkug%253D%253D&md5=103d948b1d1dade9cfe4a472bd25baff</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fncomms14688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms14688%26sid%3Dliteratum%253Aachs%26aulast%3DChabu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DD.%2BM.%26aulast%3DXu%26aufirst%3DT.%26atitle%3DEGFR%252FARF6%2520regulation%2520of%2520Hh%2520signalling%2520stimulates%2520oncogenic%2520Ras%2520tumor%2520overgrowth%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D14688%26doi%3D10.1038%2Fncomms14688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L. T.</span></span> <span> </span><span class="NLM_article-title">Down-regulation of GEP100 causes increase in E-cadherin levels and inhibits pancreatic cancer cell invasion</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e37854</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0037854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1371%2Fjournal.pone.0037854" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e37854&author=C.+G.+Xieauthor=S.+M.+Weiauthor=J.+M.+Chenauthor=X.+F.+Xuauthor=J.+T.+Caiauthor=Q.+Y.+Chenauthor=L.+T.+Jia&title=Down-regulation+of+GEP100+causes+increase+in+E-cadherin+levels+and+inhibits+pancreatic+cancer+cell+invasion&doi=10.1371%2Fjournal.pone.0037854"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0037854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0037854%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DC.%2BG.%26aulast%3DWei%26aufirst%3DS.%2BM.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DXu%26aufirst%3DX.%2BF.%26aulast%3DCai%26aufirst%3DJ.%2BT.%26aulast%3DChen%26aufirst%3DQ.%2BY.%26aulast%3DJia%26aufirst%3DL.%2BT.%26atitle%3DDown-regulation%2520of%2520GEP100%2520causes%2520increase%2520in%2520E-cadherin%2520levels%2520and%2520inhibits%2520pancreatic%2520cancer%2520cell%2520invasion%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De37854%26doi%3D10.1371%2Fjournal.pone.0037854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ying, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmelman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssiotis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher-Sananikone, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locasale, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coloff, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimaraes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hezel, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissleder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePinho, R. A.</span></span> <span> </span><span class="NLM_article-title">Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">670</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.01.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.cell.2012.01.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=22541435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Kjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=656-670&author=H.+Yingauthor=A.+C.+Kimmelmanauthor=C.+A.+Lyssiotisauthor=S.+Huaauthor=G.+C.+Chuauthor=E.+Fletcher-Sananikoneauthor=J.+W.+Locasaleauthor=J.+Sonauthor=H.+Zhangauthor=J.+L.+Coloffauthor=H.+Yanauthor=W.+Wangauthor=S.+Chenauthor=A.+Vialeauthor=H.+Zhengauthor=J.+H.+Paikauthor=C.+Limauthor=A.+R.+Guimaraesauthor=E.+S.+Martinauthor=J.+Changauthor=A.+F.+Hezelauthor=S.+R.+Perryauthor=J.+Huauthor=B.+Ganauthor=Y.+Xiaoauthor=J.+M.+Asaraauthor=R.+Weisslederauthor=Y.+A.+Wangauthor=L.+Chinauthor=L.+C.+Cantleyauthor=R.+A.+DePinho&title=Oncogenic+Kras+maintains+pancreatic+tumors+through+regulation+of+anabolic+glucose+metabolism&doi=10.1016%2Fj.cell.2012.01.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism</span></div><div class="casAuthors">Ying, Haoqiang; Kimmelman, Alec C.; Lyssiotis, Costas A.; Hua, Sujun; Chu, Gerald C.; Fletcher-Sananikone, Eliot; Locasale, Jason W.; Son, Jaekyoung; Zhang, Hailei; Coloff, Jonathan L.; Yan, Haiyan; Wang, Wei; Chen, Shujuan; Viale, Andrea; Zheng, Hongwu; Paik, Ji-hye; Lim, Carol; Guimaraes, Alexander R.; Martin, Eric S.; Chang, Jeffery; Hezel, Aram F.; Perry, Samuel R.; Hu, Jian; Gan, Boyi; Xiao, Yonghong; Asara, John M.; Weissleder, Ralph; Wang, Y. Alan; Chin, Lynda; Cantley, Lewis C.; DePinho, Ronald A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">656-670</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Tumor maintenance relies on continued activity of driver oncogenes, although their rate-limiting role is highly context dependent.  Oncogenic Kras mutation is the signature event in pancreatic ductal adenocarcinoma (PDAC), serving a crit. role in tumor initiation.  Here, an inducible KrasG12D-driven PDAC mouse model establishes that advanced PDAC remains strictly dependent on KrasG12D expression.  Transcriptome and metabolomic analyses indicate that KrasG12D serves a vital role in controlling tumor metab. through stimulation of glucose uptake and channeling of glucose intermediates into the hexosamine biosynthesis and pentose phosphate pathways (PPP).  These studies also reveal that oncogenic Kras promotes ribose biogenesis.  Unlike canonical models, we demonstrate that KrasG12D drives glycolysis intermediates into the nonoxidative PPP, thereby decoupling ribose biogenesis from NADP/NADPH-mediated redox control.  Together, this work provides in vivo mechanistic insights into how oncogenic Kras promotes metabolic reprogramming in native tumors and illuminates potential metabolic targets that can be exploited for therapeutic benefit in PDAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0n15htmLPUrVg90H21EOLACvtfcHk0ljkSEbJrAcMeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Kjs7k%253D&md5=c8474034804faf04fb8bd108dd958540</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.01.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.01.058%26sid%3Dliteratum%253Aachs%26aulast%3DYing%26aufirst%3DH.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26aulast%3DLyssiotis%26aufirst%3DC.%2BA.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DChu%26aufirst%3DG.%2BC.%26aulast%3DFletcher-Sananikone%26aufirst%3DE.%26aulast%3DLocasale%26aufirst%3DJ.%2BW.%26aulast%3DSon%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DColoff%26aufirst%3DJ.%2BL.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DPaik%26aufirst%3DJ.%2BH.%26aulast%3DLim%26aufirst%3DC.%26aulast%3DGuimaraes%26aufirst%3DA.%2BR.%26aulast%3DMartin%26aufirst%3DE.%2BS.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DHezel%26aufirst%3DA.%2BF.%26aulast%3DPerry%26aufirst%3DS.%2BR.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DGan%26aufirst%3DB.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DWeissleder%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%2BA.%26aulast%3DChin%26aufirst%3DL.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26atitle%3DOncogenic%2520Kras%2520maintains%2520pancreatic%2520tumors%2520through%2520regulation%2520of%2520anabolic%2520glucose%2520metabolism%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D656%26epage%3D670%26doi%3D10.1016%2Fj.cell.2012.01.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selwan, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finicle, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edinger, A. L.</span></span> <span> </span><span class="NLM_article-title">Attacking the supply wagons to starve cancer cells to death</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>590</i></span>,  <span class="NLM_fpage">885</span>– <span class="NLM_lpage">907</span>, <span class="refDoi"> DOI: 10.1002/1873-3468.12121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1002%2F1873-3468.12121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26938658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Krur%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=590&publication_year=2016&pages=885-907&author=E.+M.+Selwanauthor=B.+T.+Finicleauthor=S.+M.+Kimauthor=A.+L.+Edinger&title=Attacking+the+supply+wagons+to+starve+cancer+cells+to+death&doi=10.1002%2F1873-3468.12121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Attacking the supply wagons to starve cancer cells to death</span></div><div class="casAuthors">Selwan, Elizabeth M.; Finicle, Brendan T.; Kim, Seong M.; Edinger, Aimee L.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">590</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">885-907</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The constitutive anabolism of cancer cells not only supports proliferation but also addicts tumor cells to a steady influx of exogenous nutrients.  Limiting access to metabolic substrates could be an effective and selective means to block cancer growth.  In this review, we define the pathways by which cancer cells acquire the raw materials for anabolism, highlight the actionable proteins in each pathway, and discuss the status of therapeutic interventions that disrupt nutrient acquisition.  Crit. open questions to be answered before apical metabolic inhibitors can be successfully and safely deployed in the clinic are also outlined.  In summary, recent studies provide strong support that substrate limitation is a powerful therapeutic strategy to effectively, and safely, starve cancer cells to death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcJvTeNv_D8LVg90H21EOLACvtfcHk0ljkSEbJrAcMeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Krur%252FE&md5=6edb11a499a074c601be0749589a0525</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2F1873-3468.12121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1873-3468.12121%26sid%3Dliteratum%253Aachs%26aulast%3DSelwan%26aufirst%3DE.%2BM.%26aulast%3DFinicle%26aufirst%3DB.%2BT.%26aulast%3DKim%26aufirst%3DS.%2BM.%26aulast%3DEdinger%26aufirst%3DA.%2BL.%26atitle%3DAttacking%2520the%2520supply%2520wagons%2520to%2520starve%2520cancer%2520cells%2520to%2520death%26jtitle%3DFEBS%2520Lett.%26date%3D2016%26volume%3D590%26spage%3D885%26epage%3D907%26doi%3D10.1002%2F1873-3468.12121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scotti Buzhardt, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, N. R.</span></span> <span> </span><span class="NLM_article-title">Protein Kinase C Zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent mechanism</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e72061</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0072061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1371%2Fjournal.pone.0072061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e72061&author=A.+M.+Butlerauthor=M.+L.+Scotti+Buzhardtauthor=S.+Liauthor=K.+E.+Smithauthor=A.+P.+Fieldsauthor=N.+R.+Murray&title=Protein+Kinase+C+Zeta+regulates+human+pancreatic+cancer+cell+transformed+growth+and+invasion+through+a+STAT3-dependent+mechanism&doi=10.1371%2Fjournal.pone.0072061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0072061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0072061%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DA.%2BM.%26aulast%3DScotti%2BBuzhardt%26aufirst%3DM.%2BL.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DK.%2BE.%26aulast%3DFields%26aufirst%3DA.%2BP.%26aulast%3DMurray%26aufirst%3DN.%2BR.%26atitle%3DProtein%2520Kinase%2520C%2520Zeta%2520regulates%2520human%2520pancreatic%2520cancer%2520cell%2520transformed%2520growth%2520and%2520invasion%2520through%2520a%2520STAT3-dependent%2520mechanism%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De72061%26doi%3D10.1371%2Fjournal.pone.0072061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalari, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, A. P.</span></span> <span> </span><span class="NLM_article-title">Protein kinase Cι expression and oncogenic signaling mechanisms in cancer</span>. <i>J. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>226</i></span>,  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1002/jcp.22463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1002%2Fjcp.22463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=20945390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVaqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2011&pages=879-887&author=N.+R.+Murrayauthor=K.+R.+Kalariauthor=A.+P.+Fields&title=Protein+kinase+C%CE%B9+expression+and+oncogenic+signaling+mechanisms+in+cancer&doi=10.1002%2Fjcp.22463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase Cι expression and oncogenic signaling mechanisms in cancer</span></div><div class="casAuthors">Murray, Nicole R.; Kalari, Krishna R.; Fields, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">879-887</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Accumulating evidence demonstrates that PKCι is an oncogene and prognostic marker that is frequently targeted for genetic alteration in many major forms of human cancer.  Functional data demonstrate that PKCι is required for the transformed phenotype of lung, pancreatic, ovarian, prostate, colon, and brain cancer cells.  Future studies will be required to det. whether PKCι is also an oncogene in the many other cancer types that also overexpress PKCι.  Studies of PKCι using genetically defined models of tumorigenesis have revealed a crit. role for PKCι in multiple stages of tumorigenesis, including tumor initiation, progression, and metastasis.  Recent studies in a genetic model of lung adenocarcinoma suggest a role for PKCι in transformation of lung cancer stem cells.  These studies have important implications for the therapeutic use of aurothiomalate (ATM), a highly selective PKCι signaling inhibitor currently undergoing clin. evaluation.  Significant progress has been made in detg. the mol. mechanisms by which PKCι drives the transformed phenotype, particularly the central role played by the oncogenic PKCι-Par6 complex in transformed growth and invasion, and of several PKCι-dependent survival pathways in chemo-resistance.  Future studies will be required to det. the compn. and dynamics of the PKCι-Par6 complex, and the mechanisms by which oncogenic signaling through this complex is regulated.  Likewise, a better understanding of the crit. downstream effectors of PKCι in various human tumor types holds promise for identifying novel prognostic and surrogate markers of oncogenic PKCι activity that may be clin. useful in ongoing clin. trials of ATM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc4wV5OkXZLrVg90H21EOLACvtfcHk0liYE1OCQ4a2vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVaqu7s%253D&md5=4eb7859eda072eeda723b7daa4bcaf3c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fjcp.22463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.22463%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DN.%2BR.%26aulast%3DKalari%26aufirst%3DK.%2BR.%26aulast%3DFields%26aufirst%3DA.%2BP.%26atitle%3DProtein%2520kinase%2520C%25CE%25B9%2520expression%2520and%2520oncogenic%2520signaling%2520mechanisms%2520in%2520cancer%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2011%26volume%3D226%26spage%3D879%26epage%3D887%26doi%3D10.1002%2Fjcp.22463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubbi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donahue, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, M.</span></span> <span> </span><span class="NLM_article-title">Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0128814</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0128814</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1371%2Fjournal.pone.0128814" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0128814&author=M.+J.+Thompsonauthor=L.+Rubbiauthor=D.+W.+Dawsonauthor=T.+R.+Donahueauthor=M.+Pellegrini&title=Pancreatic+cancer+patient+survival+correlates+with+DNA+methylation+of+pancreas+development+genes&doi=10.1371%2Fjournal.pone.0128814"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0128814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0128814%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DM.%2BJ.%26aulast%3DRubbi%26aufirst%3DL.%26aulast%3DDawson%26aufirst%3DD.%2BW.%26aulast%3DDonahue%26aufirst%3DT.%2BR.%26aulast%3DPellegrini%26aufirst%3DM.%26atitle%3DPancreatic%2520cancer%2520patient%2520survival%2520correlates%2520with%2520DNA%2520methylation%2520of%2520pancreas%2520development%2520genes%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0128814%26doi%3D10.1371%2Fjournal.pone.0128814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muranen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selfors, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallegos, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coloff, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoreen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brugge, J. S.</span></span> <span> </span><span class="NLM_article-title">ERK and p38 MAPK activities determine sensitivity to PI3K/mTOR inhibition via regulation of MYC and YAP</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">7168</span>– <span class="NLM_lpage">7180</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-0155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1158%2F0008-5472.CAN-16-0155" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=7168-7180&author=T.+Muranenauthor=L.+M.+Selforsauthor=J.+Hwangauthor=L.+L.+Gallegosauthor=J.+L.+Coloffauthor=C.+C.+Thoreenauthor=S.+A.+Kangauthor=D.+M.+Sabatiniauthor=G.+B.+Millsauthor=J.+S.+Brugge&title=ERK+and+p38+MAPK+activities+determine+sensitivity+to+PI3K%2FmTOR+inhibition+via+regulation+of+MYC+and+YAP&doi=10.1158%2F0008-5472.CAN-16-0155"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-0155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-0155%26sid%3Dliteratum%253Aachs%26aulast%3DMuranen%26aufirst%3DT.%26aulast%3DSelfors%26aufirst%3DL.%2BM.%26aulast%3DHwang%26aufirst%3DJ.%26aulast%3DGallegos%26aufirst%3DL.%2BL.%26aulast%3DColoff%26aufirst%3DJ.%2BL.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DBrugge%26aufirst%3DJ.%2BS.%26atitle%3DERK%2520and%2520p38%2520MAPK%2520activities%2520determine%2520sensitivity%2520to%2520PI3K%252FmTOR%2520inhibition%2520via%2520regulation%2520of%2520MYC%2520and%2520YAP%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D7168%26epage%3D7180%26doi%3D10.1158%2F0008-5472.CAN-16-0155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ireland, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rainer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaranta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weyer-Czernilofsky, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engle, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Mancera, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coupland, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taktak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogenrieder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mielgo, A.</span></span> <span> </span><span class="NLM_article-title">Chemoresistance in pancreatic cancer is driven by stroma-derived insulin-like growth factors</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">6851</span>– <span class="NLM_lpage">6863</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-1201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1158%2F0008-5472.CAN-16-1201" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=6851-6863&author=L.+Irelandauthor=A.+Santosauthor=M.+S.+Ahmedauthor=C.+Rainerauthor=S.+R.+Nielsenauthor=V.+Quarantaauthor=U.+Weyer-Czernilofskyauthor=D.+D.+Engleauthor=P.+A.+Perez-Manceraauthor=S.+E.+Couplandauthor=A.+Taktakauthor=T.+Bogenriederauthor=D.+A.+Tuvesonauthor=F.+Campbellauthor=M.+C.+Schmidauthor=A.+Mielgo&title=Chemoresistance+in+pancreatic+cancer+is+driven+by+stroma-derived+insulin-like+growth+factors&doi=10.1158%2F0008-5472.CAN-16-1201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-1201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-1201%26sid%3Dliteratum%253Aachs%26aulast%3DIreland%26aufirst%3DL.%26aulast%3DSantos%26aufirst%3DA.%26aulast%3DAhmed%26aufirst%3DM.%2BS.%26aulast%3DRainer%26aufirst%3DC.%26aulast%3DNielsen%26aufirst%3DS.%2BR.%26aulast%3DQuaranta%26aufirst%3DV.%26aulast%3DWeyer-Czernilofsky%26aufirst%3DU.%26aulast%3DEngle%26aufirst%3DD.%2BD.%26aulast%3DPerez-Mancera%26aufirst%3DP.%2BA.%26aulast%3DCoupland%26aufirst%3DS.%2BE.%26aulast%3DTaktak%26aufirst%3DA.%26aulast%3DBogenrieder%26aufirst%3DT.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DCampbell%26aufirst%3DF.%26aulast%3DSchmid%26aufirst%3DM.%2BC.%26aulast%3DMielgo%26aufirst%3DA.%26atitle%3DChemoresistance%2520in%2520pancreatic%2520cancer%2520is%2520driven%2520by%2520stroma-derived%2520insulin-like%2520growth%2520factors%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D6851%26epage%3D6863%26doi%3D10.1158%2F0008-5472.CAN-16-1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourdoncle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulé, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosh, J. R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergny, J.-L.</span></span> <span> </span><span class="NLM_article-title">G-quadruplexes and helicases</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1989</span>– <span class="NLM_lpage">2006</span>, <span class="refDoi"> DOI: 10.1093/nar/gkw079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fnar%2Fgkw079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=26883636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Sqsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=1989-2006&author=O.+Mendozaauthor=A.+Bourdoncleauthor=J.-B.+Boul%C3%A9author=J.+R.+M.+Broshauthor=J.-L.+Mergny&title=G-quadruplexes+and+helicases&doi=10.1093%2Fnar%2Fgkw079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">G-quadruplexes and helicases</span></div><div class="casAuthors">Mendoza, Oscar; Bourdoncle, Anne; Boule, Jean-Baptiste; Brosh, Robert M., Jr.; Mergny, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1989-2006</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Guanine-rich DNA strands can fold in vitro into non-canonical DNA structures called G-quadruplexes.  These structures may be very stable under physiol. conditions.  Evidence suggests that G-quadruplex structures may act as 'knots' within genomic DNA, and it has been hypothesized that proteins may have evolved to remove these structures.  The first indication of how G-quadruplex structures could be unfolded enzymically came in the late 1990s with reports that some well-known duplex DNA helicases resolved these structures in vitro.  Since then, the no. of studies reporting G-quadruplex DNA unfolding by helicase enzymes has rapidly increased.  The present review aims to present a general overview of the helicase/G-quadruplex field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1DDktyH31aLVg90H21EOLACvtfcHk0lhdq_1tkeU8XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Sqsb7E&md5=0d424783aab817ee14c56597712477ba</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw079%26sid%3Dliteratum%253Aachs%26aulast%3DMendoza%26aufirst%3DO.%26aulast%3DBourdoncle%26aufirst%3DA.%26aulast%3DBoul%25C3%25A9%26aufirst%3DJ.-B.%26aulast%3DBrosh%26aufirst%3DJ.%2BR.%2BM.%26aulast%3DMergny%26aufirst%3DJ.-L.%26atitle%3DG-quadruplexes%2520and%2520helicases%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2016%26volume%3D44%26spage%3D1989%26epage%3D2006%26doi%3D10.1093%2Fnar%2Fgkw079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Day, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layer, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleary, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tivey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinzel, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izzo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doench, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, D. M.</span></span> <span> </span><span class="NLM_article-title">PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">15110</span>, <span class="refDoi"> DOI: 10.1038/ncomms15110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fncomms15110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=28447610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC1crhs1altA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=15110&author=T.+A.+Dayauthor=J.+V.+Layerauthor=J.+P.+Clearyauthor=S.+Guhaauthor=K.+E.+Stevensonauthor=T.+Tiveyauthor=S.+Kimauthor=A.+C.+Schinzelauthor=F.+Izzoauthor=J.+Doenchauthor=D.+E.+Rootauthor=W.+C.+Hahnauthor=B.+D.+Priceauthor=D.+M.+Weinstock&title=PARP3+is+a+promoter+of+chromosomal+rearrangements+and+limits+G4+DNA&doi=10.1038%2Fncomms15110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA</span></div><div class="casAuthors">Day Tovah A; Layer Jacob V; Cleary J Patrick; Guha Srijoy; Tivey Trevor; Kim Sunhee; Izzo Francesca; Hahn William C; Weinstock David M; Stevenson Kristen E; Schinzel Anna C; Izzo Francesca; Doench John; Root David E; Hahn William C; Weinstock David M; Price Brendan D</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15110</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chromosomal rearrangements are essential events in the pathogenesis of both malignant and nonmalignant disorders, yet the factors affecting their formation are incompletely understood.  Here we develop a zinc-finger nuclease translocation reporter and screen for factors that modulate rearrangements in human cells.  We identify UBC9 and RAD50 as suppressors and 53BP1, DDB1 and poly(ADP)ribose polymerase 3 (PARP3) as promoters of chromosomal rearrangements across human cell types.  We focus on PARP3 as it is dispensable for murine viability and has druggable catalytic activity.  We find that PARP3 regulates G quadruplex (G4) DNA in response to DNA damage, which suppresses repair by nonhomologous end-joining and homologous recombination.  Chemical stabilization of G4 DNA in PARP3(-/-) cells leads to widespread DNA double-strand breaks and synthetic lethality.  We propose a model in which PARP3 suppresses G4 DNA and facilitates DNA repair by multiple pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWVSsEBvxNcJQHPYJuLg8TfW6udTcc2eYAtApT9xlpVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crhs1altA%253D%253D&md5=e9258b6721793a2f2ff9e016649858b5</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fncomms15110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms15110%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DT.%2BA.%26aulast%3DLayer%26aufirst%3DJ.%2BV.%26aulast%3DCleary%26aufirst%3DJ.%2BP.%26aulast%3DGuha%26aufirst%3DS.%26aulast%3DStevenson%26aufirst%3DK.%2BE.%26aulast%3DTivey%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DIzzo%26aufirst%3DF.%26aulast%3DDoench%26aufirst%3DJ.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DPrice%26aufirst%3DB.%2BD.%26aulast%3DWeinstock%26aufirst%3DD.%2BM.%26atitle%3DPARP3%2520is%2520a%2520promoter%2520of%2520chromosomal%2520rearrangements%2520and%2520limits%2520G4%2520DNA%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D15110%26doi%3D10.1038%2Fncomms15110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collie, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Promontorio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampel, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, G. N.</span></span> <span> </span><span class="NLM_article-title">Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">2723</span>– <span class="NLM_lpage">2731</span>, <span class="refDoi"> DOI: 10.1021/ja2102423</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja2102423" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFahtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=2723-2731&author=G.+W.+Collieauthor=R.+Promontorioauthor=S.+M.+Hampelauthor=M.+Miccoauthor=S.+Neidleauthor=G.+N.+Parkinson&title=Structural+basis+for+telomeric+G-quadruplex+targeting+by+naphthalene+diimide+ligands&doi=10.1021%2Fja2102423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Telomeric G-Quadruplex Targeting by Naphthalene Diimide Ligands</span></div><div class="casAuthors">Collie, Gavin W.; Promontorio, Rossella; Hampel, Sonja M.; Micco, Marialuisa; Neidle, Stephen; Parkinson, Gary N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2723-2731</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The folding of the single-stranded 3' end of the human telomere into G-quadruplex arrangements inhibits the overhang from hybridizing with the RNA template of telomerase and halts telomere maintenance in cancer cells.  The ability to thermally stabilize human telomeric DNA as a four-stranded G-quadruplex structure by developing selective small mol. compds. is a therapeutic path to regulating telomerase activity and thereby selectively inhibit cancer cell growth.  The development of compds. with the necessary selectivity and affinity to target parallel-stranded G-quadruplex structures has proved particularly challenging to date, relying heavily upon limited structural data.  We report here on a structure-based approach to the design of quadruplex-binding ligands to enhance affinity and selectivity for human telomeric DNA.  Crystal structures have been detd. of complexes between a 22-mer intramol. human telomeric quadruplex and two potent tetra-substituted naphthalene diimide compds., functionalized with pos. charged N-methyl-piperazine side-chains.  These compds. promote parallel-stranded quadruplex topol., binding exclusively to the 3' surface of each quadruplex.  There are significant differences between the complexes in terms of ligand mobility and in the interactions with quadruplex grooves.  One of the two ligands is markedly less mobile in the crystal complex and is more quadruplex-stabilizing, forming multiple electrostatic/hydrogen bond contacts with quadruplex phosphate groups.  The data presented here provides a structural rationale for the biophys. (effects on quadruplex thermal stabilization) and biol. data (inhibition of proliferation in cancer cell lines and evidence of in vivo antitumor activity) on compds. in this series and, thus, for the concept of telomere targeting with DNA quadruplex-binding small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi4fBPG4FU0rVg90H21EOLACvtfcHk0lhdq_1tkeU8XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFahtA%253D%253D&md5=ccacb043644092d55fec3a75afeae0ad</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fja2102423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja2102423%26sid%3Dliteratum%253Aachs%26aulast%3DCollie%26aufirst%3DG.%2BW.%26aulast%3DPromontorio%26aufirst%3DR.%26aulast%3DHampel%26aufirst%3DS.%2BM.%26aulast%3DMicco%26aufirst%3DM.%26aulast%3DNeidle%26aufirst%3DS.%26aulast%3DParkinson%26aufirst%3DG.%2BN.%26atitle%3DStructural%2520basis%2520for%2520telomeric%2520G-quadruplex%2520targeting%2520by%2520naphthalene%2520diimide%2520ligands%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D2723%26epage%3D2731%26doi%3D10.1021%2Fja2102423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totrov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span> <span> </span><span class="NLM_article-title">ICFF: a new method to incorporate implicit flexibility into an internal coordinate force field</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">254</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1002/jcc.10091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1002%2Fjcc.10091" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=254-265&author=V.+Katritchauthor=M.+Totrovauthor=R.+Abagyan&title=ICFF%3A+a+new+method+to+incorporate+implicit+flexibility+into+an+internal+coordinate+force+field&doi=10.1002%2Fjcc.10091"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Fjcc.10091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.10091%26sid%3Dliteratum%253Aachs%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DTotrov%26aufirst%3DM.%26aulast%3DAbagyan%26aufirst%3DR.%26atitle%3DICFF%253A%2520a%2520new%2520method%2520to%2520incorporate%2520implicit%2520flexibility%2520into%2520an%2520internal%2520coordinate%2520force%2520field%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2003%26volume%3D24%26spage%3D254%26epage%3D265%26doi%3D10.1002%2Fjcc.10091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schultes, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guyen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuesta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4347</span>– <span class="NLM_lpage">4351</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.05.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.bmcl.2004.05.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=15261300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVWjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4347-4351&author=C.+M.+Schultesauthor=B.+Guyenauthor=J.+Cuestaauthor=S.+Neidle&title=Synthesis%2C+biophysical+and+biological+evaluation+of+3%2C6-bis-amidoacridines+with+extended+9-anilino+substituents+as+potent+G-quadruplex-binding+telomerase+inhibitors&doi=10.1016%2Fj.bmcl.2004.05.090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors</span></div><div class="casAuthors">Schultes, Christoph M.; Guyen, Berangere; Cuesta, Javier; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4347-4351</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Telomerase and telomere maintenance are emerging targets for the treatment of human cancers.  The authors report here on the targeting of the telomere-telomerase complex with a series of small mols. based on an acridine platform.  A series of 3,6-bisamidoacridines with extended 9-anilino sidechains were designed and synthesized as potential telomeric G-quadruplex DNA (G4) interacting compds.  G4-stabilization was assessed using a high-throughput FRET (fluorescence resonance energy transfer) assay and telomerase inhibition quantified by a modified TRAP (telomerase repeat amplification protocol) method.  Within the series, the compds. showed significant G4-stabilizing ability (ΔTm values of 25-36 °C at 1 μM concn.) and telomerase inhibition in the nanomolar region (telEC50 values of 80-318 nM).  Furthermore, a direct correlation between the FRET and TRAP assays was obsd., supporting the use of the rapid screening FRET assay for early assessment of potential G4-stabilizing telomerase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnphNjm-RlurVg90H21EOLACvtfcHk0lhmxk794TUpqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVWjtL8%253D&md5=eb7f18784e96c4154bd6ce9ac7c8a168</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.05.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.05.090%26sid%3Dliteratum%253Aachs%26aulast%3DSchultes%26aufirst%3DC.%2BM.%26aulast%3DGuyen%26aufirst%3DB.%26aulast%3DCuesta%26aufirst%3DJ.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DSynthesis%252C%2520biophysical%2520and%2520biological%2520evaluation%2520of%25203%252C6-bis-amidoacridines%2520with%2520extended%25209-anilino%2520substituents%2520as%2520potent%2520G-quadruplex-binding%2520telomerase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4347%26epage%3D4351%26doi%3D10.1016%2Fj.bmcl.2004.05.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roehrl, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G.</span></span> <span> </span><span class="NLM_article-title">A general framework for development and data analysis of competitive high-throughput screens for small-molecule inhibitors of protein-protein interactions by fluorescence polarization</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">16056</span>– <span class="NLM_lpage">16066</span>, <span class="refDoi"> DOI: 10.1021/bi048233g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi048233g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVaisrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=16056-16066&author=M.+H.+Roehrlauthor=J.+Y.+Wangauthor=G.+Wagner&title=A+general+framework+for+development+and+data+analysis+of+competitive+high-throughput+screens+for+small-molecule+inhibitors+of+protein-protein+interactions+by+fluorescence+polarization&doi=10.1021%2Fbi048233g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A General Framework for Development and Data Analysis of Competitive High-Throughput Screens for Small-Molecule Inhibitors of Protein-Protein Interactions by Fluorescence Polarization</span></div><div class="casAuthors">Roehrl, Michael H. A.; Wang, Julia Y.; Wagner, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">16056-16066</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Equil. binding expts. are widely used for the accurate characterization of binding and competitive binding behavior in biol. systems.  Modern high-throughput discovery efforts in chem. biol. rely heavily upon this principle.  Here, we derive exact anal. expressions for general competitive binding models which can also explain a commonly encountered phenomenon in these types of expts., anticooperative incomplete displacement.  We explore the effects of nonspecific binding behavior and parameter misestimation.  All expressions are derived in terms of total concns. detd. a priori.  We discuss a general framework for high-throughput screening assays based on fluorescence polarization and strategies for assay development, sensitivity regimes, data quality control, anal., and ranking.  Theor. findings are visualized by simulations using realistic parameter sets.  Our results are the basis for the discovery of small-mol. inhibitors of the protein-protein interaction between human calcineurin and NFAT transcription factors, as discussed in the subsequent paper (31).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQB9PNnipisbVg90H21EOLACvtfcHk0lhmxk794TUpqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVaisrzE&md5=e5d4d47155dae79903f09c083eb3ed80</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fbi048233g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi048233g%26sid%3Dliteratum%253Aachs%26aulast%3DRoehrl%26aufirst%3DM.%2BH.%26aulast%3DWang%26aufirst%3DJ.%2BY.%26aulast%3DWagner%26aufirst%3DG.%26atitle%3DA%2520general%2520framework%2520for%2520development%2520and%2520data%2520analysis%2520of%2520competitive%2520high-throughput%2520screens%2520for%2520small-molecule%2520inhibitors%2520of%2520protein-protein%2520interactions%2520by%2520fluorescence%2520polarization%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D16056%26epage%3D16066%26doi%3D10.1021%2Fbi048233g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultes, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuesta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuenca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratnam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanious, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">582</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.1021/jm050555a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050555a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=582-599&author=M.+J.+Mooreauthor=C.+M.+Schultesauthor=J.+Cuestaauthor=F.+Cuencaauthor=M.+Gunaratnamauthor=F.+A.+Taniousauthor=W.+D.+Wilsonauthor=S.+Neidle&title=Trisubstituted+acridines+as+G-quadruplex+telomere+targeting+agents.+Effects+of+extensions+of+the+3%2C6-+and+9-side+chains+on+quadruplex+binding%2C+telomerase+activity%2C+and+cell+proliferation&doi=10.1021%2Fjm050555a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm050555a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050555a%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DM.%2BJ.%26aulast%3DSchultes%26aufirst%3DC.%2BM.%26aulast%3DCuesta%26aufirst%3DJ.%26aulast%3DCuenca%26aufirst%3DF.%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DTanious%26aufirst%3DF.%2BA.%26aulast%3DWilson%26aufirst%3DW.%2BD.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DTrisubstituted%2520acridines%2520as%2520G-quadruplex%2520telomere%2520targeting%2520agents.%2520Effects%2520of%2520extensions%2520of%2520the%25203%252C6-%2520and%25209-side%2520chains%2520on%2520quadruplex%2520binding%252C%2520telomerase%2520activity%252C%2520and%2520cell%2520proliferation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D582%26epage%3D599%26doi%3D10.1021%2Fjm050555a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboagye, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balkwill, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balmain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruder, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Double, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farningham, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glennie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelland, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozer, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedge, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span> <span> </span><span class="NLM_article-title">Guidelines for the welfare and use of animals in cancer research</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">1555</span>– <span class="NLM_lpage">1577</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6605642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1038%2Fsj.bjc.6605642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=20502460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=1555-1577&author=P.+Workmanauthor=E.+O.+Aboagyeauthor=F.+Balkwillauthor=A.+Balmainauthor=G.+Bruderauthor=D.+J.+Chaplinauthor=J.+A.+Doubleauthor=J.+Everittauthor=D.+A.+Farninghamauthor=M.+J.+Glennieauthor=L.+R.+Kellandauthor=V.+Robinsonauthor=I.+J.+Stratfordauthor=G.+M.+Tozerauthor=S.+Watsonauthor=S.+R.+Wedgeauthor=S.+A.+Eccles&title=Guidelines+for+the+welfare+and+use+of+animals+in+cancer+research&doi=10.1038%2Fsj.bjc.6605642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Guidelines for the welfare and use of animals in cancer research</span></div><div class="casAuthors">Workman P; Aboagye E O; Balkwill F; Balmain A; Bruder G; Chaplin D J; Double J A; Everitt J; Farningham D A H; Glennie M J; Kelland L R; Robinson V; Stratford I J; Tozer G M; Watson S; Wedge S R; Eccles S A</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1555-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer.  Excellent standards of animal care are fully consistent with the conduct of high quality cancer research.  Here we provide updated guidelines on the welfare and use of animals in cancer research.  All experiments should incorporate the 3Rs: replacement, reduction and refinement.  Focusing on animal welfare, we present recommendations on all aspects of cancer research, including: study design, statistics and pilot studies; choice of tumour models (e.g., genetically engineered, orthotopic and metastatic); therapy (including drugs and radiation); imaging (covering techniques, anaesthesia and restraint); humane endpoints (including tumour burden and site); and publication of best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkVD7D529OLg5nADWVYHg1fW6udTcc2eaRNPhqGO-WVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D&md5=55f4c62e16fb1ebaa1f05d59caba3989</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605642%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAboagye%26aufirst%3DE.%2BO.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DBruder%26aufirst%3DG.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DDouble%26aufirst%3DJ.%2BA.%26aulast%3DEveritt%26aufirst%3DJ.%26aulast%3DFarningham%26aufirst%3DD.%2BA.%26aulast%3DGlennie%26aufirst%3DM.%2BJ.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DRobinson%26aufirst%3DV.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DS.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26atitle%3DGuidelines%2520for%2520the%2520welfare%2520and%2520use%2520of%2520animals%2520in%2520cancer%2520research%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2010%26volume%3D102%26spage%3D1555%26epage%3D1577%26doi%3D10.1038%2Fsj.bjc.6605642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hingorani, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Multani, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deramaudt, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rustgi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span> <span> </span><span class="NLM_article-title">Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2005.04.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1016%2Fj.ccr.2005.04.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=15894267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslyitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=469-483&author=S.+R.+Hingoraniauthor=L.+Wangauthor=A.+S.+Multaniauthor=C.+Combsauthor=T.+B.+Deramaudtauthor=R.+H.+Hrubanauthor=A.+K.+Rustgiauthor=S.+Changauthor=D.+A.+Tuveson&title=Trp53R172H+and+KrasG12D+cooperate+to+promote+chromosomal+instability+and+widely+metastatic+pancreatic+ductal+adenocarcinoma+in+mice&doi=10.1016%2Fj.ccr.2005.04.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice</span></div><div class="casAuthors">Hingorani, Sunil R.; Wang, Lifu; Multani, Asha S.; Combs, Chelsea; Deramaudt, Therese B.; Hruban, Ralph H.; Rustgi, Anil K.; Chang, Sandy; Tuveson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">469-483</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">To define the genetic requirements for pancreatic ductal adenocarcinoma (PDA), we have targeted concomitant endogenous expression of Trp53R172H and KrasG12D to the mouse pancreas, revealing the cooperative development of invasive and widely metastatic carcinoma that recapitulates the human disease.  The primary carcinomas and metastases demonstrate a high degree of genomic instability manifested by nonreciprocal translocations without obvious telomere erosion-hallmarks of human carcinomas not typically obsd. in mice.  No mutations were discovered in other cardinal tumor suppressor gene pathways, which, together with previous results, suggests that there are distinct genetic pathways to PDA with different biol. behaviors.  These findings have clear implications for understanding mechanisms of disease pathogenesis, and for the development of detection and targeted treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUqdYCBqe-vrVg90H21EOLACvtfcHk0limifT_ngxbZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslyitLk%253D&md5=fef745f04506e9e64bbc760a1d6f8cf6</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.04.023%26sid%3Dliteratum%253Aachs%26aulast%3DHingorani%26aufirst%3DS.%2BR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMultani%26aufirst%3DA.%2BS.%26aulast%3DCombs%26aufirst%3DC.%26aulast%3DDeramaudt%26aufirst%3DT.%2BB.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DRustgi%26aufirst%3DA.%2BK.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26atitle%3DTrp53R172H%2520and%2520KrasG12D%2520cooperate%2520to%2520promote%2520chromosomal%2520instability%2520and%2520widely%2520metastatic%2520pancreatic%2520ductal%2520adenocarcinoma%2520in%2520mice%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D469%26epage%3D483%26doi%3D10.1016%2Fj.ccr.2005.04.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M.</span></span> <span> </span><span class="NLM_article-title">Cutadapt removes adapter sequences from high-throughput sequencing reads</span>. <i>EMBnet J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.14806/ej.17.1.200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.14806%2Fej.17.1.200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=10-12&author=M.+Martin&title=Cutadapt+removes+adapter+sequences+from+high-throughput+sequencing+reads&doi=10.14806%2Fej.17.1.200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.14806%2Fej.17.1.200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14806%252Fej.17.1.200%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%26atitle%3DCutadapt%2520removes%2520adapter%2520sequences%2520from%2520high-throughput%2520sequencing%2520reads%26jtitle%3DEMBnet%2520J.%26date%3D2011%26volume%3D17%26spage%3D10%26epage%3D12%26doi%3D10.14806%2Fej.17.1.200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertea, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapnell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pimentel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salzberg, S. L.</span></span> <span> </span><span class="NLM_article-title">TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</span>. <i>Genome Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">R36</span>, <span class="refDoi"> DOI: 10.1186/gb-2013-14-4-r36</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1186%2Fgb-2013-14-4-r36" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=23618408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsVSiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=R36&author=D.+Kimauthor=G.+Perteaauthor=C.+Trapnellauthor=H.+Pimentelauthor=R.+Kelleyauthor=S.+L.+Salzberg&title=TopHat2%3A+accurate+alignment+of+transcriptomes+in+the+presence+of+insertions%2C+deletions+and+gene+fusions&doi=10.1186%2Fgb-2013-14-4-r36"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</span></div><div class="casAuthors">Kim, Daehwan; Pertea, Geo; Trapnell, Cole; Pimentel, Harold; Kelley, Ryan; Salzberg, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Genome Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">R36/1-R36/13, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">GNBLFW</span>;
        ISSN:<span class="NLM_cas:issn">1474-760X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">TopHat is a popular spliced aligner for RNA-sequence (RNA-seq) expts.  In this paper, we describe TopHat2, which incorporates many significant enhancements to TopHat.  TopHat2 can align reads of various lengths produced by the latest sequencing technologies, while allowing for variable-length indels with respect to the ref. genome.  In addn. to de novo spliced alignment, TopHat2 can align reads across fusion breaks, which can occur after genomic translocations.  TopHat2 combines the ability to identify novel splice sites with direct mapping to known transcripts, producing sensitive and accurate alignments, even for highly repetitive genomes or in the presence of pseudogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmnW26zCa-EbVg90H21EOLACvtfcHk0limifT_ngxbZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsVSiurc%253D&md5=49098da2937f29a5fba4b429c228c62c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1186%2Fgb-2013-14-4-r36&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2013-14-4-r36%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DPertea%26aufirst%3DG.%26aulast%3DTrapnell%26aufirst%3DC.%26aulast%3DPimentel%26aufirst%3DH.%26aulast%3DKelley%26aufirst%3DR.%26aulast%3DSalzberg%26aufirst%3DS.%2BL.%26atitle%3DTopHat2%253A%2520accurate%2520alignment%2520of%2520transcriptomes%2520in%2520the%2520presence%2520of%2520insertions%252C%2520deletions%2520and%2520gene%2520fusions%26jtitle%3DGenome%2520Biol.%26date%3D2013%26volume%3D14%26spage%3DR36%26doi%3D10.1186%2Fgb-2013-14-4-r36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anders, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyl, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, W.</span></span> <span> </span><span class="NLM_article-title">HTSeq--a Python framework to work with high-throughput sequencing data</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/btu638</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fbioinformatics%2Fbtu638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=25260700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Sjt7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2015&pages=166-169&author=S.+Andersauthor=P.+T.+Pylauthor=W.+Huber&title=HTSeq%2D%2Da+Python+framework+to+work+with+high-throughput+sequencing+data&doi=10.1093%2Fbioinformatics%2Fbtu638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">HTSeq-a Python framework to work with high-throughput sequencing data</span></div><div class="casAuthors">Anders, Simon; Pyl, Paul Theodor; Huber, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">166-169</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A large choice of tools exists for many std. tasks in the anal. of high-throughput sequencing (HTS) data.  However, once a project deviates from std. workflows, custom scripts are needed.  We present HTSeq, a Python library to facilitate the rapid development of such scripts.  HTSeq offers parsers for many common data formats in HTS projects, as well as classes to represent data, such as genomic coordinates, sequences, sequencing reads, alignments, gene model information and variant calls, and provides data structures that allow for querying via genomic coordinates.  We also present htseq-count, a tool developed with HTSeq that preprocesses RNA-Seq data for differential expression anal. by counting the overlap of reads with genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsu4Wqp0zRWLVg90H21EOLACvtfcHk0lib8LrYnxqCMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Sjt7vL&md5=d9724f89b67e37183ccafb7fa2a848a0</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtu638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtu638%26sid%3Dliteratum%253Aachs%26aulast%3DAnders%26aufirst%3DS.%26aulast%3DPyl%26aufirst%3DP.%2BT.%26aulast%3DHuber%26aufirst%3DW.%26atitle%3DHTSeq--a%2520Python%2520framework%2520to%2520work%2520with%2520high-throughput%2520sequencing%2520data%26jtitle%3DBioinformatics%26date%3D2015%26volume%3D31%26spage%3D166%26epage%3D169%26doi%3D10.1093%2Fbioinformatics%2Fbtu638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, G. K.</span></span> <span> </span><span class="NLM_article-title">edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/btp616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=10.1093%2Fbioinformatics%2Fbtp616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=19910308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1WlurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=139-140&author=M.+D.+Robinsonauthor=D.+J.+McCarthyauthor=G.+K.+Smyth&title=edgeR%3A+a+Bioconductor+package+for+differential+expression+analysis+of+digital+gene+expression+data&doi=10.1093%2Fbioinformatics%2Fbtp616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</span></div><div class="casAuthors">Robinson, Mark D.; McCarthy, Davis J.; Smyth, Gordon K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-140</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Summary: It is expected that emerging digital gene expression (DGE) technologies will overtake microarray technologies in the near future for many functional genomics applications.  One of the fundamental data anal. tasks, esp. for gene expression studies, involves detg. whether there is evidence that counts for a transcript or exon are significantly different across exptl. conditions. is a Bioconductor software package for examg. differential expression of replicated count data.  An overdispersed Poisson model is used to account for both biol. and tech. variability.  Empirical Bayes methods are used to moderate the degree of overdispersion across transcripts, improving the reliability of inference.  The methodol. can be used even with the most minimal levels of replication, provided at least one phenotype or exptl. condition is replicated.  The software may have other applications beyond sequencing data, such as proteome peptide count data.  Availability: The package is freely available under the LGPL license from the Bioconductor web site (http://bioconductor.org).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmhmmSWC6LvLVg90H21EOLACvtfcHk0lib8LrYnxqCMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1WlurvO&md5=dd0d34f80067c1d182651dab85d8beef</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtp616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtp616%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DM.%2BD.%26aulast%3DMcCarthy%26aufirst%3DD.%2BJ.%26aulast%3DSmyth%26aufirst%3DG.%2BK.%26atitle%3DedgeR%253A%2520a%2520Bioconductor%2520package%2520for%2520differential%2520expression%2520analysis%2520of%2520digital%2520gene%2520expression%2520data%26jtitle%3DBioinformatics%26date%3D2010%26volume%3D26%26spage%3D139%26epage%3D140%26doi%3D10.1093%2Fbioinformatics%2Fbtp616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UYH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UYH','PDB','3UYH'); return false;">PDB: 3UYH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KF1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KF1','PDB','1KF1'); return false;">PDB: 1KF1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2T5E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2T5E','PDB','2T5E'); return false;">PDB: 2T5E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DA3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DA3','PDB','4DA3'); return false;">PDB: 4DA3</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i35"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01781">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_78750"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01781">10.1021/acs.jmedchem.7b01781</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Supplementary figures and extended descriptions of the methodology and results of the RNA-seq experiments (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf">PDF</a>)</p></li><li><p class="inline">MIAPACA2 PANC1 degene PQs summary CM03 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_002.xlsx">XLSX</a>)</p></li><li><p class="inline">Common degene PQs summary CM03 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_003.xlsx">XLSX</a>)</p></li><li><p class="inline">PQs Box Whisker Plots statistics (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_004.xls">XLS</a>)</p></li><li><p class="inline">Degenes 300 nM gemcitabine (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_005.xls">XLS</a>)</p></li><li><p class="inline">KEGG pathway common degenes PQs summary CM03 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_006.xls">XLS</a>)</p></li><li><p class="inline">MIAPACA2 PANC1 KEGG pathway degenes summary CM03 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_007.xls">XLS</a>)</p></li><li><p class="inline">KEGG pathway degenes 300 nM gemcitabine (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_008.xlsx">XLSX</a>)</p></li><li><p class="inline">SMILES molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_009.csv">CSV</a>)</p></li><li><p class="inline">CM03 with human telomeric G4 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_010.pdb">PDB</a>)</p></li><li><p class="inline">MM41 with human telomeric G4 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_011.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_001.pdf">jm7b01781_si_001.pdf (2.97 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_002.xlsx">jm7b01781_si_002.xlsx (4.25 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_003.xlsx">jm7b01781_si_003.xlsx (3.62 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_004.xls">jm7b01781_si_004.xls (61.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_005.xls">jm7b01781_si_005.xls (15.75 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_006.xls">jm7b01781_si_006.xls (107.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_007.xls">jm7b01781_si_007.xls (161.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_008.xlsx">jm7b01781_si_008.xlsx (84.42 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_009.csv">jm7b01781_si_009.csv (0.34 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_010.pdb">jm7b01781_si_010.pdb (61.09 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01781/suppl_file/jm7b01781_si_011.pdb">jm7b01781_si_011.pdb (42.18 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01781&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-6%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01781%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01781" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a83bcce3e32a9","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
